STUDYID,USUBJID,SUBJID,SITEID,SAFFL,SAFFN,TRTSEQP,TRTSEQPN,TRTSEQA,TRTSEQAN,PART,PARTN,TRTP,TRTPN,TRTA,TRTAN,EGSEQ,EPOCH,ADT,ATM,ADTM,ADY,AVISIT,AVISITN,AVISITL,ATPT,ATPTN,APERIOD,APERIODC,PARAM,PARAMCD,ACAT,AVAL,AVALC,PCSCAT,PCSCATT,EGCOVAL1,ABLFL,BASE,BASEC,BASETYPE,CHG,TRTL,DTDY
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21252.0,47259.0,1836220059.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,45.0,45,,,,Y,45.0,45,EOT/ET/Followup,nan,NA,2018-03-09T13:07 (-14)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21266.0,31380.0,1837413780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,40.0,40,,,,Y,40.0,40,Period 1,nan,C,2018-03-23T08:43 (1)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21266.0,40380.0,1837422780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,40.0,40,,,,,40.0,40,Period 1,0.0,C,2018-03-23T11:13 (1)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,4.0,TREATMENT,21273.0,31380.0,1838018580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,45.0,45,,,,Y,45.0,45,Period 2,nan,A,2018-03-30T08:43 (8)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,5.0,TREATMENT,21273.0,40380.0,1838027580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,42.0,42,,,,,45.0,45,Period 2,-3.0,A,2018-03-30T11:13 (8)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21280.0,31380.0,1838623380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,42.0,42,,,,Y,42.0,42,Period 3,nan,B,2018-04-06T08:43 (15)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,7.0,TREATMENT,21280.0,40380.0,1838632380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,40.0,40,,,,,42.0,42,Period 3,-2.0,B,2018-04-06T11:13 (15)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,8.0,END OF TREATMENT,21281.0,39180.0,1838717580.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,46.0,46,,,,,45.0,45,EOT/ET/Followup,1.0,B,2018-04-07T10:53 (16)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21252.0,47259.0,1836220059.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-09T13:07 (-14)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21266.0,31380.0,1837413780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Abnormal, NCS,,,SINUS BRADYCARDIA,Y,nan,Abnormal, NCS,Period 1,nan,C,2018-03-23T08:43 (1)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,TREATMENT,21266.0,40380.0,1837422780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Abnormal, NCS,,,SINUS BRADYCARDIA,,nan,Abnormal, NCS,Period 1,nan,C,2018-03-23T11:13 (1)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,12.0,TREATMENT,21273.0,31380.0,1838018580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,Y,nan,Normal,Period 2,nan,A,2018-03-30T08:43 (8)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,13.0,TREATMENT,21273.0,40380.0,1838027580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Abnormal, NCS,,,SINUS BRADYCARDIA,,nan,Normal,Period 2,nan,A,2018-03-30T11:13 (8)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,14.0,TREATMENT,21280.0,31380.0,1838623380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Abnormal, NCS,,,SINUS BRADYCARDIA,Y,nan,Abnormal, NCS,Period 3,nan,B,2018-04-06T08:43 (15)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,15.0,TREATMENT,21280.0,40380.0,1838632380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Abnormal, NCS,,,SINUS BRADYCARDIA,,nan,Abnormal, NCS,Period 3,nan,B,2018-04-06T11:13 (15)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,16.0,END OF TREATMENT,21281.0,39180.0,1838717580.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,B,2018-04-07T10:53 (16)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21252.0,47259.0,1836220059.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,156.0,156,,,,Y,156.0,156,EOT/ET/Followup,nan,NA,2018-03-09T13:07 (-14)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21266.0,31380.0,1837413780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,156.0,156,,,,Y,156.0,156,Period 1,nan,C,2018-03-23T08:43 (1)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21266.0,40380.0,1837422780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,154.0,154,,,,,156.0,156,Period 1,-2.0,C,2018-03-23T11:13 (1)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,20.0,TREATMENT,21273.0,31380.0,1838018580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,156.0,156,,,,Y,156.0,156,Period 2,nan,A,2018-03-30T08:43 (8)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21.0,TREATMENT,21273.0,40380.0,1838027580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,147.0,147,,,,,156.0,156,Period 2,-9.0,A,2018-03-30T11:13 (8)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,22.0,TREATMENT,21280.0,31380.0,1838623380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,153.0,153,,,,Y,153.0,153,Period 3,nan,B,2018-04-06T08:43 (15)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,23.0,TREATMENT,21280.0,40380.0,1838632380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,147.0,147,,,,,153.0,153,Period 3,-6.0,B,2018-04-06T11:13 (15)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,24.0,END OF TREATMENT,21281.0,39180.0,1838717580.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,141.0,141,,,,,156.0,156,EOT/ET/Followup,-15.0,B,2018-04-07T10:53 (16)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21252.0,47259.0,1836220059.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,100.0,100,,,,Y,100.0,100,EOT/ET/Followup,nan,NA,2018-03-09T13:07 (-14)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,26.0,TREATMENT,21266.0,31380.0,1837413780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,100.0,100,,,,Y,100.0,100,Period 1,nan,C,2018-03-23T08:43 (1)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,27.0,TREATMENT,21266.0,40380.0,1837422780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,,100.0,100,Period 1,-1.0,C,2018-03-23T11:13 (1)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,28.0,TREATMENT,21273.0,31380.0,1838018580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,Y,99.0,99,Period 2,nan,A,2018-03-30T08:43 (8)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,TREATMENT,21273.0,40380.0,1838027580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,105.0,105,,,,,99.0,99,Period 2,6.0,A,2018-03-30T11:13 (8)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,30.0,TREATMENT,21280.0,31380.0,1838623380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,Y,97.0,97,Period 3,nan,B,2018-04-06T08:43 (15)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,31.0,TREATMENT,21280.0,40380.0,1838632380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,104.0,104,,,,,97.0,97,Period 3,7.0,B,2018-04-06T11:13 (15)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,32.0,END OF TREATMENT,21281.0,39180.0,1838717580.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,,100.0,100,EOT/ET/Followup,-1.0,B,2018-04-07T10:53 (16)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21252.0,47259.0,1836220059.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,424.0,424,,,,Y,424.0,424,EOT/ET/Followup,nan,NA,2018-03-09T13:07 (-14)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,34.0,TREATMENT,21266.0,31380.0,1837413780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,442.0,442,,,,Y,442.0,442,Period 1,nan,C,2018-03-23T08:43 (1)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,35.0,TREATMENT,21266.0,40380.0,1837422780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,445.0,445,,,,,442.0,442,Period 1,3.0,C,2018-03-23T11:13 (1)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,36.0,TREATMENT,21273.0,31380.0,1838018580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,433.0,433,,,,Y,433.0,433,Period 2,nan,A,2018-03-30T08:43 (8)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,37.0,TREATMENT,21273.0,40380.0,1838027580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,435.0,435,,,,,433.0,433,Period 2,2.0,A,2018-03-30T11:13 (8)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,38.0,TREATMENT,21280.0,31380.0,1838623380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,449.0,449,,,,Y,449.0,449,Period 3,nan,B,2018-04-06T08:43 (15)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,39.0,TREATMENT,21280.0,40380.0,1838632380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,443.0,443,,,,,449.0,449,Period 3,-6.0,B,2018-04-06T11:13 (15)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,40.0,END OF TREATMENT,21281.0,39180.0,1838717580.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,422.0,422,,,,,424.0,424,EOT/ET/Followup,-2.0,B,2018-04-07T10:53 (16)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21252.0,47259.0,1836220059.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,369.0,369,,,,Y,369.0,369,EOT/ET/Followup,nan,NA,2018-03-09T13:07 (-14)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,42.0,TREATMENT,21266.0,31380.0,1837413780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,362.0,362,,,,Y,362.0,362,Period 1,nan,C,2018-03-23T08:43 (1)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,43.0,TREATMENT,21266.0,40380.0,1837422780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,364.0,364,,,,,362.0,362,Period 1,2.0,C,2018-03-23T11:13 (1)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,44.0,TREATMENT,21273.0,31380.0,1838018580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,377.0,377,,,,Y,377.0,377,Period 2,nan,A,2018-03-30T08:43 (8)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,45.0,TREATMENT,21273.0,40380.0,1838027580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,367.0,367,,,,,377.0,377,Period 2,-10.0,A,2018-03-30T11:13 (8)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,46.0,TREATMENT,21280.0,31380.0,1838623380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,379.0,379,,,,Y,379.0,379,Period 3,nan,B,2018-04-06T08:43 (15)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,47.0,TREATMENT,21280.0,40380.0,1838632380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,365.0,365,,,,,379.0,379,Period 3,-14.0,B,2018-04-06T11:13 (15)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,48.0,END OF TREATMENT,21281.0,39180.0,1838717580.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,371.0,371,,,,,369.0,369,EOT/ET/Followup,2.0,B,2018-04-07T10:53 (16)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21252.0,47259.0,1836220059.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,386.0,386,,,,Y,386.0,386,EOT/ET/Followup,nan,NA,2018-03-09T13:07 (-14)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,50.0,TREATMENT,21266.0,31380.0,1837413780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,387.0,387,,,,Y,387.0,387,Period 1,nan,C,2018-03-23T08:43 (1)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,51.0,TREATMENT,21266.0,40380.0,1837422780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,389.0,389,,,,,387.0,387,Period 1,2.0,C,2018-03-23T11:13 (1)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,52.0,TREATMENT,21273.0,31380.0,1838018580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,394.0,394,,,,Y,394.0,394,Period 2,nan,A,2018-03-30T08:43 (8)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,53.0,TREATMENT,21273.0,40380.0,1838027580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,388.0,388,,,,,394.0,394,Period 2,-6.0,A,2018-03-30T11:13 (8)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,54.0,TREATMENT,21280.0,31380.0,1838623380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,401.0,401,,,,Y,401.0,401,Period 3,nan,B,2018-04-06T08:43 (15)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,55.0,TREATMENT,21280.0,40380.0,1838632380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,389.0,389,,,,,401.0,401,Period 3,-12.0,B,2018-04-06T11:13 (15)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,56.0,END OF TREATMENT,21281.0,39180.0,1838717580.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,387.0,387,,,,,386.0,386,EOT/ET/Followup,1.0,B,2018-04-07T10:53 (16)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21252.0,47259.0,1836220059.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,1319.0,1319,,,,Y,1319.0,1319,EOT/ET/Followup,nan,NA,2018-03-09T13:07 (-14)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,58.0,TREATMENT,21266.0,31380.0,1837413780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1486.0,1486,,,,Y,1486.0,1486,Period 1,nan,C,2018-03-23T08:43 (1)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,59.0,TREATMENT,21266.0,40380.0,1837422780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1488.0,1488,,,,,1486.0,1486,Period 1,2.0,C,2018-03-23T11:13 (1)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,60.0,TREATMENT,21273.0,31380.0,1838018580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1319.0,1319,,,,Y,1319.0,1319,Period 2,nan,A,2018-03-30T08:43 (8)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,61.0,TREATMENT,21273.0,40380.0,1838027580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1401.0,1401,,,,,1319.0,1319,Period 2,82.0,A,2018-03-30T11:13 (8)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,62.0,TREATMENT,21280.0,31380.0,1838623380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1401.0,1401,,,,Y,1401.0,1401,Period 3,nan,B,2018-04-06T08:43 (15)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,63.0,TREATMENT,21280.0,40380.0,1838632380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1472.0,1472,,,,,1401.0,1401,Period 3,71.0,B,2018-04-06T11:13 (15)
3110-103-002,3110-103-002.103001005,103001005,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,64.0,END OF TREATMENT,21281.0,39180.0,1838717580.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1287.0,1287,,,,,1319.0,1319,EOT/ET/Followup,-32.0,B,2018-04-07T10:53 (16)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21252.0,45990.0,1836218790.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,67.0,67,,,,Y,67.0,67,EOT/ET/Followup,nan,NA,2018-03-09T12:46 (-14)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21266.0,30975.0,1837413375.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,55.0,55,,,,Y,55.0,55,Period 1,nan,C,2018-03-23T08:36 (1)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21266.0,39960.0,1837422360.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,57.0,57,,,,,55.0,55,Period 1,2.0,C,2018-03-23T11:06 (1)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,END OF TREATMENT,21272.0,58320.0,1837959120.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,64.0,64,,,,,67.0,67,EOT/ET/Followup,-3.0,C,2018-03-29T16:12 (7)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,5.0,SCREENING,21252.0,45990.0,1836218790.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-09T12:46 (-14)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,6.0,TREATMENT,21266.0,30975.0,1837413375.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,C,2018-03-23T08:36 (1)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,TREATMENT,21266.0,39960.0,1837422360.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,C,2018-03-23T11:06 (1)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,END OF TREATMENT,21272.0,58320.0,1837959120.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,C,2018-03-29T16:12 (7)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21252.0,45990.0,1836218790.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,126.0,126,,,,Y,126.0,126,EOT/ET/Followup,nan,NA,2018-03-09T12:46 (-14)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21266.0,30975.0,1837413375.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,139.0,139,,,,Y,139.0,139,Period 1,nan,C,2018-03-23T08:36 (1)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,TREATMENT,21266.0,39960.0,1837422360.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,133.0,133,,,,,139.0,139,Period 1,-6.0,C,2018-03-23T11:06 (1)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,12.0,END OF TREATMENT,21272.0,58320.0,1837959120.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,127.0,127,,,,,126.0,126,EOT/ET/Followup,1.0,C,2018-03-29T16:12 (7)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21252.0,45990.0,1836218790.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,Y,98.0,98,EOT/ET/Followup,nan,NA,2018-03-09T12:46 (-14)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,14.0,TREATMENT,21266.0,30975.0,1837413375.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,Y,94.0,94,Period 1,nan,C,2018-03-23T08:36 (1)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,15.0,TREATMENT,21266.0,39960.0,1837422360.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,,94.0,94,Period 1,4.0,C,2018-03-23T11:06 (1)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,16.0,END OF TREATMENT,21272.0,58320.0,1837959120.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,101.0,101,,,,,98.0,98,EOT/ET/Followup,3.0,C,2018-03-29T16:12 (7)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21252.0,45990.0,1836218790.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,373.0,373,,,,Y,373.0,373,EOT/ET/Followup,nan,NA,2018-03-09T12:46 (-14)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21266.0,30975.0,1837413375.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,398.0,398,,,,Y,398.0,398,Period 1,nan,C,2018-03-23T08:36 (1)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21266.0,39960.0,1837422360.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,395.0,395,,,,,398.0,398,Period 1,-3.0,C,2018-03-23T11:06 (1)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,END OF TREATMENT,21272.0,58320.0,1837959120.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,384.0,384,,,,,373.0,373,EOT/ET/Followup,11.0,C,2018-03-29T16:12 (7)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,21.0,SCREENING,21252.0,45990.0,1836218790.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,395.0,395,,,,Y,395.0,395,EOT/ET/Followup,nan,NA,2018-03-09T12:46 (-14)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,TREATMENT,21266.0,30975.0,1837413375.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,383.0,383,,,,Y,383.0,383,Period 1,nan,C,2018-03-23T08:36 (1)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,23.0,TREATMENT,21266.0,39960.0,1837422360.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,387.0,387,,,,,383.0,383,Period 1,4.0,C,2018-03-23T11:06 (1)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,24.0,END OF TREATMENT,21272.0,58320.0,1837959120.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,397.0,397,,,,,395.0,395,EOT/ET/Followup,2.0,C,2018-03-29T16:12 (7)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21252.0,45990.0,1836218790.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,387.0,387,,,,Y,387.0,387,EOT/ET/Followup,nan,NA,2018-03-09T12:46 (-14)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,26.0,TREATMENT,21266.0,30975.0,1837413375.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,388.0,388,,,,Y,388.0,388,Period 1,nan,C,2018-03-23T08:36 (1)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,27.0,TREATMENT,21266.0,39960.0,1837422360.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,389.0,389,,,,,388.0,388,Period 1,1.0,C,2018-03-23T11:06 (1)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,28.0,END OF TREATMENT,21272.0,58320.0,1837959120.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,392.0,392,,,,,387.0,387,EOT/ET/Followup,5.0,C,2018-03-29T16:12 (7)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,29.0,SCREENING,21252.0,45990.0,1836218790.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,891.0,891,,,,Y,891.0,891,EOT/ET/Followup,nan,NA,2018-03-09T12:46 (-14)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,30.0,TREATMENT,21266.0,30975.0,1837413375.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1076.0,1076,,,,Y,1076.0,1076,Period 1,nan,C,2018-03-23T08:36 (1)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,31.0,TREATMENT,21266.0,39960.0,1837422360.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1041.0,1041,,,,,1076.0,1076,Period 1,-35.0,C,2018-03-23T11:06 (1)
3110-103-002,3110-103-002.103001007,103001007,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,32.0,END OF TREATMENT,21272.0,58320.0,1837959120.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,935.0,935,,,,,891.0,891,EOT/ET/Followup,44.0,C,2018-03-29T16:12 (7)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21252.0,46980.0,1836219780.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,46.0,46,,,,Y,46.0,46,EOT/ET/Followup,nan,NA,2018-03-09T13:03 (-14)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,2.0,TREATMENT,21266.0,31440.0,1837413840.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,48.0,48,,,,Y,48.0,48,Period 1,nan,A,2018-03-23T08:44 (1)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21266.0,40440.0,1837422840.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,46.0,46,,,,,48.0,48,Period 1,-2.0,A,2018-03-23T11:14 (1)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,TREATMENT,21273.0,31440.0,1838018640.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,48.0,48,,,,Y,48.0,48,Period 2,nan,C,2018-03-30T08:44 (8)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,5.0,TREATMENT,21273.0,40440.0,1838027640.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,50.0,50,,,,,48.0,48,Period 2,2.0,C,2018-03-30T11:14 (8)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21280.0,31440.0,1838623440.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,49.0,49,,,,Y,49.0,49,Period 3,nan,B,2018-04-06T08:44 (15)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,7.0,TREATMENT,21280.0,40440.0,1838632440.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,50.0,50,,,,,49.0,49,Period 3,1.0,B,2018-04-06T11:14 (15)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,8.0,END OF TREATMENT,21281.0,39240.0,1838717640.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,62.0,62,,,,,46.0,46,EOT/ET/Followup,16.0,B,2018-04-07T10:54 (16)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21252.0,46980.0,1836219780.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-09T13:03 (-14)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,10.0,TREATMENT,21266.0,31440.0,1837413840.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,Y,nan,Normal,Period 1,nan,A,2018-03-23T08:44 (1)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,11.0,TREATMENT,21266.0,40440.0,1837422840.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,,nan,Normal,Period 1,nan,A,2018-03-23T11:14 (1)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,12.0,TREATMENT,21273.0,31440.0,1838018640.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,Y,nan,Normal,Period 2,nan,C,2018-03-30T08:44 (8)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,13.0,TREATMENT,21273.0,40440.0,1838027640.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,C,2018-03-30T11:14 (8)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,14.0,TREATMENT,21280.0,31440.0,1838623440.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,Y,nan,Normal,Period 3,nan,B,2018-04-06T08:44 (15)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,15.0,TREATMENT,21280.0,40440.0,1838632440.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,B,2018-04-06T11:14 (15)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,16.0,END OF TREATMENT,21281.0,39240.0,1838717640.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,B,2018-04-07T10:54 (16)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21252.0,46980.0,1836219780.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,165.0,165,,,,Y,165.0,165,EOT/ET/Followup,nan,NA,2018-03-09T13:03 (-14)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,18.0,TREATMENT,21266.0,31440.0,1837413840.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,162.0,162,,,,Y,162.0,162,Period 1,nan,A,2018-03-23T08:44 (1)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,19.0,TREATMENT,21266.0,40440.0,1837422840.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,152.0,152,,,,,162.0,162,Period 1,-10.0,A,2018-03-23T11:14 (1)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,TREATMENT,21273.0,31440.0,1838018640.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,157.0,157,,,,Y,157.0,157,Period 2,nan,C,2018-03-30T08:44 (8)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21.0,TREATMENT,21273.0,40440.0,1838027640.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,152.0,152,,,,,157.0,157,Period 2,-5.0,C,2018-03-30T11:14 (8)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,22.0,TREATMENT,21280.0,31440.0,1838623440.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,153.0,153,,,,Y,153.0,153,Period 3,nan,B,2018-04-06T08:44 (15)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,23.0,TREATMENT,21280.0,40440.0,1838632440.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,157.0,157,,,,,153.0,153,Period 3,4.0,B,2018-04-06T11:14 (15)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,24.0,END OF TREATMENT,21281.0,39240.0,1838717640.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,148.0,148,,,,,165.0,165,EOT/ET/Followup,-17.0,B,2018-04-07T10:54 (16)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21252.0,46980.0,1836219780.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,105.0,105,,,,Y,105.0,105,EOT/ET/Followup,nan,NA,2018-03-09T13:03 (-14)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,26.0,TREATMENT,21266.0,31440.0,1837413840.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,Y,97.0,97,Period 1,nan,A,2018-03-23T08:44 (1)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,TREATMENT,21266.0,40440.0,1837422840.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,,97.0,97,Period 1,2.0,A,2018-03-23T11:14 (1)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,28.0,TREATMENT,21273.0,31440.0,1838018640.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,Y,97.0,97,Period 2,nan,C,2018-03-30T08:44 (8)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,29.0,TREATMENT,21273.0,40440.0,1838027640.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,,97.0,97,Period 2,2.0,C,2018-03-30T11:14 (8)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,30.0,TREATMENT,21280.0,31440.0,1838623440.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,Y,99.0,99,Period 3,nan,B,2018-04-06T08:44 (15)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,31.0,TREATMENT,21280.0,40440.0,1838632440.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,,99.0,99,Period 3,0.0,B,2018-04-06T11:14 (15)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,32.0,END OF TREATMENT,21281.0,39240.0,1838717640.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,,105.0,105,EOT/ET/Followup,-7.0,B,2018-04-07T10:54 (16)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21252.0,46980.0,1836219780.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,444.0,444,,,,Y,444.0,444,EOT/ET/Followup,nan,NA,2018-03-09T13:03 (-14)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,34.0,TREATMENT,21266.0,31440.0,1837413840.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,452.0,452,,,,Y,452.0,452,Period 1,nan,A,2018-03-23T08:44 (1)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,35.0,TREATMENT,21266.0,40440.0,1837422840.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,442.0,442,,,,,452.0,452,Period 1,-10.0,A,2018-03-23T11:14 (1)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,36.0,TREATMENT,21273.0,31440.0,1838018640.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,461.0,461,,,,Y,461.0,461,Period 2,nan,C,2018-03-30T08:44 (8)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,37.0,TREATMENT,21273.0,40440.0,1838027640.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,448.0,448,,,,,461.0,461,Period 2,-13.0,C,2018-03-30T11:14 (8)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,38.0,TREATMENT,21280.0,31440.0,1838623440.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,428.0,428,,,,Y,428.0,428,Period 3,nan,B,2018-04-06T08:44 (15)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,39.0,TREATMENT,21280.0,40440.0,1838632440.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,425.0,425,,,,,428.0,428,Period 3,-3.0,B,2018-04-06T11:14 (15)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,40.0,END OF TREATMENT,21281.0,39240.0,1838717640.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,407.0,407,,,,,444.0,444,EOT/ET/Followup,-37.0,B,2018-04-07T10:54 (16)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21252.0,46980.0,1836219780.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,389.0,389,,,,Y,389.0,389,EOT/ET/Followup,nan,NA,2018-03-09T13:03 (-14)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,42.0,TREATMENT,21266.0,31440.0,1837413840.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,405.0,405,,,,Y,405.0,405,Period 1,nan,A,2018-03-23T08:44 (1)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,43.0,TREATMENT,21266.0,40440.0,1837422840.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,390.0,390,,,,,405.0,405,Period 1,-15.0,A,2018-03-23T11:14 (1)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,44.0,TREATMENT,21273.0,31440.0,1838018640.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,414.0,414,,,,Y,414.0,414,Period 2,nan,C,2018-03-30T08:44 (8)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,45.0,TREATMENT,21273.0,40440.0,1838027640.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,409.0,409,,,,,414.0,414,Period 2,-5.0,C,2018-03-30T11:14 (8)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,46.0,TREATMENT,21280.0,31440.0,1838623440.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,387.0,387,,,,Y,387.0,387,Period 3,nan,B,2018-04-06T08:44 (15)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,47.0,TREATMENT,21280.0,40440.0,1838632440.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,389.0,389,,,,,387.0,387,Period 3,2.0,B,2018-04-06T11:14 (15)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,48.0,END OF TREATMENT,21281.0,39240.0,1838717640.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,414.0,414,,,,,389.0,389,EOT/ET/Followup,25.0,B,2018-04-07T10:54 (16)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21252.0,46980.0,1836219780.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,406.0,406,,,,Y,406.0,406,EOT/ET/Followup,nan,NA,2018-03-09T13:03 (-14)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,50.0,TREATMENT,21266.0,31440.0,1837413840.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,420.0,420,,,,Y,420.0,420,Period 1,nan,A,2018-03-23T08:44 (1)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,51.0,TREATMENT,21266.0,40440.0,1837422840.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,406.0,406,,,,,420.0,420,Period 1,-14.0,A,2018-03-23T11:14 (1)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,52.0,TREATMENT,21273.0,31440.0,1838018640.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,429.0,429,,,,Y,429.0,429,Period 2,nan,C,2018-03-30T08:44 (8)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,53.0,TREATMENT,21273.0,40440.0,1838027640.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,422.0,422,,,,,429.0,429,Period 2,-7.0,C,2018-03-30T11:14 (8)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,54.0,TREATMENT,21280.0,31440.0,1838623440.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,400.0,400,,,,Y,400.0,400,Period 3,nan,B,2018-04-06T08:44 (15)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,55.0,TREATMENT,21280.0,40440.0,1838632440.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,400.0,400,,,,,400.0,400,Period 3,0.0,B,2018-04-06T11:14 (15)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,56.0,END OF TREATMENT,21281.0,39240.0,1838717640.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,412.0,412,,,,,406.0,406,EOT/ET/Followup,6.0,B,2018-04-07T10:54 (16)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21252.0,46980.0,1836219780.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,1300.0,1300,,,,Y,1300.0,1300,EOT/ET/Followup,nan,NA,2018-03-09T13:03 (-14)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,58.0,TREATMENT,21266.0,31440.0,1837413840.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1243.0,1243,,,,Y,1243.0,1243,Period 1,nan,A,2018-03-23T08:44 (1)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,59.0,TREATMENT,21266.0,40440.0,1837422840.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1281.0,1281,,,,,1243.0,1243,Period 1,38.0,A,2018-03-23T11:14 (1)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,60.0,TREATMENT,21273.0,31440.0,1838018640.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1235.0,1235,,,,Y,1235.0,1235,Period 2,nan,C,2018-03-30T08:44 (8)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,61.0,TREATMENT,21273.0,40440.0,1838027640.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1194.0,1194,,,,,1235.0,1235,Period 2,-41.0,C,2018-03-30T11:14 (8)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,62.0,TREATMENT,21280.0,31440.0,1838623440.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1218.0,1218,,,,Y,1218.0,1218,Period 3,nan,B,2018-04-06T08:44 (15)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,63.0,TREATMENT,21280.0,40440.0,1838632440.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1193.0,1193,,,,,1218.0,1218,Period 3,-25.0,B,2018-04-06T11:14 (15)
3110-103-002,3110-103-002.103001008,103001008,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,64.0,END OF TREATMENT,21281.0,39240.0,1838717640.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,964.0,964,,,,,1300.0,1300,EOT/ET/Followup,-336.0,B,2018-04-07T10:54 (16)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21252.0,49985.0,1836222785.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,64.0,64,,,,Y,64.0,64,EOT/ET/Followup,nan,NA,2018-03-09T13:53 (-14)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,2.0,TREATMENT,21266.0,32460.0,1837414860.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,73.0,73,,,,Y,73.0,73,Period 1,nan,B,2018-03-23T09:01 (1)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,3.0,TREATMENT,21266.0,41472.0,1837423872.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,57.0,57,,,,,73.0,73,Period 1,-16.0,B,2018-03-23T11:31 (1)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,4.0,TREATMENT,21273.0,32460.0,1838019660.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,66.0,66,,,,Y,66.0,66,Period 2,nan,A,2018-03-30T09:01 (8)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,5.0,TREATMENT,21273.0,41460.0,1838028660.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,66.0,66,,,,,66.0,66,Period 2,0.0,A,2018-03-30T11:31 (8)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,6.0,TREATMENT,21280.0,32460.0,1838624460.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,68.0,68,,,,Y,68.0,68,Period 3,nan,C,2018-04-06T09:01 (15)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,TREATMENT,21280.0,41460.0,1838633460.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,63.0,63,,,,,68.0,68,Period 3,-5.0,C,2018-04-06T11:31 (15)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,END OF TREATMENT,21281.0,40260.0,1838718660.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,75.0,75,,,,,64.0,64,EOT/ET/Followup,11.0,C,2018-04-07T11:11 (16)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21252.0,49985.0,1836222785.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-09T13:53 (-14)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,10.0,TREATMENT,21266.0,32460.0,1837414860.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,B,2018-03-23T09:01 (1)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,11.0,TREATMENT,21266.0,41472.0,1837423872.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,B,2018-03-23T11:31 (1)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,12.0,TREATMENT,21273.0,32460.0,1838019660.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,A,2018-03-30T09:01 (8)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,13.0,TREATMENT,21273.0,41460.0,1838028660.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,A,2018-03-30T11:31 (8)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,14.0,TREATMENT,21280.0,32460.0,1838624460.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,C,2018-04-06T09:01 (15)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,15.0,TREATMENT,21280.0,41460.0,1838633460.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,C,2018-04-06T11:31 (15)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,16.0,END OF TREATMENT,21281.0,40260.0,1838718660.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,C,2018-04-07T11:11 (16)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21252.0,49985.0,1836222785.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,148.0,148,,,,Y,148.0,148,EOT/ET/Followup,nan,NA,2018-03-09T13:53 (-14)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,18.0,TREATMENT,21266.0,32460.0,1837414860.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,145.0,145,,,,Y,145.0,145,Period 1,nan,B,2018-03-23T09:01 (1)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21266.0,41472.0,1837423872.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,154.0,154,,,,,145.0,145,Period 1,9.0,B,2018-03-23T11:31 (1)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,20.0,TREATMENT,21273.0,32460.0,1838019660.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,131.0,131,,,,Y,131.0,131,Period 2,nan,A,2018-03-30T09:01 (8)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21.0,TREATMENT,21273.0,41460.0,1838028660.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,137.0,137,,,,,131.0,131,Period 2,6.0,A,2018-03-30T11:31 (8)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,TREATMENT,21280.0,32460.0,1838624460.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,137.0,137,,,,Y,137.0,137,Period 3,nan,C,2018-04-06T09:01 (15)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,23.0,TREATMENT,21280.0,41460.0,1838633460.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,138.0,138,,,,,137.0,137,Period 3,1.0,C,2018-04-06T11:31 (15)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,24.0,END OF TREATMENT,21281.0,40260.0,1838718660.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,148.0,148,,,,,148.0,148,EOT/ET/Followup,0.0,C,2018-04-07T11:11 (16)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21252.0,49985.0,1836222785.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,87.0,87,,,,Y,87.0,87,EOT/ET/Followup,nan,NA,2018-03-09T13:53 (-14)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,26.0,TREATMENT,21266.0,32460.0,1837414860.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,87.0,87,,,,Y,87.0,87,Period 1,nan,B,2018-03-23T09:01 (1)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,27.0,TREATMENT,21266.0,41472.0,1837423872.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,88.0,88,,,,,87.0,87,Period 1,1.0,B,2018-03-23T11:31 (1)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,28.0,TREATMENT,21273.0,32460.0,1838019660.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,87.0,87,,,,Y,87.0,87,Period 2,nan,A,2018-03-30T09:01 (8)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,TREATMENT,21273.0,41460.0,1838028660.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,88.0,88,,,,,87.0,87,Period 2,1.0,A,2018-03-30T11:31 (8)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,30.0,TREATMENT,21280.0,32460.0,1838624460.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,86.0,86,,,,Y,86.0,86,Period 3,nan,C,2018-04-06T09:01 (15)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,31.0,TREATMENT,21280.0,41460.0,1838633460.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,89.0,89,,,,,86.0,86,Period 3,3.0,C,2018-04-06T11:31 (15)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,32.0,END OF TREATMENT,21281.0,40260.0,1838718660.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,86.0,86,,,,,87.0,87,EOT/ET/Followup,-1.0,C,2018-04-07T11:11 (16)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21252.0,49985.0,1836222785.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,386.0,386,,,,Y,386.0,386,EOT/ET/Followup,nan,NA,2018-03-09T13:53 (-14)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21266.0,32460.0,1837414860.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,384.0,384,,,,Y,384.0,384,Period 1,nan,B,2018-03-23T09:01 (1)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,35.0,TREATMENT,21266.0,41472.0,1837423872.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,417.0,417,,,,,384.0,384,Period 1,33.0,B,2018-03-23T11:31 (1)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,36.0,TREATMENT,21273.0,32460.0,1838019660.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,388.0,388,,,,Y,388.0,388,Period 2,nan,A,2018-03-30T09:01 (8)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,37.0,TREATMENT,21273.0,41460.0,1838028660.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,388.0,388,,,,,388.0,388,Period 2,0.0,A,2018-03-30T11:31 (8)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,38.0,TREATMENT,21280.0,32460.0,1838624460.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,377.0,377,,,,Y,377.0,377,Period 3,nan,C,2018-04-06T09:01 (15)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,39.0,TREATMENT,21280.0,41460.0,1838633460.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,389.0,389,,,,,377.0,377,Period 3,12.0,C,2018-04-06T11:31 (15)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,40.0,END OF TREATMENT,21281.0,40260.0,1838718660.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,355.0,355,,,,,386.0,386,EOT/ET/Followup,-31.0,C,2018-04-07T11:11 (16)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21252.0,49985.0,1836222785.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,398.0,398,,,,Y,398.0,398,EOT/ET/Followup,nan,NA,2018-03-09T13:53 (-14)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,42.0,TREATMENT,21266.0,32460.0,1837414860.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,423.0,423,,,,Y,423.0,423,Period 1,nan,B,2018-03-23T09:01 (1)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,43.0,TREATMENT,21266.0,41472.0,1837423872.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,409.0,409,,,,,423.0,423,Period 1,-14.0,B,2018-03-23T11:31 (1)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,44.0,TREATMENT,21273.0,32460.0,1838019660.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,406.0,406,,,,Y,406.0,406,Period 2,nan,A,2018-03-30T09:01 (8)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,45.0,TREATMENT,21273.0,41460.0,1838028660.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,408.0,408,,,,,406.0,406,Period 2,2.0,A,2018-03-30T11:31 (8)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,46.0,TREATMENT,21280.0,32460.0,1838624460.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,402.0,402,,,,Y,402.0,402,Period 3,nan,C,2018-04-06T09:01 (15)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,47.0,TREATMENT,21280.0,41460.0,1838633460.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,399.0,399,,,,,402.0,402,Period 3,-3.0,C,2018-04-06T11:31 (15)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,48.0,END OF TREATMENT,21281.0,40260.0,1838718660.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,399.0,399,,,,,398.0,398,EOT/ET/Followup,1.0,C,2018-04-07T11:11 (16)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21252.0,49985.0,1836222785.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,394.0,394,,,,Y,394.0,394,EOT/ET/Followup,nan,NA,2018-03-09T13:53 (-14)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,50.0,TREATMENT,21266.0,32460.0,1837414860.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,410.0,410,,,,Y,410.0,410,Period 1,nan,B,2018-03-23T09:01 (1)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,51.0,TREATMENT,21266.0,41472.0,1837423872.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,412.0,412,,,,,410.0,410,Period 1,2.0,B,2018-03-23T11:31 (1)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,52.0,TREATMENT,21273.0,32460.0,1838019660.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,400.0,400,,,,Y,400.0,400,Period 2,nan,A,2018-03-30T09:01 (8)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,53.0,TREATMENT,21273.0,41460.0,1838028660.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,401.0,401,,,,,400.0,400,Period 2,1.0,A,2018-03-30T11:31 (8)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,54.0,TREATMENT,21280.0,32460.0,1838624460.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,393.0,393,,,,Y,393.0,393,Period 3,nan,C,2018-04-06T09:01 (15)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,55.0,TREATMENT,21280.0,41460.0,1838633460.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,395.0,395,,,,,393.0,393,Period 3,2.0,C,2018-04-06T11:31 (15)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,56.0,END OF TREATMENT,21281.0,40260.0,1838718660.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,383.0,383,,,,,394.0,394,EOT/ET/Followup,-11.0,C,2018-04-07T11:11 (16)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21252.0,49985.0,1836222785.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,937.0,937,,,,Y,937.0,937,EOT/ET/Followup,nan,NA,2018-03-09T13:53 (-14)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,58.0,TREATMENT,21266.0,32460.0,1837414860.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,821.0,821,,,,Y,821.0,821,Period 1,nan,B,2018-03-23T09:01 (1)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,59.0,TREATMENT,21266.0,41472.0,1837423872.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1035.0,1035,,,,,821.0,821,Period 1,214.0,B,2018-03-23T11:31 (1)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,60.0,TREATMENT,21273.0,32460.0,1838019660.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,909.0,909,,,,Y,909.0,909,Period 2,nan,A,2018-03-30T09:01 (8)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,61.0,TREATMENT,21273.0,41460.0,1838028660.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,901.0,901,,,,,909.0,909,Period 2,-8.0,A,2018-03-30T11:31 (8)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,62.0,TREATMENT,21280.0,32460.0,1838624460.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,878.0,878,,,,Y,878.0,878,Period 3,nan,C,2018-04-06T09:01 (15)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,63.0,TREATMENT,21280.0,41460.0,1838633460.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,950.0,950,,,,,878.0,878,Period 3,72.0,C,2018-04-06T11:31 (15)
3110-103-002,3110-103-002.103001009,103001009,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,64.0,END OF TREATMENT,21281.0,40260.0,1838718660.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,791.0,791,,,,,937.0,937,EOT/ET/Followup,-146.0,C,2018-04-07T11:11 (16)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21252.0,48900.0,1836221700.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,59.0,59,,,,Y,59.0,59,EOT/ET/Followup,nan,NA,2018-03-09T13:35 (-14)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,2.0,TREATMENT,21266.0,30420.0,1837412820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,53.0,53,,,,Y,53.0,53,Period 1,nan,A,2018-03-23T08:27 (1)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21266.0,39420.0,1837421820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,49.0,49,,,,,53.0,53,Period 1,-4.0,A,2018-03-23T10:57 (1)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,4.0,TREATMENT,21273.0,30420.0,1838017620.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,52.0,52,,,,Y,52.0,52,Period 2,nan,B,2018-03-30T08:27 (8)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21273.0,39420.0,1838026620.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,53.0,53,,,,,52.0,52,Period 2,1.0,B,2018-03-30T10:57 (8)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,6.0,TREATMENT,21280.0,30420.0,1838622420.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,51.0,51,,,,Y,51.0,51,Period 3,nan,C,2018-04-06T08:27 (15)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,TREATMENT,21280.0,39420.0,1838631420.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,53.0,53,,,,,51.0,51,Period 3,2.0,C,2018-04-06T10:57 (15)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,END OF TREATMENT,21281.0,38220.0,1838716620.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,54.0,54,,,,,59.0,59,EOT/ET/Followup,-5.0,C,2018-04-07T10:37 (16)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21252.0,48900.0,1836221700.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-09T13:35 (-14)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,10.0,TREATMENT,21266.0,30420.0,1837412820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,A,2018-03-23T08:27 (1)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,11.0,TREATMENT,21266.0,39420.0,1837421820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,,nan,Normal,Period 1,nan,A,2018-03-23T10:57 (1)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,12.0,TREATMENT,21273.0,30420.0,1838017620.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,B,2018-03-30T08:27 (8)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,13.0,TREATMENT,21273.0,39420.0,1838026620.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,B,2018-03-30T10:57 (8)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,14.0,TREATMENT,21280.0,30420.0,1838622420.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,C,2018-04-06T08:27 (15)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,15.0,TREATMENT,21280.0,39420.0,1838631420.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,C,2018-04-06T10:57 (15)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,16.0,END OF TREATMENT,21281.0,38220.0,1838716620.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,C,2018-04-07T10:37 (16)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21252.0,48900.0,1836221700.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,174.0,174,,,,Y,174.0,174,EOT/ET/Followup,nan,NA,2018-03-09T13:35 (-14)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,18.0,TREATMENT,21266.0,30420.0,1837412820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,171.0,171,,,,Y,171.0,171,Period 1,nan,A,2018-03-23T08:27 (1)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,19.0,TREATMENT,21266.0,39420.0,1837421820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,176.0,176,,,,,171.0,171,Period 1,5.0,A,2018-03-23T10:57 (1)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21273.0,30420.0,1838017620.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,172.0,172,,,,Y,172.0,172,Period 2,nan,B,2018-03-30T08:27 (8)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21.0,TREATMENT,21273.0,39420.0,1838026620.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,166.0,166,,,,,172.0,172,Period 2,-6.0,B,2018-03-30T10:57 (8)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,TREATMENT,21280.0,30420.0,1838622420.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,167.0,167,,,,Y,167.0,167,Period 3,nan,C,2018-04-06T08:27 (15)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,23.0,TREATMENT,21280.0,39420.0,1838631420.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,170.0,170,,,,,167.0,167,Period 3,3.0,C,2018-04-06T10:57 (15)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,24.0,END OF TREATMENT,21281.0,38220.0,1838716620.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,164.0,164,,,,,174.0,174,EOT/ET/Followup,-10.0,C,2018-04-07T10:37 (16)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21252.0,48900.0,1836221700.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,Y,99.0,99,EOT/ET/Followup,nan,NA,2018-03-09T13:35 (-14)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,26.0,TREATMENT,21266.0,30420.0,1837412820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,Y,98.0,98,Period 1,nan,A,2018-03-23T08:27 (1)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,TREATMENT,21266.0,39420.0,1837421820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,,98.0,98,Period 1,1.0,A,2018-03-23T10:57 (1)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,28.0,TREATMENT,21273.0,30420.0,1838017620.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,104.0,104,,,,Y,104.0,104,Period 2,nan,B,2018-03-30T08:27 (8)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,29.0,TREATMENT,21273.0,39420.0,1838026620.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,,104.0,104,Period 2,-5.0,B,2018-03-30T10:57 (8)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,30.0,TREATMENT,21280.0,30420.0,1838622420.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,Y,99.0,99,Period 3,nan,C,2018-04-06T08:27 (15)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,31.0,TREATMENT,21280.0,39420.0,1838631420.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,100.0,100,,,,,99.0,99,Period 3,1.0,C,2018-04-06T10:57 (15)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,32.0,END OF TREATMENT,21281.0,38220.0,1838716620.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,,99.0,99,EOT/ET/Followup,-1.0,C,2018-04-07T10:37 (16)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21252.0,48900.0,1836221700.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,419.0,419,,,,Y,419.0,419,EOT/ET/Followup,nan,NA,2018-03-09T13:35 (-14)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,34.0,TREATMENT,21266.0,30420.0,1837412820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,438.0,438,,,,Y,438.0,438,Period 1,nan,A,2018-03-23T08:27 (1)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,35.0,TREATMENT,21266.0,39420.0,1837421820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,448.0,448,,,,,438.0,438,Period 1,10.0,A,2018-03-23T10:57 (1)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,TREATMENT,21273.0,30420.0,1838017620.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,459.0,459,,,,Y,459.0,459,Period 2,nan,B,2018-03-30T08:27 (8)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,37.0,TREATMENT,21273.0,39420.0,1838026620.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,460.0,460,,,,,459.0,459,Period 2,1.0,B,2018-03-30T10:57 (8)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,38.0,TREATMENT,21280.0,30420.0,1838622420.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,460.0,460,,,,Y,460.0,460,Period 3,nan,C,2018-04-06T08:27 (15)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,39.0,TREATMENT,21280.0,39420.0,1838631420.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,442.0,442,,,,,460.0,460,Period 3,-18.0,C,2018-04-06T10:57 (15)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,40.0,END OF TREATMENT,21281.0,38220.0,1838716620.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,435.0,435,,,,,419.0,419,EOT/ET/Followup,16.0,C,2018-04-07T10:37 (16)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21252.0,48900.0,1836221700.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,416.0,416,,,,Y,416.0,416,EOT/ET/Followup,nan,NA,2018-03-09T13:35 (-14)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,42.0,TREATMENT,21266.0,30420.0,1837412820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,414.0,414,,,,Y,414.0,414,Period 1,nan,A,2018-03-23T08:27 (1)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,43.0,TREATMENT,21266.0,39420.0,1837421820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,406.0,406,,,,,414.0,414,Period 1,-8.0,A,2018-03-23T10:57 (1)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,44.0,TREATMENT,21273.0,30420.0,1838017620.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,430.0,430,,,,Y,430.0,430,Period 2,nan,B,2018-03-30T08:27 (8)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,45.0,TREATMENT,21273.0,39420.0,1838026620.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,433.0,433,,,,,430.0,430,Period 2,3.0,B,2018-03-30T10:57 (8)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,46.0,TREATMENT,21280.0,30420.0,1838622420.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,425.0,425,,,,Y,425.0,425,Period 3,nan,C,2018-04-06T08:27 (15)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,47.0,TREATMENT,21280.0,39420.0,1838631420.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,417.0,417,,,,,425.0,425,Period 3,-8.0,C,2018-04-06T10:57 (15)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,48.0,END OF TREATMENT,21281.0,38220.0,1838716620.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,414.0,414,,,,,416.0,416,EOT/ET/Followup,-2.0,C,2018-04-07T10:37 (16)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21252.0,48900.0,1836221700.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,417.0,417,,,,Y,417.0,417,EOT/ET/Followup,nan,NA,2018-03-09T13:35 (-14)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,50.0,TREATMENT,21266.0,30420.0,1837412820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,422.0,422,,,,Y,422.0,422,Period 1,nan,A,2018-03-23T08:27 (1)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,51.0,TREATMENT,21266.0,39420.0,1837421820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,420.0,420,,,,,422.0,422,Period 1,-2.0,A,2018-03-23T10:57 (1)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,52.0,TREATMENT,21273.0,30420.0,1838017620.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,439.0,439,,,,Y,439.0,439,Period 2,nan,B,2018-03-30T08:27 (8)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,53.0,TREATMENT,21273.0,39420.0,1838026620.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,442.0,442,,,,,439.0,439,Period 2,3.0,B,2018-03-30T10:57 (8)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,54.0,TREATMENT,21280.0,30420.0,1838622420.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,436.0,436,,,,Y,436.0,436,Period 3,nan,C,2018-04-06T08:27 (15)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,55.0,TREATMENT,21280.0,39420.0,1838631420.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,425.0,425,,,,,436.0,436,Period 3,-11.0,C,2018-04-06T10:57 (15)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,56.0,END OF TREATMENT,21281.0,38220.0,1838716620.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,421.0,421,,,,,417.0,417,EOT/ET/Followup,4.0,C,2018-04-07T10:37 (16)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21252.0,48900.0,1836221700.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,1010.0,1010,,,,Y,1010.0,1010,EOT/ET/Followup,nan,NA,2018-03-09T13:35 (-14)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,58.0,TREATMENT,21266.0,30420.0,1837412820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1118.0,1118,,,,Y,1118.0,1118,Period 1,nan,A,2018-03-23T08:27 (1)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,59.0,TREATMENT,21266.0,39420.0,1837421820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1213.0,1213,,,,,1118.0,1118,Period 1,95.0,A,2018-03-23T10:57 (1)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,60.0,TREATMENT,21273.0,30420.0,1838017620.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1136.0,1136,,,,Y,1136.0,1136,Period 2,nan,B,2018-03-30T08:27 (8)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,61.0,TREATMENT,21273.0,39420.0,1838026620.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1126.0,1126,,,,,1136.0,1136,Period 2,-10.0,B,2018-03-30T10:57 (8)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,62.0,TREATMENT,21280.0,30420.0,1838622420.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1171.0,1171,,,,Y,1171.0,1171,Period 3,nan,C,2018-04-06T08:27 (15)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,63.0,TREATMENT,21280.0,39420.0,1838631420.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1120.0,1120,,,,,1171.0,1171,Period 3,-51.0,C,2018-04-06T10:57 (15)
3110-103-002,3110-103-002.103001010,103001010,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,64.0,END OF TREATMENT,21281.0,38220.0,1838716620.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1103.0,1103,,,,,1010.0,1010,EOT/ET/Followup,93.0,C,2018-04-07T10:37 (16)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21252.0,52385.0,1836225185.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,63.0,63,,,,Y,63.0,63,EOT/ET/Followup,nan,NA,2018-03-09T14:33 (-14)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,2.0,TREATMENT,21266.0,30480.0,1837412880.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,55.0,55,,,,Y,55.0,55,Period 1,nan,A,2018-03-23T08:28 (1)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21266.0,39480.0,1837421880.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,57.0,57,,,,,55.0,55,Period 1,2.0,A,2018-03-23T10:58 (1)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,TREATMENT,21273.0,30480.0,1838017680.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,49.0,49,,,,Y,49.0,49,Period 2,nan,C,2018-03-30T08:28 (8)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,5.0,TREATMENT,21273.0,39480.0,1838026680.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,61.0,61,,,,,49.0,49,Period 2,12.0,C,2018-03-30T10:58 (8)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21280.0,30500.0,1838622500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,57.0,57,,,,Y,57.0,57,Period 3,nan,B,2018-04-06T08:28 (15)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,7.0,TREATMENT,21280.0,39480.0,1838631480.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,54.0,54,,,,,57.0,57,Period 3,-3.0,B,2018-04-06T10:58 (15)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,8.0,END OF TREATMENT,21281.0,38280.0,1838716680.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,61.0,61,,,,,63.0,63,EOT/ET/Followup,-2.0,B,2018-04-07T10:38 (16)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21252.0,52385.0,1836225185.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-09T14:33 (-14)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,10.0,TREATMENT,21266.0,30480.0,1837412880.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,A,2018-03-23T08:28 (1)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,11.0,TREATMENT,21266.0,39480.0,1837421880.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,A,2018-03-23T10:58 (1)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,12.0,TREATMENT,21273.0,30480.0,1838017680.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,Y,nan,Normal,Period 2,nan,C,2018-03-30T08:28 (8)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,13.0,TREATMENT,21273.0,39480.0,1838026680.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,C,2018-03-30T10:58 (8)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,14.0,TREATMENT,21280.0,30500.0,1838622500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,B,2018-04-06T08:28 (15)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,15.0,TREATMENT,21280.0,39480.0,1838631480.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,B,2018-04-06T10:58 (15)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,16.0,END OF TREATMENT,21281.0,38280.0,1838716680.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,B,2018-04-07T10:38 (16)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21252.0,52385.0,1836225185.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,165.0,165,,,,Y,165.0,165,EOT/ET/Followup,nan,NA,2018-03-09T14:33 (-14)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,18.0,TREATMENT,21266.0,30480.0,1837412880.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,172.0,172,,,,Y,172.0,172,Period 1,nan,A,2018-03-23T08:28 (1)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,19.0,TREATMENT,21266.0,39480.0,1837421880.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,166.0,166,,,,,172.0,172,Period 1,-6.0,A,2018-03-23T10:58 (1)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,TREATMENT,21273.0,30480.0,1838017680.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,164.0,164,,,,Y,164.0,164,Period 2,nan,C,2018-03-30T08:28 (8)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21.0,TREATMENT,21273.0,39480.0,1838026680.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,158.0,158,,,,,164.0,164,Period 2,-6.0,C,2018-03-30T10:58 (8)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,22.0,TREATMENT,21280.0,30500.0,1838622500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,164.0,164,,,,Y,164.0,164,Period 3,nan,B,2018-04-06T08:28 (15)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,23.0,TREATMENT,21280.0,39480.0,1838631480.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,163.0,163,,,,,164.0,164,Period 3,-1.0,B,2018-04-06T10:58 (15)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,24.0,END OF TREATMENT,21281.0,38280.0,1838716680.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,159.0,159,,,,,165.0,165,EOT/ET/Followup,-6.0,B,2018-04-07T10:38 (16)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21252.0,52385.0,1836225185.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,104.0,104,,,,Y,104.0,104,EOT/ET/Followup,nan,NA,2018-03-09T14:33 (-14)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,26.0,TREATMENT,21266.0,30480.0,1837412880.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,Y,99.0,99,Period 1,nan,A,2018-03-23T08:28 (1)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,TREATMENT,21266.0,39480.0,1837421880.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,,99.0,99,Period 1,-1.0,A,2018-03-23T10:58 (1)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,28.0,TREATMENT,21273.0,30480.0,1838017680.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,100.0,100,,,,Y,100.0,100,Period 2,nan,C,2018-03-30T08:28 (8)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,29.0,TREATMENT,21273.0,39480.0,1838026680.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,,100.0,100,Period 2,-1.0,C,2018-03-30T10:58 (8)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,30.0,TREATMENT,21280.0,30500.0,1838622500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,Y,99.0,99,Period 3,nan,B,2018-04-06T08:28 (15)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,31.0,TREATMENT,21280.0,39480.0,1838631480.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,,99.0,99,Period 3,0.0,B,2018-04-06T10:58 (15)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,32.0,END OF TREATMENT,21281.0,38280.0,1838716680.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,,104.0,104,EOT/ET/Followup,-5.0,B,2018-04-07T10:38 (16)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21252.0,52385.0,1836225185.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,426.0,426,,,,Y,426.0,426,EOT/ET/Followup,nan,NA,2018-03-09T14:33 (-14)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,34.0,TREATMENT,21266.0,30480.0,1837412880.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,442.0,442,,,,Y,442.0,442,Period 1,nan,A,2018-03-23T08:28 (1)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,35.0,TREATMENT,21266.0,39480.0,1837421880.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,429.0,429,,,,,442.0,442,Period 1,-13.0,A,2018-03-23T10:58 (1)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,36.0,TREATMENT,21273.0,30480.0,1838017680.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,460.0,460,,,,Y,460.0,460,Period 2,nan,C,2018-03-30T08:28 (8)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,37.0,TREATMENT,21273.0,39480.0,1838026680.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,444.0,444,,,,,460.0,460,Period 2,-16.0,C,2018-03-30T10:58 (8)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,38.0,TREATMENT,21280.0,30500.0,1838622500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,450.0,450,,,,Y,450.0,450,Period 3,nan,B,2018-04-06T08:28 (15)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,39.0,TREATMENT,21280.0,39480.0,1838631480.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,441.0,441,,,,,450.0,450,Period 3,-9.0,B,2018-04-06T10:58 (15)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,40.0,END OF TREATMENT,21281.0,38280.0,1838716680.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,428.0,428,,,,,426.0,426,EOT/ET/Followup,2.0,B,2018-04-07T10:38 (16)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21252.0,52385.0,1836225185.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,437.0,437,,,,Y,437.0,437,EOT/ET/Followup,nan,NA,2018-03-09T14:33 (-14)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,42.0,TREATMENT,21266.0,30480.0,1837412880.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,423.0,423,,,,Y,423.0,423,Period 1,nan,A,2018-03-23T08:28 (1)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,43.0,TREATMENT,21266.0,39480.0,1837421880.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,421.0,421,,,,,423.0,423,Period 1,-2.0,A,2018-03-23T10:58 (1)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,44.0,TREATMENT,21273.0,30480.0,1838017680.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,419.0,419,,,,Y,419.0,419,Period 2,nan,C,2018-03-30T08:28 (8)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,45.0,TREATMENT,21273.0,39480.0,1838026680.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,448.0,448,,,,,419.0,419,Period 2,29.0,C,2018-03-30T10:58 (8)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,46.0,TREATMENT,21280.0,30500.0,1838622500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,439.0,439,,,,Y,439.0,439,Period 3,nan,B,2018-04-06T08:28 (15)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,47.0,TREATMENT,21280.0,39480.0,1838631480.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,422.0,422,,,,,439.0,439,Period 3,-17.0,B,2018-04-06T10:58 (15)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,48.0,END OF TREATMENT,21281.0,38280.0,1838716680.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,432.0,432,,,,,437.0,437,EOT/ET/Followup,-5.0,B,2018-04-07T10:38 (16)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21252.0,52385.0,1836225185.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,433.0,433,,,,Y,433.0,433,EOT/ET/Followup,nan,NA,2018-03-09T14:33 (-14)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,50.0,TREATMENT,21266.0,30480.0,1837412880.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,429.0,429,,,,Y,429.0,429,Period 1,nan,A,2018-03-23T08:28 (1)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,51.0,TREATMENT,21266.0,39480.0,1837421880.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,423.0,423,,,,,429.0,429,Period 1,-6.0,A,2018-03-23T10:58 (1)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,52.0,TREATMENT,21273.0,30480.0,1838017680.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,432.0,432,,,,Y,432.0,432,Period 2,nan,C,2018-03-30T08:28 (8)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,53.0,TREATMENT,21273.0,39480.0,1838026680.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,447.0,447,,,,,432.0,432,Period 2,15.0,C,2018-03-30T10:58 (8)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,54.0,TREATMENT,21280.0,30500.0,1838622500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,443.0,443,,,,Y,443.0,443,Period 3,nan,B,2018-04-06T08:28 (15)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,55.0,TREATMENT,21280.0,39480.0,1838631480.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,428.0,428,,,,,443.0,443,Period 3,-15.0,B,2018-04-06T10:58 (15)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,56.0,END OF TREATMENT,21281.0,38280.0,1838716680.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,430.0,430,,,,,433.0,433,EOT/ET/Followup,-3.0,B,2018-04-07T10:38 (16)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21252.0,52385.0,1836225185.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,948.0,948,,,,Y,948.0,948,EOT/ET/Followup,nan,NA,2018-03-09T14:33 (-14)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,58.0,TREATMENT,21266.0,30480.0,1837412880.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1088.0,1088,,,,Y,1088.0,1088,Period 1,nan,A,2018-03-23T08:28 (1)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,59.0,TREATMENT,21266.0,39480.0,1837421880.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1036.0,1036,,,,,1088.0,1088,Period 1,-52.0,A,2018-03-23T10:58 (1)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,60.0,TREATMENT,21273.0,30480.0,1838017680.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1201.0,1201,,,,Y,1201.0,1201,Period 2,nan,C,2018-03-30T08:28 (8)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,61.0,TREATMENT,21273.0,39480.0,1838026680.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,980.0,980,,,,,1201.0,1201,Period 2,-221.0,C,2018-03-30T10:58 (8)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,62.0,TREATMENT,21280.0,30500.0,1838622500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1048.0,1048,,,,Y,1048.0,1048,Period 3,nan,B,2018-04-06T08:28 (15)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,63.0,TREATMENT,21280.0,39480.0,1838631480.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1092.0,1092,,,,,1048.0,1048,Period 3,44.0,B,2018-04-06T10:58 (15)
3110-103-002,3110-103-002.103001015,103001015,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,64.0,END OF TREATMENT,21281.0,38280.0,1838716680.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,981.0,981,,,,,948.0,948,EOT/ET/Followup,33.0,B,2018-04-07T10:38 (16)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21252.0,53190.0,1836225990.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,63.0,63,,,,Y,63.0,63,EOT/ET/Followup,nan,NA,2018-03-09T14:46 (-14)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,2.0,TREATMENT,21266.0,32520.0,1837414920.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,58.0,58,,,,Y,58.0,58,Period 1,nan,A,2018-03-23T09:02 (1)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21266.0,41520.0,1837423920.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,53.0,53,,,,,58.0,58,Period 1,-5.0,A,2018-03-23T11:32 (1)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,TREATMENT,21273.0,32520.0,1838019720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,64.0,64,,,,Y,64.0,64,Period 2,nan,C,2018-03-30T09:02 (8)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,5.0,TREATMENT,21273.0,41520.0,1838028720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,60.0,60,,,,,64.0,64,Period 2,-4.0,C,2018-03-30T11:32 (8)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21280.0,32520.0,1838624520.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,65.0,65,,,,Y,65.0,65,Period 3,nan,B,2018-04-06T09:02 (15)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,7.0,TREATMENT,21280.0,41520.0,1838633520.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,59.0,59,,,,,65.0,65,Period 3,-6.0,B,2018-04-06T11:32 (15)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,8.0,END OF TREATMENT,21281.0,40320.0,1838718720.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,60.0,60,,,,,63.0,63,EOT/ET/Followup,-3.0,B,2018-04-07T11:12 (16)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21252.0,53190.0,1836225990.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-09T14:46 (-14)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,10.0,TREATMENT,21266.0,32520.0,1837414920.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,A,2018-03-23T09:02 (1)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,11.0,TREATMENT,21266.0,41520.0,1837423920.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,,nan,Normal,Period 1,nan,A,2018-03-23T11:32 (1)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,12.0,TREATMENT,21273.0,32520.0,1838019720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,C,2018-03-30T09:02 (8)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,13.0,TREATMENT,21273.0,41520.0,1838028720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,C,2018-03-30T11:32 (8)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,14.0,TREATMENT,21280.0,32520.0,1838624520.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,B,2018-04-06T09:02 (15)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,15.0,TREATMENT,21280.0,41520.0,1838633520.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,B,2018-04-06T11:32 (15)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,16.0,END OF TREATMENT,21281.0,40320.0,1838718720.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,B,2018-04-07T11:12 (16)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21252.0,53190.0,1836225990.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,172.0,172,,,,Y,172.0,172,EOT/ET/Followup,nan,NA,2018-03-09T14:46 (-14)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,18.0,TREATMENT,21266.0,32520.0,1837414920.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,185.0,185,,,,Y,185.0,185,Period 1,nan,A,2018-03-23T09:02 (1)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,19.0,TREATMENT,21266.0,41520.0,1837423920.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,176.0,176,,,,,185.0,185,Period 1,-9.0,A,2018-03-23T11:32 (1)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,TREATMENT,21273.0,32520.0,1838019720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,166.0,166,,,,Y,166.0,166,Period 2,nan,C,2018-03-30T09:02 (8)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21.0,TREATMENT,21273.0,41520.0,1838028720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,171.0,171,,,,,166.0,166,Period 2,5.0,C,2018-03-30T11:32 (8)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,22.0,TREATMENT,21280.0,32520.0,1838624520.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,166.0,166,,,,Y,166.0,166,Period 3,nan,B,2018-04-06T09:02 (15)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,23.0,TREATMENT,21280.0,41520.0,1838633520.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,168.0,168,,,,,166.0,166,Period 3,2.0,B,2018-04-06T11:32 (15)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,24.0,END OF TREATMENT,21281.0,40320.0,1838718720.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,167.0,167,,,,,172.0,172,EOT/ET/Followup,-5.0,B,2018-04-07T11:12 (16)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21252.0,53190.0,1836225990.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,86.0,86,,,,Y,86.0,86,EOT/ET/Followup,nan,NA,2018-03-09T14:46 (-14)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,26.0,TREATMENT,21266.0,32520.0,1837414920.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,82.0,82,,,,Y,82.0,82,Period 1,nan,A,2018-03-23T09:02 (1)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,TREATMENT,21266.0,41520.0,1837423920.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,,82.0,82,Period 1,17.0,A,2018-03-23T11:32 (1)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,28.0,TREATMENT,21273.0,32520.0,1838019720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,87.0,87,,,,Y,87.0,87,Period 2,nan,C,2018-03-30T09:02 (8)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,29.0,TREATMENT,21273.0,41520.0,1838028720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,83.0,83,,,,,87.0,87,Period 2,-4.0,C,2018-03-30T11:32 (8)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,30.0,TREATMENT,21280.0,32520.0,1838624520.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,86.0,86,,,,Y,86.0,86,Period 3,nan,B,2018-04-06T09:02 (15)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,31.0,TREATMENT,21280.0,41520.0,1838633520.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,91.0,91,,,,,86.0,86,Period 3,5.0,B,2018-04-06T11:32 (15)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,32.0,END OF TREATMENT,21281.0,40320.0,1838718720.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,92.0,92,,,,,86.0,86,EOT/ET/Followup,6.0,B,2018-04-07T11:12 (16)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21252.0,53190.0,1836225990.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,417.0,417,,,,Y,417.0,417,EOT/ET/Followup,nan,NA,2018-03-09T14:46 (-14)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,34.0,TREATMENT,21266.0,32520.0,1837414920.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,444.0,444,,,,Y,444.0,444,Period 1,nan,A,2018-03-23T09:02 (1)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,35.0,TREATMENT,21266.0,41520.0,1837423920.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,443.0,443,,,,,444.0,444,Period 1,-1.0,A,2018-03-23T11:32 (1)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,36.0,TREATMENT,21273.0,32520.0,1838019720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,427.0,427,,,,Y,427.0,427,Period 2,nan,C,2018-03-30T09:02 (8)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,37.0,TREATMENT,21273.0,41520.0,1838028720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,429.0,429,,,,,427.0,427,Period 2,2.0,C,2018-03-30T11:32 (8)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,38.0,TREATMENT,21280.0,32520.0,1838624520.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,421.0,421,,,,Y,421.0,421,Period 3,nan,B,2018-04-06T09:02 (15)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,39.0,TREATMENT,21280.0,41520.0,1838633520.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,438.0,438,,,,,421.0,421,Period 3,17.0,B,2018-04-06T11:32 (15)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,40.0,END OF TREATMENT,21281.0,40320.0,1838718720.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,420.0,420,,,,,417.0,417,EOT/ET/Followup,3.0,B,2018-04-07T11:12 (16)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21252.0,53190.0,1836225990.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,427.0,427,,,,Y,427.0,427,EOT/ET/Followup,nan,NA,2018-03-09T14:46 (-14)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,42.0,TREATMENT,21266.0,32520.0,1837414920.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,437.0,437,,,,Y,437.0,437,Period 1,nan,A,2018-03-23T09:02 (1)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,43.0,TREATMENT,21266.0,41520.0,1837423920.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,419.0,419,,,,,437.0,437,Period 1,-18.0,A,2018-03-23T11:32 (1)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,44.0,TREATMENT,21273.0,32520.0,1838019720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,441.0,441,,,,Y,441.0,441,Period 2,nan,C,2018-03-30T09:02 (8)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,45.0,TREATMENT,21273.0,41520.0,1838028720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,430.0,430,,,,,441.0,441,Period 2,-11.0,C,2018-03-30T11:32 (8)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,46.0,TREATMENT,21280.0,32520.0,1838624520.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,440.0,440,,,,Y,440.0,440,Period 3,nan,B,2018-04-06T09:02 (15)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,47.0,TREATMENT,21280.0,41520.0,1838633520.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,436.0,436,,,,,440.0,440,Period 3,-4.0,B,2018-04-06T11:32 (15)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,48.0,END OF TREATMENT,21281.0,40320.0,1838718720.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,421.0,421,,,,,427.0,427,EOT/ET/Followup,-6.0,B,2018-04-07T11:12 (16)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21252.0,53190.0,1836225990.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,424.0,424,,,,Y,424.0,424,EOT/ET/Followup,nan,NA,2018-03-09T14:46 (-14)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,50.0,TREATMENT,21266.0,32520.0,1837414920.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,439.0,439,,,,Y,439.0,439,Period 1,nan,A,2018-03-23T09:02 (1)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,51.0,TREATMENT,21266.0,41520.0,1837423920.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,426.0,426,,,,,439.0,439,Period 1,-13.0,A,2018-03-23T11:32 (1)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,52.0,TREATMENT,21273.0,32520.0,1838019720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,436.0,436,,,,Y,436.0,436,Period 2,nan,C,2018-03-30T09:02 (8)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,53.0,TREATMENT,21273.0,41520.0,1838028720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,430.0,430,,,,,436.0,436,Period 2,-6.0,C,2018-03-30T11:32 (8)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,54.0,TREATMENT,21280.0,32520.0,1838624520.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,433.0,433,,,,Y,433.0,433,Period 3,nan,B,2018-04-06T09:02 (15)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,55.0,TREATMENT,21280.0,41520.0,1838633520.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,437.0,437,,,,,433.0,433,Period 3,4.0,B,2018-04-06T11:32 (15)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,56.0,END OF TREATMENT,21281.0,40320.0,1838718720.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,421.0,421,,,,,424.0,424,EOT/ET/Followup,-3.0,B,2018-04-07T11:12 (16)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21252.0,53190.0,1836225990.0,-14.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,951.0,951,,,,Y,951.0,951,EOT/ET/Followup,nan,NA,2018-03-09T14:46 (-14)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,58.0,TREATMENT,21266.0,32520.0,1837414920.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1028.0,1028,,,,Y,1028.0,1028,Period 1,nan,A,2018-03-23T09:02 (1)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,59.0,TREATMENT,21266.0,41520.0,1837423920.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1117.0,1117,,,,,1028.0,1028,Period 1,89.0,A,2018-03-23T11:32 (1)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,60.0,TREATMENT,21273.0,32520.0,1838019720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,936.0,936,,,,Y,936.0,936,Period 2,nan,C,2018-03-30T09:02 (8)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,61.0,TREATMENT,21273.0,41520.0,1838028720.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,993.0,993,,,,,936.0,936,Period 2,57.0,C,2018-03-30T11:32 (8)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,62.0,TREATMENT,21280.0,32520.0,1838624520.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,915.0,915,,,,Y,915.0,915,Period 3,nan,B,2018-04-06T09:02 (15)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,63.0,TREATMENT,21280.0,41520.0,1838633520.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1005.0,1005,,,,,915.0,915,Period 3,90.0,B,2018-04-06T11:32 (15)
3110-103-002,3110-103-002.103001022,103001022,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,64.0,END OF TREATMENT,21281.0,40320.0,1838718720.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,992.0,992,,,,,951.0,951,EOT/ET/Followup,41.0,B,2018-04-07T11:12 (16)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21255.0,51734.0,1836483734.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,70.0,70,,,,Y,70.0,70,EOT/ET/Followup,nan,NA,2018-03-12T14:22 (-11)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,2.0,TREATMENT,21266.0,31500.0,1837413900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,64.0,64,,,,Y,64.0,64,Period 1,nan,B,2018-03-23T08:45 (1)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,3.0,TREATMENT,21266.0,40500.0,1837422900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,66.0,66,,,,,64.0,64,Period 1,2.0,B,2018-03-23T11:15 (1)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,TREATMENT,21273.0,31500.0,1838018700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,76.0,76,,,,Y,76.0,76,Period 2,nan,C,2018-03-30T08:45 (8)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,5.0,TREATMENT,21273.0,40503.0,1838027703.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,66.0,66,,,,,76.0,76,Period 2,-10.0,C,2018-03-30T11:15 (8)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,6.0,TREATMENT,21280.0,31500.0,1838623500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,61.0,61,,,,Y,61.0,61,Period 3,nan,A,2018-04-06T08:45 (15)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,7.0,TREATMENT,21280.0,40530.0,1838632530.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,61.0,61,,,,,61.0,61,Period 3,0.0,A,2018-04-06T11:15 (15)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,8.0,END OF TREATMENT,21281.0,39300.0,1838717700.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,75.0,75,,,,,70.0,70,EOT/ET/Followup,5.0,A,2018-04-07T10:55 (16)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21255.0,51734.0,1836483734.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-12T14:22 (-11)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,10.0,TREATMENT,21266.0,31500.0,1837413900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,B,2018-03-23T08:45 (1)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,11.0,TREATMENT,21266.0,40500.0,1837422900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,B,2018-03-23T11:15 (1)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,12.0,TREATMENT,21273.0,31500.0,1838018700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,C,2018-03-30T08:45 (8)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,13.0,TREATMENT,21273.0,40503.0,1838027703.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,C,2018-03-30T11:15 (8)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,14.0,TREATMENT,21280.0,31500.0,1838623500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,A,2018-04-06T08:45 (15)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,15.0,TREATMENT,21280.0,40530.0,1838632530.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,A,2018-04-06T11:15 (15)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,16.0,END OF TREATMENT,21281.0,39300.0,1838717700.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,A,2018-04-07T10:55 (16)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21255.0,51734.0,1836483734.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,162.0,162,,,,Y,162.0,162,EOT/ET/Followup,nan,NA,2018-03-12T14:22 (-11)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,18.0,TREATMENT,21266.0,31500.0,1837413900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,159.0,159,,,,Y,159.0,159,Period 1,nan,B,2018-03-23T08:45 (1)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21266.0,40500.0,1837422900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,153.0,153,,,,,159.0,159,Period 1,-6.0,B,2018-03-23T11:15 (1)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,TREATMENT,21273.0,31500.0,1838018700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,165.0,165,,,,Y,165.0,165,Period 2,nan,C,2018-03-30T08:45 (8)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21.0,TREATMENT,21273.0,40503.0,1838027703.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,152.0,152,,,,,165.0,165,Period 2,-13.0,C,2018-03-30T11:15 (8)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,22.0,TREATMENT,21280.0,31500.0,1838623500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,161.0,161,,,,Y,161.0,161,Period 3,nan,A,2018-04-06T08:45 (15)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,23.0,TREATMENT,21280.0,40530.0,1838632530.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,160.0,160,,,,,161.0,161,Period 3,-1.0,A,2018-04-06T11:15 (15)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,24.0,END OF TREATMENT,21281.0,39300.0,1838717700.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,154.0,154,,,,,162.0,162,EOT/ET/Followup,-8.0,A,2018-04-07T10:55 (16)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21255.0,51734.0,1836483734.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,86.0,86,,,,Y,86.0,86,EOT/ET/Followup,nan,NA,2018-03-12T14:22 (-11)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,26.0,TREATMENT,21266.0,31500.0,1837413900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,85.0,85,,,,Y,85.0,85,Period 1,nan,B,2018-03-23T08:45 (1)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,27.0,TREATMENT,21266.0,40500.0,1837422900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,83.0,83,,,,,85.0,85,Period 1,-2.0,B,2018-03-23T11:15 (1)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,28.0,TREATMENT,21273.0,31500.0,1838018700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,83.0,83,,,,Y,83.0,83,Period 2,nan,C,2018-03-30T08:45 (8)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,29.0,TREATMENT,21273.0,40503.0,1838027703.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,81.0,81,,,,,83.0,83,Period 2,-2.0,C,2018-03-30T11:15 (8)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,30.0,TREATMENT,21280.0,31500.0,1838623500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,84.0,84,,,,Y,84.0,84,Period 3,nan,A,2018-04-06T08:45 (15)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,31.0,TREATMENT,21280.0,40530.0,1838632530.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,88.0,88,,,,,84.0,84,Period 3,4.0,A,2018-04-06T11:15 (15)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,32.0,END OF TREATMENT,21281.0,39300.0,1838717700.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,81.0,81,,,,,86.0,86,EOT/ET/Followup,-5.0,A,2018-04-07T10:55 (16)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21255.0,51734.0,1836483734.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,398.0,398,,,,Y,398.0,398,EOT/ET/Followup,nan,NA,2018-03-12T14:22 (-11)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21266.0,31500.0,1837413900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,393.0,393,,,,Y,393.0,393,Period 1,nan,B,2018-03-23T08:45 (1)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,35.0,TREATMENT,21266.0,40500.0,1837422900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,386.0,386,,,,,393.0,393,Period 1,-7.0,B,2018-03-23T11:15 (1)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,36.0,TREATMENT,21273.0,31500.0,1838018700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,379.0,379,,,,Y,379.0,379,Period 2,nan,C,2018-03-30T08:45 (8)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,37.0,TREATMENT,21273.0,40503.0,1838027703.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,383.0,383,,,,,379.0,379,Period 2,4.0,C,2018-03-30T11:15 (8)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,38.0,TREATMENT,21280.0,31500.0,1838623500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,415.0,415,,,,Y,415.0,415,Period 3,nan,A,2018-04-06T08:45 (15)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,39.0,TREATMENT,21280.0,40530.0,1838632530.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,383.0,383,,,,,415.0,415,Period 3,-32.0,A,2018-04-06T11:15 (15)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,40.0,END OF TREATMENT,21281.0,39300.0,1838717700.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,371.0,371,,,,,398.0,398,EOT/ET/Followup,-27.0,A,2018-04-07T10:55 (16)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21255.0,51734.0,1836483734.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,431.0,431,,,,Y,431.0,431,EOT/ET/Followup,nan,NA,2018-03-12T14:22 (-11)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,42.0,TREATMENT,21266.0,31500.0,1837413900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,406.0,406,,,,Y,406.0,406,Period 1,nan,B,2018-03-23T08:45 (1)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,43.0,TREATMENT,21266.0,40500.0,1837422900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,405.0,405,,,,,406.0,406,Period 1,-1.0,B,2018-03-23T11:15 (1)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,44.0,TREATMENT,21273.0,31500.0,1838018700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,427.0,427,,,,Y,427.0,427,Period 2,nan,C,2018-03-30T08:45 (8)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,45.0,TREATMENT,21273.0,40503.0,1838027703.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,401.0,401,,,,,427.0,427,Period 2,-26.0,C,2018-03-30T11:15 (8)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,46.0,TREATMENT,21280.0,31500.0,1838623500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,421.0,421,,,,Y,421.0,421,Period 3,nan,A,2018-04-06T08:45 (15)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,47.0,TREATMENT,21280.0,40530.0,1838632530.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,388.0,388,,,,,421.0,421,Period 3,-33.0,A,2018-04-06T11:15 (15)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,48.0,END OF TREATMENT,21281.0,39300.0,1838717700.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,415.0,415,,,,,431.0,431,EOT/ET/Followup,-16.0,A,2018-04-07T10:55 (16)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21255.0,51734.0,1836483734.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,420.0,420,,,,Y,420.0,420,EOT/ET/Followup,nan,NA,2018-03-12T14:22 (-11)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,50.0,TREATMENT,21266.0,31500.0,1837413900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,402.0,402,,,,Y,402.0,402,Period 1,nan,B,2018-03-23T08:45 (1)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,51.0,TREATMENT,21266.0,40500.0,1837422900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,399.0,399,,,,,402.0,402,Period 1,-3.0,B,2018-03-23T11:15 (1)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,52.0,TREATMENT,21273.0,31500.0,1838018700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,410.0,410,,,,Y,410.0,410,Period 2,nan,C,2018-03-30T08:45 (8)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,53.0,TREATMENT,21273.0,40503.0,1838027703.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,395.0,395,,,,,410.0,410,Period 2,-15.0,C,2018-03-30T11:15 (8)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,54.0,TREATMENT,21280.0,31500.0,1838623500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,419.0,419,,,,Y,419.0,419,Period 3,nan,A,2018-04-06T08:45 (15)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,55.0,TREATMENT,21280.0,40530.0,1838632530.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,386.0,386,,,,,419.0,419,Period 3,-33.0,A,2018-04-06T11:15 (15)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,56.0,END OF TREATMENT,21281.0,39300.0,1838717700.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,399.0,399,,,,,420.0,420,EOT/ET/Followup,-21.0,A,2018-04-07T10:55 (16)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21255.0,51734.0,1836483734.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,850.0,850,,,,Y,850.0,850,EOT/ET/Followup,nan,NA,2018-03-12T14:22 (-11)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,58.0,TREATMENT,21266.0,31500.0,1837413900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,934.0,934,,,,Y,934.0,934,Period 1,nan,B,2018-03-23T08:45 (1)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,59.0,TREATMENT,21266.0,40500.0,1837422900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,905.0,905,,,,,934.0,934,Period 1,-29.0,B,2018-03-23T11:15 (1)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,60.0,TREATMENT,21273.0,31500.0,1838018700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,785.0,785,,,,Y,785.0,785,Period 2,nan,C,2018-03-30T08:45 (8)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,61.0,TREATMENT,21273.0,40503.0,1838027703.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,909.0,909,,,,,785.0,785,Period 2,124.0,C,2018-03-30T11:15 (8)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,62.0,TREATMENT,21280.0,31500.0,1838623500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,968.0,968,,,,Y,968.0,968,Period 3,nan,A,2018-04-06T08:45 (15)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,63.0,TREATMENT,21280.0,40530.0,1838632530.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,974.0,974,,,,,968.0,968,Period 3,6.0,A,2018-04-06T11:15 (15)
3110-103-002,3110-103-002.103001031,103001031,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,64.0,END OF TREATMENT,21281.0,39300.0,1838717700.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,798.0,798,,,,,850.0,850,EOT/ET/Followup,-52.0,A,2018-04-07T10:55 (16)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21255.0,47658.0,1836479658.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,57.0,57,,,,Y,57.0,57,EOT/ET/Followup,nan,NA,2018-03-12T13:14 (-11)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,2.0,TREATMENT,21266.0,31560.0,1837413960.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,71.0,71,,,,Y,71.0,71,Period 1,nan,B,2018-03-23T08:46 (1)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,3.0,TREATMENT,21266.0,40560.0,1837422960.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,55.0,55,,,,,71.0,71,Period 1,-16.0,B,2018-03-23T11:16 (1)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,4.0,TREATMENT,21273.0,31560.0,1838018760.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,73.0,73,,,,Y,73.0,73,Period 2,nan,A,2018-03-30T08:46 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,5.0,TREATMENT,21273.0,40560.0,1838027760.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,53.0,53,,,,,73.0,73,Period 2,-20.0,A,2018-03-30T11:16 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,6.0,TREATMENT,21280.0,31560.0,1838623560.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,91.0,91,,,,Y,91.0,91,Period 3,nan,C,2018-04-06T08:46 (15)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,TREATMENT,21280.0,40560.0,1838632560.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,55.0,55,,,,,91.0,91,Period 3,-36.0,C,2018-04-06T11:16 (15)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,END OF TREATMENT,21281.0,39360.0,1838717760.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,60.0,60,,,,,57.0,57,EOT/ET/Followup,3.0,C,2018-04-07T10:56 (16)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21255.0,47658.0,1836479658.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-12T13:14 (-11)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,10.0,TREATMENT,21266.0,31560.0,1837413960.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,B,2018-03-23T08:46 (1)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,11.0,TREATMENT,21266.0,40560.0,1837422960.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,B,2018-03-23T11:16 (1)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,12.0,TREATMENT,21273.0,31560.0,1838018760.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,A,2018-03-30T08:46 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,13.0,TREATMENT,21273.0,40560.0,1838027760.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,A,2018-03-30T11:16 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,14.0,TREATMENT,21280.0,31560.0,1838623560.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,C,2018-04-06T08:46 (15)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,15.0,TREATMENT,21280.0,40560.0,1838632560.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,C,2018-04-06T11:16 (15)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,16.0,END OF TREATMENT,21281.0,39360.0,1838717760.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,C,2018-04-07T10:56 (16)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21255.0,47658.0,1836479658.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,149.0,149,,,,Y,149.0,149,EOT/ET/Followup,nan,NA,2018-03-12T13:14 (-11)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,18.0,TREATMENT,21266.0,31560.0,1837413960.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,149.0,149,,,,Y,149.0,149,Period 1,nan,B,2018-03-23T08:46 (1)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21266.0,40560.0,1837422960.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,143.0,143,,,,,149.0,149,Period 1,-6.0,B,2018-03-23T11:16 (1)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,20.0,TREATMENT,21273.0,31560.0,1838018760.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,137.0,137,,,,Y,137.0,137,Period 2,nan,A,2018-03-30T08:46 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21.0,TREATMENT,21273.0,40560.0,1838027760.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,157.0,157,,,,,137.0,137,Period 2,20.0,A,2018-03-30T11:16 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,TREATMENT,21280.0,31560.0,1838623560.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,145.0,145,,,,Y,145.0,145,Period 3,nan,C,2018-04-06T08:46 (15)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,23.0,TREATMENT,21280.0,40560.0,1838632560.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,151.0,151,,,,,145.0,145,Period 3,6.0,C,2018-04-06T11:16 (15)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,24.0,END OF TREATMENT,21281.0,39360.0,1838717760.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,155.0,155,,,,,149.0,149,EOT/ET/Followup,6.0,C,2018-04-07T10:56 (16)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21255.0,47658.0,1836479658.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,Y,97.0,97,EOT/ET/Followup,nan,NA,2018-03-12T13:14 (-11)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,26.0,TREATMENT,21266.0,31560.0,1837413960.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,Y,97.0,97,Period 1,nan,B,2018-03-23T08:46 (1)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,27.0,TREATMENT,21266.0,40560.0,1837422960.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,,97.0,97,Period 1,1.0,B,2018-03-23T11:16 (1)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,28.0,TREATMENT,21273.0,31560.0,1838018760.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,Y,96.0,96,Period 2,nan,A,2018-03-30T08:46 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,TREATMENT,21273.0,40560.0,1838027760.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,100.0,100,,,,,96.0,96,Period 2,4.0,A,2018-03-30T11:16 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,30.0,TREATMENT,21280.0,31560.0,1838623560.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,Y,99.0,99,Period 3,nan,C,2018-04-06T08:46 (15)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,31.0,TREATMENT,21280.0,40560.0,1838632560.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,,99.0,99,Period 3,-5.0,C,2018-04-06T11:16 (15)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,32.0,END OF TREATMENT,21281.0,39360.0,1838717760.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,,97.0,97,EOT/ET/Followup,2.0,C,2018-04-07T10:56 (16)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21255.0,47658.0,1836479658.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,413.0,413,,,,Y,413.0,413,EOT/ET/Followup,nan,NA,2018-03-12T13:14 (-11)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21266.0,31560.0,1837413960.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,383.0,383,,,,Y,383.0,383,Period 1,nan,B,2018-03-23T08:46 (1)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,35.0,TREATMENT,21266.0,40560.0,1837422960.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,402.0,402,,,,,383.0,383,Period 1,19.0,B,2018-03-23T11:16 (1)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,36.0,TREATMENT,21273.0,31560.0,1838018760.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,377.0,377,,,,Y,377.0,377,Period 2,nan,A,2018-03-30T08:46 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,37.0,TREATMENT,21273.0,40560.0,1838027760.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,410.0,410,,,,,377.0,377,Period 2,33.0,A,2018-03-30T11:16 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,38.0,TREATMENT,21280.0,31560.0,1838623560.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,341.0,341,,,,Y,341.0,341,Period 3,nan,C,2018-04-06T08:46 (15)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,39.0,TREATMENT,21280.0,40560.0,1838632560.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,397.0,397,,,,,341.0,341,Period 3,56.0,C,2018-04-06T11:16 (15)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,40.0,END OF TREATMENT,21281.0,39360.0,1838717760.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,389.0,389,,,,,413.0,413,EOT/ET/Followup,-24.0,C,2018-04-07T10:56 (16)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21255.0,47658.0,1836479658.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,403.0,403,,,,Y,403.0,403,EOT/ET/Followup,nan,NA,2018-03-12T13:14 (-11)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,42.0,TREATMENT,21266.0,31560.0,1837413960.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,418.0,418,,,,Y,418.0,418,Period 1,nan,B,2018-03-23T08:46 (1)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,43.0,TREATMENT,21266.0,40560.0,1837422960.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,385.0,385,,,,,418.0,418,Period 1,-33.0,B,2018-03-23T11:16 (1)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,44.0,TREATMENT,21273.0,31560.0,1838018760.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,417.0,417,,,,Y,417.0,417,Period 2,nan,A,2018-03-30T08:46 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,45.0,TREATMENT,21273.0,40560.0,1838027760.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,386.0,386,,,,,417.0,417,Period 2,-31.0,A,2018-03-30T11:16 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,46.0,TREATMENT,21280.0,31560.0,1838623560.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,421.0,421,,,,Y,421.0,421,Period 3,nan,C,2018-04-06T08:46 (15)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,47.0,TREATMENT,21280.0,40560.0,1838632560.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,381.0,381,,,,,421.0,421,Period 3,-40.0,C,2018-04-06T11:16 (15)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,48.0,END OF TREATMENT,21281.0,39360.0,1838717760.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,390.0,390,,,,,403.0,403,EOT/ET/Followup,-13.0,C,2018-04-07T10:56 (16)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21255.0,47658.0,1836479658.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,406.0,406,,,,Y,406.0,406,EOT/ET/Followup,nan,NA,2018-03-12T13:14 (-11)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,50.0,TREATMENT,21266.0,31560.0,1837413960.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,406.0,406,,,,Y,406.0,406,Period 1,nan,B,2018-03-23T08:46 (1)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,51.0,TREATMENT,21266.0,40560.0,1837422960.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,390.0,390,,,,,406.0,406,Period 1,-16.0,B,2018-03-23T11:16 (1)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,52.0,TREATMENT,21273.0,31560.0,1838018760.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,403.0,403,,,,Y,403.0,403,Period 2,nan,A,2018-03-30T08:46 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,53.0,TREATMENT,21273.0,40560.0,1838027760.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,393.0,393,,,,,403.0,403,Period 2,-10.0,A,2018-03-30T11:16 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,54.0,TREATMENT,21280.0,31560.0,1838623560.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,392.0,392,,,,Y,392.0,392,Period 3,nan,C,2018-04-06T08:46 (15)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,55.0,TREATMENT,21280.0,40560.0,1838632560.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,386.0,386,,,,,392.0,392,Period 3,-6.0,C,2018-04-06T11:16 (15)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,56.0,END OF TREATMENT,21281.0,39360.0,1838717760.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,389.0,389,,,,,406.0,406,EOT/ET/Followup,-17.0,C,2018-04-07T10:56 (16)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21255.0,47658.0,1836479658.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,1050.0,1050,,,,Y,1050.0,1050,EOT/ET/Followup,nan,NA,2018-03-12T13:14 (-11)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,58.0,TREATMENT,21266.0,31560.0,1837413960.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,839.0,839,,,,Y,839.0,839,Period 1,nan,B,2018-03-23T08:46 (1)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,59.0,TREATMENT,21266.0,40560.0,1837422960.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1089.0,1089,,,,,839.0,839,Period 1,250.0,B,2018-03-23T11:16 (1)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,60.0,TREATMENT,21273.0,31560.0,1838018760.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,815.0,815,,,,Y,815.0,815,Period 2,nan,A,2018-03-30T08:46 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,61.0,TREATMENT,21273.0,40560.0,1838027760.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1128.0,1128,,,,,815.0,815,Period 2,313.0,A,2018-03-30T11:16 (8)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,62.0,TREATMENT,21280.0,31560.0,1838623560.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,655.0,655,,,,Y,655.0,655,Period 3,nan,C,2018-04-06T08:46 (15)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,63.0,TREATMENT,21280.0,40560.0,1838632560.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1081.0,1081,,,,,655.0,655,Period 3,426.0,C,2018-04-06T11:16 (15)
3110-103-002,3110-103-002.103001032,103001032,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,64.0,END OF TREATMENT,21281.0,39360.0,1838717760.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,994.0,994,,,,,1050.0,1050,EOT/ET/Followup,-56.0,C,2018-04-07T10:56 (16)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21255.0,45968.0,1836477968.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,46.0,46,,,,Y,46.0,46,EOT/ET/Followup,nan,NA,2018-03-12T12:46 (-11)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21266.0,30540.0,1837412940.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,50.0,50,,,,Y,50.0,50,Period 1,nan,C,2018-03-23T08:29 (1)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21266.0,39540.0,1837421940.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,50.0,50,,,,,50.0,50,Period 1,0.0,C,2018-03-23T10:59 (1)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,4.0,TREATMENT,21273.0,30540.0,1838017740.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,56.0,56,,,,Y,56.0,56,Period 2,nan,B,2018-03-30T08:29 (8)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21273.0,39540.0,1838026740.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,50.0,50,,,,,56.0,56,Period 2,-6.0,B,2018-03-30T10:59 (8)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,6.0,TREATMENT,21280.0,30540.0,1838622540.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,42.0,42,,,,Y,42.0,42,Period 3,nan,A,2018-04-06T08:29 (15)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,7.0,TREATMENT,21280.0,39540.0,1838631540.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,49.0,49,,,,,42.0,42,Period 3,7.0,A,2018-04-06T10:59 (15)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,8.0,END OF TREATMENT,21281.0,38348.0,1838716748.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,59.0,59,,,,,46.0,46,EOT/ET/Followup,13.0,A,2018-04-07T10:39 (16)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21255.0,45968.0,1836477968.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-12T12:46 (-11)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21266.0,30540.0,1837412940.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,C,2018-03-23T08:29 (1)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,TREATMENT,21266.0,39540.0,1837421940.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,C,2018-03-23T10:59 (1)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,12.0,TREATMENT,21273.0,30540.0,1838017740.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,B,2018-03-30T08:29 (8)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,13.0,TREATMENT,21273.0,39540.0,1838026740.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,B,2018-03-30T10:59 (8)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,14.0,TREATMENT,21280.0,30540.0,1838622540.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Abnormal, NCS,,,SINUS BRADYCARDIA,Y,nan,Abnormal, NCS,Period 3,nan,A,2018-04-06T08:29 (15)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,15.0,TREATMENT,21280.0,39540.0,1838631540.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,,nan,Abnormal, NCS,Period 3,nan,A,2018-04-06T10:59 (15)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,16.0,END OF TREATMENT,21281.0,38348.0,1838716748.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,A,2018-04-07T10:39 (16)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21255.0,45968.0,1836477968.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,166.0,166,,,,Y,166.0,166,EOT/ET/Followup,nan,NA,2018-03-12T12:46 (-11)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21266.0,30540.0,1837412940.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,161.0,161,,,,Y,161.0,161,Period 1,nan,C,2018-03-23T08:29 (1)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21266.0,39540.0,1837421940.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,168.0,168,,,,,161.0,161,Period 1,7.0,C,2018-03-23T10:59 (1)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21273.0,30540.0,1838017740.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,164.0,164,,,,Y,164.0,164,Period 2,nan,B,2018-03-30T08:29 (8)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21.0,TREATMENT,21273.0,39540.0,1838026740.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,162.0,162,,,,,164.0,164,Period 2,-2.0,B,2018-03-30T10:59 (8)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,22.0,TREATMENT,21280.0,30540.0,1838622540.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,164.0,164,,,,Y,164.0,164,Period 3,nan,A,2018-04-06T08:29 (15)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,23.0,TREATMENT,21280.0,39540.0,1838631540.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,162.0,162,,,,,164.0,164,Period 3,-2.0,A,2018-04-06T10:59 (15)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,24.0,END OF TREATMENT,21281.0,38348.0,1838716748.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,157.0,157,,,,,166.0,166,EOT/ET/Followup,-9.0,A,2018-04-07T10:39 (16)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21255.0,45968.0,1836477968.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,Y,99.0,99,EOT/ET/Followup,nan,NA,2018-03-12T12:46 (-11)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,26.0,TREATMENT,21266.0,30540.0,1837412940.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,Y,97.0,97,Period 1,nan,C,2018-03-23T08:29 (1)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,27.0,TREATMENT,21266.0,39540.0,1837421940.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,87.0,87,,,,,97.0,97,Period 1,-10.0,C,2018-03-23T10:59 (1)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,28.0,TREATMENT,21273.0,30540.0,1838017740.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,100.0,100,,,,Y,100.0,100,Period 2,nan,B,2018-03-30T08:29 (8)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,29.0,TREATMENT,21273.0,39540.0,1838026740.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,,100.0,100,Period 2,-2.0,B,2018-03-30T10:59 (8)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,30.0,TREATMENT,21280.0,30540.0,1838622540.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,Y,98.0,98,Period 3,nan,A,2018-04-06T08:29 (15)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,31.0,TREATMENT,21280.0,39540.0,1838631540.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,,98.0,98,Period 3,0.0,A,2018-04-06T10:59 (15)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,32.0,END OF TREATMENT,21281.0,38348.0,1838716748.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,92.0,92,,,,,99.0,99,EOT/ET/Followup,-7.0,A,2018-04-07T10:39 (16)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21255.0,45968.0,1836477968.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,432.0,432,,,,Y,432.0,432,EOT/ET/Followup,nan,NA,2018-03-12T12:46 (-11)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,34.0,TREATMENT,21266.0,30540.0,1837412940.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,447.0,447,,,,Y,447.0,447,Period 1,nan,C,2018-03-23T08:29 (1)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,35.0,TREATMENT,21266.0,39540.0,1837421940.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,424.0,424,,,,,447.0,447,Period 1,-23.0,C,2018-03-23T10:59 (1)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,TREATMENT,21273.0,30540.0,1838017740.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,448.0,448,,,,Y,448.0,448,Period 2,nan,B,2018-03-30T08:29 (8)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,37.0,TREATMENT,21273.0,39540.0,1838026740.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,455.0,455,,,,,448.0,448,Period 2,7.0,B,2018-03-30T10:59 (8)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,38.0,TREATMENT,21280.0,30540.0,1838622540.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,477.0,477,,,,Y,477.0,477,Period 3,nan,A,2018-04-06T08:29 (15)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,39.0,TREATMENT,21280.0,39540.0,1838631540.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,444.0,444,,,,,477.0,477,Period 3,-33.0,A,2018-04-06T10:59 (15)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,40.0,END OF TREATMENT,21281.0,38348.0,1838716748.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,429.0,429,,,,,432.0,432,EOT/ET/Followup,-3.0,A,2018-04-07T10:39 (16)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21255.0,45968.0,1836477968.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,379.0,379,,,,Y,379.0,379,EOT/ET/Followup,nan,NA,2018-03-12T12:46 (-11)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,42.0,TREATMENT,21266.0,30540.0,1837412940.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,410.0,410,,,,Y,410.0,410,Period 1,nan,C,2018-03-23T08:29 (1)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,43.0,TREATMENT,21266.0,39540.0,1837421940.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,387.0,387,,,,,410.0,410,Period 1,-23.0,C,2018-03-23T10:59 (1)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,44.0,TREATMENT,21273.0,30540.0,1838017740.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,434.0,434,,,,Y,434.0,434,Period 2,nan,B,2018-03-30T08:29 (8)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,45.0,TREATMENT,21273.0,39540.0,1838026740.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,417.0,417,,,,,434.0,434,Period 2,-17.0,B,2018-03-30T10:59 (8)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,46.0,TREATMENT,21280.0,30540.0,1838622540.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,402.0,402,,,,Y,402.0,402,Period 3,nan,A,2018-04-06T08:29 (15)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,47.0,TREATMENT,21280.0,39540.0,1838631540.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,402.0,402,,,,,402.0,402,Period 3,0.0,A,2018-04-06T10:59 (15)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,48.0,END OF TREATMENT,21281.0,38348.0,1838716748.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,427.0,427,,,,,379.0,379,EOT/ET/Followup,48.0,A,2018-04-07T10:39 (16)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21255.0,45968.0,1836477968.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,396.0,396,,,,Y,396.0,396,EOT/ET/Followup,nan,NA,2018-03-12T12:46 (-11)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,50.0,TREATMENT,21266.0,30540.0,1837412940.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,422.0,422,,,,Y,422.0,422,Period 1,nan,C,2018-03-23T08:29 (1)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,51.0,TREATMENT,21266.0,39540.0,1837421940.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,398.0,398,,,,,422.0,422,Period 1,-24.0,C,2018-03-23T10:59 (1)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,52.0,TREATMENT,21273.0,30540.0,1838017740.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,439.0,439,,,,Y,439.0,439,Period 2,nan,B,2018-03-30T08:29 (8)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,53.0,TREATMENT,21273.0,39540.0,1838026740.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,429.0,429,,,,,439.0,439,Period 2,-10.0,B,2018-03-30T10:59 (8)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,54.0,TREATMENT,21280.0,30540.0,1838622540.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,426.0,426,,,,Y,426.0,426,Period 3,nan,A,2018-04-06T08:29 (15)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,55.0,TREATMENT,21280.0,39540.0,1838631540.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,415.0,415,,,,,426.0,426,Period 3,-11.0,A,2018-04-06T10:59 (15)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,56.0,END OF TREATMENT,21281.0,38348.0,1838716748.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,428.0,428,,,,,396.0,396,EOT/ET/Followup,32.0,A,2018-04-07T10:39 (16)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21255.0,45968.0,1836477968.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,1293.0,1293,,,,Y,1293.0,1293,EOT/ET/Followup,nan,NA,2018-03-12T12:46 (-11)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,58.0,TREATMENT,21266.0,30540.0,1837412940.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1185.0,1185,,,,Y,1185.0,1185,Period 1,nan,C,2018-03-23T08:29 (1)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,59.0,TREATMENT,21266.0,39540.0,1837421940.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1200.0,1200,,,,,1185.0,1185,Period 1,15.0,C,2018-03-23T10:59 (1)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,60.0,TREATMENT,21273.0,30540.0,1838017740.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1062.0,1062,,,,Y,1062.0,1062,Period 2,nan,B,2018-03-30T08:29 (8)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,61.0,TREATMENT,21273.0,39540.0,1838026740.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1185.0,1185,,,,,1062.0,1062,Period 2,123.0,B,2018-03-30T10:59 (8)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,62.0,TREATMENT,21280.0,30540.0,1838622540.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1402.0,1402,,,,Y,1402.0,1402,Period 3,nan,A,2018-04-06T08:29 (15)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,63.0,TREATMENT,21280.0,39540.0,1838631540.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1216.0,1216,,,,,1402.0,1402,Period 3,-186.0,A,2018-04-06T10:59 (15)
3110-103-002,3110-103-002.103001034,103001034,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,64.0,END OF TREATMENT,21281.0,38348.0,1838716748.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1007.0,1007,,,,,1293.0,1293,EOT/ET/Followup,-286.0,A,2018-04-07T10:39 (16)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21255.0,49039.0,1836481039.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,68.0,68,,,,Y,68.0,68,EOT/ET/Followup,nan,NA,2018-03-12T13:37 (-11)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21266.0,32580.0,1837414980.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,78.0,78,,,,Y,78.0,78,Period 1,nan,C,2018-03-23T09:03 (1)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21266.0,41580.0,1837423980.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,68.0,68,,,,,78.0,78,Period 1,-10.0,C,2018-03-23T11:33 (1)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,4.0,TREATMENT,21273.0,32580.0,1838019780.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,73.0,73,,,,Y,73.0,73,Period 2,nan,A,2018-03-30T09:03 (8)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,5.0,TREATMENT,21273.0,41580.0,1838028780.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,68.0,68,,,,,73.0,73,Period 2,-5.0,A,2018-03-30T11:33 (8)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21280.0,32580.0,1838624580.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,73.0,73,,,,Y,73.0,73,Period 3,nan,B,2018-04-06T09:03 (15)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,7.0,TREATMENT,21280.0,41580.0,1838633580.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,65.0,65,,,,,73.0,73,Period 3,-8.0,B,2018-04-06T11:33 (15)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,8.0,END OF TREATMENT,21281.0,40380.0,1838718780.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,71.0,71,,,,,68.0,68,EOT/ET/Followup,3.0,B,2018-04-07T11:13 (16)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21255.0,49039.0,1836481039.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-12T13:37 (-11)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21266.0,32580.0,1837414980.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,C,2018-03-23T09:03 (1)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,TREATMENT,21266.0,41580.0,1837423980.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,C,2018-03-23T11:33 (1)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,12.0,TREATMENT,21273.0,32580.0,1838019780.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,A,2018-03-30T09:03 (8)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,13.0,TREATMENT,21273.0,41580.0,1838028780.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,A,2018-03-30T11:33 (8)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,14.0,TREATMENT,21280.0,32580.0,1838624580.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,B,2018-04-06T09:03 (15)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,15.0,TREATMENT,21280.0,41580.0,1838633580.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,B,2018-04-06T11:33 (15)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,16.0,END OF TREATMENT,21281.0,40380.0,1838718780.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,B,2018-04-07T11:13 (16)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21255.0,49039.0,1836481039.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,150.0,150,,,,Y,150.0,150,EOT/ET/Followup,nan,NA,2018-03-12T13:37 (-11)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21266.0,32580.0,1837414980.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,143.0,143,,,,Y,143.0,143,Period 1,nan,C,2018-03-23T09:03 (1)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21266.0,41580.0,1837423980.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,148.0,148,,,,,143.0,143,Period 1,5.0,C,2018-03-23T11:33 (1)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,20.0,TREATMENT,21273.0,32580.0,1838019780.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,136.0,136,,,,Y,136.0,136,Period 2,nan,A,2018-03-30T09:03 (8)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21.0,TREATMENT,21273.0,41580.0,1838028780.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,125.0,125,,,,,136.0,136,Period 2,-11.0,A,2018-03-30T11:33 (8)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,22.0,TREATMENT,21280.0,32580.0,1838624580.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,121.0,121,,,,Y,121.0,121,Period 3,nan,B,2018-04-06T09:03 (15)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,23.0,TREATMENT,21280.0,41580.0,1838633580.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,120.0,120,,,,,121.0,121,Period 3,-1.0,B,2018-04-06T11:33 (15)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,24.0,END OF TREATMENT,21281.0,40380.0,1838718780.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,132.0,132,,,,,150.0,150,EOT/ET/Followup,-18.0,B,2018-04-07T11:13 (16)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21255.0,49039.0,1836481039.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,93.0,93,,,,Y,93.0,93,EOT/ET/Followup,nan,NA,2018-03-12T13:37 (-11)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,26.0,TREATMENT,21266.0,32580.0,1837414980.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,Y,96.0,96,Period 1,nan,C,2018-03-23T09:03 (1)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,27.0,TREATMENT,21266.0,41580.0,1837423980.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,93.0,93,,,,,96.0,96,Period 1,-3.0,C,2018-03-23T11:33 (1)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,28.0,TREATMENT,21273.0,32580.0,1838019780.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,91.0,91,,,,Y,91.0,91,Period 2,nan,A,2018-03-30T09:03 (8)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,TREATMENT,21273.0,41580.0,1838028780.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,92.0,92,,,,,91.0,91,Period 2,1.0,A,2018-03-30T11:33 (8)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,30.0,TREATMENT,21280.0,32580.0,1838624580.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,Y,94.0,94,Period 3,nan,B,2018-04-06T09:03 (15)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,31.0,TREATMENT,21280.0,41580.0,1838633580.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,92.0,92,,,,,94.0,94,Period 3,-2.0,B,2018-04-06T11:33 (15)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,32.0,END OF TREATMENT,21281.0,40380.0,1838718780.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,92.0,92,,,,,93.0,93,EOT/ET/Followup,-1.0,B,2018-04-07T11:13 (16)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21255.0,49039.0,1836481039.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,371.0,371,,,,Y,371.0,371,EOT/ET/Followup,nan,NA,2018-03-12T13:37 (-11)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,34.0,TREATMENT,21266.0,32580.0,1837414980.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,371.0,371,,,,Y,371.0,371,Period 1,nan,C,2018-03-23T09:03 (1)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,35.0,TREATMENT,21266.0,41580.0,1837423980.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,384.0,384,,,,,371.0,371,Period 1,13.0,C,2018-03-23T11:33 (1)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,36.0,TREATMENT,21273.0,32580.0,1838019780.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,368.0,368,,,,Y,368.0,368,Period 2,nan,A,2018-03-30T09:03 (8)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,37.0,TREATMENT,21273.0,41580.0,1838028780.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,374.0,374,,,,,368.0,368,Period 2,6.0,A,2018-03-30T11:33 (8)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,38.0,TREATMENT,21280.0,32580.0,1838624580.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,357.0,357,,,,Y,357.0,357,Period 3,nan,B,2018-04-06T09:03 (15)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,39.0,TREATMENT,21280.0,41580.0,1838633580.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,382.0,382,,,,,357.0,357,Period 3,25.0,B,2018-04-06T11:33 (15)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,40.0,END OF TREATMENT,21281.0,40380.0,1838718780.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,364.0,364,,,,,371.0,371,EOT/ET/Followup,-7.0,B,2018-04-07T11:13 (16)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21255.0,49039.0,1836481039.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,396.0,396,,,,Y,396.0,396,EOT/ET/Followup,nan,NA,2018-03-12T13:37 (-11)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,42.0,TREATMENT,21266.0,32580.0,1837414980.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,423.0,423,,,,Y,423.0,423,Period 1,nan,C,2018-03-23T09:03 (1)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,43.0,TREATMENT,21266.0,41580.0,1837423980.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,409.0,409,,,,,423.0,423,Period 1,-14.0,C,2018-03-23T11:33 (1)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,44.0,TREATMENT,21273.0,32580.0,1838019780.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,407.0,407,,,,Y,407.0,407,Period 2,nan,A,2018-03-30T09:03 (8)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,45.0,TREATMENT,21273.0,41580.0,1838028780.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,398.0,398,,,,,407.0,407,Period 2,-9.0,A,2018-03-30T11:33 (8)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,46.0,TREATMENT,21280.0,32580.0,1838624580.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,395.0,395,,,,Y,395.0,395,Period 3,nan,B,2018-04-06T09:03 (15)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,47.0,TREATMENT,21280.0,41580.0,1838633580.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,399.0,399,,,,,395.0,395,Period 3,4.0,B,2018-04-06T11:33 (15)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,48.0,END OF TREATMENT,21281.0,40380.0,1838718780.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,398.0,398,,,,,396.0,396,EOT/ET/Followup,2.0,B,2018-04-07T11:13 (16)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21255.0,49039.0,1836481039.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,388.0,388,,,,Y,388.0,388,EOT/ET/Followup,nan,NA,2018-03-12T13:37 (-11)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,50.0,TREATMENT,21266.0,32580.0,1837414980.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,404.0,404,,,,Y,404.0,404,Period 1,nan,C,2018-03-23T09:03 (1)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,51.0,TREATMENT,21266.0,41580.0,1837423980.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,400.0,400,,,,,404.0,404,Period 1,-4.0,C,2018-03-23T11:33 (1)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,52.0,TREATMENT,21273.0,32580.0,1838019780.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,393.0,393,,,,Y,393.0,393,Period 2,nan,A,2018-03-30T09:03 (8)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,53.0,TREATMENT,21273.0,41580.0,1838028780.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,389.0,389,,,,,393.0,393,Period 2,-4.0,A,2018-03-30T11:33 (8)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,54.0,TREATMENT,21280.0,32580.0,1838624580.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,382.0,382,,,,Y,382.0,382,Period 3,nan,B,2018-04-06T09:03 (15)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,55.0,TREATMENT,21280.0,41580.0,1838633580.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,393.0,393,,,,,382.0,382,Period 3,11.0,B,2018-04-06T11:33 (15)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,56.0,END OF TREATMENT,21281.0,40380.0,1838718780.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,386.0,386,,,,,388.0,388,EOT/ET/Followup,-2.0,B,2018-04-07T11:13 (16)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21255.0,49039.0,1836481039.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,874.0,874,,,,Y,874.0,874,EOT/ET/Followup,nan,NA,2018-03-12T13:37 (-11)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,58.0,TREATMENT,21266.0,32580.0,1837414980.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,769.0,769,,,,Y,769.0,769,Period 1,nan,C,2018-03-23T09:03 (1)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,59.0,TREATMENT,21266.0,41580.0,1837423980.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,881.0,881,,,,,769.0,769,Period 1,112.0,C,2018-03-23T11:33 (1)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,60.0,TREATMENT,21273.0,32580.0,1838019780.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,815.0,815,,,,Y,815.0,815,Period 2,nan,A,2018-03-30T09:03 (8)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,61.0,TREATMENT,21273.0,41580.0,1838028780.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,882.0,882,,,,,815.0,815,Period 2,67.0,A,2018-03-30T11:33 (8)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,62.0,TREATMENT,21280.0,32580.0,1838624580.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,813.0,813,,,,Y,813.0,813,Period 3,nan,B,2018-04-06T09:03 (15)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,63.0,TREATMENT,21280.0,41580.0,1838633580.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,913.0,913,,,,,813.0,813,Period 3,100.0,B,2018-04-06T11:33 (15)
3110-103-002,3110-103-002.103001035,103001035,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,64.0,END OF TREATMENT,21281.0,40380.0,1838718780.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,836.0,836,,,,,874.0,874,EOT/ET/Followup,-38.0,B,2018-04-07T11:13 (16)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21255.0,45420.0,1836477420.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,52.0,52,,,,Y,52.0,52,EOT/ET/Followup,nan,NA,2018-03-12T12:37 (-11)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,2.0,TREATMENT,21266.0,31020.0,1837413420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,48.0,48,,,,Y,48.0,48,Period 1,nan,A,2018-03-23T08:37 (1)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21266.0,40020.0,1837422420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,44.0,44,,,,,48.0,48,Period 1,-4.0,A,2018-03-23T11:07 (1)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,4.0,TREATMENT,21273.0,31020.0,1838018220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,50.0,50,,,,Y,50.0,50,Period 2,nan,B,2018-03-30T08:37 (8)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21273.0,40020.0,1838027220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,47.0,47,,,,,50.0,50,Period 2,-3.0,B,2018-03-30T11:07 (8)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,6.0,TREATMENT,21280.0,31020.0,1838623020.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,49.0,49,,,,Y,49.0,49,Period 3,nan,C,2018-04-06T08:37 (15)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,TREATMENT,21280.0,40020.0,1838632020.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,45.0,45,,,,,49.0,49,Period 3,-4.0,C,2018-04-06T11:07 (15)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,END OF TREATMENT,21281.0,38820.0,1838717220.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,47.0,47,,,,,52.0,52,EOT/ET/Followup,-5.0,C,2018-04-07T10:47 (16)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21255.0,45420.0,1836477420.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-12T12:37 (-11)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,10.0,TREATMENT,21266.0,31020.0,1837413420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,Y,nan,Normal,Period 1,nan,A,2018-03-23T08:37 (1)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,11.0,TREATMENT,21266.0,40020.0,1837422420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Abnormal, NCS,,,SINUS BRADYCARDIA,,nan,Normal,Period 1,nan,A,2018-03-23T11:07 (1)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,12.0,TREATMENT,21273.0,31020.0,1838018220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,B,2018-03-30T08:37 (8)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,13.0,TREATMENT,21273.0,40020.0,1838027220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,,nan,Normal,Period 2,nan,B,2018-03-30T11:07 (8)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,14.0,TREATMENT,21280.0,31020.0,1838623020.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,Y,nan,Normal,Period 3,nan,C,2018-04-06T08:37 (15)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,15.0,TREATMENT,21280.0,40020.0,1838632020.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,,nan,Normal,Period 3,nan,C,2018-04-06T11:07 (15)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,16.0,END OF TREATMENT,21281.0,38820.0,1838717220.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,C,2018-04-07T10:47 (16)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21255.0,45420.0,1836477420.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,142.0,142,,,,Y,142.0,142,EOT/ET/Followup,nan,NA,2018-03-12T12:37 (-11)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,18.0,TREATMENT,21266.0,31020.0,1837413420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,141.0,141,,,,Y,141.0,141,Period 1,nan,A,2018-03-23T08:37 (1)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,19.0,TREATMENT,21266.0,40020.0,1837422420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,141.0,141,,,,,141.0,141,Period 1,0.0,A,2018-03-23T11:07 (1)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21273.0,31020.0,1838018220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,144.0,144,,,,Y,144.0,144,Period 2,nan,B,2018-03-30T08:37 (8)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21.0,TREATMENT,21273.0,40020.0,1838027220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,135.0,135,,,,,144.0,144,Period 2,-9.0,B,2018-03-30T11:07 (8)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,TREATMENT,21280.0,31020.0,1838623020.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,141.0,141,,,,Y,141.0,141,Period 3,nan,C,2018-04-06T08:37 (15)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,23.0,TREATMENT,21280.0,40020.0,1838632020.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,138.0,138,,,,,141.0,141,Period 3,-3.0,C,2018-04-06T11:07 (15)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,24.0,END OF TREATMENT,21281.0,38820.0,1838717220.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,130.0,130,,,,,142.0,142,EOT/ET/Followup,-12.0,C,2018-04-07T10:47 (16)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21255.0,45420.0,1836477420.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,Y,98.0,98,EOT/ET/Followup,nan,NA,2018-03-12T12:37 (-11)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,26.0,TREATMENT,21266.0,31020.0,1837413420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,Y,98.0,98,Period 1,nan,A,2018-03-23T08:37 (1)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,TREATMENT,21266.0,40020.0,1837422420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,95.0,95,,,,,98.0,98,Period 1,-3.0,A,2018-03-23T11:07 (1)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,28.0,TREATMENT,21273.0,31020.0,1838018220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,Y,99.0,99,Period 2,nan,B,2018-03-30T08:37 (8)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,29.0,TREATMENT,21273.0,40020.0,1838027220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,,99.0,99,Period 2,-3.0,B,2018-03-30T11:07 (8)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,30.0,TREATMENT,21280.0,31020.0,1838623020.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,Y,96.0,96,Period 3,nan,C,2018-04-06T08:37 (15)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,31.0,TREATMENT,21280.0,40020.0,1838632020.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,95.0,95,,,,,96.0,96,Period 3,-1.0,C,2018-04-06T11:07 (15)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,32.0,END OF TREATMENT,21281.0,38820.0,1838717220.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,,98.0,98,EOT/ET/Followup,0.0,C,2018-04-07T10:47 (16)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21255.0,45420.0,1836477420.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,447.0,447,,,,Y,447.0,447,EOT/ET/Followup,nan,NA,2018-03-12T12:37 (-11)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,34.0,TREATMENT,21266.0,31020.0,1837413420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,446.0,446,,,,Y,446.0,446,Period 1,nan,A,2018-03-23T08:37 (1)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,35.0,TREATMENT,21266.0,40020.0,1837422420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,447.0,447,,,,,446.0,446,Period 1,1.0,A,2018-03-23T11:07 (1)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,TREATMENT,21273.0,31020.0,1838018220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,442.0,442,,,,Y,442.0,442,Period 2,nan,B,2018-03-30T08:37 (8)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,37.0,TREATMENT,21273.0,40020.0,1838027220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,444.0,444,,,,,442.0,442,Period 2,2.0,B,2018-03-30T11:07 (8)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,38.0,TREATMENT,21280.0,31020.0,1838623020.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,459.0,459,,,,Y,459.0,459,Period 3,nan,C,2018-04-06T08:37 (15)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,39.0,TREATMENT,21280.0,40020.0,1838632020.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,445.0,445,,,,,459.0,459,Period 3,-14.0,C,2018-04-06T11:07 (15)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,40.0,END OF TREATMENT,21281.0,38820.0,1838717220.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,451.0,451,,,,,447.0,447,EOT/ET/Followup,4.0,C,2018-04-07T10:47 (16)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21255.0,45420.0,1836477420.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,417.0,417,,,,Y,417.0,417,EOT/ET/Followup,nan,NA,2018-03-12T12:37 (-11)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,42.0,TREATMENT,21266.0,31020.0,1837413420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,399.0,399,,,,Y,399.0,399,Period 1,nan,A,2018-03-23T08:37 (1)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,43.0,TREATMENT,21266.0,40020.0,1837422420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,385.0,385,,,,,399.0,399,Period 1,-14.0,A,2018-03-23T11:07 (1)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,44.0,TREATMENT,21273.0,31020.0,1838018220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,404.0,404,,,,Y,404.0,404,Period 2,nan,B,2018-03-30T08:37 (8)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,45.0,TREATMENT,21273.0,40020.0,1838027220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,396.0,396,,,,,404.0,404,Period 2,-8.0,B,2018-03-30T11:07 (8)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,46.0,TREATMENT,21280.0,31020.0,1838623020.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,417.0,417,,,,Y,417.0,417,Period 3,nan,C,2018-04-06T08:37 (15)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,47.0,TREATMENT,21280.0,40020.0,1838632020.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,389.0,389,,,,,417.0,417,Period 3,-28.0,C,2018-04-06T11:07 (15)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,48.0,END OF TREATMENT,21281.0,38820.0,1838717220.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,401.0,401,,,,,417.0,417,EOT/ET/Followup,-16.0,C,2018-04-07T10:47 (16)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21255.0,45420.0,1836477420.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,426.0,426,,,,Y,426.0,426,EOT/ET/Followup,nan,NA,2018-03-12T12:37 (-11)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,50.0,TREATMENT,21266.0,31020.0,1837413420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,414.0,414,,,,Y,414.0,414,Period 1,nan,A,2018-03-23T08:37 (1)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,51.0,TREATMENT,21266.0,40020.0,1837422420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,405.0,405,,,,,414.0,414,Period 1,-9.0,A,2018-03-23T11:07 (1)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,52.0,TREATMENT,21273.0,31020.0,1838018220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,416.0,416,,,,Y,416.0,416,Period 2,nan,B,2018-03-30T08:37 (8)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,53.0,TREATMENT,21273.0,40020.0,1838027220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,412.0,412,,,,,416.0,416,Period 2,-4.0,B,2018-03-30T11:07 (8)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,54.0,TREATMENT,21280.0,31020.0,1838623020.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,430.0,430,,,,Y,430.0,430,Period 3,nan,C,2018-04-06T08:37 (15)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,55.0,TREATMENT,21280.0,40020.0,1838632020.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,407.0,407,,,,,430.0,430,Period 3,-23.0,C,2018-04-06T11:07 (15)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,56.0,END OF TREATMENT,21281.0,38820.0,1838717220.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,417.0,417,,,,,426.0,426,EOT/ET/Followup,-9.0,C,2018-04-07T10:47 (16)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21255.0,45420.0,1836477420.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,1149.0,1149,,,,Y,1149.0,1149,EOT/ET/Followup,nan,NA,2018-03-12T12:37 (-11)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,58.0,TREATMENT,21266.0,31020.0,1837413420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1244.0,1244,,,,Y,1244.0,1244,Period 1,nan,A,2018-03-23T08:37 (1)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,59.0,TREATMENT,21266.0,40020.0,1837422420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1343.0,1343,,,,,1244.0,1244,Period 1,99.0,A,2018-03-23T11:07 (1)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,60.0,TREATMENT,21273.0,31020.0,1838018220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1192.0,1192,,,,Y,1192.0,1192,Period 2,nan,B,2018-03-30T08:37 (8)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,61.0,TREATMENT,21273.0,40020.0,1838027220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1251.0,1251,,,,,1192.0,1192,Period 2,59.0,B,2018-03-30T11:07 (8)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,62.0,TREATMENT,21280.0,31020.0,1838623020.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1208.0,1208,,,,Y,1208.0,1208,Period 3,nan,C,2018-04-06T08:37 (15)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,63.0,TREATMENT,21280.0,40020.0,1838632020.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1307.0,1307,,,,,1208.0,1208,Period 3,99.0,C,2018-04-06T11:07 (15)
3110-103-002,3110-103-002.103001037,103001037,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,64.0,END OF TREATMENT,21281.0,38820.0,1838717220.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1262.0,1262,,,,,1149.0,1149,EOT/ET/Followup,113.0,C,2018-04-07T10:47 (16)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21255.0,49333.0,1836481333.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,67.0,67,,,,Y,67.0,67,EOT/ET/Followup,nan,NA,2018-03-12T13:42 (-11)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21266.0,31620.0,1837414020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,74.0,74,,,,Y,74.0,74,Period 1,nan,C,2018-03-23T08:47 (1)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21266.0,40620.0,1837423020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,60.0,60,,,,,74.0,74,Period 1,-14.0,C,2018-03-23T11:17 (1)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,4.0,TREATMENT,21273.0,31620.0,1838018820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,59.0,59,,,,Y,59.0,59,Period 2,nan,B,2018-03-30T08:47 (8)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21273.0,40620.0,1838027820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,63.0,63,,,,,59.0,59,Period 2,4.0,B,2018-03-30T11:17 (8)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,6.0,TREATMENT,21280.0,31634.0,1838623634.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,75.0,75,,,,Y,75.0,75,Period 3,nan,A,2018-04-06T08:47 (15)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,7.0,TREATMENT,21280.0,40620.0,1838632620.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,51.0,51,,,,,75.0,75,Period 3,-24.0,A,2018-04-06T11:17 (15)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,8.0,END OF TREATMENT,21281.0,39420.0,1838717820.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,73.0,73,,,,,67.0,67,EOT/ET/Followup,6.0,A,2018-04-07T10:57 (16)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21255.0,49333.0,1836481333.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-12T13:42 (-11)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21266.0,31620.0,1837414020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,C,2018-03-23T08:47 (1)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,TREATMENT,21266.0,40620.0,1837423020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,C,2018-03-23T11:17 (1)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,12.0,TREATMENT,21273.0,31620.0,1838018820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,B,2018-03-30T08:47 (8)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,13.0,TREATMENT,21273.0,40620.0,1838027820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,B,2018-03-30T11:17 (8)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,14.0,TREATMENT,21280.0,31634.0,1838623634.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,A,2018-04-06T08:47 (15)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,15.0,TREATMENT,21280.0,40620.0,1838632620.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,A,2018-04-06T11:17 (15)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,16.0,END OF TREATMENT,21281.0,39420.0,1838717820.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;Noise Noted;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,A,2018-04-07T10:57 (16)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21255.0,49333.0,1836481333.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,180.0,180,,,,Y,180.0,180,EOT/ET/Followup,nan,NA,2018-03-12T13:42 (-11)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21266.0,31620.0,1837414020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,169.0,169,,,,Y,169.0,169,Period 1,nan,C,2018-03-23T08:47 (1)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21266.0,40620.0,1837423020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,176.0,176,,,,,169.0,169,Period 1,7.0,C,2018-03-23T11:17 (1)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21273.0,31620.0,1838018820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,166.0,166,,,,Y,166.0,166,Period 2,nan,B,2018-03-30T08:47 (8)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21.0,TREATMENT,21273.0,40620.0,1838027820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,176.0,176,,,,,166.0,166,Period 2,10.0,B,2018-03-30T11:17 (8)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,22.0,TREATMENT,21280.0,31634.0,1838623634.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,172.0,172,,,,Y,172.0,172,Period 3,nan,A,2018-04-06T08:47 (15)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,23.0,TREATMENT,21280.0,40620.0,1838632620.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,169.0,169,,,,,172.0,172,Period 3,-3.0,A,2018-04-06T11:17 (15)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,24.0,END OF TREATMENT,21281.0,39420.0,1838717820.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,158.0,158,,,,,180.0,180,EOT/ET/Followup,-22.0,A,2018-04-07T10:57 (16)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21255.0,49333.0,1836481333.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,87.0,87,,,,Y,87.0,87,EOT/ET/Followup,nan,NA,2018-03-12T13:42 (-11)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,26.0,TREATMENT,21266.0,31620.0,1837414020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,90.0,90,,,,Y,90.0,90,Period 1,nan,C,2018-03-23T08:47 (1)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,27.0,TREATMENT,21266.0,40620.0,1837423020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,88.0,88,,,,,90.0,90,Period 1,-2.0,C,2018-03-23T11:17 (1)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,28.0,TREATMENT,21273.0,31620.0,1838018820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,88.0,88,,,,Y,88.0,88,Period 2,nan,B,2018-03-30T08:47 (8)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,29.0,TREATMENT,21273.0,40620.0,1838027820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,91.0,91,,,,,88.0,88,Period 2,3.0,B,2018-03-30T11:17 (8)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,30.0,TREATMENT,21280.0,31634.0,1838623634.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,83.0,83,,,,Y,83.0,83,Period 3,nan,A,2018-04-06T08:47 (15)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,31.0,TREATMENT,21280.0,40620.0,1838632620.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,93.0,93,,,,,83.0,83,Period 3,10.0,A,2018-04-06T11:17 (15)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,32.0,END OF TREATMENT,21281.0,39420.0,1838717820.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,88.0,88,,,,,87.0,87,EOT/ET/Followup,1.0,A,2018-04-07T10:57 (16)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21255.0,49333.0,1836481333.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,376.0,376,,,,Y,376.0,376,EOT/ET/Followup,nan,NA,2018-03-12T13:42 (-11)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,34.0,TREATMENT,21266.0,31620.0,1837414020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,396.0,396,,,,Y,396.0,396,Period 1,nan,C,2018-03-23T08:47 (1)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,35.0,TREATMENT,21266.0,40620.0,1837423020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,392.0,392,,,,,396.0,396,Period 1,-4.0,C,2018-03-23T11:17 (1)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,TREATMENT,21273.0,31620.0,1838018820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,407.0,407,,,,Y,407.0,407,Period 2,nan,B,2018-03-30T08:47 (8)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,37.0,TREATMENT,21273.0,40620.0,1838027820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,402.0,402,,,,,407.0,407,Period 2,-5.0,B,2018-03-30T11:17 (8)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,38.0,TREATMENT,21280.0,31634.0,1838623634.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,366.0,366,,,,Y,366.0,366,Period 3,nan,A,2018-04-06T08:47 (15)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,39.0,TREATMENT,21280.0,40620.0,1838632620.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,405.0,405,,,,,366.0,366,Period 3,39.0,A,2018-04-06T11:17 (15)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,40.0,END OF TREATMENT,21281.0,39420.0,1838717820.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,362.0,362,,,,,376.0,376,EOT/ET/Followup,-14.0,A,2018-04-07T10:57 (16)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21255.0,49333.0,1836481333.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,399.0,399,,,,Y,399.0,399,EOT/ET/Followup,nan,NA,2018-03-12T13:42 (-11)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,42.0,TREATMENT,21266.0,31620.0,1837414020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,441.0,441,,,,Y,441.0,441,Period 1,nan,C,2018-03-23T08:47 (1)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,43.0,TREATMENT,21266.0,40620.0,1837423020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,394.0,394,,,,,441.0,441,Period 1,-47.0,C,2018-03-23T11:17 (1)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,44.0,TREATMENT,21273.0,31620.0,1838018820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,403.0,403,,,,Y,403.0,403,Period 2,nan,B,2018-03-30T08:47 (8)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,45.0,TREATMENT,21273.0,40620.0,1838027820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,413.0,413,,,,,403.0,403,Period 2,10.0,B,2018-03-30T11:17 (8)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,46.0,TREATMENT,21280.0,31634.0,1838623634.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,410.0,410,,,,Y,410.0,410,Period 3,nan,A,2018-04-06T08:47 (15)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,47.0,TREATMENT,21280.0,40620.0,1838632620.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,375.0,375,,,,,410.0,410,Period 3,-35.0,A,2018-04-06T11:17 (15)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,48.0,END OF TREATMENT,21281.0,39420.0,1838717820.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,399.0,399,,,,,399.0,399,EOT/ET/Followup,0.0,A,2018-04-07T10:57 (16)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21255.0,49333.0,1836481333.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,391.0,391,,,,Y,391.0,391,EOT/ET/Followup,nan,NA,2018-03-12T13:42 (-11)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,50.0,TREATMENT,21266.0,31620.0,1837414020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,425.0,425,,,,Y,425.0,425,Period 1,nan,C,2018-03-23T08:47 (1)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,51.0,TREATMENT,21266.0,40620.0,1837423020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,393.0,393,,,,,425.0,425,Period 1,-32.0,C,2018-03-23T11:17 (1)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,52.0,TREATMENT,21273.0,31620.0,1838018820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,404.0,404,,,,Y,404.0,404,Period 2,nan,B,2018-03-30T08:47 (8)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,53.0,TREATMENT,21273.0,40620.0,1838027820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,409.0,409,,,,,404.0,404,Period 2,5.0,B,2018-03-30T11:17 (8)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,54.0,TREATMENT,21280.0,31634.0,1838623634.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,395.0,395,,,,Y,395.0,395,Period 3,nan,A,2018-04-06T08:47 (15)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,55.0,TREATMENT,21280.0,40620.0,1838632620.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,385.0,385,,,,,395.0,395,Period 3,-10.0,A,2018-04-06T11:17 (15)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,56.0,END OF TREATMENT,21281.0,39420.0,1838717820.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,386.0,386,,,,,391.0,391,EOT/ET/Followup,-5.0,A,2018-04-07T10:57 (16)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21255.0,49333.0,1836481333.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,885.0,885,,,,Y,885.0,885,EOT/ET/Followup,nan,NA,2018-03-12T13:42 (-11)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,58.0,TREATMENT,21266.0,31620.0,1837414020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,804.0,804,,,,Y,804.0,804,Period 1,nan,C,2018-03-23T08:47 (1)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,59.0,TREATMENT,21266.0,40620.0,1837423020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,988.0,988,,,,,804.0,804,Period 1,184.0,C,2018-03-23T11:17 (1)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,60.0,TREATMENT,21273.0,31620.0,1838018820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1015.0,1015,,,,Y,1015.0,1015,Period 2,nan,B,2018-03-30T08:47 (8)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,61.0,TREATMENT,21273.0,40620.0,1838027820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,945.0,945,,,,,1015.0,1015,Period 2,-70.0,B,2018-03-30T11:17 (8)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,62.0,TREATMENT,21280.0,31634.0,1838623634.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,794.0,794,,,,Y,794.0,794,Period 3,nan,A,2018-04-06T08:47 (15)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,63.0,TREATMENT,21280.0,40620.0,1838632620.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1161.0,1161,,,,,794.0,794,Period 3,367.0,A,2018-04-06T11:17 (15)
3110-103-002,3110-103-002.103001038,103001038,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,64.0,END OF TREATMENT,21281.0,39420.0,1838717820.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,820.0,820,,,,,885.0,885,EOT/ET/Followup,-65.0,A,2018-04-07T10:57 (16)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21255.0,49860.0,1836481860.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,58.0,58,,,,Y,58.0,58,EOT/ET/Followup,nan,NA,2018-03-12T13:51 (-11)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,2.0,TREATMENT,21266.0,32100.0,1837414500.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,64.0,64,,,,Y,64.0,64,Period 1,nan,A,2018-03-23T08:55 (1)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21266.0,41100.0,1837423500.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,55.0,55,,,,,64.0,64,Period 1,-9.0,A,2018-03-23T11:25 (1)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,4.0,TREATMENT,21273.0,32100.0,1838019300.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,57.0,57,,,,Y,57.0,57,Period 2,nan,B,2018-03-30T08:55 (8)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21273.0,41100.0,1838028300.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,58.0,58,,,,,57.0,57,Period 2,1.0,B,2018-03-30T11:25 (8)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,6.0,TREATMENT,21280.0,32100.0,1838624100.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,66.0,66,,,,Y,66.0,66,Period 3,nan,C,2018-04-06T08:55 (15)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,TREATMENT,21280.0,41100.0,1838633100.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,52.0,52,,,,,66.0,66,Period 3,-14.0,C,2018-04-06T11:25 (15)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,END OF TREATMENT,21281.0,39900.0,1838718300.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,66.0,66,,,,,58.0,58,EOT/ET/Followup,8.0,C,2018-04-07T11:05 (16)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21255.0,49860.0,1836481860.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-12T13:51 (-11)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,10.0,TREATMENT,21266.0,32100.0,1837414500.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,A,2018-03-23T08:55 (1)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,11.0,TREATMENT,21266.0,41100.0,1837423500.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,A,2018-03-23T11:25 (1)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,12.0,TREATMENT,21273.0,32100.0,1838019300.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,B,2018-03-30T08:55 (8)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,13.0,TREATMENT,21273.0,41100.0,1838028300.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,B,2018-03-30T11:25 (8)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,14.0,TREATMENT,21280.0,32100.0,1838624100.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,C,2018-04-06T08:55 (15)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,15.0,TREATMENT,21280.0,41100.0,1838633100.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,C,2018-04-06T11:25 (15)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,16.0,END OF TREATMENT,21281.0,39900.0,1838718300.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,C,2018-04-07T11:05 (16)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21255.0,49860.0,1836481860.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,195.0,195,,,,Y,195.0,195,EOT/ET/Followup,nan,NA,2018-03-12T13:51 (-11)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,18.0,TREATMENT,21266.0,32100.0,1837414500.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,184.0,184,,,,Y,184.0,184,Period 1,nan,A,2018-03-23T08:55 (1)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,19.0,TREATMENT,21266.0,41100.0,1837423500.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,193.0,193,,,,,184.0,184,Period 1,9.0,A,2018-03-23T11:25 (1)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21273.0,32100.0,1838019300.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,183.0,183,,,,Y,183.0,183,Period 2,nan,B,2018-03-30T08:55 (8)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21.0,TREATMENT,21273.0,41100.0,1838028300.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,203.0,203,,,,,183.0,183,Period 2,20.0,B,2018-03-30T11:25 (8)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,TREATMENT,21280.0,32100.0,1838624100.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,182.0,182,,,,Y,182.0,182,Period 3,nan,C,2018-04-06T08:55 (15)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,23.0,TREATMENT,21280.0,41100.0,1838633100.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,164.0,164,,,,,182.0,182,Period 3,-18.0,C,2018-04-06T11:25 (15)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,24.0,END OF TREATMENT,21281.0,39900.0,1838718300.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,169.0,169,,,,,195.0,195,EOT/ET/Followup,-26.0,C,2018-04-07T11:05 (16)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21255.0,49860.0,1836481860.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,92.0,92,,,,Y,92.0,92,EOT/ET/Followup,nan,NA,2018-03-12T13:51 (-11)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,26.0,TREATMENT,21266.0,32100.0,1837414500.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,Y,96.0,96,Period 1,nan,A,2018-03-23T08:55 (1)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,TREATMENT,21266.0,41100.0,1837423500.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,92.0,92,,,,,96.0,96,Period 1,-4.0,A,2018-03-23T11:25 (1)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,28.0,TREATMENT,21273.0,32100.0,1838019300.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,89.0,89,,,,Y,89.0,89,Period 2,nan,B,2018-03-30T08:55 (8)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,29.0,TREATMENT,21273.0,41100.0,1838028300.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,89.0,89,,,,,89.0,89,Period 2,0.0,B,2018-03-30T11:25 (8)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,30.0,TREATMENT,21280.0,32100.0,1838624100.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,91.0,91,,,,Y,91.0,91,Period 3,nan,C,2018-04-06T08:55 (15)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,31.0,TREATMENT,21280.0,41100.0,1838633100.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,93.0,93,,,,,91.0,91,Period 3,2.0,C,2018-04-06T11:25 (15)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,32.0,END OF TREATMENT,21281.0,39900.0,1838718300.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,,92.0,92,EOT/ET/Followup,2.0,C,2018-04-07T11:05 (16)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21255.0,49860.0,1836481860.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,385.0,385,,,,Y,385.0,385,EOT/ET/Followup,nan,NA,2018-03-12T13:51 (-11)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,34.0,TREATMENT,21266.0,32100.0,1837414500.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,376.0,376,,,,Y,376.0,376,Period 1,nan,A,2018-03-23T08:55 (1)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,35.0,TREATMENT,21266.0,41100.0,1837423500.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,381.0,381,,,,,376.0,376,Period 1,5.0,A,2018-03-23T11:25 (1)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,TREATMENT,21273.0,32100.0,1838019300.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,398.0,398,,,,Y,398.0,398,Period 2,nan,B,2018-03-30T08:55 (8)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,37.0,TREATMENT,21273.0,41100.0,1838028300.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,392.0,392,,,,,398.0,398,Period 2,-6.0,B,2018-03-30T11:25 (8)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,38.0,TREATMENT,21280.0,32100.0,1838624100.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,356.0,356,,,,Y,356.0,356,Period 3,nan,C,2018-04-06T08:55 (15)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,39.0,TREATMENT,21280.0,41100.0,1838633100.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,386.0,386,,,,,356.0,356,Period 3,30.0,C,2018-04-06T11:25 (15)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,40.0,END OF TREATMENT,21281.0,39900.0,1838718300.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,363.0,363,,,,,385.0,385,EOT/ET/Followup,-22.0,C,2018-04-07T11:05 (16)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21255.0,49860.0,1836481860.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,379.0,379,,,,Y,379.0,379,EOT/ET/Followup,nan,NA,2018-03-12T13:51 (-11)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,42.0,TREATMENT,21266.0,32100.0,1837414500.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,389.0,389,,,,Y,389.0,389,Period 1,nan,A,2018-03-23T08:55 (1)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,43.0,TREATMENT,21266.0,41100.0,1837423500.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,365.0,365,,,,,389.0,389,Period 1,-24.0,A,2018-03-23T11:25 (1)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,44.0,TREATMENT,21273.0,32100.0,1838019300.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,390.0,390,,,,Y,390.0,390,Period 2,nan,B,2018-03-30T08:55 (8)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,45.0,TREATMENT,21273.0,41100.0,1838028300.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,387.0,387,,,,,390.0,390,Period 2,-3.0,B,2018-03-30T11:25 (8)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,46.0,TREATMENT,21280.0,32100.0,1838624100.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,373.0,373,,,,Y,373.0,373,Period 3,nan,C,2018-04-06T08:55 (15)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,47.0,TREATMENT,21280.0,41100.0,1838633100.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,362.0,362,,,,,373.0,373,Period 3,-11.0,C,2018-04-06T11:25 (15)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,48.0,END OF TREATMENT,21281.0,39900.0,1838718300.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,382.0,382,,,,,379.0,379,EOT/ET/Followup,3.0,C,2018-04-07T11:05 (16)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21255.0,49860.0,1836481860.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,381.0,381,,,,Y,381.0,381,EOT/ET/Followup,nan,NA,2018-03-12T13:51 (-11)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,50.0,TREATMENT,21266.0,32100.0,1837414500.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,385.0,385,,,,Y,385.0,385,Period 1,nan,A,2018-03-23T08:55 (1)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,51.0,TREATMENT,21266.0,41100.0,1837423500.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,370.0,370,,,,,385.0,385,Period 1,-15.0,A,2018-03-23T11:25 (1)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,52.0,TREATMENT,21273.0,32100.0,1838019300.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,392.0,392,,,,Y,392.0,392,Period 2,nan,B,2018-03-30T08:55 (8)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,53.0,TREATMENT,21273.0,41100.0,1838028300.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,388.0,388,,,,,392.0,392,Period 2,-4.0,B,2018-03-30T11:25 (8)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,54.0,TREATMENT,21280.0,32100.0,1838624100.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,367.0,367,,,,Y,367.0,367,Period 3,nan,C,2018-04-06T08:55 (15)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,55.0,TREATMENT,21280.0,41100.0,1838633100.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,369.0,369,,,,,367.0,367,Period 3,2.0,C,2018-04-06T11:25 (15)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,56.0,END OF TREATMENT,21281.0,39900.0,1838718300.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,376.0,376,,,,,381.0,381,EOT/ET/Followup,-5.0,C,2018-04-07T11:05 (16)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21255.0,49860.0,1836481860.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,1027.0,1027,,,,Y,1027.0,1027,EOT/ET/Followup,nan,NA,2018-03-12T13:51 (-11)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,58.0,TREATMENT,21266.0,32100.0,1837414500.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,931.0,931,,,,Y,931.0,931,Period 1,nan,A,2018-03-23T08:55 (1)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,59.0,TREATMENT,21266.0,41100.0,1837423500.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1088.0,1088,,,,,931.0,931,Period 1,157.0,A,2018-03-23T11:25 (1)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,60.0,TREATMENT,21273.0,32100.0,1838019300.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1041.0,1041,,,,Y,1041.0,1041,Period 2,nan,B,2018-03-30T08:55 (8)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,61.0,TREATMENT,21273.0,41100.0,1838028300.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1026.0,1026,,,,,1041.0,1041,Period 2,-15.0,B,2018-03-30T11:25 (8)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,62.0,TREATMENT,21280.0,32100.0,1838624100.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,907.0,907,,,,Y,907.0,907,Period 3,nan,C,2018-04-06T08:55 (15)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,63.0,TREATMENT,21280.0,41100.0,1838633100.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1136.0,1136,,,,,907.0,907,Period 3,229.0,C,2018-04-06T11:25 (15)
3110-103-002,3110-103-002.103001044,103001044,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,64.0,END OF TREATMENT,21281.0,39900.0,1838718300.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,899.0,899,,,,,1027.0,1027,EOT/ET/Followup,-128.0,C,2018-04-07T11:05 (16)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21255.0,53900.0,1836485900.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,54.0,54,,,,Y,54.0,54,EOT/ET/Followup,nan,NA,2018-03-12T14:58 (-11)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,2.0,TREATMENT,21266.0,30600.0,1837413000.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,58.0,58,,,,Y,58.0,58,Period 1,nan,B,2018-03-23T08:30 (1)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,3.0,TREATMENT,21266.0,39600.0,1837422000.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,52.0,52,,,,,58.0,58,Period 1,-6.0,B,2018-03-23T11:00 (1)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,4.0,TREATMENT,21273.0,30600.0,1838017800.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,52.0,52,,,,Y,52.0,52,Period 2,nan,A,2018-03-30T08:30 (8)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,5.0,TREATMENT,21273.0,39600.0,1838026800.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,50.0,50,,,,,52.0,52,Period 2,-2.0,A,2018-03-30T11:00 (8)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,6.0,TREATMENT,21280.0,30600.0,1838622600.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,50.0,50,,,,Y,50.0,50,Period 3,nan,C,2018-04-06T08:30 (15)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,TREATMENT,21280.0,39600.0,1838631600.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,51.0,51,,,,,50.0,50,Period 3,1.0,C,2018-04-06T11:00 (15)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,END OF TREATMENT,21281.0,38400.0,1838716800.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,52.0,52,,,,,54.0,54,EOT/ET/Followup,-2.0,C,2018-04-07T10:40 (16)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21255.0,53900.0,1836485900.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-12T14:58 (-11)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,10.0,TREATMENT,21266.0,30600.0,1837413000.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,B,2018-03-23T08:30 (1)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,11.0,TREATMENT,21266.0,39600.0,1837422000.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,B,2018-03-23T11:00 (1)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,12.0,TREATMENT,21273.0,30600.0,1838017800.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,A,2018-03-30T08:30 (8)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,13.0,TREATMENT,21273.0,39600.0,1838026800.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,A,2018-03-30T11:00 (8)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,14.0,TREATMENT,21280.0,30600.0,1838622600.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,C,2018-04-06T08:30 (15)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,15.0,TREATMENT,21280.0,39600.0,1838631600.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,C,2018-04-06T11:00 (15)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,16.0,END OF TREATMENT,21281.0,38400.0,1838716800.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,C,2018-04-07T10:40 (16)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21255.0,53900.0,1836485900.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,154.0,154,,,,Y,154.0,154,EOT/ET/Followup,nan,NA,2018-03-12T14:58 (-11)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,18.0,TREATMENT,21266.0,30600.0,1837413000.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,149.0,149,,,,Y,149.0,149,Period 1,nan,B,2018-03-23T08:30 (1)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21266.0,39600.0,1837422000.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,154.0,154,,,,,149.0,149,Period 1,5.0,B,2018-03-23T11:00 (1)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,20.0,TREATMENT,21273.0,30600.0,1838017800.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,149.0,149,,,,Y,149.0,149,Period 2,nan,A,2018-03-30T08:30 (8)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21.0,TREATMENT,21273.0,39600.0,1838026800.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,153.0,153,,,,,149.0,149,Period 2,4.0,A,2018-03-30T11:00 (8)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,TREATMENT,21280.0,30600.0,1838622600.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,160.0,160,,,,Y,160.0,160,Period 3,nan,C,2018-04-06T08:30 (15)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,23.0,TREATMENT,21280.0,39600.0,1838631600.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,158.0,158,,,,,160.0,160,Period 3,-2.0,C,2018-04-06T11:00 (15)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,24.0,END OF TREATMENT,21281.0,38400.0,1838716800.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,152.0,152,,,,,154.0,154,EOT/ET/Followup,-2.0,C,2018-04-07T10:40 (16)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21255.0,53900.0,1836485900.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,107.0,107,,,,Y,107.0,107,EOT/ET/Followup,nan,NA,2018-03-12T14:58 (-11)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,26.0,TREATMENT,21266.0,30600.0,1837413000.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,Y,99.0,99,Period 1,nan,B,2018-03-23T08:30 (1)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,27.0,TREATMENT,21266.0,39600.0,1837422000.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,,99.0,99,Period 1,-2.0,B,2018-03-23T11:00 (1)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,28.0,TREATMENT,21273.0,30600.0,1838017800.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,109.0,109,,,,Y,109.0,109,Period 2,nan,A,2018-03-30T08:30 (8)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,TREATMENT,21273.0,39600.0,1838026800.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,100.0,100,,,,,109.0,109,Period 2,-9.0,A,2018-03-30T11:00 (8)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,30.0,TREATMENT,21280.0,30600.0,1838622600.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,Y,99.0,99,Period 3,nan,C,2018-04-06T08:30 (15)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,31.0,TREATMENT,21280.0,39600.0,1838631600.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,,99.0,99,Period 3,-2.0,C,2018-04-06T11:00 (15)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,32.0,END OF TREATMENT,21281.0,38400.0,1838716800.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,,107.0,107,EOT/ET/Followup,-8.0,C,2018-04-07T10:40 (16)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21255.0,53900.0,1836485900.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,416.0,416,,,,Y,416.0,416,EOT/ET/Followup,nan,NA,2018-03-12T14:58 (-11)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21266.0,30600.0,1837413000.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,404.0,404,,,,Y,404.0,404,Period 1,nan,B,2018-03-23T08:30 (1)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,35.0,TREATMENT,21266.0,39600.0,1837422000.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,405.0,405,,,,,404.0,404,Period 1,1.0,B,2018-03-23T11:00 (1)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,36.0,TREATMENT,21273.0,30600.0,1838017800.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,429.0,429,,,,Y,429.0,429,Period 2,nan,A,2018-03-30T08:30 (8)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,37.0,TREATMENT,21273.0,39600.0,1838026800.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,424.0,424,,,,,429.0,429,Period 2,-5.0,A,2018-03-30T11:00 (8)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,38.0,TREATMENT,21280.0,30600.0,1838622600.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,433.0,433,,,,Y,433.0,433,Period 3,nan,C,2018-04-06T08:30 (15)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,39.0,TREATMENT,21280.0,39600.0,1838631600.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,412.0,412,,,,,433.0,433,Period 3,-21.0,C,2018-04-06T11:00 (15)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,40.0,END OF TREATMENT,21281.0,38400.0,1838716800.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,413.0,413,,,,,416.0,416,EOT/ET/Followup,-3.0,C,2018-04-07T10:40 (16)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21255.0,53900.0,1836485900.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,394.0,394,,,,Y,394.0,394,EOT/ET/Followup,nan,NA,2018-03-12T14:58 (-11)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,42.0,TREATMENT,21266.0,30600.0,1837413000.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,397.0,397,,,,Y,397.0,397,Period 1,nan,B,2018-03-23T08:30 (1)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,43.0,TREATMENT,21266.0,39600.0,1837422000.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,379.0,379,,,,,397.0,397,Period 1,-18.0,B,2018-03-23T11:00 (1)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,44.0,TREATMENT,21273.0,30600.0,1838017800.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,402.0,402,,,,Y,402.0,402,Period 2,nan,A,2018-03-30T08:30 (8)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,45.0,TREATMENT,21273.0,39600.0,1838026800.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,388.0,388,,,,,402.0,402,Period 2,-14.0,A,2018-03-30T11:00 (8)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,46.0,TREATMENT,21280.0,30600.0,1838622600.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,397.0,397,,,,Y,397.0,397,Period 3,nan,C,2018-04-06T08:30 (15)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,47.0,TREATMENT,21280.0,39600.0,1838631600.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,383.0,383,,,,,397.0,397,Period 3,-14.0,C,2018-04-06T11:00 (15)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,48.0,END OF TREATMENT,21281.0,38400.0,1838716800.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,384.0,384,,,,,394.0,394,EOT/ET/Followup,-10.0,C,2018-04-07T10:40 (16)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21255.0,53900.0,1836485900.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,401.0,401,,,,Y,401.0,401,EOT/ET/Followup,nan,NA,2018-03-12T14:58 (-11)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,50.0,TREATMENT,21266.0,30600.0,1837413000.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,399.0,399,,,,Y,399.0,399,Period 1,nan,B,2018-03-23T08:30 (1)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,51.0,TREATMENT,21266.0,39600.0,1837422000.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,387.0,387,,,,,399.0,399,Period 1,-12.0,B,2018-03-23T11:00 (1)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,52.0,TREATMENT,21273.0,30600.0,1838017800.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,411.0,411,,,,Y,411.0,411,Period 2,nan,A,2018-03-30T08:30 (8)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,53.0,TREATMENT,21273.0,39600.0,1838026800.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,400.0,400,,,,,411.0,411,Period 2,-11.0,A,2018-03-30T11:00 (8)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,54.0,TREATMENT,21280.0,30600.0,1838622600.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,408.0,408,,,,Y,408.0,408,Period 3,nan,C,2018-04-06T08:30 (15)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,55.0,TREATMENT,21280.0,39600.0,1838631600.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,392.0,392,,,,,408.0,408,Period 3,-16.0,C,2018-04-06T11:00 (15)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,56.0,END OF TREATMENT,21281.0,38400.0,1838716800.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,394.0,394,,,,,401.0,401,EOT/ET/Followup,-7.0,C,2018-04-07T10:40 (16)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21255.0,53900.0,1836485900.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,1111.0,1111,,,,Y,1111.0,1111,EOT/ET/Followup,nan,NA,2018-03-12T14:58 (-11)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,58.0,TREATMENT,21266.0,30600.0,1837413000.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1033.0,1033,,,,Y,1033.0,1033,Period 1,nan,B,2018-03-23T08:30 (1)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,59.0,TREATMENT,21266.0,39600.0,1837422000.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1141.0,1141,,,,,1033.0,1033,Period 1,108.0,B,2018-03-23T11:00 (1)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,60.0,TREATMENT,21273.0,30600.0,1838017800.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1134.0,1134,,,,Y,1134.0,1134,Period 2,nan,A,2018-03-30T08:30 (8)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,61.0,TREATMENT,21273.0,39600.0,1838026800.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1190.0,1190,,,,,1134.0,1134,Period 2,56.0,A,2018-03-30T11:00 (8)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,62.0,TREATMENT,21280.0,30600.0,1838622600.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1187.0,1187,,,,Y,1187.0,1187,Period 3,nan,C,2018-04-06T08:30 (15)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,63.0,TREATMENT,21280.0,39600.0,1838631600.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1155.0,1155,,,,,1187.0,1187,Period 3,-32.0,C,2018-04-06T11:00 (15)
3110-103-002,3110-103-002.103001048,103001048,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,64.0,END OF TREATMENT,21281.0,38400.0,1838716800.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1151.0,1151,,,,,1111.0,1111,EOT/ET/Followup,40.0,C,2018-04-07T10:40 (16)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21255.0,55027.0,1836487027.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,66.0,66,,,,Y,66.0,66,EOT/ET/Followup,nan,NA,2018-03-12T15:17 (-11)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,2.0,TREATMENT,21266.0,30660.0,1837413060.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,71.0,71,,,,Y,71.0,71,Period 1,nan,A,2018-03-23T08:31 (1)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21266.0,39660.0,1837422060.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,62.0,62,,,,,71.0,71,Period 1,-9.0,A,2018-03-23T11:01 (1)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,TREATMENT,21273.0,30660.0,1838017860.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,82.0,82,,,,Y,82.0,82,Period 2,nan,C,2018-03-30T08:31 (8)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,5.0,TREATMENT,21273.0,39660.0,1838026860.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,67.0,67,,,,,82.0,82,Period 2,-15.0,C,2018-03-30T11:01 (8)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21280.0,30660.0,1838622660.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,79.0,79,,,,Y,79.0,79,Period 3,nan,B,2018-04-06T08:31 (15)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,7.0,TREATMENT,21280.0,39660.0,1838631660.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,72.0,72,,,,,79.0,79,Period 3,-7.0,B,2018-04-06T11:01 (15)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,8.0,END OF TREATMENT,21281.0,38460.0,1838716860.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,78.0,78,,,,,66.0,66,EOT/ET/Followup,12.0,B,2018-04-07T10:41 (16)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21255.0,55027.0,1836487027.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-12T15:17 (-11)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,10.0,TREATMENT,21266.0,30660.0,1837413060.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,A,2018-03-23T08:31 (1)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,11.0,TREATMENT,21266.0,39660.0,1837422060.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,A,2018-03-23T11:01 (1)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,12.0,TREATMENT,21273.0,30660.0,1838017860.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,C,2018-03-30T08:31 (8)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,13.0,TREATMENT,21273.0,39660.0,1838026860.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,C,2018-03-30T11:01 (8)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,14.0,TREATMENT,21280.0,30660.0,1838622660.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,B,2018-04-06T08:31 (15)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,15.0,TREATMENT,21280.0,39660.0,1838631660.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,B,2018-04-06T11:01 (15)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,16.0,END OF TREATMENT,21281.0,38460.0,1838716860.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,B,2018-04-07T10:41 (16)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21255.0,55027.0,1836487027.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,163.0,163,,,,Y,163.0,163,EOT/ET/Followup,nan,NA,2018-03-12T15:17 (-11)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,18.0,TREATMENT,21266.0,30660.0,1837413060.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,158.0,158,,,,Y,158.0,158,Period 1,nan,A,2018-03-23T08:31 (1)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,19.0,TREATMENT,21266.0,39660.0,1837422060.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,143.0,143,,,,,158.0,158,Period 1,-15.0,A,2018-03-23T11:01 (1)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,TREATMENT,21273.0,30660.0,1838017860.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,158.0,158,,,,Y,158.0,158,Period 2,nan,C,2018-03-30T08:31 (8)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21.0,TREATMENT,21273.0,39660.0,1838026860.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,161.0,161,,,,,158.0,158,Period 2,3.0,C,2018-03-30T11:01 (8)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,22.0,TREATMENT,21280.0,30660.0,1838622660.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,156.0,156,,,,Y,156.0,156,Period 3,nan,B,2018-04-06T08:31 (15)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,23.0,TREATMENT,21280.0,39660.0,1838631660.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,156.0,156,,,,,156.0,156,Period 3,0.0,B,2018-04-06T11:01 (15)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,24.0,END OF TREATMENT,21281.0,38460.0,1838716860.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,133.0,133,,,,,163.0,163,EOT/ET/Followup,-30.0,B,2018-04-07T10:41 (16)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21255.0,55027.0,1836487027.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,83.0,83,,,,Y,83.0,83,EOT/ET/Followup,nan,NA,2018-03-12T15:17 (-11)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,26.0,TREATMENT,21266.0,30660.0,1837413060.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,84.0,84,,,,Y,84.0,84,Period 1,nan,A,2018-03-23T08:31 (1)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,TREATMENT,21266.0,39660.0,1837422060.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,86.0,86,,,,,84.0,84,Period 1,2.0,A,2018-03-23T11:01 (1)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,28.0,TREATMENT,21273.0,30660.0,1838017860.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,74.0,74,,,,Y,74.0,74,Period 2,nan,C,2018-03-30T08:31 (8)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,29.0,TREATMENT,21273.0,39660.0,1838026860.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,85.0,85,,,,,74.0,74,Period 2,11.0,C,2018-03-30T11:01 (8)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,30.0,TREATMENT,21280.0,30660.0,1838622660.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,77.0,77,,,,Y,77.0,77,Period 3,nan,B,2018-04-06T08:31 (15)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,31.0,TREATMENT,21280.0,39660.0,1838631660.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,82.0,82,,,,,77.0,77,Period 3,5.0,B,2018-04-06T11:01 (15)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,32.0,END OF TREATMENT,21281.0,38460.0,1838716860.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,84.0,84,,,,,83.0,83,EOT/ET/Followup,1.0,B,2018-04-07T10:41 (16)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21255.0,55027.0,1836487027.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,374.0,374,,,,Y,374.0,374,EOT/ET/Followup,nan,NA,2018-03-12T15:17 (-11)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,34.0,TREATMENT,21266.0,30660.0,1837413060.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,382.0,382,,,,Y,382.0,382,Period 1,nan,A,2018-03-23T08:31 (1)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,35.0,TREATMENT,21266.0,39660.0,1837422060.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,390.0,390,,,,,382.0,382,Period 1,8.0,A,2018-03-23T11:01 (1)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,36.0,TREATMENT,21273.0,30660.0,1838017860.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,347.0,347,,,,Y,347.0,347,Period 2,nan,C,2018-03-30T08:31 (8)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,37.0,TREATMENT,21273.0,39660.0,1838026860.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,379.0,379,,,,,347.0,347,Period 2,32.0,C,2018-03-30T11:01 (8)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,38.0,TREATMENT,21280.0,30660.0,1838622660.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,370.0,370,,,,Y,370.0,370,Period 3,nan,B,2018-04-06T08:31 (15)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,39.0,TREATMENT,21280.0,39660.0,1838631660.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,368.0,368,,,,,370.0,370,Period 3,-2.0,B,2018-04-06T11:01 (15)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,40.0,END OF TREATMENT,21281.0,38460.0,1838716860.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,350.0,350,,,,,374.0,374,EOT/ET/Followup,-24.0,B,2018-04-07T10:41 (16)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21255.0,55027.0,1836487027.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,394.0,394,,,,Y,394.0,394,EOT/ET/Followup,nan,NA,2018-03-12T15:17 (-11)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,42.0,TREATMENT,21266.0,30660.0,1837413060.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,416.0,416,,,,Y,416.0,416,Period 1,nan,A,2018-03-23T08:31 (1)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,43.0,TREATMENT,21266.0,39660.0,1837422060.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,396.0,396,,,,,416.0,416,Period 1,-20.0,A,2018-03-23T11:01 (1)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,44.0,TREATMENT,21273.0,30660.0,1838017860.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,406.0,406,,,,Y,406.0,406,Period 2,nan,C,2018-03-30T08:31 (8)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,45.0,TREATMENT,21273.0,39660.0,1838026860.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,402.0,402,,,,,406.0,406,Period 2,-4.0,C,2018-03-30T11:01 (8)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,46.0,TREATMENT,21280.0,30660.0,1838622660.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,424.0,424,,,,Y,424.0,424,Period 3,nan,B,2018-04-06T08:31 (15)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,47.0,TREATMENT,21280.0,39660.0,1838631660.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,403.0,403,,,,,424.0,424,Period 3,-21.0,B,2018-04-06T11:01 (15)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,48.0,END OF TREATMENT,21281.0,38460.0,1838716860.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,399.0,399,,,,,394.0,394,EOT/ET/Followup,5.0,B,2018-04-07T10:41 (16)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21255.0,55027.0,1836487027.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,387.0,387,,,,Y,387.0,387,EOT/ET/Followup,nan,NA,2018-03-12T15:17 (-11)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,50.0,TREATMENT,21266.0,30660.0,1837413060.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,404.0,404,,,,Y,404.0,404,Period 1,nan,A,2018-03-23T08:31 (1)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,51.0,TREATMENT,21266.0,39660.0,1837422060.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,394.0,394,,,,,404.0,404,Period 1,-10.0,A,2018-03-23T11:01 (1)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,52.0,TREATMENT,21273.0,30660.0,1838017860.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,385.0,385,,,,Y,385.0,385,Period 2,nan,C,2018-03-30T08:31 (8)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,53.0,TREATMENT,21273.0,39660.0,1838026860.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,394.0,394,,,,,385.0,385,Period 2,9.0,C,2018-03-30T11:01 (8)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,54.0,TREATMENT,21280.0,30660.0,1838622660.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,405.0,405,,,,Y,405.0,405,Period 3,nan,B,2018-04-06T08:31 (15)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,55.0,TREATMENT,21280.0,39660.0,1838631660.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,391.0,391,,,,,405.0,405,Period 3,-14.0,B,2018-04-06T11:01 (15)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,56.0,END OF TREATMENT,21281.0,38460.0,1838716860.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,382.0,382,,,,,387.0,387,EOT/ET/Followup,-5.0,B,2018-04-07T10:41 (16)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21255.0,55027.0,1836487027.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,898.0,898,,,,Y,898.0,898,EOT/ET/Followup,nan,NA,2018-03-12T15:17 (-11)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,58.0,TREATMENT,21266.0,30660.0,1837413060.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,841.0,841,,,,Y,841.0,841,Period 1,nan,A,2018-03-23T08:31 (1)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,59.0,TREATMENT,21266.0,39660.0,1837422060.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,966.0,966,,,,,841.0,841,Period 1,125.0,A,2018-03-23T11:01 (1)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,60.0,TREATMENT,21273.0,30660.0,1838017860.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,728.0,728,,,,Y,728.0,728,Period 2,nan,C,2018-03-30T08:31 (8)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,61.0,TREATMENT,21273.0,39660.0,1838026860.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,887.0,887,,,,,728.0,728,Period 2,159.0,C,2018-03-30T11:01 (8)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,62.0,TREATMENT,21280.0,30660.0,1838622660.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,758.0,758,,,,Y,758.0,758,Period 3,nan,B,2018-04-06T08:31 (15)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,63.0,TREATMENT,21280.0,39660.0,1838631660.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,832.0,832,,,,,758.0,758,Period 3,74.0,B,2018-04-06T11:01 (15)
3110-103-002,3110-103-002.103001052,103001052,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,64.0,END OF TREATMENT,21281.0,38460.0,1838716860.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,767.0,767,,,,,898.0,898,EOT/ET/Followup,-131.0,B,2018-04-07T10:41 (16)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21255.0,47220.0,1836479220.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,63.0,63,,,,Y,63.0,63,EOT/ET/Followup,nan,NA,2018-03-12T13:07 (-11)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21266.0,30720.0,1837413120.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,58.0,58,,,,Y,58.0,58,Period 1,nan,C,2018-03-23T08:32 (1)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21266.0,39720.0,1837422120.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,53.0,53,,,,,58.0,58,Period 1,-5.0,C,2018-03-23T11:02 (1)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,4.0,TREATMENT,21273.0,30720.0,1838017920.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,58.0,58,,,,Y,58.0,58,Period 2,nan,A,2018-03-30T08:32 (8)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,5.0,TREATMENT,21273.0,39720.0,1838026920.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,55.0,55,,,,,58.0,58,Period 2,-3.0,A,2018-03-30T11:02 (8)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21280.0,30720.0,1838622720.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,57.0,57,,,,Y,57.0,57,Period 3,nan,B,2018-04-06T08:32 (15)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,7.0,TREATMENT,21280.0,39720.0,1838631720.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,55.0,55,,,,,57.0,57,Period 3,-2.0,B,2018-04-06T11:02 (15)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,8.0,END OF TREATMENT,21281.0,38520.0,1838716920.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,55.0,55,,,,,63.0,63,EOT/ET/Followup,-8.0,B,2018-04-07T10:42 (16)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21255.0,47220.0,1836479220.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-12T13:07 (-11)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21266.0,30720.0,1837413120.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,C,2018-03-23T08:32 (1)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,TREATMENT,21266.0,39720.0,1837422120.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,C,2018-03-23T11:02 (1)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,12.0,TREATMENT,21273.0,30720.0,1838017920.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,A,2018-03-30T08:32 (8)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,13.0,TREATMENT,21273.0,39720.0,1838026920.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,A,2018-03-30T11:02 (8)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,14.0,TREATMENT,21280.0,30720.0,1838622720.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,B,2018-04-06T08:32 (15)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,15.0,TREATMENT,21280.0,39720.0,1838631720.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,B,2018-04-06T11:02 (15)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,16.0,END OF TREATMENT,21281.0,38520.0,1838716920.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,B,2018-04-07T10:42 (16)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21255.0,47220.0,1836479220.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,140.0,140,,,,Y,140.0,140,EOT/ET/Followup,nan,NA,2018-03-12T13:07 (-11)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21266.0,30720.0,1837413120.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,138.0,138,,,,Y,138.0,138,Period 1,nan,C,2018-03-23T08:32 (1)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21266.0,39720.0,1837422120.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,133.0,133,,,,,138.0,138,Period 1,-5.0,C,2018-03-23T11:02 (1)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,20.0,TREATMENT,21273.0,30720.0,1838017920.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,140.0,140,,,,Y,140.0,140,Period 2,nan,A,2018-03-30T08:32 (8)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21.0,TREATMENT,21273.0,39720.0,1838026920.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,123.0,123,,,,,140.0,140,Period 2,-17.0,A,2018-03-30T11:02 (8)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,22.0,TREATMENT,21280.0,30720.0,1838622720.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,142.0,142,,,,Y,142.0,142,Period 3,nan,B,2018-04-06T08:32 (15)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,23.0,TREATMENT,21280.0,39720.0,1838631720.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,146.0,146,,,,,142.0,142,Period 3,4.0,B,2018-04-06T11:02 (15)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,24.0,END OF TREATMENT,21281.0,38520.0,1838716920.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,144.0,144,,,,,140.0,140,EOT/ET/Followup,4.0,B,2018-04-07T10:42 (16)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21255.0,47220.0,1836479220.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,90.0,90,,,,Y,90.0,90,EOT/ET/Followup,nan,NA,2018-03-12T13:07 (-11)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,26.0,TREATMENT,21266.0,30720.0,1837413120.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,Y,96.0,96,Period 1,nan,C,2018-03-23T08:32 (1)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,27.0,TREATMENT,21266.0,39720.0,1837422120.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,90.0,90,,,,,96.0,96,Period 1,-6.0,C,2018-03-23T11:02 (1)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,28.0,TREATMENT,21273.0,30720.0,1838017920.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,Y,96.0,96,Period 2,nan,A,2018-03-30T08:32 (8)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,TREATMENT,21273.0,39720.0,1838026920.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,,96.0,96,Period 2,0.0,A,2018-03-30T11:02 (8)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,30.0,TREATMENT,21280.0,30720.0,1838622720.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,87.0,87,,,,Y,87.0,87,Period 3,nan,B,2018-04-06T08:32 (15)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,31.0,TREATMENT,21280.0,39720.0,1838631720.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,88.0,88,,,,,87.0,87,Period 3,1.0,B,2018-04-06T11:02 (15)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,32.0,END OF TREATMENT,21281.0,38520.0,1838716920.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,89.0,89,,,,,90.0,90,EOT/ET/Followup,-1.0,B,2018-04-07T10:42 (16)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21255.0,47220.0,1836479220.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,396.0,396,,,,Y,396.0,396,EOT/ET/Followup,nan,NA,2018-03-12T13:07 (-11)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,34.0,TREATMENT,21266.0,30720.0,1837413120.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,399.0,399,,,,Y,399.0,399,Period 1,nan,C,2018-03-23T08:32 (1)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,35.0,TREATMENT,21266.0,39720.0,1837422120.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,399.0,399,,,,,399.0,399,Period 1,0.0,C,2018-03-23T11:02 (1)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,36.0,TREATMENT,21273.0,30720.0,1838017920.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,394.0,394,,,,Y,394.0,394,Period 2,nan,A,2018-03-30T08:32 (8)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,37.0,TREATMENT,21273.0,39720.0,1838026920.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,413.0,413,,,,,394.0,394,Period 2,19.0,A,2018-03-30T11:02 (8)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,38.0,TREATMENT,21280.0,30720.0,1838622720.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,401.0,401,,,,Y,401.0,401,Period 3,nan,B,2018-04-06T08:32 (15)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,39.0,TREATMENT,21280.0,39720.0,1838631720.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,388.0,388,,,,,401.0,401,Period 3,-13.0,B,2018-04-06T11:02 (15)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,40.0,END OF TREATMENT,21281.0,38520.0,1838716920.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,391.0,391,,,,,396.0,396,EOT/ET/Followup,-5.0,B,2018-04-07T10:42 (16)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21255.0,47220.0,1836479220.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,407.0,407,,,,Y,407.0,407,EOT/ET/Followup,nan,NA,2018-03-12T13:07 (-11)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,42.0,TREATMENT,21266.0,30720.0,1837413120.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,393.0,393,,,,Y,393.0,393,Period 1,nan,C,2018-03-23T08:32 (1)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,43.0,TREATMENT,21266.0,39720.0,1837422120.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,376.0,376,,,,,393.0,393,Period 1,-17.0,C,2018-03-23T11:02 (1)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,44.0,TREATMENT,21273.0,30720.0,1838017920.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,388.0,388,,,,Y,388.0,388,Period 2,nan,A,2018-03-30T08:32 (8)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,45.0,TREATMENT,21273.0,39720.0,1838026920.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,397.0,397,,,,,388.0,388,Period 2,9.0,A,2018-03-30T11:02 (8)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,46.0,TREATMENT,21280.0,30720.0,1838622720.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,391.0,391,,,,Y,391.0,391,Period 3,nan,B,2018-04-06T08:32 (15)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,47.0,TREATMENT,21280.0,39720.0,1838631720.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,372.0,372,,,,,391.0,391,Period 3,-19.0,B,2018-04-06T11:02 (15)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,48.0,END OF TREATMENT,21281.0,38520.0,1838716920.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,374.0,374,,,,,407.0,407,EOT/ET/Followup,-33.0,B,2018-04-07T10:42 (16)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21255.0,47220.0,1836479220.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,403.0,403,,,,Y,403.0,403,EOT/ET/Followup,nan,NA,2018-03-12T13:07 (-11)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,50.0,TREATMENT,21266.0,30720.0,1837413120.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,395.0,395,,,,Y,395.0,395,Period 1,nan,C,2018-03-23T08:32 (1)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,51.0,TREATMENT,21266.0,39720.0,1837422120.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,383.0,383,,,,,395.0,395,Period 1,-12.0,C,2018-03-23T11:02 (1)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,52.0,TREATMENT,21273.0,30720.0,1838017920.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,390.0,390,,,,Y,390.0,390,Period 2,nan,A,2018-03-30T08:32 (8)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,53.0,TREATMENT,21273.0,39720.0,1838026920.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,402.0,402,,,,,390.0,390,Period 2,12.0,A,2018-03-30T11:02 (8)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,54.0,TREATMENT,21280.0,30720.0,1838622720.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,394.0,394,,,,Y,394.0,394,Period 3,nan,B,2018-04-06T08:32 (15)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,55.0,TREATMENT,21280.0,39720.0,1838631720.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,377.0,377,,,,,394.0,394,Period 3,-17.0,B,2018-04-06T11:02 (15)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,56.0,END OF TREATMENT,21281.0,38520.0,1838716920.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,380.0,380,,,,,403.0,403,EOT/ET/Followup,-23.0,B,2018-04-07T10:42 (16)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21255.0,47220.0,1836479220.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,944.0,944,,,,Y,944.0,944,EOT/ET/Followup,nan,NA,2018-03-12T13:07 (-11)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,58.0,TREATMENT,21266.0,30720.0,1837413120.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1029.0,1029,,,,Y,1029.0,1029,Period 1,nan,C,2018-03-23T08:32 (1)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,59.0,TREATMENT,21266.0,39720.0,1837422120.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1123.0,1123,,,,,1029.0,1029,Period 1,94.0,C,2018-03-23T11:02 (1)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,60.0,TREATMENT,21273.0,30720.0,1838017920.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1029.0,1029,,,,Y,1029.0,1029,Period 2,nan,A,2018-03-30T08:32 (8)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,61.0,TREATMENT,21273.0,39720.0,1838026920.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1081.0,1081,,,,,1029.0,1029,Period 2,52.0,A,2018-03-30T11:02 (8)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,62.0,TREATMENT,21280.0,30720.0,1838622720.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1048.0,1048,,,,Y,1048.0,1048,Period 3,nan,B,2018-04-06T08:32 (15)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,63.0,TREATMENT,21280.0,39720.0,1838631720.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1086.0,1086,,,,,1048.0,1048,Period 3,38.0,B,2018-04-06T11:02 (15)
3110-103-002,3110-103-002.103001054,103001054,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,64.0,END OF TREATMENT,21281.0,38520.0,1838716920.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1088.0,1088,,,,,944.0,944,EOT/ET/Followup,144.0,B,2018-04-07T10:42 (16)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21255.0,57371.0,1836489371.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,57.0,57,,,,Y,57.0,57,EOT/ET/Followup,nan,NA,2018-03-12T15:56 (-11)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,2.0,TREATMENT,21266.0,31320.0,1837413720.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,51.0,51,,,,Y,51.0,51,Period 1,nan,A,2018-03-23T08:42 (1)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21266.0,40320.0,1837422720.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,44.0,44,,,,,51.0,51,Period 1,-7.0,A,2018-03-23T11:12 (1)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,TREATMENT,21273.0,31320.0,1838018520.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,53.0,53,,,,Y,53.0,53,Period 2,nan,C,2018-03-30T08:42 (8)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,5.0,TREATMENT,21273.0,40320.0,1838027520.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,50.0,50,,,,,53.0,53,Period 2,-3.0,C,2018-03-30T11:12 (8)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21280.0,31320.0,1838623320.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,49.0,49,,,,Y,49.0,49,Period 3,nan,B,2018-04-06T08:42 (15)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,7.0,TREATMENT,21280.0,40333.0,1838632333.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,52.0,52,,,,,49.0,49,Period 3,3.0,B,2018-04-06T11:12 (15)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,8.0,END OF TREATMENT,21281.0,39122.0,1838717522.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,49.0,49,,,,,57.0,57,EOT/ET/Followup,-8.0,B,2018-04-07T10:52 (16)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21255.0,57371.0,1836489371.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-12T15:56 (-11)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,10.0,TREATMENT,21266.0,31320.0,1837413720.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,A,2018-03-23T08:42 (1)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,11.0,TREATMENT,21266.0,40320.0,1837422720.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Abnormal, NCS,,,SINUS BRADYCARDIA,,nan,Normal,Period 1,nan,A,2018-03-23T11:12 (1)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,12.0,TREATMENT,21273.0,31320.0,1838018520.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,C,2018-03-30T08:42 (8)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,13.0,TREATMENT,21273.0,40320.0,1838027520.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,C,2018-03-30T11:12 (8)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,14.0,TREATMENT,21280.0,31320.0,1838623320.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,Y,nan,Normal,Period 3,nan,B,2018-04-06T08:42 (15)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,15.0,TREATMENT,21280.0,40333.0,1838632333.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,B,2018-04-06T11:12 (15)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,16.0,END OF TREATMENT,21281.0,39122.0,1838717522.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,B,2018-04-07T10:52 (16)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21255.0,57371.0,1836489371.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,172.0,172,,,,Y,172.0,172,EOT/ET/Followup,nan,NA,2018-03-12T15:56 (-11)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,18.0,TREATMENT,21266.0,31320.0,1837413720.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,162.0,162,,,,Y,162.0,162,Period 1,nan,A,2018-03-23T08:42 (1)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,19.0,TREATMENT,21266.0,40320.0,1837422720.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,166.0,166,,,,,162.0,162,Period 1,4.0,A,2018-03-23T11:12 (1)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,TREATMENT,21273.0,31320.0,1838018520.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,167.0,167,,,,Y,167.0,167,Period 2,nan,C,2018-03-30T08:42 (8)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21.0,TREATMENT,21273.0,40320.0,1838027520.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,160.0,160,,,,,167.0,167,Period 2,-7.0,C,2018-03-30T11:12 (8)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,22.0,TREATMENT,21280.0,31320.0,1838623320.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,165.0,165,,,,Y,165.0,165,Period 3,nan,B,2018-04-06T08:42 (15)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,23.0,TREATMENT,21280.0,40333.0,1838632333.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,159.0,159,,,,,165.0,165,Period 3,-6.0,B,2018-04-06T11:12 (15)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,24.0,END OF TREATMENT,21281.0,39122.0,1838717522.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,167.0,167,,,,,172.0,172,EOT/ET/Followup,-5.0,B,2018-04-07T10:52 (16)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21255.0,57371.0,1836489371.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,Y,94.0,94,EOT/ET/Followup,nan,NA,2018-03-12T15:56 (-11)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,26.0,TREATMENT,21266.0,31320.0,1837413720.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,Y,94.0,94,Period 1,nan,A,2018-03-23T08:42 (1)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,TREATMENT,21266.0,40320.0,1837422720.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,88.0,88,,,,,94.0,94,Period 1,-6.0,A,2018-03-23T11:12 (1)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,28.0,TREATMENT,21273.0,31320.0,1838018520.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,89.0,89,,,,Y,89.0,89,Period 2,nan,C,2018-03-30T08:42 (8)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,29.0,TREATMENT,21273.0,40320.0,1838027520.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,91.0,91,,,,,89.0,89,Period 2,2.0,C,2018-03-30T11:12 (8)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,30.0,TREATMENT,21280.0,31320.0,1838623320.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,86.0,86,,,,Y,86.0,86,Period 3,nan,B,2018-04-06T08:42 (15)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,31.0,TREATMENT,21280.0,40333.0,1838632333.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,93.0,93,,,,,86.0,86,Period 3,7.0,B,2018-04-06T11:12 (15)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,32.0,END OF TREATMENT,21281.0,39122.0,1838717522.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,92.0,92,,,,,94.0,94,EOT/ET/Followup,-2.0,B,2018-04-07T10:52 (16)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21255.0,57371.0,1836489371.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,387.0,387,,,,Y,387.0,387,EOT/ET/Followup,nan,NA,2018-03-12T15:56 (-11)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,34.0,TREATMENT,21266.0,31320.0,1837413720.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,412.0,412,,,,Y,412.0,412,Period 1,nan,A,2018-03-23T08:42 (1)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,35.0,TREATMENT,21266.0,40320.0,1837422720.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,404.0,404,,,,,412.0,412,Period 1,-8.0,A,2018-03-23T11:12 (1)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,36.0,TREATMENT,21273.0,31320.0,1838018520.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,397.0,397,,,,Y,397.0,397,Period 2,nan,C,2018-03-30T08:42 (8)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,37.0,TREATMENT,21273.0,40320.0,1838027520.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,415.0,415,,,,,397.0,397,Period 2,18.0,C,2018-03-30T11:12 (8)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,38.0,TREATMENT,21280.0,31320.0,1838623320.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,408.0,408,,,,Y,408.0,408,Period 3,nan,B,2018-04-06T08:42 (15)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,39.0,TREATMENT,21280.0,40333.0,1838632333.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,403.0,403,,,,,408.0,408,Period 3,-5.0,B,2018-04-06T11:12 (15)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,40.0,END OF TREATMENT,21281.0,39122.0,1838717522.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,400.0,400,,,,,387.0,387,EOT/ET/Followup,13.0,B,2018-04-07T10:52 (16)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21255.0,57371.0,1836489371.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,378.0,378,,,,Y,378.0,378,EOT/ET/Followup,nan,NA,2018-03-12T15:56 (-11)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,42.0,TREATMENT,21266.0,31320.0,1837413720.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,381.0,381,,,,Y,381.0,381,Period 1,nan,A,2018-03-23T08:42 (1)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,43.0,TREATMENT,21266.0,40320.0,1837422720.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,348.0,348,,,,,381.0,381,Period 1,-33.0,A,2018-03-23T11:12 (1)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,44.0,TREATMENT,21273.0,31320.0,1838018520.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,375.0,375,,,,Y,375.0,375,Period 2,nan,C,2018-03-30T08:42 (8)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,45.0,TREATMENT,21273.0,40320.0,1838027520.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,382.0,382,,,,,375.0,375,Period 2,7.0,C,2018-03-30T11:12 (8)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,46.0,TREATMENT,21280.0,31320.0,1838623320.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,371.0,371,,,,Y,371.0,371,Period 3,nan,B,2018-04-06T08:42 (15)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,47.0,TREATMENT,21280.0,40333.0,1838632333.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,376.0,376,,,,,371.0,371,Period 3,5.0,B,2018-04-06T11:12 (15)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,48.0,END OF TREATMENT,21281.0,39122.0,1838717522.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,362.0,362,,,,,378.0,378,EOT/ET/Followup,-16.0,B,2018-04-07T10:52 (16)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21255.0,57371.0,1836489371.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,380.0,380,,,,Y,380.0,380,EOT/ET/Followup,nan,NA,2018-03-12T15:56 (-11)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,50.0,TREATMENT,21266.0,31320.0,1837413720.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,391.0,391,,,,Y,391.0,391,Period 1,nan,A,2018-03-23T08:42 (1)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,51.0,TREATMENT,21266.0,40320.0,1837422720.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,366.0,366,,,,,391.0,391,Period 1,-25.0,A,2018-03-23T11:12 (1)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,52.0,TREATMENT,21273.0,31320.0,1838018520.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,382.0,382,,,,Y,382.0,382,Period 2,nan,C,2018-03-30T08:42 (8)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,53.0,TREATMENT,21273.0,40320.0,1838027520.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,392.0,392,,,,,382.0,382,Period 2,10.0,C,2018-03-30T11:12 (8)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,54.0,TREATMENT,21280.0,31320.0,1838623320.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,382.0,382,,,,Y,382.0,382,Period 3,nan,B,2018-04-06T08:42 (15)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,55.0,TREATMENT,21280.0,40333.0,1838632333.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,385.0,385,,,,,382.0,382,Period 3,3.0,B,2018-04-06T11:12 (15)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,56.0,END OF TREATMENT,21281.0,39122.0,1838717522.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,374.0,374,,,,,380.0,380,EOT/ET/Followup,-6.0,B,2018-04-07T10:52 (16)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21255.0,57371.0,1836489371.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,1048.0,1048,,,,Y,1048.0,1048,EOT/ET/Followup,nan,NA,2018-03-12T15:56 (-11)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,58.0,TREATMENT,21266.0,31320.0,1837413720.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1165.0,1165,,,,Y,1165.0,1165,Period 1,nan,A,2018-03-23T08:42 (1)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,59.0,TREATMENT,21266.0,40320.0,1837422720.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1344.0,1344,,,,,1165.0,1165,Period 1,179.0,A,2018-03-23T11:12 (1)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,60.0,TREATMENT,21273.0,31320.0,1838018520.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1115.0,1115,,,,Y,1115.0,1115,Period 2,nan,C,2018-03-30T08:42 (8)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,61.0,TREATMENT,21273.0,40320.0,1838027520.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1180.0,1180,,,,,1115.0,1115,Period 2,65.0,C,2018-03-30T11:12 (8)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,62.0,TREATMENT,21280.0,31320.0,1838623320.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1209.0,1209,,,,Y,1209.0,1209,Period 3,nan,B,2018-04-06T08:42 (15)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,63.0,TREATMENT,21280.0,40333.0,1838632333.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1146.0,1146,,,,,1209.0,1209,Period 3,-63.0,B,2018-04-06T11:12 (15)
3110-103-002,3110-103-002.103001057,103001057,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,64.0,END OF TREATMENT,21281.0,39122.0,1838717522.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1216.0,1216,,,,,1048.0,1048,EOT/ET/Followup,168.0,B,2018-04-07T10:52 (16)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21255.0,58440.0,1836490440.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,85.0,85,,,,Y,85.0,85,EOT/ET/Followup,nan,NA,2018-03-12T16:14 (-11)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21266.0,31080.0,1837413480.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,65.0,65,,,,Y,65.0,65,Period 1,nan,C,2018-03-23T08:38 (1)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21266.0,40080.0,1837422480.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,62.0,62,,,,,65.0,65,Period 1,-3.0,C,2018-03-23T11:08 (1)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,END OF TREATMENT,21272.0,61866.0,1837962666.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,68.0,68,,,,,85.0,85,EOT/ET/Followup,-17.0,C,2018-03-29T17:11 (7)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,5.0,SCREENING,21255.0,58440.0,1836490440.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-12T16:14 (-11)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,6.0,TREATMENT,21266.0,31080.0,1837413480.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,C,2018-03-23T08:38 (1)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,TREATMENT,21266.0,40080.0,1837422480.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,C,2018-03-23T11:08 (1)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,END OF TREATMENT,21272.0,61866.0,1837962666.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,C,2018-03-29T17:11 (7)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21255.0,58440.0,1836490440.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,163.0,163,,,,Y,163.0,163,EOT/ET/Followup,nan,NA,2018-03-12T16:14 (-11)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21266.0,31080.0,1837413480.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,151.0,151,,,,Y,151.0,151,Period 1,nan,C,2018-03-23T08:38 (1)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,TREATMENT,21266.0,40080.0,1837422480.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,161.0,161,,,,,151.0,151,Period 1,10.0,C,2018-03-23T11:08 (1)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,12.0,END OF TREATMENT,21272.0,61866.0,1837962666.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,155.0,155,,,,,163.0,163,EOT/ET/Followup,-8.0,C,2018-03-29T17:11 (7)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21255.0,58440.0,1836490440.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,89.0,89,,,,Y,89.0,89,EOT/ET/Followup,nan,NA,2018-03-12T16:14 (-11)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,14.0,TREATMENT,21266.0,31080.0,1837413480.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,93.0,93,,,,Y,93.0,93,Period 1,nan,C,2018-03-23T08:38 (1)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,15.0,TREATMENT,21266.0,40080.0,1837422480.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,90.0,90,,,,,93.0,93,Period 1,-3.0,C,2018-03-23T11:08 (1)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,16.0,END OF TREATMENT,21272.0,61866.0,1837962666.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,95.0,95,,,,,89.0,89,EOT/ET/Followup,6.0,C,2018-03-29T17:11 (7)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21255.0,58440.0,1836490440.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,357.0,357,,,,Y,357.0,357,EOT/ET/Followup,nan,NA,2018-03-12T16:14 (-11)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21266.0,31080.0,1837413480.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,417.0,417,,,,Y,417.0,417,Period 1,nan,C,2018-03-23T08:38 (1)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21266.0,40080.0,1837422480.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,413.0,413,,,,,417.0,417,Period 1,-4.0,C,2018-03-23T11:08 (1)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,END OF TREATMENT,21272.0,61866.0,1837962666.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,408.0,408,,,,,357.0,357,EOT/ET/Followup,51.0,C,2018-03-29T17:11 (7)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,21.0,SCREENING,21255.0,58440.0,1836490440.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,427.0,427,,,,Y,427.0,427,EOT/ET/Followup,nan,NA,2018-03-12T16:14 (-11)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,TREATMENT,21266.0,31080.0,1837413480.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,434.0,434,,,,Y,434.0,434,Period 1,nan,C,2018-03-23T08:38 (1)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,23.0,TREATMENT,21266.0,40080.0,1837422480.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,422.0,422,,,,,434.0,434,Period 1,-12.0,C,2018-03-23T11:08 (1)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,24.0,END OF TREATMENT,21272.0,61866.0,1837962666.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,434.0,434,,,,,427.0,427,EOT/ET/Followup,7.0,C,2018-03-29T17:11 (7)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21255.0,58440.0,1836490440.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,402.0,402,,,,Y,402.0,402,EOT/ET/Followup,nan,NA,2018-03-12T16:14 (-11)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,26.0,TREATMENT,21266.0,31080.0,1837413480.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,428.0,428,,,,Y,428.0,428,Period 1,nan,C,2018-03-23T08:38 (1)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,27.0,TREATMENT,21266.0,40080.0,1837422480.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,419.0,419,,,,,428.0,428,Period 1,-9.0,C,2018-03-23T11:08 (1)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,28.0,END OF TREATMENT,21272.0,61866.0,1837962666.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,425.0,425,,,,,402.0,402,EOT/ET/Followup,23.0,C,2018-03-29T17:11 (7)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,29.0,SCREENING,21255.0,58440.0,1836490440.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,698.0,698,,,,Y,698.0,698,EOT/ET/Followup,nan,NA,2018-03-12T16:14 (-11)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,30.0,TREATMENT,21266.0,31080.0,1837413480.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,923.0,923,,,,Y,923.0,923,Period 1,nan,C,2018-03-23T08:38 (1)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,31.0,TREATMENT,21266.0,40080.0,1837422480.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,955.0,955,,,,,923.0,923,Period 1,32.0,C,2018-03-23T11:08 (1)
3110-103-002,3110-103-002.103001058,103001058,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,32.0,END OF TREATMENT,21272.0,61866.0,1837962666.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,882.0,882,,,,,698.0,698,EOT/ET/Followup,184.0,C,2018-03-29T17:11 (7)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21255.0,56586.0,1836488586.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,58.0,58,,,,Y,58.0,58,EOT/ET/Followup,nan,NA,2018-03-12T15:43 (-11)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,2.0,TREATMENT,21266.0,32640.0,1837415040.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,64.0,64,,,,Y,64.0,64,Period 1,nan,A,2018-03-23T09:04 (1)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21266.0,41640.0,1837424040.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,53.0,53,,,,,64.0,64,Period 1,-11.0,A,2018-03-23T11:34 (1)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,4.0,SCREENING,21255.0,56586.0,1836488586.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-12T15:43 (-11)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,5.0,TREATMENT,21266.0,32640.0,1837415040.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,A,2018-03-23T09:04 (1)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,6.0,TREATMENT,21266.0,41640.0,1837424040.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,A,2018-03-23T11:34 (1)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,7.0,SCREENING,21255.0,56586.0,1836488586.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,162.0,162,,,,Y,162.0,162,EOT/ET/Followup,nan,NA,2018-03-12T15:43 (-11)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,8.0,TREATMENT,21266.0,32640.0,1837415040.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,160.0,160,,,,Y,160.0,160,Period 1,nan,A,2018-03-23T09:04 (1)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,9.0,TREATMENT,21266.0,41640.0,1837424040.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,157.0,157,,,,,160.0,160,Period 1,-3.0,A,2018-03-23T11:34 (1)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,10.0,SCREENING,21255.0,56586.0,1836488586.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,86.0,86,,,,Y,86.0,86,EOT/ET/Followup,nan,NA,2018-03-12T15:43 (-11)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,11.0,TREATMENT,21266.0,32640.0,1837415040.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,88.0,88,,,,Y,88.0,88,Period 1,nan,A,2018-03-23T09:04 (1)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,12.0,TREATMENT,21266.0,41640.0,1837424040.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,87.0,87,,,,,88.0,88,Period 1,-1.0,A,2018-03-23T11:34 (1)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21255.0,56586.0,1836488586.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,392.0,392,,,,Y,392.0,392,EOT/ET/Followup,nan,NA,2018-03-12T15:43 (-11)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,14.0,TREATMENT,21266.0,32640.0,1837415040.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,400.0,400,,,,Y,400.0,400,Period 1,nan,A,2018-03-23T09:04 (1)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,15.0,TREATMENT,21266.0,41640.0,1837424040.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,418.0,418,,,,,400.0,400,Period 1,18.0,A,2018-03-23T11:34 (1)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,16.0,SCREENING,21255.0,56586.0,1836488586.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,388.0,388,,,,Y,388.0,388,EOT/ET/Followup,nan,NA,2018-03-12T15:43 (-11)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,17.0,TREATMENT,21266.0,32640.0,1837415040.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,415.0,415,,,,Y,415.0,415,Period 1,nan,A,2018-03-23T09:04 (1)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,18.0,TREATMENT,21266.0,41640.0,1837424040.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,394.0,394,,,,,415.0,415,Period 1,-21.0,A,2018-03-23T11:34 (1)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,19.0,SCREENING,21255.0,56586.0,1836488586.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,389.0,389,,,,Y,389.0,389,EOT/ET/Followup,nan,NA,2018-03-12T15:43 (-11)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,20.0,TREATMENT,21266.0,32640.0,1837415040.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,410.0,410,,,,Y,410.0,410,Period 1,nan,A,2018-03-23T09:04 (1)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21.0,TREATMENT,21266.0,41640.0,1837424040.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,402.0,402,,,,,410.0,410,Period 1,-8.0,A,2018-03-23T11:34 (1)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,22.0,SCREENING,21255.0,56586.0,1836488586.0,-11.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,1018.0,1018,,,,Y,1018.0,1018,EOT/ET/Followup,nan,NA,2018-03-12T15:43 (-11)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,23.0,TREATMENT,21266.0,32640.0,1837415040.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,926.0,926,,,,Y,926.0,926,Period 1,nan,A,2018-03-23T09:04 (1)
3110-103-002,3110-103-002.103001059,103001059,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,24.0,TREATMENT,21266.0,41640.0,1837424040.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1124.0,1124,,,,,926.0,926,Period 1,198.0,A,2018-03-23T11:34 (1)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21256.0,46921.0,1836565321.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,66.0,66,,,,Y,66.0,66,EOT/ET/Followup,nan,NA,2018-03-13T13:02 (-10)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,2.0,TREATMENT,21266.0,31680.0,1837414080.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,63.0,63,,,,Y,63.0,63,Period 1,nan,A,2018-03-23T08:48 (1)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21266.0,40680.0,1837423080.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,58.0,58,,,,,63.0,63,Period 1,-5.0,A,2018-03-23T11:18 (1)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,4.0,TREATMENT,21273.0,31680.0,1838018880.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,71.0,71,,,,Y,71.0,71,Period 2,nan,B,2018-03-30T08:48 (8)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21273.0,40680.0,1838027880.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,57.0,57,,,,,71.0,71,Period 2,-14.0,B,2018-03-30T11:18 (8)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,6.0,TREATMENT,21280.0,31680.0,1838623680.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,63.0,63,,,,Y,63.0,63,Period 3,nan,C,2018-04-06T08:48 (15)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,TREATMENT,21280.0,40680.0,1838632680.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,61.0,61,,,,,63.0,63,Period 3,-2.0,C,2018-04-06T11:18 (15)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,END OF TREATMENT,21281.0,39480.0,1838717880.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,54.0,54,,,,,66.0,66,EOT/ET/Followup,-12.0,C,2018-04-07T10:58 (16)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21256.0,46921.0,1836565321.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-13T13:02 (-10)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,10.0,TREATMENT,21266.0,31680.0,1837414080.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,A,2018-03-23T08:48 (1)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,11.0,TREATMENT,21266.0,40680.0,1837423080.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,A,2018-03-23T11:18 (1)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,12.0,TREATMENT,21273.0,31680.0,1838018880.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,B,2018-03-30T08:48 (8)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,13.0,TREATMENT,21273.0,40680.0,1838027880.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,B,2018-03-30T11:18 (8)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,14.0,TREATMENT,21280.0,31680.0,1838623680.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,C,2018-04-06T08:48 (15)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,15.0,TREATMENT,21280.0,40680.0,1838632680.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,C,2018-04-06T11:18 (15)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,16.0,END OF TREATMENT,21281.0,39480.0,1838717880.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,C,2018-04-07T10:58 (16)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21256.0,46921.0,1836565321.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,161.0,161,,,,Y,161.0,161,EOT/ET/Followup,nan,NA,2018-03-13T13:02 (-10)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,18.0,TREATMENT,21266.0,31680.0,1837414080.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,167.0,167,,,,Y,167.0,167,Period 1,nan,A,2018-03-23T08:48 (1)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,19.0,TREATMENT,21266.0,40680.0,1837423080.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,154.0,154,,,,,167.0,167,Period 1,-13.0,A,2018-03-23T11:18 (1)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21273.0,31680.0,1838018880.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,149.0,149,,,,Y,149.0,149,Period 2,nan,B,2018-03-30T08:48 (8)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21.0,TREATMENT,21273.0,40680.0,1838027880.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,145.0,145,,,,,149.0,149,Period 2,-4.0,B,2018-03-30T11:18 (8)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,TREATMENT,21280.0,31680.0,1838623680.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,163.0,163,,,,Y,163.0,163,Period 3,nan,C,2018-04-06T08:48 (15)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,23.0,TREATMENT,21280.0,40680.0,1838632680.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,127.0,127,,,,,163.0,163,Period 3,-36.0,C,2018-04-06T11:18 (15)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,24.0,END OF TREATMENT,21281.0,39480.0,1838717880.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,159.0,159,,,,,161.0,161,EOT/ET/Followup,-2.0,C,2018-04-07T10:58 (16)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21256.0,46921.0,1836565321.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,95.0,95,,,,Y,95.0,95,EOT/ET/Followup,nan,NA,2018-03-13T13:02 (-10)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,26.0,TREATMENT,21266.0,31680.0,1837414080.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,95.0,95,,,,Y,95.0,95,Period 1,nan,A,2018-03-23T08:48 (1)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,TREATMENT,21266.0,40680.0,1837423080.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,,95.0,95,Period 1,1.0,A,2018-03-23T11:18 (1)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,28.0,TREATMENT,21273.0,31680.0,1838018880.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,Y,99.0,99,Period 2,nan,B,2018-03-30T08:48 (8)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,29.0,TREATMENT,21273.0,40680.0,1838027880.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,,99.0,99,Period 2,-3.0,B,2018-03-30T11:18 (8)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,30.0,TREATMENT,21280.0,31680.0,1838623680.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,Y,94.0,94,Period 3,nan,C,2018-04-06T08:48 (15)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,31.0,TREATMENT,21280.0,40680.0,1838632680.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,,94.0,94,Period 3,2.0,C,2018-04-06T11:18 (15)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,32.0,END OF TREATMENT,21281.0,39480.0,1838717880.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,,95.0,95,EOT/ET/Followup,1.0,C,2018-04-07T10:58 (16)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21256.0,46921.0,1836565321.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,375.0,375,,,,Y,375.0,375,EOT/ET/Followup,nan,NA,2018-03-13T13:02 (-10)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,34.0,TREATMENT,21266.0,31680.0,1837414080.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,368.0,368,,,,Y,368.0,368,Period 1,nan,A,2018-03-23T08:48 (1)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,35.0,TREATMENT,21266.0,40680.0,1837423080.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,377.0,377,,,,,368.0,368,Period 1,9.0,A,2018-03-23T11:18 (1)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,TREATMENT,21273.0,31680.0,1838018880.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,358.0,358,,,,Y,358.0,358,Period 2,nan,B,2018-03-30T08:48 (8)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,37.0,TREATMENT,21273.0,40680.0,1838027880.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,361.0,361,,,,,358.0,358,Period 2,3.0,B,2018-03-30T11:18 (8)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,38.0,TREATMENT,21280.0,31680.0,1838623680.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,376.0,376,,,,Y,376.0,376,Period 3,nan,C,2018-04-06T08:48 (15)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,39.0,TREATMENT,21280.0,40680.0,1838632680.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,375.0,375,,,,,376.0,376,Period 3,-1.0,C,2018-04-06T11:18 (15)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,40.0,END OF TREATMENT,21281.0,39480.0,1838717880.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,386.0,386,,,,,375.0,375,EOT/ET/Followup,11.0,C,2018-04-07T10:58 (16)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21256.0,46921.0,1836565321.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,394.0,394,,,,Y,394.0,394,EOT/ET/Followup,nan,NA,2018-03-13T13:02 (-10)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,42.0,TREATMENT,21266.0,31680.0,1837414080.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,379.0,379,,,,Y,379.0,379,Period 1,nan,A,2018-03-23T08:48 (1)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,43.0,TREATMENT,21266.0,40680.0,1837423080.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,373.0,373,,,,,379.0,379,Period 1,-6.0,A,2018-03-23T11:18 (1)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,44.0,TREATMENT,21273.0,31680.0,1838018880.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,390.0,390,,,,Y,390.0,390,Period 2,nan,B,2018-03-30T08:48 (8)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,45.0,TREATMENT,21273.0,40680.0,1838027880.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,353.0,353,,,,,390.0,390,Period 2,-37.0,B,2018-03-30T11:18 (8)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,46.0,TREATMENT,21280.0,31680.0,1838623680.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,386.0,386,,,,Y,386.0,386,Period 3,nan,C,2018-04-06T08:48 (15)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,47.0,TREATMENT,21280.0,40680.0,1838632680.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,378.0,378,,,,,386.0,386,Period 3,-8.0,C,2018-04-06T11:18 (15)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,48.0,END OF TREATMENT,21281.0,39480.0,1838717880.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,367.0,367,,,,,394.0,394,EOT/ET/Followup,-27.0,C,2018-04-07T10:58 (16)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21256.0,46921.0,1836565321.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,387.0,387,,,,Y,387.0,387,EOT/ET/Followup,nan,NA,2018-03-13T13:02 (-10)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,50.0,TREATMENT,21266.0,31680.0,1837414080.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,375.0,375,,,,Y,375.0,375,Period 1,nan,A,2018-03-23T08:48 (1)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,51.0,TREATMENT,21266.0,40680.0,1837423080.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,374.0,374,,,,,375.0,375,Period 1,-1.0,A,2018-03-23T11:18 (1)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,52.0,TREATMENT,21273.0,31680.0,1838018880.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,379.0,379,,,,Y,379.0,379,Period 2,nan,B,2018-03-30T08:48 (8)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,53.0,TREATMENT,21273.0,40680.0,1838027880.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,355.0,355,,,,,379.0,379,Period 2,-24.0,B,2018-03-30T11:18 (8)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,54.0,TREATMENT,21280.0,31680.0,1838623680.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,382.0,382,,,,Y,382.0,382,Period 3,nan,C,2018-04-06T08:48 (15)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,55.0,TREATMENT,21280.0,40680.0,1838632680.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,377.0,377,,,,,382.0,382,Period 3,-5.0,C,2018-04-06T11:18 (15)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,56.0,END OF TREATMENT,21281.0,39480.0,1838717880.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,373.0,373,,,,,387.0,387,EOT/ET/Followup,-14.0,C,2018-04-07T10:58 (16)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21256.0,46921.0,1836565321.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,903.0,903,,,,Y,903.0,903,EOT/ET/Followup,nan,NA,2018-03-13T13:02 (-10)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,58.0,TREATMENT,21266.0,31680.0,1837414080.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,942.0,942,,,,Y,942.0,942,Period 1,nan,A,2018-03-23T08:48 (1)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,59.0,TREATMENT,21266.0,40680.0,1837423080.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1020.0,1020,,,,,942.0,942,Period 1,78.0,A,2018-03-23T11:18 (1)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,60.0,TREATMENT,21273.0,31680.0,1838018880.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,842.0,842,,,,Y,842.0,842,Period 2,nan,B,2018-03-30T08:48 (8)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,61.0,TREATMENT,21273.0,40680.0,1838027880.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1044.0,1044,,,,,842.0,842,Period 2,202.0,B,2018-03-30T11:18 (8)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,62.0,TREATMENT,21280.0,31680.0,1838623680.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,948.0,948,,,,Y,948.0,948,Period 3,nan,C,2018-04-06T08:48 (15)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,63.0,TREATMENT,21280.0,40680.0,1838632680.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,980.0,980,,,,,948.0,948,Period 3,32.0,C,2018-04-06T11:18 (15)
3110-103-002,3110-103-002.103001066,103001066,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,64.0,END OF TREATMENT,21281.0,39480.0,1838717880.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1106.0,1106,,,,,903.0,903,EOT/ET/Followup,203.0,C,2018-04-07T10:58 (16)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21256.0,45930.0,1836564330.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,72.0,72,,,,Y,72.0,72,EOT/ET/Followup,nan,NA,2018-03-13T12:45 (-10)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,2.0,TREATMENT,21266.0,31740.0,1837414140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,60.0,60,,,,Y,60.0,60,Period 1,nan,A,2018-03-23T08:49 (1)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21266.0,40740.0,1837423140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,54.0,54,,,,,60.0,60,Period 1,-6.0,A,2018-03-23T11:19 (1)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,4.0,TREATMENT,21273.0,31740.0,1838018940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,60.0,60,,,,Y,60.0,60,Period 2,nan,B,2018-03-30T08:49 (8)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21273.0,40740.0,1838027940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,51.0,51,,,,,60.0,60,Period 2,-9.0,B,2018-03-30T11:19 (8)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,6.0,TREATMENT,21280.0,31740.0,1838623740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,55.0,55,,,,Y,55.0,55,Period 3,nan,C,2018-04-06T08:49 (15)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,TREATMENT,21280.0,40740.0,1838632740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,47.0,47,,,,,55.0,55,Period 3,-8.0,C,2018-04-06T11:19 (15)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,END OF TREATMENT,21281.0,39552.0,1838717952.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,55.0,55,,,,,72.0,72,EOT/ET/Followup,-17.0,C,2018-04-07T10:59 (16)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21256.0,45930.0,1836564330.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-13T12:45 (-10)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,10.0,TREATMENT,21266.0,31740.0,1837414140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,A,2018-03-23T08:49 (1)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,11.0,TREATMENT,21266.0,40740.0,1837423140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,A,2018-03-23T11:19 (1)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,12.0,TREATMENT,21273.0,31740.0,1838018940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,B,2018-03-30T08:49 (8)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,13.0,TREATMENT,21273.0,40740.0,1838027940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,B,2018-03-30T11:19 (8)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,14.0,TREATMENT,21280.0,31740.0,1838623740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,C,2018-04-06T08:49 (15)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,15.0,TREATMENT,21280.0,40740.0,1838632740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,,nan,Normal,Period 3,nan,C,2018-04-06T11:19 (15)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,16.0,END OF TREATMENT,21281.0,39552.0,1838717952.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,C,2018-04-07T10:59 (16)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21256.0,45930.0,1836564330.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,150.0,150,,,,Y,150.0,150,EOT/ET/Followup,nan,NA,2018-03-13T12:45 (-10)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,18.0,TREATMENT,21266.0,31740.0,1837414140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,132.0,132,,,,Y,132.0,132,Period 1,nan,A,2018-03-23T08:49 (1)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,19.0,TREATMENT,21266.0,40740.0,1837423140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,138.0,138,,,,,132.0,132,Period 1,6.0,A,2018-03-23T11:19 (1)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21273.0,31740.0,1838018940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,133.0,133,,,,Y,133.0,133,Period 2,nan,B,2018-03-30T08:49 (8)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21.0,TREATMENT,21273.0,40740.0,1838027940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,133.0,133,,,,,133.0,133,Period 2,0.0,B,2018-03-30T11:19 (8)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,TREATMENT,21280.0,31740.0,1838623740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,134.0,134,,,,Y,134.0,134,Period 3,nan,C,2018-04-06T08:49 (15)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,23.0,TREATMENT,21280.0,40740.0,1838632740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,132.0,132,,,,,134.0,134,Period 3,-2.0,C,2018-04-06T11:19 (15)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,24.0,END OF TREATMENT,21281.0,39552.0,1838717952.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,138.0,138,,,,,150.0,150,EOT/ET/Followup,-12.0,C,2018-04-07T10:59 (16)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21256.0,45930.0,1836564330.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,Y,99.0,99,EOT/ET/Followup,nan,NA,2018-03-13T12:45 (-10)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,26.0,TREATMENT,21266.0,31740.0,1837414140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,Y,98.0,98,Period 1,nan,A,2018-03-23T08:49 (1)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,TREATMENT,21266.0,40740.0,1837423140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,,98.0,98,Period 1,-4.0,A,2018-03-23T11:19 (1)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,28.0,TREATMENT,21273.0,31740.0,1838018940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,Y,94.0,94,Period 2,nan,B,2018-03-30T08:49 (8)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,29.0,TREATMENT,21273.0,40740.0,1838027940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,,94.0,94,Period 2,0.0,B,2018-03-30T11:19 (8)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,30.0,TREATMENT,21280.0,31740.0,1838623740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,Y,94.0,94,Period 3,nan,C,2018-04-06T08:49 (15)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,31.0,TREATMENT,21280.0,40740.0,1838632740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,,94.0,94,Period 3,4.0,C,2018-04-06T11:19 (15)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,32.0,END OF TREATMENT,21281.0,39552.0,1838717952.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,,99.0,99,EOT/ET/Followup,-3.0,C,2018-04-07T10:59 (16)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21256.0,45930.0,1836564330.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,385.0,385,,,,Y,385.0,385,EOT/ET/Followup,nan,NA,2018-03-13T12:45 (-10)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,34.0,TREATMENT,21266.0,31740.0,1837414140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,410.0,410,,,,Y,410.0,410,Period 1,nan,A,2018-03-23T08:49 (1)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,35.0,TREATMENT,21266.0,40740.0,1837423140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,426.0,426,,,,,410.0,410,Period 1,16.0,A,2018-03-23T11:19 (1)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,TREATMENT,21273.0,31740.0,1838018940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,409.0,409,,,,Y,409.0,409,Period 2,nan,B,2018-03-30T08:49 (8)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,37.0,TREATMENT,21273.0,40740.0,1838027940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,433.0,433,,,,,409.0,409,Period 2,24.0,B,2018-03-30T11:19 (8)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,38.0,TREATMENT,21280.0,31740.0,1838623740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,417.0,417,,,,Y,417.0,417,Period 3,nan,C,2018-04-06T08:49 (15)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,39.0,TREATMENT,21280.0,40740.0,1838632740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,440.0,440,,,,,417.0,417,Period 3,23.0,C,2018-04-06T11:19 (15)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,40.0,END OF TREATMENT,21281.0,39552.0,1838717952.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,413.0,413,,,,,385.0,385,EOT/ET/Followup,28.0,C,2018-04-07T10:59 (16)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21256.0,45930.0,1836564330.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,422.0,422,,,,Y,422.0,422,EOT/ET/Followup,nan,NA,2018-03-13T12:45 (-10)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,42.0,TREATMENT,21266.0,31740.0,1837414140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,412.0,412,,,,Y,412.0,412,Period 1,nan,A,2018-03-23T08:49 (1)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,43.0,TREATMENT,21266.0,40740.0,1837423140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,406.0,406,,,,,412.0,412,Period 1,-6.0,A,2018-03-23T11:19 (1)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,44.0,TREATMENT,21273.0,31740.0,1838018940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,409.0,409,,,,Y,409.0,409,Period 2,nan,B,2018-03-30T08:49 (8)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,45.0,TREATMENT,21273.0,40740.0,1838027940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,400.0,400,,,,,409.0,409,Period 2,-9.0,B,2018-03-30T11:19 (8)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,46.0,TREATMENT,21280.0,31740.0,1838623740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,400.0,400,,,,Y,400.0,400,Period 3,nan,C,2018-04-06T08:49 (15)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,47.0,TREATMENT,21280.0,40740.0,1838632740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,390.0,390,,,,,400.0,400,Period 3,-10.0,C,2018-04-06T11:19 (15)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,48.0,END OF TREATMENT,21281.0,39552.0,1838717952.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,396.0,396,,,,,422.0,422,EOT/ET/Followup,-26.0,C,2018-04-07T10:59 (16)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21256.0,45930.0,1836564330.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,409.0,409,,,,Y,409.0,409,EOT/ET/Followup,nan,NA,2018-03-13T12:45 (-10)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,50.0,TREATMENT,21266.0,31740.0,1837414140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,411.0,411,,,,Y,411.0,411,Period 1,nan,A,2018-03-23T08:49 (1)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,51.0,TREATMENT,21266.0,40740.0,1837423140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,413.0,413,,,,,411.0,411,Period 1,2.0,A,2018-03-23T11:19 (1)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,52.0,TREATMENT,21273.0,31740.0,1838018940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,409.0,409,,,,Y,409.0,409,Period 2,nan,B,2018-03-30T08:49 (8)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,53.0,TREATMENT,21273.0,40740.0,1838027940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,410.0,410,,,,,409.0,409,Period 2,1.0,B,2018-03-30T11:19 (8)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,54.0,TREATMENT,21280.0,31740.0,1838623740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,405.0,405,,,,Y,405.0,405,Period 3,nan,C,2018-04-06T08:49 (15)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,55.0,TREATMENT,21280.0,40740.0,1838632740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,406.0,406,,,,,405.0,405,Period 3,1.0,C,2018-04-06T11:19 (15)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,56.0,END OF TREATMENT,21281.0,39552.0,1838717952.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,402.0,402,,,,,409.0,409,EOT/ET/Followup,-7.0,C,2018-04-07T10:59 (16)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21256.0,45930.0,1836564330.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,831.0,831,,,,Y,831.0,831,EOT/ET/Followup,nan,NA,2018-03-13T12:45 (-10)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,58.0,TREATMENT,21266.0,31740.0,1837414140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,988.0,988,,,,Y,988.0,988,Period 1,nan,A,2018-03-23T08:49 (1)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,59.0,TREATMENT,21266.0,40740.0,1837423140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1096.0,1096,,,,,988.0,988,Period 1,108.0,A,2018-03-23T11:19 (1)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,60.0,TREATMENT,21273.0,31740.0,1838018940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,996.0,996,,,,Y,996.0,996,Period 2,nan,B,2018-03-30T08:49 (8)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,61.0,TREATMENT,21273.0,40740.0,1838027940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1170.0,1170,,,,,996.0,996,Period 2,174.0,B,2018-03-30T11:19 (8)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,62.0,TREATMENT,21280.0,31740.0,1838623740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1086.0,1086,,,,Y,1086.0,1086,Period 3,nan,C,2018-04-06T08:49 (15)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,63.0,TREATMENT,21280.0,40740.0,1838632740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1270.0,1270,,,,,1086.0,1086,Period 3,184.0,C,2018-04-06T11:19 (15)
3110-103-002,3110-103-002.103001067,103001067,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,64.0,END OF TREATMENT,21281.0,39552.0,1838717952.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1083.0,1083,,,,,831.0,831,EOT/ET/Followup,252.0,C,2018-04-07T10:59 (16)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21256.0,49440.0,1836567840.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,58.0,58,,,,Y,58.0,58,EOT/ET/Followup,nan,NA,2018-03-13T13:44 (-10)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,2.0,TREATMENT,21266.0,32820.0,1837415220.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,64.0,64,,,,Y,64.0,64,Period 1,nan,B,2018-03-23T09:07 (1)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,3.0,TREATMENT,21266.0,41820.0,1837424220.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,57.0,57,,,,,64.0,64,Period 1,-7.0,B,2018-03-23T11:37 (1)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,4.0,TREATMENT,21273.0,32820.0,1838020020.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,66.0,66,,,,Y,66.0,66,Period 2,nan,A,2018-03-30T09:07 (8)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,5.0,TREATMENT,21273.0,41820.0,1838029020.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,57.0,57,,,,,66.0,66,Period 2,-9.0,A,2018-03-30T11:37 (8)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,6.0,TREATMENT,21280.0,32820.0,1838624820.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,69.0,69,,,,Y,69.0,69,Period 3,nan,C,2018-04-06T09:07 (15)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,TREATMENT,21280.0,41820.0,1838633820.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,65.0,65,,,,,69.0,69,Period 3,-4.0,C,2018-04-06T11:37 (15)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,END OF TREATMENT,21281.0,40620.0,1838719020.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,63.0,63,,,,,58.0,58,EOT/ET/Followup,5.0,C,2018-04-07T11:17 (16)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21256.0,49440.0,1836567840.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-13T13:44 (-10)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,10.0,TREATMENT,21266.0,32820.0,1837415220.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,B,2018-03-23T09:07 (1)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,11.0,TREATMENT,21266.0,41820.0,1837424220.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,B,2018-03-23T11:37 (1)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,12.0,TREATMENT,21273.0,32820.0,1838020020.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,A,2018-03-30T09:07 (8)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,13.0,TREATMENT,21273.0,41820.0,1838029020.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,A,2018-03-30T11:37 (8)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,14.0,TREATMENT,21280.0,32820.0,1838624820.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,C,2018-04-06T09:07 (15)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,15.0,TREATMENT,21280.0,41820.0,1838633820.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,C,2018-04-06T11:37 (15)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,16.0,END OF TREATMENT,21281.0,40620.0,1838719020.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,C,2018-04-07T11:17 (16)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21256.0,49440.0,1836567840.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,145.0,145,,,,Y,145.0,145,EOT/ET/Followup,nan,NA,2018-03-13T13:44 (-10)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,18.0,TREATMENT,21266.0,32820.0,1837415220.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,155.0,155,,,,Y,155.0,155,Period 1,nan,B,2018-03-23T09:07 (1)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21266.0,41820.0,1837424220.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,145.0,145,,,,,155.0,155,Period 1,-10.0,B,2018-03-23T11:37 (1)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,20.0,TREATMENT,21273.0,32820.0,1838020020.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,150.0,150,,,,Y,150.0,150,Period 2,nan,A,2018-03-30T09:07 (8)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21.0,TREATMENT,21273.0,41820.0,1838029020.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,146.0,146,,,,,150.0,150,Period 2,-4.0,A,2018-03-30T11:37 (8)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,TREATMENT,21280.0,32820.0,1838624820.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,140.0,140,,,,Y,140.0,140,Period 3,nan,C,2018-04-06T09:07 (15)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,23.0,TREATMENT,21280.0,41820.0,1838633820.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,148.0,148,,,,,140.0,140,Period 3,8.0,C,2018-04-06T11:37 (15)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,24.0,END OF TREATMENT,21281.0,40620.0,1838719020.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,143.0,143,,,,,145.0,145,EOT/ET/Followup,-2.0,C,2018-04-07T11:17 (16)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21256.0,49440.0,1836567840.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,101.0,101,,,,Y,101.0,101,EOT/ET/Followup,nan,NA,2018-03-13T13:44 (-10)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,26.0,TREATMENT,21266.0,32820.0,1837415220.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,Y,97.0,97,Period 1,nan,B,2018-03-23T09:07 (1)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,27.0,TREATMENT,21266.0,41820.0,1837424220.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,,97.0,97,Period 1,1.0,B,2018-03-23T11:37 (1)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,28.0,TREATMENT,21273.0,32820.0,1838020020.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,Y,97.0,97,Period 2,nan,A,2018-03-30T09:07 (8)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,TREATMENT,21273.0,41820.0,1838029020.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,100.0,100,,,,,97.0,97,Period 2,3.0,A,2018-03-30T11:37 (8)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,30.0,TREATMENT,21280.0,32820.0,1838624820.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,Y,97.0,97,Period 3,nan,C,2018-04-06T09:07 (15)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,31.0,TREATMENT,21280.0,41820.0,1838633820.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,,97.0,97,Period 3,-1.0,C,2018-04-06T11:37 (15)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,32.0,END OF TREATMENT,21281.0,40620.0,1838719020.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,,101.0,101,EOT/ET/Followup,-2.0,C,2018-04-07T11:17 (16)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21256.0,49440.0,1836567840.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,393.0,393,,,,Y,393.0,393,EOT/ET/Followup,nan,NA,2018-03-13T13:44 (-10)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21266.0,32820.0,1837415220.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,392.0,392,,,,Y,392.0,392,Period 1,nan,B,2018-03-23T09:07 (1)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,35.0,TREATMENT,21266.0,41820.0,1837424220.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,399.0,399,,,,,392.0,392,Period 1,7.0,B,2018-03-23T11:37 (1)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,36.0,TREATMENT,21273.0,32820.0,1838020020.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,379.0,379,,,,Y,379.0,379,Period 2,nan,A,2018-03-30T09:07 (8)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,37.0,TREATMENT,21273.0,41820.0,1838029020.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,400.0,400,,,,,379.0,379,Period 2,21.0,A,2018-03-30T11:37 (8)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,38.0,TREATMENT,21280.0,32820.0,1838624820.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,387.0,387,,,,Y,387.0,387,Period 3,nan,C,2018-04-06T09:07 (15)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,39.0,TREATMENT,21280.0,41820.0,1838633820.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,385.0,385,,,,,387.0,387,Period 3,-2.0,C,2018-04-06T11:37 (15)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,40.0,END OF TREATMENT,21281.0,40620.0,1838719020.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,385.0,385,,,,,393.0,393,EOT/ET/Followup,-8.0,C,2018-04-07T11:17 (16)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21256.0,49440.0,1836567840.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,388.0,388,,,,Y,388.0,388,EOT/ET/Followup,nan,NA,2018-03-13T13:44 (-10)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,42.0,TREATMENT,21266.0,32820.0,1837415220.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,405.0,405,,,,Y,405.0,405,Period 1,nan,B,2018-03-23T09:07 (1)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,43.0,TREATMENT,21266.0,41820.0,1837424220.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,389.0,389,,,,,405.0,405,Period 1,-16.0,B,2018-03-23T11:37 (1)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,44.0,TREATMENT,21273.0,32820.0,1838020020.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,399.0,399,,,,Y,399.0,399,Period 2,nan,A,2018-03-30T09:07 (8)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,45.0,TREATMENT,21273.0,41820.0,1838029020.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,391.0,391,,,,,399.0,399,Period 2,-8.0,A,2018-03-30T11:37 (8)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,46.0,TREATMENT,21280.0,32820.0,1838624820.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,415.0,415,,,,Y,415.0,415,Period 3,nan,C,2018-04-06T09:07 (15)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,47.0,TREATMENT,21280.0,41820.0,1838633820.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,402.0,402,,,,,415.0,415,Period 3,-13.0,C,2018-04-06T11:37 (15)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,48.0,END OF TREATMENT,21281.0,40620.0,1838719020.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,397.0,397,,,,,388.0,388,EOT/ET/Followup,9.0,C,2018-04-07T11:17 (16)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21256.0,49440.0,1836567840.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,390.0,390,,,,Y,390.0,390,EOT/ET/Followup,nan,NA,2018-03-13T13:44 (-10)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,50.0,TREATMENT,21266.0,32820.0,1837415220.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,401.0,401,,,,Y,401.0,401,Period 1,nan,B,2018-03-23T09:07 (1)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,51.0,TREATMENT,21266.0,41820.0,1837424220.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,392.0,392,,,,,401.0,401,Period 1,-9.0,B,2018-03-23T11:37 (1)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,52.0,TREATMENT,21273.0,32820.0,1838020020.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,392.0,392,,,,Y,392.0,392,Period 2,nan,A,2018-03-30T09:07 (8)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,53.0,TREATMENT,21273.0,41820.0,1838029020.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,394.0,394,,,,,392.0,392,Period 2,2.0,A,2018-03-30T11:37 (8)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,54.0,TREATMENT,21280.0,32820.0,1838624820.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,406.0,406,,,,Y,406.0,406,Period 3,nan,C,2018-04-06T09:07 (15)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,55.0,TREATMENT,21280.0,41820.0,1838633820.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,396.0,396,,,,,406.0,406,Period 3,-10.0,C,2018-04-06T11:37 (15)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,56.0,END OF TREATMENT,21281.0,40620.0,1838719020.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,393.0,393,,,,,390.0,390,EOT/ET/Followup,3.0,C,2018-04-07T11:17 (16)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21256.0,49440.0,1836567840.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,1021.0,1021,,,,Y,1021.0,1021,EOT/ET/Followup,nan,NA,2018-03-13T13:44 (-10)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,58.0,TREATMENT,21266.0,32820.0,1837415220.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,934.0,934,,,,Y,934.0,934,Period 1,nan,B,2018-03-23T09:07 (1)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,59.0,TREATMENT,21266.0,41820.0,1837424220.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1047.0,1047,,,,,934.0,934,Period 1,113.0,B,2018-03-23T11:37 (1)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,60.0,TREATMENT,21273.0,32820.0,1838020020.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,898.0,898,,,,Y,898.0,898,Period 2,nan,A,2018-03-30T09:07 (8)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,61.0,TREATMENT,21273.0,41820.0,1838029020.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1042.0,1042,,,,,898.0,898,Period 2,144.0,A,2018-03-30T11:37 (8)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,62.0,TREATMENT,21280.0,32820.0,1838624820.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,866.0,866,,,,Y,866.0,866,Period 3,nan,C,2018-04-06T09:07 (15)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,63.0,TREATMENT,21280.0,41820.0,1838633820.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,917.0,917,,,,,866.0,866,Period 3,51.0,C,2018-04-06T11:37 (15)
3110-103-002,3110-103-002.103001074,103001074,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,64.0,END OF TREATMENT,21281.0,40620.0,1838719020.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,940.0,940,,,,,1021.0,1021,EOT/ET/Followup,-81.0,C,2018-04-07T11:17 (16)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21256.0,50105.0,1836568505.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,70.0,70,,,,Y,70.0,70,EOT/ET/Followup,nan,NA,2018-03-13T13:55 (-10)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21266.0,31800.0,1837414200.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,68.0,68,,,,Y,68.0,68,Period 1,nan,C,2018-03-23T08:50 (1)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21266.0,40800.0,1837423200.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,59.0,59,,,,,68.0,68,Period 1,-9.0,C,2018-03-23T11:20 (1)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,4.0,TREATMENT,21273.0,31800.0,1838019000.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,69.0,69,,,,Y,69.0,69,Period 2,nan,A,2018-03-30T08:50 (8)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,5.0,TREATMENT,21273.0,40800.0,1838028000.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,62.0,62,,,,,69.0,69,Period 2,-7.0,A,2018-03-30T11:20 (8)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21280.0,31800.0,1838623800.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,69.0,69,,,,Y,69.0,69,Period 3,nan,B,2018-04-06T08:50 (15)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,7.0,TREATMENT,21280.0,40807.0,1838632807.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,75.0,75,,,,,69.0,69,Period 3,6.0,B,2018-04-06T11:20 (15)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,8.0,END OF TREATMENT,21281.0,39600.0,1838718000.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,69.0,69,,,,,70.0,70,EOT/ET/Followup,-1.0,B,2018-04-07T11:00 (16)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21256.0,50105.0,1836568505.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-13T13:55 (-10)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21266.0,31800.0,1837414200.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,C,2018-03-23T08:50 (1)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,TREATMENT,21266.0,40800.0,1837423200.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,C,2018-03-23T11:20 (1)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,12.0,TREATMENT,21273.0,31800.0,1838019000.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,A,2018-03-30T08:50 (8)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,13.0,TREATMENT,21273.0,40800.0,1838028000.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,A,2018-03-30T11:20 (8)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,14.0,TREATMENT,21280.0,31800.0,1838623800.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,B,2018-04-06T08:50 (15)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,15.0,TREATMENT,21280.0,40807.0,1838632807.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,B,2018-04-06T11:20 (15)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,16.0,END OF TREATMENT,21281.0,39600.0,1838718000.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,B,2018-04-07T11:00 (16)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21256.0,50105.0,1836568505.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,181.0,181,,,,Y,181.0,181,EOT/ET/Followup,nan,NA,2018-03-13T13:55 (-10)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21266.0,31800.0,1837414200.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,191.0,191,,,,Y,191.0,191,Period 1,nan,C,2018-03-23T08:50 (1)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21266.0,40800.0,1837423200.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,168.0,168,,,,,191.0,191,Period 1,-23.0,C,2018-03-23T11:20 (1)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,20.0,TREATMENT,21273.0,31800.0,1838019000.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,181.0,181,,,,Y,181.0,181,Period 2,nan,A,2018-03-30T08:50 (8)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21.0,TREATMENT,21273.0,40800.0,1838028000.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,160.0,160,,,,,181.0,181,Period 2,-21.0,A,2018-03-30T11:20 (8)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,22.0,TREATMENT,21280.0,31800.0,1838623800.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,176.0,176,,,,Y,176.0,176,Period 3,nan,B,2018-04-06T08:50 (15)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,23.0,TREATMENT,21280.0,40807.0,1838632807.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,172.0,172,,,,,176.0,176,Period 3,-4.0,B,2018-04-06T11:20 (15)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,24.0,END OF TREATMENT,21281.0,39600.0,1838718000.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,165.0,165,,,,,181.0,181,EOT/ET/Followup,-16.0,B,2018-04-07T11:00 (16)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21256.0,50105.0,1836568505.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,Y,97.0,97,EOT/ET/Followup,nan,NA,2018-03-13T13:55 (-10)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,26.0,TREATMENT,21266.0,31800.0,1837414200.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,Y,94.0,94,Period 1,nan,C,2018-03-23T08:50 (1)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,27.0,TREATMENT,21266.0,40800.0,1837423200.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,,94.0,94,Period 1,3.0,C,2018-03-23T11:20 (1)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,28.0,TREATMENT,21273.0,31800.0,1838019000.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,Y,97.0,97,Period 2,nan,A,2018-03-30T08:50 (8)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,TREATMENT,21273.0,40800.0,1838028000.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,,97.0,97,Period 2,-1.0,A,2018-03-30T11:20 (8)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,30.0,TREATMENT,21280.0,31800.0,1838623800.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,Y,98.0,98,Period 3,nan,B,2018-04-06T08:50 (15)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,31.0,TREATMENT,21280.0,40807.0,1838632807.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,95.0,95,,,,,98.0,98,Period 3,-3.0,B,2018-04-06T11:20 (15)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,32.0,END OF TREATMENT,21281.0,39600.0,1838718000.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,,97.0,97,EOT/ET/Followup,-3.0,B,2018-04-07T11:00 (16)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21256.0,50105.0,1836568505.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,374.0,374,,,,Y,374.0,374,EOT/ET/Followup,nan,NA,2018-03-13T13:55 (-10)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,34.0,TREATMENT,21266.0,31800.0,1837414200.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,379.0,379,,,,Y,379.0,379,Period 1,nan,C,2018-03-23T08:50 (1)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,35.0,TREATMENT,21266.0,40800.0,1837423200.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,373.0,373,,,,,379.0,379,Period 1,-6.0,C,2018-03-23T11:20 (1)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,36.0,TREATMENT,21273.0,31800.0,1838019000.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,385.0,385,,,,Y,385.0,385,Period 2,nan,A,2018-03-30T08:50 (8)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,37.0,TREATMENT,21273.0,40800.0,1838028000.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,377.0,377,,,,,385.0,385,Period 2,-8.0,A,2018-03-30T11:20 (8)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,38.0,TREATMENT,21280.0,31800.0,1838623800.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,387.0,387,,,,Y,387.0,387,Period 3,nan,B,2018-04-06T08:50 (15)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,39.0,TREATMENT,21280.0,40807.0,1838632807.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,364.0,364,,,,,387.0,387,Period 3,-23.0,B,2018-04-06T11:20 (15)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,40.0,END OF TREATMENT,21281.0,39600.0,1838718000.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,366.0,366,,,,,374.0,374,EOT/ET/Followup,-8.0,B,2018-04-07T11:00 (16)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21256.0,50105.0,1836568505.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,405.0,405,,,,Y,405.0,405,EOT/ET/Followup,nan,NA,2018-03-13T13:55 (-10)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,42.0,TREATMENT,21266.0,31800.0,1837414200.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,406.0,406,,,,Y,406.0,406,Period 1,nan,C,2018-03-23T08:50 (1)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,43.0,TREATMENT,21266.0,40800.0,1837423200.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,371.0,371,,,,,406.0,406,Period 1,-35.0,C,2018-03-23T11:20 (1)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,44.0,TREATMENT,21273.0,31800.0,1838019000.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,413.0,413,,,,Y,413.0,413,Period 2,nan,A,2018-03-30T08:50 (8)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,45.0,TREATMENT,21273.0,40800.0,1838028000.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,385.0,385,,,,,413.0,413,Period 2,-28.0,A,2018-03-30T11:20 (8)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,46.0,TREATMENT,21280.0,31800.0,1838623800.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,417.0,417,,,,Y,417.0,417,Period 3,nan,B,2018-04-06T08:50 (15)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,47.0,TREATMENT,21280.0,40807.0,1838632807.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,408.0,408,,,,,417.0,417,Period 3,-9.0,B,2018-04-06T11:20 (15)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,48.0,END OF TREATMENT,21281.0,39600.0,1838718000.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,393.0,393,,,,,405.0,405,EOT/ET/Followup,-12.0,B,2018-04-07T11:00 (16)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21256.0,50105.0,1836568505.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,394.0,394,,,,Y,394.0,394,EOT/ET/Followup,nan,NA,2018-03-13T13:55 (-10)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,50.0,TREATMENT,21266.0,31800.0,1837414200.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,397.0,397,,,,Y,397.0,397,Period 1,nan,C,2018-03-23T08:50 (1)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,51.0,TREATMENT,21266.0,40800.0,1837423200.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,372.0,372,,,,,397.0,397,Period 1,-25.0,C,2018-03-23T11:20 (1)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,52.0,TREATMENT,21273.0,31800.0,1838019000.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,403.0,403,,,,Y,403.0,403,Period 2,nan,A,2018-03-30T08:50 (8)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,53.0,TREATMENT,21273.0,40800.0,1838028000.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,382.0,382,,,,,403.0,403,Period 2,-21.0,A,2018-03-30T11:20 (8)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,54.0,TREATMENT,21280.0,31800.0,1838623800.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,407.0,407,,,,Y,407.0,407,Period 3,nan,B,2018-04-06T08:50 (15)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,55.0,TREATMENT,21280.0,40807.0,1838632807.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,393.0,393,,,,,407.0,407,Period 3,-14.0,B,2018-04-06T11:20 (15)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,56.0,END OF TREATMENT,21281.0,39600.0,1838718000.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,383.0,383,,,,,394.0,394,EOT/ET/Followup,-11.0,B,2018-04-07T11:00 (16)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21256.0,50105.0,1836568505.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,849.0,849,,,,Y,849.0,849,EOT/ET/Followup,nan,NA,2018-03-13T13:55 (-10)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,58.0,TREATMENT,21266.0,31800.0,1837414200.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,870.0,870,,,,Y,870.0,870,Period 1,nan,C,2018-03-23T08:50 (1)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,59.0,TREATMENT,21266.0,40800.0,1837423200.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1007.0,1007,,,,,870.0,870,Period 1,137.0,C,2018-03-23T11:20 (1)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,60.0,TREATMENT,21273.0,31800.0,1838019000.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,868.0,868,,,,Y,868.0,868,Period 2,nan,A,2018-03-30T08:50 (8)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,61.0,TREATMENT,21273.0,40800.0,1838028000.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,958.0,958,,,,,868.0,868,Period 2,90.0,A,2018-03-30T11:20 (8)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,62.0,TREATMENT,21280.0,31800.0,1838623800.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,859.0,859,,,,Y,859.0,859,Period 3,nan,B,2018-04-06T08:50 (15)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,63.0,TREATMENT,21280.0,40807.0,1838632807.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,793.0,793,,,,,859.0,859,Period 3,-66.0,B,2018-04-06T11:20 (15)
3110-103-002,3110-103-002.103001079,103001079,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,64.0,END OF TREATMENT,21281.0,39600.0,1838718000.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,867.0,867,,,,,849.0,849,EOT/ET/Followup,18.0,B,2018-04-07T11:00 (16)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21256.0,52384.0,1836570784.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,60.0,60,,,,Y,60.0,60,EOT/ET/Followup,nan,NA,2018-03-13T14:33 (-10)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,2.0,TREATMENT,21266.0,32880.0,1837415280.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,64.0,64,,,,Y,64.0,64,Period 1,nan,B,2018-03-23T09:08 (1)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,3.0,TREATMENT,21266.0,41880.0,1837424280.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,63.0,63,,,,,64.0,64,Period 1,-1.0,B,2018-03-23T11:38 (1)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,TREATMENT,21273.0,32880.0,1838020080.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,63.0,63,,,,Y,63.0,63,Period 2,nan,C,2018-03-30T09:08 (8)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,5.0,TREATMENT,21273.0,41890.0,1838029090.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,54.0,54,,,,,63.0,63,Period 2,-9.0,C,2018-03-30T11:38 (8)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,6.0,TREATMENT,21280.0,32887.0,1838624887.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,64.0,64,,,,Y,64.0,64,Period 3,nan,A,2018-04-06T09:08 (15)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,7.0,TREATMENT,21280.0,41880.0,1838633880.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,57.0,57,,,,,64.0,64,Period 3,-7.0,A,2018-04-06T11:38 (15)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,8.0,END OF TREATMENT,21281.0,40680.0,1838719080.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,59.0,59,,,,,60.0,60,EOT/ET/Followup,-1.0,A,2018-04-07T11:18 (16)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21256.0,52384.0,1836570784.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-13T14:33 (-10)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,10.0,TREATMENT,21266.0,32880.0,1837415280.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,B,2018-03-23T09:08 (1)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,11.0,TREATMENT,21266.0,41880.0,1837424280.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,B,2018-03-23T11:38 (1)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,12.0,TREATMENT,21273.0,32880.0,1838020080.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,C,2018-03-30T09:08 (8)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,13.0,TREATMENT,21273.0,41890.0,1838029090.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,C,2018-03-30T11:38 (8)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,14.0,TREATMENT,21280.0,32887.0,1838624887.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,A,2018-04-06T09:08 (15)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,15.0,TREATMENT,21280.0,41880.0,1838633880.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,A,2018-04-06T11:38 (15)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,16.0,END OF TREATMENT,21281.0,40680.0,1838719080.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,A,2018-04-07T11:18 (16)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21256.0,52384.0,1836570784.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,130.0,130,,,,Y,130.0,130,EOT/ET/Followup,nan,NA,2018-03-13T14:33 (-10)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,18.0,TREATMENT,21266.0,32880.0,1837415280.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,141.0,141,,,,Y,141.0,141,Period 1,nan,B,2018-03-23T09:08 (1)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21266.0,41880.0,1837424280.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,140.0,140,,,,,141.0,141,Period 1,-1.0,B,2018-03-23T11:38 (1)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,TREATMENT,21273.0,32880.0,1838020080.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,138.0,138,,,,Y,138.0,138,Period 2,nan,C,2018-03-30T09:08 (8)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21.0,TREATMENT,21273.0,41890.0,1838029090.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,130.0,130,,,,,138.0,138,Period 2,-8.0,C,2018-03-30T11:38 (8)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,22.0,TREATMENT,21280.0,32887.0,1838624887.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,135.0,135,,,,Y,135.0,135,Period 3,nan,A,2018-04-06T09:08 (15)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,23.0,TREATMENT,21280.0,41880.0,1838633880.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,127.0,127,,,,,135.0,135,Period 3,-8.0,A,2018-04-06T11:38 (15)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,24.0,END OF TREATMENT,21281.0,40680.0,1838719080.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,136.0,136,,,,,130.0,130,EOT/ET/Followup,6.0,A,2018-04-07T11:18 (16)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21256.0,52384.0,1836570784.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,Y,94.0,94,EOT/ET/Followup,nan,NA,2018-03-13T14:33 (-10)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,26.0,TREATMENT,21266.0,32880.0,1837415280.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,92.0,92,,,,Y,92.0,92,Period 1,nan,B,2018-03-23T09:08 (1)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,27.0,TREATMENT,21266.0,41880.0,1837424280.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,88.0,88,,,,,92.0,92,Period 1,-4.0,B,2018-03-23T11:38 (1)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,28.0,TREATMENT,21273.0,32880.0,1838020080.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,93.0,93,,,,Y,93.0,93,Period 2,nan,C,2018-03-30T09:08 (8)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,29.0,TREATMENT,21273.0,41890.0,1838029090.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,93.0,93,,,,,93.0,93,Period 2,0.0,C,2018-03-30T11:38 (8)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,30.0,TREATMENT,21280.0,32887.0,1838624887.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,88.0,88,,,,Y,88.0,88,Period 3,nan,A,2018-04-06T09:08 (15)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,31.0,TREATMENT,21280.0,41880.0,1838633880.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,92.0,92,,,,,88.0,88,Period 3,4.0,A,2018-04-06T11:38 (15)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,32.0,END OF TREATMENT,21281.0,40680.0,1838719080.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,92.0,92,,,,,94.0,94,EOT/ET/Followup,-2.0,A,2018-04-07T11:18 (16)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21256.0,52384.0,1836570784.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,373.0,373,,,,Y,373.0,373,EOT/ET/Followup,nan,NA,2018-03-13T14:33 (-10)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21266.0,32880.0,1837415280.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,369.0,369,,,,Y,369.0,369,Period 1,nan,B,2018-03-23T09:08 (1)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,35.0,TREATMENT,21266.0,41880.0,1837424280.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,375.0,375,,,,,369.0,369,Period 1,6.0,B,2018-03-23T11:38 (1)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,36.0,TREATMENT,21273.0,32880.0,1838020080.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,373.0,373,,,,Y,373.0,373,Period 2,nan,C,2018-03-30T09:08 (8)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,37.0,TREATMENT,21273.0,41890.0,1838029090.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,382.0,382,,,,,373.0,373,Period 2,9.0,C,2018-03-30T11:38 (8)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,38.0,TREATMENT,21280.0,32887.0,1838624887.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,371.0,371,,,,Y,371.0,371,Period 3,nan,A,2018-04-06T09:08 (15)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,39.0,TREATMENT,21280.0,41880.0,1838633880.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,372.0,372,,,,,371.0,371,Period 3,1.0,A,2018-04-06T11:38 (15)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,40.0,END OF TREATMENT,21281.0,40680.0,1838719080.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,365.0,365,,,,,373.0,373,EOT/ET/Followup,-8.0,A,2018-04-07T11:18 (16)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21256.0,52384.0,1836570784.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,374.0,374,,,,Y,374.0,374,EOT/ET/Followup,nan,NA,2018-03-13T14:33 (-10)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,42.0,TREATMENT,21266.0,32880.0,1837415280.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,382.0,382,,,,Y,382.0,382,Period 1,nan,B,2018-03-23T09:08 (1)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,43.0,TREATMENT,21266.0,41880.0,1837424280.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,384.0,384,,,,,382.0,382,Period 1,2.0,B,2018-03-23T11:38 (1)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,44.0,TREATMENT,21273.0,32880.0,1838020080.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,383.0,383,,,,Y,383.0,383,Period 2,nan,C,2018-03-30T09:08 (8)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,45.0,TREATMENT,21273.0,41890.0,1838029090.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,362.0,362,,,,,383.0,383,Period 2,-21.0,C,2018-03-30T11:38 (8)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,46.0,TREATMENT,21280.0,32887.0,1838624887.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,384.0,384,,,,Y,384.0,384,Period 3,nan,A,2018-04-06T09:08 (15)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,47.0,TREATMENT,21280.0,41880.0,1838633880.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,363.0,363,,,,,384.0,384,Period 3,-21.0,A,2018-04-06T11:38 (15)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,48.0,END OF TREATMENT,21281.0,40680.0,1838719080.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,363.0,363,,,,,374.0,374,EOT/ET/Followup,-11.0,A,2018-04-07T11:18 (16)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21256.0,52384.0,1836570784.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,373.0,373,,,,Y,373.0,373,EOT/ET/Followup,nan,NA,2018-03-13T14:33 (-10)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,50.0,TREATMENT,21266.0,32880.0,1837415280.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,377.0,377,,,,Y,377.0,377,Period 1,nan,B,2018-03-23T09:08 (1)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,51.0,TREATMENT,21266.0,41880.0,1837424280.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,381.0,381,,,,,377.0,377,Period 1,4.0,B,2018-03-23T11:38 (1)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,52.0,TREATMENT,21273.0,32880.0,1838020080.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,379.0,379,,,,Y,379.0,379,Period 2,nan,C,2018-03-30T09:08 (8)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,53.0,TREATMENT,21273.0,41890.0,1838029090.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,369.0,369,,,,,379.0,379,Period 2,-10.0,C,2018-03-30T11:38 (8)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,54.0,TREATMENT,21280.0,32887.0,1838624887.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,380.0,380,,,,Y,380.0,380,Period 3,nan,A,2018-04-06T09:08 (15)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,55.0,TREATMENT,21280.0,41880.0,1838633880.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,366.0,366,,,,,380.0,380,Period 3,-14.0,A,2018-04-06T11:38 (15)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,56.0,END OF TREATMENT,21281.0,40680.0,1838719080.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,363.0,363,,,,,373.0,373,EOT/ET/Followup,-10.0,A,2018-04-07T11:18 (16)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21256.0,52384.0,1836570784.0,-10.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,993.0,993,,,,Y,993.0,993,EOT/ET/Followup,nan,NA,2018-03-13T14:33 (-10)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,58.0,TREATMENT,21266.0,32880.0,1837415280.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,931.0,931,,,,Y,931.0,931,Period 1,nan,B,2018-03-23T09:08 (1)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,59.0,TREATMENT,21266.0,41880.0,1837424280.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,952.0,952,,,,,931.0,931,Period 1,21.0,B,2018-03-23T11:38 (1)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,60.0,TREATMENT,21273.0,32880.0,1838020080.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,948.0,948,,,,Y,948.0,948,Period 2,nan,C,2018-03-30T09:08 (8)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,61.0,TREATMENT,21273.0,41890.0,1838029090.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1109.0,1109,,,,,948.0,948,Period 2,161.0,C,2018-03-30T11:38 (8)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,62.0,TREATMENT,21280.0,32887.0,1838624887.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,930.0,930,,,,Y,930.0,930,Period 3,nan,A,2018-04-06T09:08 (15)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,63.0,TREATMENT,21280.0,41880.0,1838633880.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1046.0,1046,,,,,930.0,930,Period 3,116.0,A,2018-04-06T11:38 (15)
3110-103-002,3110-103-002.103001089,103001089,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,64.0,END OF TREATMENT,21281.0,40680.0,1838719080.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1010.0,1010,,,,,993.0,993,EOT/ET/Followup,17.0,A,2018-04-07T11:18 (16)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21259.0,38110.0,1836815710.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,48.0,48,,,,Y,48.0,48,EOT/ET/Followup,nan,NA,2018-03-16T10:35 (-7)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21266.0,31200.0,1837413600.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,47.0,47,,,,Y,47.0,47,Period 1,nan,C,2018-03-23T08:40 (1)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21266.0,40200.0,1837422600.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,51.0,51,,,,,47.0,47,Period 1,4.0,C,2018-03-23T11:10 (1)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,4.0,TREATMENT,21273.0,31200.0,1838018400.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,48.0,48,,,,Y,48.0,48,Period 2,nan,B,2018-03-30T08:40 (8)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21273.0,40200.0,1838027400.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,51.0,51,,,,,48.0,48,Period 2,3.0,B,2018-03-30T11:10 (8)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,6.0,TREATMENT,21280.0,31200.0,1838623200.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,49.0,49,,,,Y,49.0,49,Period 3,nan,A,2018-04-06T08:40 (15)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,7.0,TREATMENT,21280.0,40200.0,1838632200.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,50.0,50,,,,,49.0,49,Period 3,1.0,A,2018-04-06T11:10 (15)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,8.0,END OF TREATMENT,21281.0,39000.0,1838717400.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,51.0,51,,,,,48.0,48,EOT/ET/Followup,3.0,A,2018-04-07T10:50 (16)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21259.0,38110.0,1836815710.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-16T10:35 (-7)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21266.0,31200.0,1837413600.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,Y,nan,Normal,Period 1,nan,C,2018-03-23T08:40 (1)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,TREATMENT,21266.0,40200.0,1837422600.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,C,2018-03-23T11:10 (1)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,12.0,TREATMENT,21273.0,31200.0,1838018400.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,Y,nan,Normal,Period 2,nan,B,2018-03-30T08:40 (8)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,13.0,TREATMENT,21273.0,40200.0,1838027400.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,B,2018-03-30T11:10 (8)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,14.0,TREATMENT,21280.0,31200.0,1838623200.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,Y,nan,Normal,Period 3,nan,A,2018-04-06T08:40 (15)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,15.0,TREATMENT,21280.0,40200.0,1838632200.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,A,2018-04-06T11:10 (15)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,16.0,END OF TREATMENT,21281.0,39000.0,1838717400.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,A,2018-04-07T10:50 (16)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21259.0,38110.0,1836815710.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,183.0,183,,,,Y,183.0,183,EOT/ET/Followup,nan,NA,2018-03-16T10:35 (-7)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21266.0,31200.0,1837413600.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,176.0,176,,,,Y,176.0,176,Period 1,nan,C,2018-03-23T08:40 (1)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21266.0,40200.0,1837422600.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,181.0,181,,,,,176.0,176,Period 1,5.0,C,2018-03-23T11:10 (1)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21273.0,31200.0,1838018400.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,193.0,193,,,,Y,193.0,193,Period 2,nan,B,2018-03-30T08:40 (8)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21.0,TREATMENT,21273.0,40200.0,1838027400.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,189.0,189,,,,,193.0,193,Period 2,-4.0,B,2018-03-30T11:10 (8)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,22.0,TREATMENT,21280.0,31200.0,1838623200.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,178.0,178,,,,Y,178.0,178,Period 3,nan,A,2018-04-06T08:40 (15)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,23.0,TREATMENT,21280.0,40200.0,1838632200.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,167.0,167,,,,,178.0,178,Period 3,-11.0,A,2018-04-06T11:10 (15)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,24.0,END OF TREATMENT,21281.0,39000.0,1838717400.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,175.0,175,,,,,183.0,183,EOT/ET/Followup,-8.0,A,2018-04-07T10:50 (16)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21259.0,38110.0,1836815710.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,Y,97.0,97,EOT/ET/Followup,nan,NA,2018-03-16T10:35 (-7)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,26.0,TREATMENT,21266.0,31200.0,1837413600.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,Y,94.0,94,Period 1,nan,C,2018-03-23T08:40 (1)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,27.0,TREATMENT,21266.0,40200.0,1837422600.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,,94.0,94,Period 1,0.0,C,2018-03-23T11:10 (1)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,28.0,TREATMENT,21273.0,31200.0,1838018400.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,Y,98.0,98,Period 2,nan,B,2018-03-30T08:40 (8)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,29.0,TREATMENT,21273.0,40200.0,1838027400.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,90.0,90,,,,,98.0,98,Period 2,-8.0,B,2018-03-30T11:10 (8)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,30.0,TREATMENT,21280.0,31200.0,1838623200.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,Y,94.0,94,Period 3,nan,A,2018-04-06T08:40 (15)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,31.0,TREATMENT,21280.0,40200.0,1838632200.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,,94.0,94,Period 3,3.0,A,2018-04-06T11:10 (15)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,32.0,END OF TREATMENT,21281.0,39000.0,1838717400.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,,97.0,97,EOT/ET/Followup,-3.0,A,2018-04-07T10:50 (16)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21259.0,38110.0,1836815710.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,439.0,439,,,,Y,439.0,439,EOT/ET/Followup,nan,NA,2018-03-16T10:35 (-7)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,34.0,TREATMENT,21266.0,31200.0,1837413600.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,459.0,459,,,,Y,459.0,459,Period 1,nan,C,2018-03-23T08:40 (1)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,35.0,TREATMENT,21266.0,40200.0,1837422600.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,447.0,447,,,,,459.0,459,Period 1,-12.0,C,2018-03-23T11:10 (1)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,TREATMENT,21273.0,31200.0,1838018400.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,464.0,464,,,,Y,464.0,464,Period 2,nan,B,2018-03-30T08:40 (8)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,37.0,TREATMENT,21273.0,40200.0,1838027400.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,443.0,443,,,,,464.0,464,Period 2,-21.0,B,2018-03-30T11:10 (8)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,38.0,TREATMENT,21280.0,31200.0,1838623200.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,459.0,459,,,,Y,459.0,459,Period 3,nan,A,2018-04-06T08:40 (15)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,39.0,TREATMENT,21280.0,40200.0,1838632200.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,453.0,453,,,,,459.0,459,Period 3,-6.0,A,2018-04-06T11:10 (15)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,40.0,END OF TREATMENT,21281.0,39000.0,1838717400.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,442.0,442,,,,,439.0,439,EOT/ET/Followup,3.0,A,2018-04-07T10:50 (16)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21259.0,38110.0,1836815710.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,393.0,393,,,,Y,393.0,393,EOT/ET/Followup,nan,NA,2018-03-16T10:35 (-7)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,42.0,TREATMENT,21266.0,31200.0,1837413600.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,409.0,409,,,,Y,409.0,409,Period 1,nan,C,2018-03-23T08:40 (1)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,43.0,TREATMENT,21266.0,40200.0,1837422600.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,415.0,415,,,,,409.0,409,Period 1,6.0,C,2018-03-23T11:10 (1)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,44.0,TREATMENT,21273.0,31200.0,1838018400.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,416.0,416,,,,Y,416.0,416,Period 2,nan,B,2018-03-30T08:40 (8)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,45.0,TREATMENT,21273.0,40200.0,1838027400.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,412.0,412,,,,,416.0,416,Period 2,-4.0,B,2018-03-30T11:10 (8)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,46.0,TREATMENT,21280.0,31200.0,1838623200.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,417.0,417,,,,Y,417.0,417,Period 3,nan,A,2018-04-06T08:40 (15)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,47.0,TREATMENT,21280.0,40200.0,1838632200.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,415.0,415,,,,,417.0,417,Period 3,-2.0,A,2018-04-06T11:10 (15)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,48.0,END OF TREATMENT,21281.0,39000.0,1838717400.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,408.0,408,,,,,393.0,393,EOT/ET/Followup,15.0,A,2018-04-07T10:50 (16)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21259.0,38110.0,1836815710.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,408.0,408,,,,Y,408.0,408,EOT/ET/Followup,nan,NA,2018-03-16T10:35 (-7)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,50.0,TREATMENT,21266.0,31200.0,1837413600.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,425.0,425,,,,Y,425.0,425,Period 1,nan,C,2018-03-23T08:40 (1)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,51.0,TREATMENT,21266.0,40200.0,1837422600.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,425.0,425,,,,,425.0,425,Period 1,0.0,C,2018-03-23T11:10 (1)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,52.0,TREATMENT,21273.0,31200.0,1838018400.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,432.0,432,,,,Y,432.0,432,Period 2,nan,B,2018-03-30T08:40 (8)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,53.0,TREATMENT,21273.0,40200.0,1838027400.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,422.0,422,,,,,432.0,432,Period 2,-10.0,B,2018-03-30T11:10 (8)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,54.0,TREATMENT,21280.0,31200.0,1838623200.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,430.0,430,,,,Y,430.0,430,Period 3,nan,A,2018-04-06T08:40 (15)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,55.0,TREATMENT,21280.0,40200.0,1838632200.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,427.0,427,,,,,430.0,430,Period 3,-3.0,A,2018-04-06T11:10 (15)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,56.0,END OF TREATMENT,21281.0,39000.0,1838717400.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,419.0,419,,,,,408.0,408,EOT/ET/Followup,11.0,A,2018-04-07T10:50 (16)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21259.0,38110.0,1836815710.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,1242.0,1242,,,,Y,1242.0,1242,EOT/ET/Followup,nan,NA,2018-03-16T10:35 (-7)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,58.0,TREATMENT,21266.0,31200.0,1837413600.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1258.0,1258,,,,Y,1258.0,1258,Period 1,nan,C,2018-03-23T08:40 (1)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,59.0,TREATMENT,21266.0,40200.0,1837422600.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1159.0,1159,,,,,1258.0,1258,Period 1,-99.0,C,2018-03-23T11:10 (1)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,60.0,TREATMENT,21273.0,31200.0,1838018400.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1239.0,1239,,,,Y,1239.0,1239,Period 2,nan,B,2018-03-30T08:40 (8)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,61.0,TREATMENT,21273.0,40200.0,1838027400.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1155.0,1155,,,,,1239.0,1239,Period 2,-84.0,B,2018-03-30T11:10 (8)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,62.0,TREATMENT,21280.0,31200.0,1838623200.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1209.0,1209,,,,Y,1209.0,1209,Period 3,nan,A,2018-04-06T08:40 (15)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,63.0,TREATMENT,21280.0,40200.0,1838632200.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1188.0,1188,,,,,1209.0,1209,Period 3,-21.0,A,2018-04-06T11:10 (15)
3110-103-002,3110-103-002.103001092,103001092,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,64.0,END OF TREATMENT,21281.0,39000.0,1838717400.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1173.0,1173,,,,,1242.0,1242,EOT/ET/Followup,-69.0,A,2018-04-07T10:50 (16)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21259.0,47767.0,1836825367.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,47.0,47,,,,Y,47.0,47,EOT/ET/Followup,nan,NA,2018-03-16T13:16 (-7)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21266.0,32040.0,1837414440.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,53.0,53,,,,Y,53.0,53,Period 1,nan,C,2018-03-23T08:54 (1)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21266.0,41040.0,1837423440.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,55.0,55,,,,,53.0,53,Period 1,2.0,C,2018-03-23T11:24 (1)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,4.0,TREATMENT,21273.0,32040.0,1838019240.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,50.0,50,,,,Y,50.0,50,Period 2,nan,B,2018-03-30T08:54 (8)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21273.0,41040.0,1838028240.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,50.0,50,,,,,50.0,50,Period 2,0.0,B,2018-03-30T11:24 (8)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,6.0,TREATMENT,21280.0,32040.0,1838624040.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,56.0,56,,,,Y,56.0,56,Period 3,nan,A,2018-04-06T08:54 (15)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,7.0,TREATMENT,21280.0,41040.0,1838633040.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,50.0,50,,,,,56.0,56,Period 3,-6.0,A,2018-04-06T11:24 (15)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,8.0,END OF TREATMENT,21281.0,39840.0,1838718240.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,53.0,53,,,,,47.0,47,EOT/ET/Followup,6.0,A,2018-04-07T11:04 (16)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21259.0,47767.0,1836825367.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-16T13:16 (-7)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21266.0,32040.0,1837414440.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,C,2018-03-23T08:54 (1)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,TREATMENT,21266.0,41040.0,1837423440.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,C,2018-03-23T11:24 (1)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,12.0,TREATMENT,21273.0,32040.0,1838019240.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,B,2018-03-30T08:54 (8)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,13.0,TREATMENT,21273.0,41040.0,1838028240.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,B,2018-03-30T11:24 (8)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,14.0,TREATMENT,21280.0,32040.0,1838624040.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,A,2018-04-06T08:54 (15)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,15.0,TREATMENT,21280.0,41040.0,1838633040.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,A,2018-04-06T11:24 (15)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,16.0,END OF TREATMENT,21281.0,39840.0,1838718240.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,A,2018-04-07T11:04 (16)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21259.0,47767.0,1836825367.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,156.0,156,,,,Y,156.0,156,EOT/ET/Followup,nan,NA,2018-03-16T13:16 (-7)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21266.0,32040.0,1837414440.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,162.0,162,,,,Y,162.0,162,Period 1,nan,C,2018-03-23T08:54 (1)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21266.0,41040.0,1837423440.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,172.0,172,,,,,162.0,162,Period 1,10.0,C,2018-03-23T11:24 (1)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21273.0,32040.0,1838019240.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,160.0,160,,,,Y,160.0,160,Period 2,nan,B,2018-03-30T08:54 (8)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21.0,TREATMENT,21273.0,41040.0,1838028240.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,172.0,172,,,,,160.0,160,Period 2,12.0,B,2018-03-30T11:24 (8)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,22.0,TREATMENT,21280.0,32040.0,1838624040.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,164.0,164,,,,Y,164.0,164,Period 3,nan,A,2018-04-06T08:54 (15)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,23.0,TREATMENT,21280.0,41040.0,1838633040.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,162.0,162,,,,,164.0,164,Period 3,-2.0,A,2018-04-06T11:24 (15)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,24.0,END OF TREATMENT,21281.0,39840.0,1838718240.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,166.0,166,,,,,156.0,156,EOT/ET/Followup,10.0,A,2018-04-07T11:04 (16)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21259.0,47767.0,1836825367.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,Y,99.0,99,EOT/ET/Followup,nan,NA,2018-03-16T13:16 (-7)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,26.0,TREATMENT,21266.0,32040.0,1837414440.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,Y,99.0,99,Period 1,nan,C,2018-03-23T08:54 (1)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,27.0,TREATMENT,21266.0,41040.0,1837423440.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,,99.0,99,Period 1,-1.0,C,2018-03-23T11:24 (1)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,28.0,TREATMENT,21273.0,32040.0,1838019240.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,Y,99.0,99,Period 2,nan,B,2018-03-30T08:54 (8)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,29.0,TREATMENT,21273.0,41040.0,1838028240.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,100.0,100,,,,,99.0,99,Period 2,1.0,B,2018-03-30T11:24 (8)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,30.0,TREATMENT,21280.0,32040.0,1838624040.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,Y,98.0,98,Period 3,nan,A,2018-04-06T08:54 (15)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,31.0,TREATMENT,21280.0,41040.0,1838633040.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,,98.0,98,Period 3,1.0,A,2018-04-06T11:24 (15)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,32.0,END OF TREATMENT,21281.0,39840.0,1838718240.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,,99.0,99,EOT/ET/Followup,-2.0,A,2018-04-07T11:04 (16)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21259.0,47767.0,1836825367.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,414.0,414,,,,Y,414.0,414,EOT/ET/Followup,nan,NA,2018-03-16T13:16 (-7)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,34.0,TREATMENT,21266.0,32040.0,1837414440.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,400.0,400,,,,Y,400.0,400,Period 1,nan,C,2018-03-23T08:54 (1)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,35.0,TREATMENT,21266.0,41040.0,1837423440.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,405.0,405,,,,,400.0,400,Period 1,5.0,C,2018-03-23T11:24 (1)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,TREATMENT,21273.0,32040.0,1838019240.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,408.0,408,,,,Y,408.0,408,Period 2,nan,B,2018-03-30T08:54 (8)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,37.0,TREATMENT,21273.0,41040.0,1838028240.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,403.0,403,,,,,408.0,408,Period 2,-5.0,B,2018-03-30T11:24 (8)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,38.0,TREATMENT,21280.0,32040.0,1838624040.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,405.0,405,,,,Y,405.0,405,Period 3,nan,A,2018-04-06T08:54 (15)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,39.0,TREATMENT,21280.0,41040.0,1838633040.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,401.0,401,,,,,405.0,405,Period 3,-4.0,A,2018-04-06T11:24 (15)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,40.0,END OF TREATMENT,21281.0,39840.0,1838718240.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,401.0,401,,,,,414.0,414,EOT/ET/Followup,-13.0,A,2018-04-07T11:04 (16)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21259.0,47767.0,1836825367.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,369.0,369,,,,Y,369.0,369,EOT/ET/Followup,nan,NA,2018-03-16T13:16 (-7)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,42.0,TREATMENT,21266.0,32040.0,1837414440.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,377.0,377,,,,Y,377.0,377,Period 1,nan,C,2018-03-23T08:54 (1)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,43.0,TREATMENT,21266.0,41040.0,1837423440.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,388.0,388,,,,,377.0,377,Period 1,11.0,C,2018-03-23T11:24 (1)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,44.0,TREATMENT,21273.0,32040.0,1838019240.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,375.0,375,,,,Y,375.0,375,Period 2,nan,B,2018-03-30T08:54 (8)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,45.0,TREATMENT,21273.0,41040.0,1838028240.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,369.0,369,,,,,375.0,375,Period 2,-6.0,B,2018-03-30T11:24 (8)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,46.0,TREATMENT,21280.0,32040.0,1838624040.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,393.0,393,,,,Y,393.0,393,Period 3,nan,A,2018-04-06T08:54 (15)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,47.0,TREATMENT,21280.0,41040.0,1838633040.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,368.0,368,,,,,393.0,393,Period 3,-25.0,A,2018-04-06T11:24 (15)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,48.0,END OF TREATMENT,21281.0,39840.0,1838718240.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,378.0,378,,,,,369.0,369,EOT/ET/Followup,9.0,A,2018-04-07T11:04 (16)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21259.0,47767.0,1836825367.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,383.0,383,,,,Y,383.0,383,EOT/ET/Followup,nan,NA,2018-03-16T13:16 (-7)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,50.0,TREATMENT,21266.0,32040.0,1837414440.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,384.0,384,,,,Y,384.0,384,Period 1,nan,C,2018-03-23T08:54 (1)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,51.0,TREATMENT,21266.0,41040.0,1837423440.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,393.0,393,,,,,384.0,384,Period 1,9.0,C,2018-03-23T11:24 (1)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,52.0,TREATMENT,21273.0,32040.0,1838019240.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,386.0,386,,,,Y,386.0,386,Period 2,nan,B,2018-03-30T08:54 (8)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,53.0,TREATMENT,21273.0,41040.0,1838028240.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,380.0,380,,,,,386.0,386,Period 2,-6.0,B,2018-03-30T11:24 (8)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,54.0,TREATMENT,21280.0,32040.0,1838624040.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,397.0,397,,,,Y,397.0,397,Period 3,nan,A,2018-04-06T08:54 (15)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,55.0,TREATMENT,21280.0,41040.0,1838633040.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,378.0,378,,,,,397.0,397,Period 3,-19.0,A,2018-04-06T11:24 (15)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,56.0,END OF TREATMENT,21281.0,39840.0,1838718240.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,385.0,385,,,,,383.0,383,EOT/ET/Followup,2.0,A,2018-04-07T11:04 (16)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21259.0,47767.0,1836825367.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,1255.0,1255,,,,Y,1255.0,1255,EOT/ET/Followup,nan,NA,2018-03-16T13:16 (-7)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,58.0,TREATMENT,21266.0,32040.0,1837414440.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1125.0,1125,,,,Y,1125.0,1125,Period 1,nan,C,2018-03-23T08:54 (1)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,59.0,TREATMENT,21266.0,41040.0,1837423440.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1088.0,1088,,,,,1125.0,1125,Period 1,-37.0,C,2018-03-23T11:24 (1)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,60.0,TREATMENT,21273.0,32040.0,1838019240.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1178.0,1178,,,,Y,1178.0,1178,Period 2,nan,B,2018-03-30T08:54 (8)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,61.0,TREATMENT,21273.0,41040.0,1838028240.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1188.0,1188,,,,,1178.0,1178,Period 2,10.0,B,2018-03-30T11:24 (8)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,62.0,TREATMENT,21280.0,32040.0,1838624040.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1058.0,1058,,,,Y,1058.0,1058,Period 3,nan,A,2018-04-06T08:54 (15)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,63.0,TREATMENT,21280.0,41040.0,1838633040.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1186.0,1186,,,,,1058.0,1058,Period 3,128.0,A,2018-04-06T11:24 (15)
3110-103-002,3110-103-002.103001096,103001096,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,64.0,END OF TREATMENT,21281.0,39840.0,1838718240.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1124.0,1124,,,,,1255.0,1255,EOT/ET/Followup,-131.0,A,2018-04-07T11:04 (16)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21259.0,47280.0,1836824880.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,72.0,72,,,,Y,72.0,72,EOT/ET/Followup,nan,NA,2018-03-16T13:08 (-7)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21266.0,32220.0,1837414620.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,72.0,72,,,,Y,72.0,72,Period 1,nan,C,2018-03-23T08:57 (1)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21266.0,41220.0,1837423620.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,71.0,71,,,,,72.0,72,Period 1,-1.0,C,2018-03-23T11:27 (1)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,4.0,TREATMENT,21273.0,32220.0,1838019420.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,72.0,72,,,,Y,72.0,72,Period 2,nan,A,2018-03-30T08:57 (8)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,5.0,TREATMENT,21273.0,41220.0,1838028420.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,63.0,63,,,,,72.0,72,Period 2,-9.0,A,2018-03-30T11:27 (8)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21280.0,32220.0,1838624220.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,76.0,76,,,,Y,76.0,76,Period 3,nan,B,2018-04-06T08:57 (15)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,7.0,TREATMENT,21280.0,41220.0,1838633220.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,67.0,67,,,,,76.0,76,Period 3,-9.0,B,2018-04-06T11:27 (15)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,8.0,END OF TREATMENT,21281.0,40020.0,1838718420.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,72.0,72,,,,,72.0,72,EOT/ET/Followup,0.0,B,2018-04-07T11:07 (16)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21259.0,47280.0,1836824880.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-16T13:08 (-7)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21266.0,32220.0,1837414620.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,C,2018-03-23T08:57 (1)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,TREATMENT,21266.0,41220.0,1837423620.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,C,2018-03-23T11:27 (1)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,12.0,TREATMENT,21273.0,32220.0,1838019420.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,A,2018-03-30T08:57 (8)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,13.0,TREATMENT,21273.0,41220.0,1838028420.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,A,2018-03-30T11:27 (8)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,14.0,TREATMENT,21280.0,32220.0,1838624220.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,B,2018-04-06T08:57 (15)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,15.0,TREATMENT,21280.0,41220.0,1838633220.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,B,2018-04-06T11:27 (15)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,16.0,END OF TREATMENT,21281.0,40020.0,1838718420.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,B,2018-04-07T11:07 (16)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21259.0,47280.0,1836824880.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,148.0,148,,,,Y,148.0,148,EOT/ET/Followup,nan,NA,2018-03-16T13:08 (-7)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21266.0,32220.0,1837414620.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,154.0,154,,,,Y,154.0,154,Period 1,nan,C,2018-03-23T08:57 (1)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21266.0,41220.0,1837423620.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,157.0,157,,,,,154.0,154,Period 1,3.0,C,2018-03-23T11:27 (1)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,20.0,TREATMENT,21273.0,32220.0,1838019420.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,150.0,150,,,,Y,150.0,150,Period 2,nan,A,2018-03-30T08:57 (8)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21.0,TREATMENT,21273.0,41220.0,1838028420.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,130.0,130,,,,,150.0,150,Period 2,-20.0,A,2018-03-30T11:27 (8)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,22.0,TREATMENT,21280.0,32220.0,1838624220.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,146.0,146,,,,Y,146.0,146,Period 3,nan,B,2018-04-06T08:57 (15)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,23.0,TREATMENT,21280.0,41220.0,1838633220.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,155.0,155,,,,,146.0,146,Period 3,9.0,B,2018-04-06T11:27 (15)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,24.0,END OF TREATMENT,21281.0,40020.0,1838718420.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,156.0,156,,,,,148.0,148,EOT/ET/Followup,8.0,B,2018-04-07T11:07 (16)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21259.0,47280.0,1836824880.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,Y,97.0,97,EOT/ET/Followup,nan,NA,2018-03-16T13:08 (-7)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,26.0,TREATMENT,21266.0,32220.0,1837414620.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,93.0,93,,,,Y,93.0,93,Period 1,nan,C,2018-03-23T08:57 (1)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,27.0,TREATMENT,21266.0,41220.0,1837423620.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,93.0,93,,,,,93.0,93,Period 1,0.0,C,2018-03-23T11:27 (1)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,28.0,TREATMENT,21273.0,32220.0,1838019420.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,Y,97.0,97,Period 2,nan,A,2018-03-30T08:57 (8)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,TREATMENT,21273.0,41220.0,1838028420.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,,97.0,97,Period 2,1.0,A,2018-03-30T11:27 (8)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,30.0,TREATMENT,21280.0,32220.0,1838624220.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,90.0,90,,,,Y,90.0,90,Period 3,nan,B,2018-04-06T08:57 (15)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,31.0,TREATMENT,21280.0,41220.0,1838633220.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,,90.0,90,Period 3,4.0,B,2018-04-06T11:27 (15)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,32.0,END OF TREATMENT,21281.0,40020.0,1838718420.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,92.0,92,,,,,97.0,97,EOT/ET/Followup,-5.0,B,2018-04-07T11:07 (16)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21259.0,47280.0,1836824880.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,397.0,397,,,,Y,397.0,397,EOT/ET/Followup,nan,NA,2018-03-16T13:08 (-7)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,34.0,TREATMENT,21266.0,32220.0,1837414620.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,391.0,391,,,,Y,391.0,391,Period 1,nan,C,2018-03-23T08:57 (1)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,35.0,TREATMENT,21266.0,41220.0,1837423620.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,388.0,388,,,,,391.0,391,Period 1,-3.0,C,2018-03-23T11:27 (1)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,36.0,TREATMENT,21273.0,32220.0,1838019420.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,393.0,393,,,,Y,393.0,393,Period 2,nan,A,2018-03-30T08:57 (8)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,37.0,TREATMENT,21273.0,41220.0,1838028420.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,413.0,413,,,,,393.0,393,Period 2,20.0,A,2018-03-30T11:27 (8)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,38.0,TREATMENT,21280.0,32220.0,1838624220.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,379.0,379,,,,Y,379.0,379,Period 3,nan,B,2018-04-06T08:57 (15)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,39.0,TREATMENT,21280.0,41220.0,1838633220.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,409.0,409,,,,,379.0,379,Period 3,30.0,B,2018-04-06T11:27 (15)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,40.0,END OF TREATMENT,21281.0,40020.0,1838718420.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,393.0,393,,,,,397.0,397,EOT/ET/Followup,-4.0,B,2018-04-07T11:07 (16)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21259.0,47280.0,1836824880.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,434.0,434,,,,Y,434.0,434,EOT/ET/Followup,nan,NA,2018-03-16T13:08 (-7)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,42.0,TREATMENT,21266.0,32220.0,1837414620.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,430.0,430,,,,Y,430.0,430,Period 1,nan,C,2018-03-23T08:57 (1)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,43.0,TREATMENT,21266.0,41220.0,1837423620.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,423.0,423,,,,,430.0,430,Period 1,-7.0,C,2018-03-23T11:27 (1)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,44.0,TREATMENT,21273.0,32220.0,1838019420.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,431.0,431,,,,Y,431.0,431,Period 2,nan,A,2018-03-30T08:57 (8)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,45.0,TREATMENT,21273.0,41220.0,1838028420.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,425.0,425,,,,,431.0,431,Period 2,-6.0,A,2018-03-30T11:27 (8)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,46.0,TREATMENT,21280.0,32220.0,1838624220.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,428.0,428,,,,Y,428.0,428,Period 3,nan,B,2018-04-06T08:57 (15)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,47.0,TREATMENT,21280.0,41220.0,1838633220.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,432.0,432,,,,,428.0,428,Period 3,4.0,B,2018-04-06T11:27 (15)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,48.0,END OF TREATMENT,21281.0,40020.0,1838718420.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,432.0,432,,,,,434.0,434,EOT/ET/Followup,-2.0,B,2018-04-07T11:07 (16)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21259.0,47280.0,1836824880.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,421.0,421,,,,Y,421.0,421,EOT/ET/Followup,nan,NA,2018-03-16T13:08 (-7)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,50.0,TREATMENT,21266.0,32220.0,1837414620.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,416.0,416,,,,Y,416.0,416,Period 1,nan,C,2018-03-23T08:57 (1)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,51.0,TREATMENT,21266.0,41220.0,1837423620.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,411.0,411,,,,,416.0,416,Period 1,-5.0,C,2018-03-23T11:27 (1)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,52.0,TREATMENT,21273.0,32220.0,1838019420.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,418.0,418,,,,Y,418.0,418,Period 2,nan,A,2018-03-30T08:57 (8)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,53.0,TREATMENT,21273.0,41220.0,1838028420.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,421.0,421,,,,,418.0,418,Period 2,3.0,A,2018-03-30T11:27 (8)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,54.0,TREATMENT,21280.0,32220.0,1838624220.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,411.0,411,,,,Y,411.0,411,Period 3,nan,B,2018-04-06T08:57 (15)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,55.0,TREATMENT,21280.0,41220.0,1838633220.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,424.0,424,,,,,411.0,411,Period 3,13.0,B,2018-04-06T11:27 (15)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,56.0,END OF TREATMENT,21281.0,40020.0,1838718420.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,418.0,418,,,,,421.0,421,EOT/ET/Followup,-3.0,B,2018-04-07T11:07 (16)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21259.0,47280.0,1836824880.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,833.0,833,,,,Y,833.0,833,EOT/ET/Followup,nan,NA,2018-03-16T13:08 (-7)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,58.0,TREATMENT,21266.0,32220.0,1837414620.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,825.0,825,,,,Y,825.0,825,Period 1,nan,C,2018-03-23T08:57 (1)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,59.0,TREATMENT,21266.0,41220.0,1837423620.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,841.0,841,,,,,825.0,825,Period 1,16.0,C,2018-03-23T11:27 (1)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,60.0,TREATMENT,21273.0,32220.0,1838019420.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,828.0,828,,,,Y,828.0,828,Period 2,nan,A,2018-03-30T08:57 (8)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,61.0,TREATMENT,21273.0,41220.0,1838028420.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,942.0,942,,,,,828.0,828,Period 2,114.0,A,2018-03-30T11:27 (8)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,62.0,TREATMENT,21280.0,32220.0,1838624220.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,784.0,784,,,,Y,784.0,784,Period 3,nan,B,2018-04-06T08:57 (15)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,63.0,TREATMENT,21280.0,41220.0,1838633220.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,893.0,893,,,,,784.0,784,Period 3,109.0,B,2018-04-06T11:27 (15)
3110-103-002,3110-103-002.103001098,103001098,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,64.0,END OF TREATMENT,21281.0,40020.0,1838718420.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,827.0,827,,,,,833.0,833,EOT/ET/Followup,-6.0,B,2018-04-07T11:07 (16)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21259.0,52159.0,1836829759.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,70.0,70,,,,Y,70.0,70,EOT/ET/Followup,nan,NA,2018-03-16T14:29 (-7)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,2.0,TREATMENT,21266.0,31920.0,1837414320.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,59.0,59,,,,Y,59.0,59,Period 1,nan,A,2018-03-23T08:52 (1)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21266.0,40920.0,1837423320.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,51.0,51,,,,,59.0,59,Period 1,-8.0,A,2018-03-23T11:22 (1)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,TREATMENT,21273.0,31920.0,1838019120.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,58.0,58,,,,Y,58.0,58,Period 2,nan,C,2018-03-30T08:52 (8)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,5.0,TREATMENT,21273.0,40920.0,1838028120.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,56.0,56,,,,,58.0,58,Period 2,-2.0,C,2018-03-30T11:22 (8)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,6.0,TREATMENT,21280.0,31920.0,1838623920.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,57.0,57,,,,,nan,,,nan,NA,2018-04-06T08:52 (15)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,END OF TREATMENT,21280.0,57780.0,1838649780.0,15.0,EOT/ET,99.0,Early Term,,nan,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,77.0,77,,,,,70.0,70,EOT/ET/Followup,7.0,C,2018-04-06T16:03 (15)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,8.0,SCREENING,21259.0,52159.0,1836829759.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-16T14:29 (-7)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,9.0,TREATMENT,21266.0,31920.0,1837414320.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,A,2018-03-23T08:52 (1)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,10.0,TREATMENT,21266.0,40920.0,1837423320.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,A,2018-03-23T11:22 (1)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,TREATMENT,21273.0,31920.0,1838019120.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,C,2018-03-30T08:52 (8)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,12.0,TREATMENT,21273.0,40920.0,1838028120.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,C,2018-03-30T11:22 (8)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,13.0,TREATMENT,21280.0,31920.0,1838623920.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,,,nan,NA,2018-04-06T08:52 (15)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,14.0,END OF TREATMENT,21280.0,57780.0,1838649780.0,15.0,EOT/ET,99.0,Early Term,,nan,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,C,2018-04-06T16:03 (15)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,15.0,SCREENING,21259.0,52159.0,1836829759.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,167.0,167,,,,Y,167.0,167,EOT/ET/Followup,nan,NA,2018-03-16T14:29 (-7)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,16.0,TREATMENT,21266.0,31920.0,1837414320.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,182.0,182,,,,Y,182.0,182,Period 1,nan,A,2018-03-23T08:52 (1)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,17.0,TREATMENT,21266.0,40920.0,1837423320.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,146.0,146,,,,,182.0,182,Period 1,-36.0,A,2018-03-23T11:22 (1)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21273.0,31920.0,1838019120.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,181.0,181,,,,Y,181.0,181,Period 2,nan,C,2018-03-30T08:52 (8)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21273.0,40920.0,1838028120.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,179.0,179,,,,,181.0,181,Period 2,-2.0,C,2018-03-30T11:22 (8)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,20.0,TREATMENT,21280.0,31920.0,1838623920.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,176.0,176,,,,,nan,,,nan,NA,2018-04-06T08:52 (15)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21.0,END OF TREATMENT,21280.0,57780.0,1838649780.0,15.0,EOT/ET,99.0,Early Term,,nan,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,163.0,163,,,,,167.0,167,EOT/ET/Followup,-4.0,C,2018-04-06T16:03 (15)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,22.0,SCREENING,21259.0,52159.0,1836829759.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,Y,97.0,97,EOT/ET/Followup,nan,NA,2018-03-16T14:29 (-7)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,23.0,TREATMENT,21266.0,31920.0,1837414320.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,Y,94.0,94,Period 1,nan,A,2018-03-23T08:52 (1)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,24.0,TREATMENT,21266.0,40920.0,1837423320.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,90.0,90,,,,,94.0,94,Period 1,-4.0,A,2018-03-23T11:22 (1)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,25.0,TREATMENT,21273.0,31920.0,1838019120.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,Y,94.0,94,Period 2,nan,C,2018-03-30T08:52 (8)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,26.0,TREATMENT,21273.0,40920.0,1838028120.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,90.0,90,,,,,94.0,94,Period 2,-4.0,C,2018-03-30T11:22 (8)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,27.0,TREATMENT,21280.0,31920.0,1838623920.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,,nan,,,nan,NA,2018-04-06T08:52 (15)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,28.0,END OF TREATMENT,21280.0,57780.0,1838649780.0,15.0,EOT/ET,99.0,Early Term,,nan,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,86.0,86,,,,,97.0,97,EOT/ET/Followup,-11.0,C,2018-04-06T16:03 (15)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,29.0,SCREENING,21259.0,52159.0,1836829759.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,373.0,373,,,,Y,373.0,373,EOT/ET/Followup,nan,NA,2018-03-16T14:29 (-7)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,30.0,TREATMENT,21266.0,31920.0,1837414320.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,397.0,397,,,,Y,397.0,397,Period 1,nan,A,2018-03-23T08:52 (1)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,31.0,TREATMENT,21266.0,40920.0,1837423320.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,392.0,392,,,,,397.0,397,Period 1,-5.0,A,2018-03-23T11:22 (1)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,32.0,TREATMENT,21273.0,31920.0,1838019120.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,394.0,394,,,,Y,394.0,394,Period 2,nan,C,2018-03-30T08:52 (8)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,33.0,TREATMENT,21273.0,40920.0,1838028120.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,394.0,394,,,,,394.0,394,Period 2,0.0,C,2018-03-30T11:22 (8)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,34.0,TREATMENT,21280.0,31920.0,1838623920.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,396.0,396,,,,,nan,,,nan,NA,2018-04-06T08:52 (15)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,35.0,END OF TREATMENT,21280.0,57780.0,1838649780.0,15.0,EOT/ET,99.0,Early Term,,nan,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,351.0,351,,,,,373.0,373,EOT/ET/Followup,-22.0,C,2018-04-06T16:03 (15)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,36.0,SCREENING,21259.0,52159.0,1836829759.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,404.0,404,,,,Y,404.0,404,EOT/ET/Followup,nan,NA,2018-03-16T14:29 (-7)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,37.0,TREATMENT,21266.0,31920.0,1837414320.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,396.0,396,,,,Y,396.0,396,Period 1,nan,A,2018-03-23T08:52 (1)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,38.0,TREATMENT,21266.0,40920.0,1837423320.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,363.0,363,,,,,396.0,396,Period 1,-33.0,A,2018-03-23T11:22 (1)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,39.0,TREATMENT,21273.0,31920.0,1838019120.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,388.0,388,,,,Y,388.0,388,Period 2,nan,C,2018-03-30T08:52 (8)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,40.0,TREATMENT,21273.0,40920.0,1838028120.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,383.0,383,,,,,388.0,388,Period 2,-5.0,C,2018-03-30T11:22 (8)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,41.0,TREATMENT,21280.0,31920.0,1838623920.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,389.0,389,,,,,nan,,,nan,NA,2018-04-06T08:52 (15)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,42.0,END OF TREATMENT,21280.0,57780.0,1838649780.0,15.0,EOT/ET,99.0,Early Term,,nan,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,399.0,399,,,,,404.0,404,EOT/ET/Followup,-5.0,C,2018-04-06T16:03 (15)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,43.0,SCREENING,21259.0,52159.0,1836829759.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,393.0,393,,,,Y,393.0,393,EOT/ET/Followup,nan,NA,2018-03-16T14:29 (-7)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,44.0,TREATMENT,21266.0,31920.0,1837414320.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,396.0,396,,,,Y,396.0,396,Period 1,nan,A,2018-03-23T08:52 (1)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,45.0,TREATMENT,21266.0,40920.0,1837423320.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,372.0,372,,,,,396.0,396,Period 1,-24.0,A,2018-03-23T11:22 (1)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,46.0,TREATMENT,21273.0,31920.0,1838019120.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,390.0,390,,,,Y,390.0,390,Period 2,nan,C,2018-03-30T08:52 (8)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,47.0,TREATMENT,21273.0,40920.0,1838028120.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,387.0,387,,,,,390.0,390,Period 2,-3.0,C,2018-03-30T11:22 (8)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,48.0,TREATMENT,21280.0,31920.0,1838623920.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,391.0,391,,,,,nan,,,nan,NA,2018-04-06T08:52 (15)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,49.0,END OF TREATMENT,21280.0,57780.0,1838649780.0,15.0,EOT/ET,99.0,Early Term,,nan,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,382.0,382,,,,,393.0,393,EOT/ET/Followup,-11.0,C,2018-04-06T16:03 (15)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,50.0,SCREENING,21259.0,52159.0,1836829759.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,851.0,851,,,,Y,851.0,851,EOT/ET/Followup,nan,NA,2018-03-16T14:29 (-7)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,51.0,TREATMENT,21266.0,31920.0,1837414320.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1001.0,1001,,,,Y,1001.0,1001,Period 1,nan,A,2018-03-23T08:52 (1)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,52.0,TREATMENT,21266.0,40920.0,1837423320.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1163.0,1163,,,,,1001.0,1001,Period 1,162.0,A,2018-03-23T11:22 (1)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,53.0,TREATMENT,21273.0,31920.0,1838019120.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1031.0,1031,,,,Y,1031.0,1031,Period 2,nan,C,2018-03-30T08:52 (8)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,54.0,TREATMENT,21273.0,40920.0,1838028120.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1054.0,1054,,,,,1031.0,1031,Period 2,23.0,C,2018-03-30T11:22 (8)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,55.0,TREATMENT,21280.0,31920.0,1838623920.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,1036.0,1036,,,,,nan,,,nan,NA,2018-04-06T08:52 (15)
3110-103-002,3110-103-002.103001105,103001105,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,56.0,END OF TREATMENT,21280.0,57780.0,1838649780.0,15.0,EOT/ET,99.0,Early Term,,nan,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,773.0,773,,,,,851.0,851,EOT/ET/Followup,-78.0,C,2018-04-06T16:03 (15)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21259.0,51325.0,1836828925.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,62.0,62,,,,Y,62.0,62,EOT/ET/Followup,nan,NA,2018-03-16T14:15 (-7)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,2.0,TREATMENT,21266.0,30780.0,1837413180.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,56.0,56,,,,Y,56.0,56,Period 1,nan,B,2018-03-23T08:33 (1)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,3.0,TREATMENT,21266.0,39780.0,1837422180.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,66.0,66,,,,,56.0,56,Period 1,10.0,B,2018-03-23T11:03 (1)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,4.0,TREATMENT,21273.0,30780.0,1838017980.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,57.0,57,,,,Y,57.0,57,Period 2,nan,A,2018-03-30T08:33 (8)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,5.0,TREATMENT,21273.0,39780.0,1838026980.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,57.0,57,,,,,57.0,57,Period 2,0.0,A,2018-03-30T11:03 (8)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,6.0,TREATMENT,21280.0,30780.0,1838622780.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,64.0,64,,,,Y,64.0,64,Period 3,nan,C,2018-04-06T08:33 (15)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,TREATMENT,21280.0,39841.0,1838631841.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,64.0,64,,,,,64.0,64,Period 3,0.0,C,2018-04-06T11:04 (15)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,END OF TREATMENT,21281.0,38580.0,1838716980.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,64.0,64,,,,,62.0,62,EOT/ET/Followup,2.0,C,2018-04-07T10:43 (16)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21259.0,51325.0,1836828925.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-16T14:15 (-7)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,10.0,TREATMENT,21266.0,30780.0,1837413180.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,B,2018-03-23T08:33 (1)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,11.0,TREATMENT,21266.0,39780.0,1837422180.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,B,2018-03-23T11:03 (1)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,12.0,TREATMENT,21273.0,30780.0,1838017980.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,A,2018-03-30T08:33 (8)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,13.0,TREATMENT,21273.0,39780.0,1838026980.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,A,2018-03-30T11:03 (8)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,14.0,TREATMENT,21280.0,30780.0,1838622780.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,C,2018-04-06T08:33 (15)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,15.0,TREATMENT,21280.0,39841.0,1838631841.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,C,2018-04-06T11:04 (15)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,16.0,END OF TREATMENT,21281.0,38580.0,1838716980.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,C,2018-04-07T10:43 (16)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21259.0,51325.0,1836828925.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,152.0,152,,,,Y,152.0,152,EOT/ET/Followup,nan,NA,2018-03-16T14:15 (-7)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,18.0,TREATMENT,21266.0,30780.0,1837413180.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,143.0,143,,,,Y,143.0,143,Period 1,nan,B,2018-03-23T08:33 (1)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21266.0,39780.0,1837422180.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,153.0,153,,,,,143.0,143,Period 1,10.0,B,2018-03-23T11:03 (1)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,20.0,TREATMENT,21273.0,30780.0,1838017980.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,156.0,156,,,,Y,156.0,156,Period 2,nan,A,2018-03-30T08:33 (8)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21.0,TREATMENT,21273.0,39780.0,1838026980.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,140.0,140,,,,,156.0,156,Period 2,-16.0,A,2018-03-30T11:03 (8)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,TREATMENT,21280.0,30780.0,1838622780.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,141.0,141,,,,Y,141.0,141,Period 3,nan,C,2018-04-06T08:33 (15)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,23.0,TREATMENT,21280.0,39841.0,1838631841.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,148.0,148,,,,,141.0,141,Period 3,7.0,C,2018-04-06T11:04 (15)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,24.0,END OF TREATMENT,21281.0,38580.0,1838716980.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,146.0,146,,,,,152.0,152,EOT/ET/Followup,-6.0,C,2018-04-07T10:43 (16)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21259.0,51325.0,1836828925.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,Y,96.0,96,EOT/ET/Followup,nan,NA,2018-03-16T14:15 (-7)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,26.0,TREATMENT,21266.0,30780.0,1837413180.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,Y,96.0,96,Period 1,nan,B,2018-03-23T08:33 (1)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,27.0,TREATMENT,21266.0,39780.0,1837422180.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,,96.0,96,Period 1,0.0,B,2018-03-23T11:03 (1)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,28.0,TREATMENT,21273.0,30780.0,1838017980.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,Y,96.0,96,Period 2,nan,A,2018-03-30T08:33 (8)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,TREATMENT,21273.0,39780.0,1838026980.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,,96.0,96,Period 2,-2.0,A,2018-03-30T11:03 (8)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,30.0,TREATMENT,21280.0,30780.0,1838622780.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,Y,96.0,96,Period 3,nan,C,2018-04-06T08:33 (15)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,31.0,TREATMENT,21280.0,39841.0,1838631841.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,95.0,95,,,,,96.0,96,Period 3,-1.0,C,2018-04-06T11:04 (15)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,32.0,END OF TREATMENT,21281.0,38580.0,1838716980.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,,96.0,96,EOT/ET/Followup,0.0,C,2018-04-07T10:43 (16)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21259.0,51325.0,1836828925.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,408.0,408,,,,Y,408.0,408,EOT/ET/Followup,nan,NA,2018-03-16T14:15 (-7)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21266.0,30780.0,1837413180.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,400.0,400,,,,Y,400.0,400,Period 1,nan,B,2018-03-23T08:33 (1)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,35.0,TREATMENT,21266.0,39780.0,1837422180.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,391.0,391,,,,,400.0,400,Period 1,-9.0,B,2018-03-23T11:03 (1)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,36.0,TREATMENT,21273.0,30780.0,1838017980.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,397.0,397,,,,Y,397.0,397,Period 2,nan,A,2018-03-30T08:33 (8)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,37.0,TREATMENT,21273.0,39780.0,1838026980.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,400.0,400,,,,,397.0,397,Period 2,3.0,A,2018-03-30T11:03 (8)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,38.0,TREATMENT,21280.0,30780.0,1838622780.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,383.0,383,,,,Y,383.0,383,Period 3,nan,C,2018-04-06T08:33 (15)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,39.0,TREATMENT,21280.0,39841.0,1838631841.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,390.0,390,,,,,383.0,383,Period 3,7.0,C,2018-04-06T11:04 (15)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,40.0,END OF TREATMENT,21281.0,38580.0,1838716980.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,381.0,381,,,,,408.0,408,EOT/ET/Followup,-27.0,C,2018-04-07T10:43 (16)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21259.0,51325.0,1836828925.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,417.0,417,,,,Y,417.0,417,EOT/ET/Followup,nan,NA,2018-03-16T14:15 (-7)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,42.0,TREATMENT,21266.0,30780.0,1837413180.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,389.0,389,,,,Y,389.0,389,Period 1,nan,B,2018-03-23T08:33 (1)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,43.0,TREATMENT,21266.0,39780.0,1837422180.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,411.0,411,,,,,389.0,389,Period 1,22.0,B,2018-03-23T11:03 (1)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,44.0,TREATMENT,21273.0,30780.0,1838017980.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,388.0,388,,,,Y,388.0,388,Period 2,nan,A,2018-03-30T08:33 (8)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,45.0,TREATMENT,21273.0,39780.0,1838026980.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,390.0,390,,,,,388.0,388,Period 2,2.0,A,2018-03-30T11:03 (8)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,46.0,TREATMENT,21280.0,30780.0,1838622780.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,396.0,396,,,,Y,396.0,396,Period 3,nan,C,2018-04-06T08:33 (15)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,47.0,TREATMENT,21280.0,39841.0,1838631841.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,405.0,405,,,,,396.0,396,Period 3,9.0,C,2018-04-06T11:04 (15)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,48.0,END OF TREATMENT,21281.0,38580.0,1838716980.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,394.0,394,,,,,417.0,417,EOT/ET/Followup,-23.0,C,2018-04-07T10:43 (16)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21259.0,51325.0,1836828925.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,414.0,414,,,,Y,414.0,414,EOT/ET/Followup,nan,NA,2018-03-16T14:15 (-7)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,50.0,TREATMENT,21266.0,30780.0,1837413180.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,393.0,393,,,,Y,393.0,393,Period 1,nan,B,2018-03-23T08:33 (1)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,51.0,TREATMENT,21266.0,39780.0,1837422180.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,404.0,404,,,,,393.0,393,Period 1,11.0,B,2018-03-23T11:03 (1)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,52.0,TREATMENT,21273.0,30780.0,1838017980.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,391.0,391,,,,Y,391.0,391,Period 2,nan,A,2018-03-30T08:33 (8)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,53.0,TREATMENT,21273.0,39780.0,1838026980.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,393.0,393,,,,,391.0,391,Period 2,2.0,A,2018-03-30T11:03 (8)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,54.0,TREATMENT,21280.0,30780.0,1838622780.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,391.0,391,,,,Y,391.0,391,Period 3,nan,C,2018-04-06T08:33 (15)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,55.0,TREATMENT,21280.0,39841.0,1838631841.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,400.0,400,,,,,391.0,391,Period 3,9.0,C,2018-04-06T11:04 (15)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,56.0,END OF TREATMENT,21281.0,38580.0,1838716980.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,390.0,390,,,,,414.0,414,EOT/ET/Followup,-24.0,C,2018-04-07T10:43 (16)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21259.0,51325.0,1836828925.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,954.0,954,,,,Y,954.0,954,EOT/ET/Followup,nan,NA,2018-03-16T14:15 (-7)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,58.0,TREATMENT,21266.0,30780.0,1837413180.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1054.0,1054,,,,Y,1054.0,1054,Period 1,nan,B,2018-03-23T08:33 (1)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,59.0,TREATMENT,21266.0,39780.0,1837422180.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,904.0,904,,,,,1054.0,1054,Period 1,-150.0,B,2018-03-23T11:03 (1)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,60.0,TREATMENT,21273.0,30780.0,1838017980.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1045.0,1045,,,,Y,1045.0,1045,Period 2,nan,A,2018-03-30T08:33 (8)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,61.0,TREATMENT,21273.0,39780.0,1838026980.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1048.0,1048,,,,,1045.0,1045,Period 2,3.0,A,2018-03-30T11:03 (8)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,62.0,TREATMENT,21280.0,30780.0,1838622780.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,935.0,935,,,,Y,935.0,935,Period 3,nan,C,2018-04-06T08:33 (15)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,63.0,TREATMENT,21280.0,39841.0,1838631841.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,926.0,926,,,,,935.0,935,Period 3,-9.0,C,2018-04-06T11:04 (15)
3110-103-002,3110-103-002.103001107,103001107,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,64.0,END OF TREATMENT,21281.0,38580.0,1838716980.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,931.0,931,,,,,954.0,954,EOT/ET/Followup,-23.0,C,2018-04-07T10:43 (16)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21259.0,55504.0,1836833104.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,59.0,59,,,,Y,59.0,59,EOT/ET/Followup,nan,NA,2018-03-16T15:25 (-7)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,2.0,TREATMENT,21266.0,32700.0,1837415100.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,61.0,61,,,,Y,61.0,61,Period 1,nan,B,2018-03-23T09:05 (1)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,3.0,TREATMENT,21266.0,41700.0,1837424100.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,54.0,54,,,,,61.0,61,Period 1,-7.0,B,2018-03-23T11:35 (1)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,TREATMENT,21273.0,32700.0,1838019900.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,67.0,67,,,,Y,67.0,67,Period 2,nan,C,2018-03-30T09:05 (8)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,5.0,TREATMENT,21273.0,41700.0,1838028900.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,66.0,66,,,,,67.0,67,Period 2,-1.0,C,2018-03-30T11:35 (8)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,6.0,TREATMENT,21287.0,32700.0,1839229500.0,22.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,67.0,67,,,,Y,67.0,67,Period 3,nan,A,2018-04-13T09:05 (22)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,7.0,TREATMENT,21287.0,41700.0,1839238500.0,22.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,63.0,63,,,,,67.0,67,Period 3,-4.0,A,2018-04-13T11:35 (22)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,8.0,END OF TREATMENT,21288.0,40500.0,1839323700.0,23.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,72.0,72,,,,,59.0,59,EOT/ET/Followup,13.0,A,2018-04-14T11:15 (23)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21259.0,55504.0,1836833104.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-16T15:25 (-7)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,10.0,TREATMENT,21266.0,32700.0,1837415100.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,B,2018-03-23T09:05 (1)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,11.0,TREATMENT,21266.0,41700.0,1837424100.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,B,2018-03-23T11:35 (1)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,12.0,TREATMENT,21273.0,32700.0,1838019900.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,C,2018-03-30T09:05 (8)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,13.0,TREATMENT,21273.0,41700.0,1838028900.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,C,2018-03-30T11:35 (8)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,14.0,TREATMENT,21287.0,32700.0,1839229500.0,22.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,A,2018-04-13T09:05 (22)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,15.0,TREATMENT,21287.0,41700.0,1839238500.0,22.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,A,2018-04-13T11:35 (22)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,16.0,END OF TREATMENT,21288.0,40500.0,1839323700.0,23.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,A,2018-04-14T11:15 (23)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21259.0,55504.0,1836833104.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,177.0,177,,,,Y,177.0,177,EOT/ET/Followup,nan,NA,2018-03-16T15:25 (-7)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,18.0,TREATMENT,21266.0,32700.0,1837415100.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,183.0,183,,,,Y,183.0,183,Period 1,nan,B,2018-03-23T09:05 (1)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21266.0,41700.0,1837424100.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,178.0,178,,,,,183.0,183,Period 1,-5.0,B,2018-03-23T11:35 (1)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,TREATMENT,21273.0,32700.0,1838019900.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,189.0,189,,,,Y,189.0,189,Period 2,nan,C,2018-03-30T09:05 (8)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21.0,TREATMENT,21273.0,41700.0,1838028900.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,187.0,187,,,,,189.0,189,Period 2,-2.0,C,2018-03-30T11:35 (8)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,22.0,TREATMENT,21287.0,32700.0,1839229500.0,22.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,182.0,182,,,,Y,182.0,182,Period 3,nan,A,2018-04-13T09:05 (22)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,23.0,TREATMENT,21287.0,41700.0,1839238500.0,22.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,173.0,173,,,,,182.0,182,Period 3,-9.0,A,2018-04-13T11:35 (22)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,24.0,END OF TREATMENT,21288.0,40500.0,1839323700.0,23.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,173.0,173,,,,,177.0,177,EOT/ET/Followup,-4.0,A,2018-04-14T11:15 (23)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21259.0,55504.0,1836833104.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,81.0,81,,,,Y,81.0,81,EOT/ET/Followup,nan,NA,2018-03-16T15:25 (-7)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,26.0,TREATMENT,21266.0,32700.0,1837415100.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,74.0,74,,,,Y,74.0,74,Period 1,nan,B,2018-03-23T09:05 (1)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,27.0,TREATMENT,21266.0,41700.0,1837424100.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,74.0,74,,,,,74.0,74,Period 1,0.0,B,2018-03-23T11:35 (1)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,28.0,TREATMENT,21273.0,32700.0,1838019900.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,74.0,74,,,,Y,74.0,74,Period 2,nan,C,2018-03-30T09:05 (8)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,29.0,TREATMENT,21273.0,41700.0,1838028900.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,76.0,76,,,,,74.0,74,Period 2,2.0,C,2018-03-30T11:35 (8)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,30.0,TREATMENT,21287.0,32700.0,1839229500.0,22.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,81.0,81,,,,Y,81.0,81,Period 3,nan,A,2018-04-13T09:05 (22)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,31.0,TREATMENT,21287.0,41700.0,1839238500.0,22.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,75.0,75,,,,,81.0,81,Period 3,-6.0,A,2018-04-13T11:35 (22)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,32.0,END OF TREATMENT,21288.0,40500.0,1839323700.0,23.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,73.0,73,,,,,81.0,81,EOT/ET/Followup,-8.0,A,2018-04-14T11:15 (23)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21259.0,55504.0,1836833104.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,431.0,431,,,,Y,431.0,431,EOT/ET/Followup,nan,NA,2018-03-16T15:25 (-7)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21266.0,32700.0,1837415100.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,425.0,425,,,,Y,425.0,425,Period 1,nan,B,2018-03-23T09:05 (1)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,35.0,TREATMENT,21266.0,41700.0,1837424100.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,430.0,430,,,,,425.0,425,Period 1,5.0,B,2018-03-23T11:35 (1)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,36.0,TREATMENT,21273.0,32700.0,1838019900.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,411.0,411,,,,Y,411.0,411,Period 2,nan,C,2018-03-30T09:05 (8)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,37.0,TREATMENT,21273.0,41700.0,1838028900.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,414.0,414,,,,,411.0,411,Period 2,3.0,C,2018-03-30T11:35 (8)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,38.0,TREATMENT,21287.0,32700.0,1839229500.0,22.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,409.0,409,,,,Y,409.0,409,Period 3,nan,A,2018-04-13T09:05 (22)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,39.0,TREATMENT,21287.0,41700.0,1839238500.0,22.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,432.0,432,,,,,409.0,409,Period 3,23.0,A,2018-04-13T11:35 (22)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,40.0,END OF TREATMENT,21288.0,40500.0,1839323700.0,23.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,398.0,398,,,,,431.0,431,EOT/ET/Followup,-33.0,A,2018-04-14T11:15 (23)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21259.0,55504.0,1836833104.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,430.0,430,,,,Y,430.0,430,EOT/ET/Followup,nan,NA,2018-03-16T15:25 (-7)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,42.0,TREATMENT,21266.0,32700.0,1837415100.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,431.0,431,,,,Y,431.0,431,Period 1,nan,B,2018-03-23T09:05 (1)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,43.0,TREATMENT,21266.0,41700.0,1837424100.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,410.0,410,,,,,431.0,431,Period 1,-21.0,B,2018-03-23T11:35 (1)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,44.0,TREATMENT,21273.0,32700.0,1838019900.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,434.0,434,,,,Y,434.0,434,Period 2,nan,C,2018-03-30T09:05 (8)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,45.0,TREATMENT,21273.0,41700.0,1838028900.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,435.0,435,,,,,434.0,434,Period 2,1.0,C,2018-03-30T11:35 (8)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,46.0,TREATMENT,21287.0,32700.0,1839229500.0,22.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,433.0,433,,,,Y,433.0,433,Period 3,nan,A,2018-04-13T09:05 (22)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,47.0,TREATMENT,21287.0,41700.0,1839238500.0,22.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,443.0,443,,,,,433.0,433,Period 3,10.0,A,2018-04-13T11:35 (22)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,48.0,END OF TREATMENT,21288.0,40500.0,1839323700.0,23.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,436.0,436,,,,,430.0,430,EOT/ET/Followup,6.0,A,2018-04-14T11:15 (23)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21259.0,55504.0,1836833104.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,430.0,430,,,,Y,430.0,430,EOT/ET/Followup,nan,NA,2018-03-16T15:25 (-7)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,50.0,TREATMENT,21266.0,32700.0,1837415100.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,429.0,429,,,,Y,429.0,429,Period 1,nan,B,2018-03-23T09:05 (1)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,51.0,TREATMENT,21266.0,41700.0,1837424100.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,416.0,416,,,,,429.0,429,Period 1,-13.0,B,2018-03-23T11:35 (1)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,52.0,TREATMENT,21273.0,32700.0,1838019900.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,426.0,426,,,,Y,426.0,426,Period 2,nan,C,2018-03-30T09:05 (8)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,53.0,TREATMENT,21273.0,41700.0,1838028900.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,428.0,428,,,,,426.0,426,Period 2,2.0,C,2018-03-30T11:35 (8)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,54.0,TREATMENT,21287.0,32700.0,1839229500.0,22.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,425.0,425,,,,Y,425.0,425,Period 3,nan,A,2018-04-13T09:05 (22)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,55.0,TREATMENT,21287.0,41700.0,1839238500.0,22.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,439.0,439,,,,,425.0,425,Period 3,14.0,A,2018-04-13T11:35 (22)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,56.0,END OF TREATMENT,21288.0,40500.0,1839323700.0,23.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,422.0,422,,,,,430.0,430,EOT/ET/Followup,-8.0,A,2018-04-14T11:15 (23)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21259.0,55504.0,1836833104.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,1001.0,1001,,,,Y,1001.0,1001,EOT/ET/Followup,nan,NA,2018-03-16T15:25 (-7)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,58.0,TREATMENT,21266.0,32700.0,1837415100.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,972.0,972,,,,Y,972.0,972,Period 1,nan,B,2018-03-23T09:05 (1)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,59.0,TREATMENT,21266.0,41700.0,1837424100.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1098.0,1098,,,,,972.0,972,Period 1,126.0,B,2018-03-23T11:35 (1)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,60.0,TREATMENT,21273.0,32700.0,1838019900.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,893.0,893,,,,Y,893.0,893,Period 2,nan,C,2018-03-30T09:05 (8)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,61.0,TREATMENT,21273.0,41700.0,1838028900.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,905.0,905,,,,,893.0,893,Period 2,12.0,C,2018-03-30T11:35 (8)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,62.0,TREATMENT,21287.0,32700.0,1839229500.0,22.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,891.0,891,,,,Y,891.0,891,Period 3,nan,A,2018-04-13T09:05 (22)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,63.0,TREATMENT,21287.0,41700.0,1839238500.0,22.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,950.0,950,,,,,891.0,891,Period 3,59.0,A,2018-04-13T11:35 (22)
3110-103-002,3110-103-002.103001111,103001111,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,64.0,END OF TREATMENT,21288.0,40500.0,1839323700.0,23.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,833.0,833,,,,,1001.0,1001,EOT/ET/Followup,-168.0,A,2018-04-14T11:15 (23)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21259.0,53665.0,1836831265.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,57.0,57,,,,Y,57.0,57,EOT/ET/Followup,nan,NA,2018-03-16T14:54 (-7)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,2.0,TREATMENT,21266.0,30840.0,1837413240.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,56.0,56,,,,Y,56.0,56,Period 1,nan,A,2018-03-23T08:34 (1)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21266.0,39840.0,1837422240.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,57.0,57,,,,,56.0,56,Period 1,1.0,A,2018-03-23T11:04 (1)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,4.0,TREATMENT,21273.0,30840.0,1838018040.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,76.0,76,,,,Y,76.0,76,Period 2,nan,B,2018-03-30T08:34 (8)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21273.0,39840.0,1838027040.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,62.0,62,,,,,76.0,76,Period 2,-14.0,B,2018-03-30T11:04 (8)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,6.0,TREATMENT,21280.0,30840.0,1838622840.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,72.0,72,,,,Y,72.0,72,Period 3,nan,C,2018-04-06T08:34 (15)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,TREATMENT,21280.0,39840.0,1838631840.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,57.0,57,,,,,72.0,72,Period 3,-15.0,C,2018-04-06T11:04 (15)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,END OF TREATMENT,21281.0,38640.0,1838717040.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,63.0,63,,,,,57.0,57,EOT/ET/Followup,6.0,C,2018-04-07T10:44 (16)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21259.0,53665.0,1836831265.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-16T14:54 (-7)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,10.0,TREATMENT,21266.0,30840.0,1837413240.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,A,2018-03-23T08:34 (1)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,11.0,TREATMENT,21266.0,39840.0,1837422240.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,A,2018-03-23T11:04 (1)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,12.0,TREATMENT,21273.0,30840.0,1838018040.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,B,2018-03-30T08:34 (8)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,13.0,TREATMENT,21273.0,39840.0,1838027040.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,B,2018-03-30T11:04 (8)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,14.0,TREATMENT,21280.0,30840.0,1838622840.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,C,2018-04-06T08:34 (15)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,15.0,TREATMENT,21280.0,39840.0,1838631840.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,C,2018-04-06T11:04 (15)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,16.0,END OF TREATMENT,21281.0,38640.0,1838717040.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,C,2018-04-07T10:44 (16)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21259.0,53665.0,1836831265.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,158.0,158,,,,Y,158.0,158,EOT/ET/Followup,nan,NA,2018-03-16T14:54 (-7)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,18.0,TREATMENT,21266.0,30840.0,1837413240.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,163.0,163,,,,Y,163.0,163,Period 1,nan,A,2018-03-23T08:34 (1)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,19.0,TREATMENT,21266.0,39840.0,1837422240.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,159.0,159,,,,,163.0,163,Period 1,-4.0,A,2018-03-23T11:04 (1)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21273.0,30840.0,1838018040.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,157.0,157,,,,Y,157.0,157,Period 2,nan,B,2018-03-30T08:34 (8)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21.0,TREATMENT,21273.0,39840.0,1838027040.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,163.0,163,,,,,157.0,157,Period 2,6.0,B,2018-03-30T11:04 (8)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,TREATMENT,21280.0,30840.0,1838622840.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,159.0,159,,,,Y,159.0,159,Period 3,nan,C,2018-04-06T08:34 (15)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,23.0,TREATMENT,21280.0,39840.0,1838631840.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,152.0,152,,,,,159.0,159,Period 3,-7.0,C,2018-04-06T11:04 (15)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,24.0,END OF TREATMENT,21281.0,38640.0,1838717040.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,156.0,156,,,,,158.0,158,EOT/ET/Followup,-2.0,C,2018-04-07T10:44 (16)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21259.0,53665.0,1836831265.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,Y,97.0,97,EOT/ET/Followup,nan,NA,2018-03-16T14:54 (-7)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,26.0,TREATMENT,21266.0,30840.0,1837413240.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,Y,96.0,96,Period 1,nan,A,2018-03-23T08:34 (1)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,TREATMENT,21266.0,39840.0,1837422240.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,95.0,95,,,,,96.0,96,Period 1,-1.0,A,2018-03-23T11:04 (1)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,28.0,TREATMENT,21273.0,30840.0,1838018040.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,Y,96.0,96,Period 2,nan,B,2018-03-30T08:34 (8)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,29.0,TREATMENT,21273.0,39840.0,1838027040.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,93.0,93,,,,,96.0,96,Period 2,-3.0,B,2018-03-30T11:04 (8)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,30.0,TREATMENT,21280.0,30840.0,1838622840.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,92.0,92,,,,Y,92.0,92,Period 3,nan,C,2018-04-06T08:34 (15)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,31.0,TREATMENT,21280.0,39840.0,1838631840.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,,92.0,92,Period 3,6.0,C,2018-04-06T11:04 (15)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,32.0,END OF TREATMENT,21281.0,38640.0,1838717040.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,,97.0,97,EOT/ET/Followup,0.0,C,2018-04-07T10:44 (16)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21259.0,53665.0,1836831265.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,423.0,423,,,,Y,423.0,423,EOT/ET/Followup,nan,NA,2018-03-16T14:54 (-7)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,34.0,TREATMENT,21266.0,30840.0,1837413240.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,432.0,432,,,,Y,432.0,432,Period 1,nan,A,2018-03-23T08:34 (1)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,35.0,TREATMENT,21266.0,39840.0,1837422240.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,408.0,408,,,,,432.0,432,Period 1,-24.0,A,2018-03-23T11:04 (1)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,TREATMENT,21273.0,30840.0,1838018040.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,380.0,380,,,,Y,380.0,380,Period 2,nan,B,2018-03-30T08:34 (8)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,37.0,TREATMENT,21273.0,39840.0,1838027040.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,401.0,401,,,,,380.0,380,Period 2,21.0,B,2018-03-30T11:04 (8)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,38.0,TREATMENT,21280.0,30840.0,1838622840.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,385.0,385,,,,Y,385.0,385,Period 3,nan,C,2018-04-06T08:34 (15)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,39.0,TREATMENT,21280.0,39840.0,1838631840.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,411.0,411,,,,,385.0,385,Period 3,26.0,C,2018-04-06T11:04 (15)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,40.0,END OF TREATMENT,21281.0,38640.0,1838717040.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,395.0,395,,,,,423.0,423,EOT/ET/Followup,-28.0,C,2018-04-07T10:44 (16)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21259.0,53665.0,1836831265.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,414.0,414,,,,Y,414.0,414,EOT/ET/Followup,nan,NA,2018-03-16T14:54 (-7)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,42.0,TREATMENT,21266.0,30840.0,1837413240.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,417.0,417,,,,Y,417.0,417,Period 1,nan,A,2018-03-23T08:34 (1)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,43.0,TREATMENT,21266.0,39840.0,1837422240.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,400.0,400,,,,,417.0,417,Period 1,-17.0,A,2018-03-23T11:04 (1)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,44.0,TREATMENT,21273.0,30840.0,1838018040.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,427.0,427,,,,Y,427.0,427,Period 2,nan,B,2018-03-30T08:34 (8)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,45.0,TREATMENT,21273.0,39840.0,1838027040.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,408.0,408,,,,,427.0,427,Period 2,-19.0,B,2018-03-30T11:04 (8)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,46.0,TREATMENT,21280.0,30840.0,1838622840.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,422.0,422,,,,Y,422.0,422,Period 3,nan,C,2018-04-06T08:34 (15)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,47.0,TREATMENT,21280.0,39840.0,1838631840.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,402.0,402,,,,,422.0,422,Period 3,-20.0,C,2018-04-06T11:04 (15)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,48.0,END OF TREATMENT,21281.0,38640.0,1838717040.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,406.0,406,,,,,414.0,414,EOT/ET/Followup,-8.0,C,2018-04-07T10:44 (16)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21259.0,53665.0,1836831265.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,417.0,417,,,,Y,417.0,417,EOT/ET/Followup,nan,NA,2018-03-16T14:54 (-7)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,50.0,TREATMENT,21266.0,30840.0,1837413240.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,422.0,422,,,,Y,422.0,422,Period 1,nan,A,2018-03-23T08:34 (1)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,51.0,TREATMENT,21266.0,39840.0,1837422240.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,403.0,403,,,,,422.0,422,Period 1,-19.0,A,2018-03-23T11:04 (1)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,52.0,TREATMENT,21273.0,30840.0,1838018040.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,411.0,411,,,,Y,411.0,411,Period 2,nan,B,2018-03-30T08:34 (8)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,53.0,TREATMENT,21273.0,39840.0,1838027040.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,405.0,405,,,,,411.0,411,Period 2,-6.0,B,2018-03-30T11:04 (8)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,54.0,TREATMENT,21280.0,30840.0,1838622840.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,409.0,409,,,,Y,409.0,409,Period 3,nan,C,2018-04-06T08:34 (15)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,55.0,TREATMENT,21280.0,39840.0,1838631840.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,405.0,405,,,,,409.0,409,Period 3,-4.0,C,2018-04-06T11:04 (15)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,56.0,END OF TREATMENT,21281.0,38640.0,1838717040.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,402.0,402,,,,,417.0,417,EOT/ET/Followup,-15.0,C,2018-04-07T10:44 (16)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21259.0,53665.0,1836831265.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,1039.0,1039,,,,Y,1039.0,1039,EOT/ET/Followup,nan,NA,2018-03-16T14:54 (-7)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,58.0,TREATMENT,21266.0,30840.0,1837413240.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1071.0,1071,,,,Y,1071.0,1071,Period 1,nan,A,2018-03-23T08:34 (1)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,59.0,TREATMENT,21266.0,39840.0,1837422240.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1037.0,1037,,,,,1071.0,1071,Period 1,-34.0,A,2018-03-23T11:04 (1)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,60.0,TREATMENT,21273.0,30840.0,1838018040.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,789.0,789,,,,Y,789.0,789,Period 2,nan,B,2018-03-30T08:34 (8)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,61.0,TREATMENT,21273.0,39840.0,1838027040.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,964.0,964,,,,,789.0,789,Period 2,175.0,B,2018-03-30T11:04 (8)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,62.0,TREATMENT,21280.0,30840.0,1838622840.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,830.0,830,,,,Y,830.0,830,Period 3,nan,C,2018-04-06T08:34 (15)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,63.0,TREATMENT,21280.0,39840.0,1838631840.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1044.0,1044,,,,,830.0,830,Period 3,214.0,C,2018-04-06T11:04 (15)
3110-103-002,3110-103-002.103001114,103001114,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,64.0,END OF TREATMENT,21281.0,38640.0,1838717040.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,945.0,945,,,,,1039.0,1039,EOT/ET/Followup,-94.0,C,2018-04-07T10:44 (16)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21259.0,60215.0,1836837815.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,62.0,62,,,,Y,62.0,62,EOT/ET/Followup,nan,NA,2018-03-16T16:43 (-7)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,2.0,TREATMENT,21266.0,32400.0,1837414800.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,60.0,60,,,,Y,60.0,60,Period 1,nan,B,2018-03-23T09:00 (1)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,3.0,TREATMENT,21266.0,41400.0,1837423800.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,52.0,52,,,,,60.0,60,Period 1,-8.0,B,2018-03-23T11:30 (1)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,4.0,TREATMENT,21273.0,32400.0,1838019600.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,63.0,63,,,,Y,63.0,63,Period 2,nan,A,2018-03-30T09:00 (8)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,5.0,TREATMENT,21273.0,41400.0,1838028600.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,59.0,59,,,,,63.0,63,Period 2,-4.0,A,2018-03-30T11:30 (8)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,6.0,TREATMENT,21280.0,32427.0,1838624427.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,70.0,70,,,,Y,70.0,70,Period 3,nan,C,2018-04-06T09:00 (15)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,TREATMENT,21280.0,41400.0,1838633400.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,66.0,66,,,,,70.0,70,Period 3,-4.0,C,2018-04-06T11:30 (15)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,END OF TREATMENT,21281.0,40200.0,1838718600.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,74.0,74,,,,,62.0,62,EOT/ET/Followup,12.0,C,2018-04-07T11:10 (16)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21259.0,60215.0,1836837815.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-16T16:43 (-7)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,10.0,TREATMENT,21266.0,32400.0,1837414800.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,B,2018-03-23T09:00 (1)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,11.0,TREATMENT,21266.0,41400.0,1837423800.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,B,2018-03-23T11:30 (1)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,12.0,TREATMENT,21273.0,32400.0,1838019600.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,A,2018-03-30T09:00 (8)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,13.0,TREATMENT,21273.0,41400.0,1838028600.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,A,2018-03-30T11:30 (8)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,14.0,TREATMENT,21280.0,32427.0,1838624427.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,C,2018-04-06T09:00 (15)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,15.0,TREATMENT,21280.0,41400.0,1838633400.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,C,2018-04-06T11:30 (15)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,16.0,END OF TREATMENT,21281.0,40200.0,1838718600.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,C,2018-04-07T11:10 (16)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21259.0,60215.0,1836837815.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,124.0,124,,,,Y,124.0,124,EOT/ET/Followup,nan,NA,2018-03-16T16:43 (-7)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,18.0,TREATMENT,21266.0,32400.0,1837414800.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,133.0,133,,,,Y,133.0,133,Period 1,nan,B,2018-03-23T09:00 (1)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21266.0,41400.0,1837423800.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,130.0,130,,,,,133.0,133,Period 1,-3.0,B,2018-03-23T11:30 (1)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,20.0,TREATMENT,21273.0,32400.0,1838019600.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,152.0,152,,,,Y,152.0,152,Period 2,nan,A,2018-03-30T09:00 (8)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21.0,TREATMENT,21273.0,41400.0,1838028600.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,137.0,137,,,,,152.0,152,Period 2,-15.0,A,2018-03-30T11:30 (8)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,TREATMENT,21280.0,32427.0,1838624427.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,150.0,150,,,,Y,150.0,150,Period 3,nan,C,2018-04-06T09:00 (15)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,23.0,TREATMENT,21280.0,41400.0,1838633400.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,148.0,148,,,,,150.0,150,Period 3,-2.0,C,2018-04-06T11:30 (15)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,24.0,END OF TREATMENT,21281.0,40200.0,1838718600.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,146.0,146,,,,,124.0,124,EOT/ET/Followup,22.0,C,2018-04-07T11:10 (16)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21259.0,60215.0,1836837815.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,Y,94.0,94,EOT/ET/Followup,nan,NA,2018-03-16T16:43 (-7)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,26.0,TREATMENT,21266.0,32400.0,1837414800.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,83.0,83,,,,Y,83.0,83,Period 1,nan,B,2018-03-23T09:00 (1)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,27.0,TREATMENT,21266.0,41400.0,1837423800.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,84.0,84,,,,,83.0,83,Period 1,1.0,B,2018-03-23T11:30 (1)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,28.0,TREATMENT,21273.0,32400.0,1838019600.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,84.0,84,,,,Y,84.0,84,Period 2,nan,A,2018-03-30T09:00 (8)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,TREATMENT,21273.0,41400.0,1838028600.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,81.0,81,,,,,84.0,84,Period 2,-3.0,A,2018-03-30T11:30 (8)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,30.0,TREATMENT,21280.0,32427.0,1838624427.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,81.0,81,,,,Y,81.0,81,Period 3,nan,C,2018-04-06T09:00 (15)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,31.0,TREATMENT,21280.0,41400.0,1838633400.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,82.0,82,,,,,81.0,81,Period 3,1.0,C,2018-04-06T11:30 (15)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,32.0,END OF TREATMENT,21281.0,40200.0,1838718600.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,92.0,92,,,,,94.0,94,EOT/ET/Followup,-2.0,C,2018-04-07T11:10 (16)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21259.0,60215.0,1836837815.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,408.0,408,,,,Y,408.0,408,EOT/ET/Followup,nan,NA,2018-03-16T16:43 (-7)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21266.0,32400.0,1837414800.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,420.0,420,,,,Y,420.0,420,Period 1,nan,B,2018-03-23T09:00 (1)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,35.0,TREATMENT,21266.0,41400.0,1837423800.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,435.0,435,,,,,420.0,420,Period 1,15.0,B,2018-03-23T11:30 (1)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,36.0,TREATMENT,21273.0,32400.0,1838019600.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,410.0,410,,,,Y,410.0,410,Period 2,nan,A,2018-03-30T09:00 (8)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,37.0,TREATMENT,21273.0,41400.0,1838028600.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,424.0,424,,,,,410.0,410,Period 2,14.0,A,2018-03-30T11:30 (8)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,38.0,TREATMENT,21280.0,32427.0,1838624427.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,386.0,386,,,,Y,386.0,386,Period 3,nan,C,2018-04-06T09:00 (15)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,39.0,TREATMENT,21280.0,41400.0,1838633400.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,387.0,387,,,,,386.0,386,Period 3,1.0,C,2018-04-06T11:30 (15)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,40.0,END OF TREATMENT,21281.0,40200.0,1838718600.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,378.0,378,,,,,408.0,408,EOT/ET/Followup,-30.0,C,2018-04-07T11:10 (16)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21259.0,60215.0,1836837815.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,417.0,417,,,,Y,417.0,417,EOT/ET/Followup,nan,NA,2018-03-16T16:43 (-7)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,42.0,TREATMENT,21266.0,32400.0,1837414800.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,422.0,422,,,,Y,422.0,422,Period 1,nan,B,2018-03-23T09:00 (1)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,43.0,TREATMENT,21266.0,41400.0,1837423800.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,406.0,406,,,,,422.0,422,Period 1,-16.0,B,2018-03-23T11:30 (1)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,44.0,TREATMENT,21273.0,32400.0,1838019600.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,422.0,422,,,,Y,422.0,422,Period 2,nan,A,2018-03-30T09:00 (8)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,45.0,TREATMENT,21273.0,41400.0,1838028600.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,420.0,420,,,,,422.0,422,Period 2,-2.0,A,2018-03-30T11:30 (8)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,46.0,TREATMENT,21280.0,32427.0,1838624427.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,419.0,419,,,,Y,419.0,419,Period 3,nan,C,2018-04-06T09:00 (15)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,47.0,TREATMENT,21280.0,41400.0,1838633400.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,406.0,406,,,,,419.0,419,Period 3,-13.0,C,2018-04-06T11:30 (15)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,48.0,END OF TREATMENT,21281.0,40200.0,1838718600.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,422.0,422,,,,,417.0,417,EOT/ET/Followup,5.0,C,2018-04-07T11:10 (16)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21259.0,60215.0,1836837815.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,414.0,414,,,,Y,414.0,414,EOT/ET/Followup,nan,NA,2018-03-16T16:43 (-7)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,50.0,TREATMENT,21266.0,32400.0,1837414800.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,421.0,421,,,,Y,421.0,421,Period 1,nan,B,2018-03-23T09:00 (1)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,51.0,TREATMENT,21266.0,41400.0,1837423800.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,415.0,415,,,,,421.0,421,Period 1,-6.0,B,2018-03-23T11:30 (1)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,52.0,TREATMENT,21273.0,32400.0,1838019600.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,418.0,418,,,,Y,418.0,418,Period 2,nan,A,2018-03-30T09:00 (8)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,53.0,TREATMENT,21273.0,41400.0,1838028600.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,421.0,421,,,,,418.0,418,Period 2,3.0,A,2018-03-30T11:30 (8)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,54.0,TREATMENT,21280.0,32427.0,1838624427.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,408.0,408,,,,Y,408.0,408,Period 3,nan,C,2018-04-06T09:00 (15)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,55.0,TREATMENT,21280.0,41400.0,1838633400.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,399.0,399,,,,,408.0,408,Period 3,-9.0,C,2018-04-06T11:30 (15)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,56.0,END OF TREATMENT,21281.0,40200.0,1838718600.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,407.0,407,,,,,414.0,414,EOT/ET/Followup,-7.0,C,2018-04-07T11:10 (16)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21259.0,60215.0,1836837815.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,955.0,955,,,,Y,955.0,955,EOT/ET/Followup,nan,NA,2018-03-16T16:43 (-7)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,58.0,TREATMENT,21266.0,32400.0,1837414800.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,986.0,986,,,,Y,986.0,986,Period 1,nan,B,2018-03-23T09:00 (1)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,59.0,TREATMENT,21266.0,41400.0,1837423800.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1147.0,1147,,,,,986.0,986,Period 1,161.0,B,2018-03-23T11:30 (1)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,60.0,TREATMENT,21273.0,32400.0,1838019600.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,941.0,941,,,,Y,941.0,941,Period 2,nan,A,2018-03-30T09:00 (8)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,61.0,TREATMENT,21273.0,41400.0,1838028600.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1015.0,1015,,,,,941.0,941,Period 2,74.0,A,2018-03-30T11:30 (8)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,62.0,TREATMENT,21280.0,32427.0,1838624427.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,846.0,846,,,,Y,846.0,846,Period 3,nan,C,2018-04-06T09:00 (15)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,63.0,TREATMENT,21280.0,41400.0,1838633400.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,906.0,906,,,,,846.0,846,Period 3,60.0,C,2018-04-06T11:30 (15)
3110-103-002,3110-103-002.103001129,103001129,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,64.0,END OF TREATMENT,21281.0,40200.0,1838718600.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,801.0,801,,,,,955.0,955,EOT/ET/Followup,-154.0,C,2018-04-07T11:10 (16)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21262.0,32533.0,1837069333.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,67.0,67,,,,Y,67.0,67,EOT/ET/Followup,nan,NA,2018-03-19T09:02 (-4)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,2.0,TREATMENT,21266.0,31260.0,1837413660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,58.0,58,,,,Y,58.0,58,Period 1,nan,B,2018-03-23T08:41 (1)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,3.0,TREATMENT,21266.0,40260.0,1837422660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,53.0,53,,,,,58.0,58,Period 1,-5.0,B,2018-03-23T11:11 (1)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,TREATMENT,21273.0,31260.0,1838018460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,59.0,59,,,,Y,59.0,59,Period 2,nan,C,2018-03-30T08:41 (8)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,5.0,TREATMENT,21273.0,40260.0,1838027460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,60.0,60,,,,,59.0,59,Period 2,1.0,C,2018-03-30T11:11 (8)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,6.0,TREATMENT,21280.0,31260.0,1838623260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,67.0,67,,,,Y,67.0,67,Period 3,nan,A,2018-04-06T08:41 (15)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,7.0,TREATMENT,21280.0,40260.0,1838632260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,58.0,58,,,,,67.0,67,Period 3,-9.0,A,2018-04-06T11:11 (15)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,8.0,END OF TREATMENT,21281.0,39060.0,1838717460.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,76.0,76,,,,,67.0,67,EOT/ET/Followup,9.0,A,2018-04-07T10:51 (16)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21262.0,32533.0,1837069333.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-19T09:02 (-4)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,10.0,TREATMENT,21266.0,31260.0,1837413660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,B,2018-03-23T08:41 (1)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,11.0,TREATMENT,21266.0,40260.0,1837422660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,B,2018-03-23T11:11 (1)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,12.0,TREATMENT,21273.0,31260.0,1838018460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,C,2018-03-30T08:41 (8)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,13.0,TREATMENT,21273.0,40260.0,1838027460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,C,2018-03-30T11:11 (8)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,14.0,TREATMENT,21280.0,31260.0,1838623260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,A,2018-04-06T08:41 (15)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,15.0,TREATMENT,21280.0,40260.0,1838632260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,A,2018-04-06T11:11 (15)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,16.0,END OF TREATMENT,21281.0,39060.0,1838717460.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,A,2018-04-07T10:51 (16)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21262.0,32533.0,1837069333.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,145.0,145,,,,Y,145.0,145,EOT/ET/Followup,nan,NA,2018-03-19T09:02 (-4)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,18.0,TREATMENT,21266.0,31260.0,1837413660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,157.0,157,,,,Y,157.0,157,Period 1,nan,B,2018-03-23T08:41 (1)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21266.0,40260.0,1837422660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,155.0,155,,,,,157.0,157,Period 1,-2.0,B,2018-03-23T11:11 (1)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,TREATMENT,21273.0,31260.0,1838018460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,154.0,154,,,,Y,154.0,154,Period 2,nan,C,2018-03-30T08:41 (8)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21.0,TREATMENT,21273.0,40260.0,1838027460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,148.0,148,,,,,154.0,154,Period 2,-6.0,C,2018-03-30T11:11 (8)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,22.0,TREATMENT,21280.0,31260.0,1838623260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,146.0,146,,,,Y,146.0,146,Period 3,nan,A,2018-04-06T08:41 (15)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,23.0,TREATMENT,21280.0,40260.0,1838632260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,146.0,146,,,,,146.0,146,Period 3,0.0,A,2018-04-06T11:11 (15)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,24.0,END OF TREATMENT,21281.0,39060.0,1838717460.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,146.0,146,,,,,145.0,145,EOT/ET/Followup,1.0,A,2018-04-07T10:51 (16)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21262.0,32533.0,1837069333.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,81.0,81,,,,Y,81.0,81,EOT/ET/Followup,nan,NA,2018-03-19T09:02 (-4)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,26.0,TREATMENT,21266.0,31260.0,1837413660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,93.0,93,,,,Y,93.0,93,Period 1,nan,B,2018-03-23T08:41 (1)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,27.0,TREATMENT,21266.0,40260.0,1837422660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,90.0,90,,,,,93.0,93,Period 1,-3.0,B,2018-03-23T11:11 (1)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,28.0,TREATMENT,21273.0,31260.0,1838018460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,82.0,82,,,,Y,82.0,82,Period 2,nan,C,2018-03-30T08:41 (8)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,29.0,TREATMENT,21273.0,40260.0,1838027460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,86.0,86,,,,,82.0,82,Period 2,4.0,C,2018-03-30T11:11 (8)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,30.0,TREATMENT,21280.0,31260.0,1838623260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,86.0,86,,,,Y,86.0,86,Period 3,nan,A,2018-04-06T08:41 (15)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,31.0,TREATMENT,21280.0,40260.0,1838632260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,88.0,88,,,,,86.0,86,Period 3,2.0,A,2018-04-06T11:11 (15)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,32.0,END OF TREATMENT,21281.0,39060.0,1838717460.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,81.0,81,,,,,81.0,81,EOT/ET/Followup,0.0,A,2018-04-07T10:51 (16)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21262.0,32533.0,1837069333.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,371.0,371,,,,Y,371.0,371,EOT/ET/Followup,nan,NA,2018-03-19T09:02 (-4)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21266.0,31260.0,1837413660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,396.0,396,,,,Y,396.0,396,Period 1,nan,B,2018-03-23T08:41 (1)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,35.0,TREATMENT,21266.0,40260.0,1837422660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,404.0,404,,,,,396.0,396,Period 1,8.0,B,2018-03-23T11:11 (1)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,36.0,TREATMENT,21273.0,31260.0,1838018460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,385.0,385,,,,Y,385.0,385,Period 2,nan,C,2018-03-30T08:41 (8)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,37.0,TREATMENT,21273.0,40260.0,1838027460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,395.0,395,,,,,385.0,385,Period 2,10.0,C,2018-03-30T11:11 (8)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,38.0,TREATMENT,21280.0,31260.0,1838623260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,376.0,376,,,,Y,376.0,376,Period 3,nan,A,2018-04-06T08:41 (15)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,39.0,TREATMENT,21280.0,40260.0,1838632260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,390.0,390,,,,,376.0,376,Period 3,14.0,A,2018-04-06T11:11 (15)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,40.0,END OF TREATMENT,21281.0,39060.0,1838717460.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,361.0,361,,,,,371.0,371,EOT/ET/Followup,-10.0,A,2018-04-07T10:51 (16)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21262.0,32533.0,1837069333.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,393.0,393,,,,Y,393.0,393,EOT/ET/Followup,nan,NA,2018-03-19T09:02 (-4)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,42.0,TREATMENT,21266.0,31260.0,1837413660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,391.0,391,,,,Y,391.0,391,Period 1,nan,B,2018-03-23T08:41 (1)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,43.0,TREATMENT,21266.0,40260.0,1837422660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,381.0,381,,,,,391.0,391,Period 1,-10.0,B,2018-03-23T11:11 (1)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,44.0,TREATMENT,21273.0,31260.0,1838018460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,381.0,381,,,,Y,381.0,381,Period 2,nan,C,2018-03-30T08:41 (8)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,45.0,TREATMENT,21273.0,40260.0,1838027460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,395.0,395,,,,,381.0,381,Period 2,14.0,C,2018-03-30T11:11 (8)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,46.0,TREATMENT,21280.0,31260.0,1838623260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,397.0,397,,,,Y,397.0,397,Period 3,nan,A,2018-04-06T08:41 (15)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,47.0,TREATMENT,21280.0,40260.0,1838632260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,386.0,386,,,,,397.0,397,Period 3,-11.0,A,2018-04-06T11:11 (15)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,48.0,END OF TREATMENT,21281.0,39060.0,1838717460.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,406.0,406,,,,,393.0,393,EOT/ET/Followup,13.0,A,2018-04-07T10:51 (16)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21262.0,32533.0,1837069333.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,385.0,385,,,,Y,385.0,385,EOT/ET/Followup,nan,NA,2018-03-19T09:02 (-4)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,50.0,TREATMENT,21266.0,31260.0,1837413660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,392.0,392,,,,Y,392.0,392,Period 1,nan,B,2018-03-23T08:41 (1)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,51.0,TREATMENT,21266.0,40260.0,1837422660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,388.0,388,,,,,392.0,392,Period 1,-4.0,B,2018-03-23T11:11 (1)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,52.0,TREATMENT,21273.0,31260.0,1838018460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,382.0,382,,,,Y,382.0,382,Period 2,nan,C,2018-03-30T08:41 (8)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,53.0,TREATMENT,21273.0,40260.0,1838027460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,395.0,395,,,,,382.0,382,Period 2,13.0,C,2018-03-30T11:11 (8)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,54.0,TREATMENT,21280.0,31260.0,1838623260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,390.0,390,,,,Y,390.0,390,Period 3,nan,A,2018-04-06T08:41 (15)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,55.0,TREATMENT,21280.0,40260.0,1838632260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,387.0,387,,,,,390.0,390,Period 3,-3.0,A,2018-04-06T11:11 (15)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,56.0,END OF TREATMENT,21281.0,39060.0,1838717460.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,390.0,390,,,,,385.0,385,EOT/ET/Followup,5.0,A,2018-04-07T10:51 (16)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21262.0,32533.0,1837069333.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,891.0,891,,,,Y,891.0,891,EOT/ET/Followup,nan,NA,2018-03-19T09:02 (-4)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,58.0,TREATMENT,21266.0,31260.0,1837413660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1025.0,1025,,,,Y,1025.0,1025,Period 1,nan,B,2018-03-23T08:41 (1)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,59.0,TREATMENT,21266.0,40260.0,1837422660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1124.0,1124,,,,,1025.0,1025,Period 1,99.0,B,2018-03-23T11:11 (1)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,60.0,TREATMENT,21273.0,31260.0,1838018460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1016.0,1016,,,,Y,1016.0,1016,Period 2,nan,C,2018-03-30T08:41 (8)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,61.0,TREATMENT,21273.0,40260.0,1838027460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,998.0,998,,,,,1016.0,1016,Period 2,-18.0,C,2018-03-30T11:11 (8)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,62.0,TREATMENT,21280.0,31260.0,1838623260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,894.0,894,,,,Y,894.0,894,Period 3,nan,A,2018-04-06T08:41 (15)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,63.0,TREATMENT,21280.0,40260.0,1838632260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1018.0,1018,,,,,894.0,894,Period 3,124.0,A,2018-04-06T11:11 (15)
3110-103-002,3110-103-002.103001136,103001136,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,64.0,END OF TREATMENT,21281.0,39060.0,1838717460.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,789.0,789,,,,,891.0,891,EOT/ET/Followup,-102.0,A,2018-04-07T10:51 (16)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21262.0,36000.0,1837072800.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,65.0,65,,,,Y,65.0,65,EOT/ET/Followup,nan,NA,2018-03-19T10:00 (-4)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,2.0,TREATMENT,21266.0,30900.0,1837413300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,64.0,64,,,,Y,64.0,64,Period 1,nan,B,2018-03-23T08:35 (1)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,3.0,TREATMENT,21266.0,39900.0,1837422300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,50.0,50,,,,,64.0,64,Period 1,-14.0,B,2018-03-23T11:05 (1)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,TREATMENT,21273.0,30900.0,1838018100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,55.0,55,,,,Y,55.0,55,Period 2,nan,C,2018-03-30T08:35 (8)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,5.0,TREATMENT,21273.0,39900.0,1838027100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,53.0,53,,,,,55.0,55,Period 2,-2.0,C,2018-03-30T11:05 (8)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,6.0,TREATMENT,21280.0,30900.0,1838622900.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,62.0,62,,,,Y,62.0,62,Period 3,nan,A,2018-04-06T08:35 (15)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,7.0,TREATMENT,21280.0,39900.0,1838631900.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,56.0,56,,,,,62.0,62,Period 3,-6.0,A,2018-04-06T11:05 (15)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,8.0,END OF TREATMENT,21281.0,38700.0,1838717100.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,60.0,60,,,,,65.0,65,EOT/ET/Followup,-5.0,A,2018-04-07T10:45 (16)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21262.0,36000.0,1837072800.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-19T10:00 (-4)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,10.0,TREATMENT,21266.0,30900.0,1837413300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,B,2018-03-23T08:35 (1)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,11.0,TREATMENT,21266.0,39900.0,1837422300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,B,2018-03-23T11:05 (1)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,12.0,TREATMENT,21273.0,30900.0,1838018100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,C,2018-03-30T08:35 (8)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,13.0,TREATMENT,21273.0,39900.0,1838027100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,C,2018-03-30T11:05 (8)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,14.0,TREATMENT,21280.0,30900.0,1838622900.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,A,2018-04-06T08:35 (15)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,15.0,TREATMENT,21280.0,39900.0,1838631900.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,A,2018-04-06T11:05 (15)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,16.0,END OF TREATMENT,21281.0,38700.0,1838717100.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,A,2018-04-07T10:45 (16)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21262.0,36000.0,1837072800.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,160.0,160,,,,Y,160.0,160,EOT/ET/Followup,nan,NA,2018-03-19T10:00 (-4)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,18.0,TREATMENT,21266.0,30900.0,1837413300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,163.0,163,,,,Y,163.0,163,Period 1,nan,B,2018-03-23T08:35 (1)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21266.0,39900.0,1837422300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,158.0,158,,,,,163.0,163,Period 1,-5.0,B,2018-03-23T11:05 (1)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,TREATMENT,21273.0,30900.0,1838018100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,170.0,170,,,,Y,170.0,170,Period 2,nan,C,2018-03-30T08:35 (8)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21.0,TREATMENT,21273.0,39900.0,1838027100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,164.0,164,,,,,170.0,170,Period 2,-6.0,C,2018-03-30T11:05 (8)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,22.0,TREATMENT,21280.0,30900.0,1838622900.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,163.0,163,,,,Y,163.0,163,Period 3,nan,A,2018-04-06T08:35 (15)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,23.0,TREATMENT,21280.0,39900.0,1838631900.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,160.0,160,,,,,163.0,163,Period 3,-3.0,A,2018-04-06T11:05 (15)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,24.0,END OF TREATMENT,21281.0,38700.0,1838717100.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,167.0,167,,,,,160.0,160,EOT/ET/Followup,7.0,A,2018-04-07T10:45 (16)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21262.0,36000.0,1837072800.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,Y,96.0,96,EOT/ET/Followup,nan,NA,2018-03-19T10:00 (-4)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,26.0,TREATMENT,21266.0,30900.0,1837413300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,Y,96.0,96,Period 1,nan,B,2018-03-23T08:35 (1)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,27.0,TREATMENT,21266.0,39900.0,1837422300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,,96.0,96,Period 1,2.0,B,2018-03-23T11:05 (1)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,28.0,TREATMENT,21273.0,30900.0,1838018100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,92.0,92,,,,Y,92.0,92,Period 2,nan,C,2018-03-30T08:35 (8)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,29.0,TREATMENT,21273.0,39900.0,1838027100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,,92.0,92,Period 2,2.0,C,2018-03-30T11:05 (8)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,30.0,TREATMENT,21280.0,30900.0,1838622900.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,Y,94.0,94,Period 3,nan,A,2018-04-06T08:35 (15)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,31.0,TREATMENT,21280.0,39900.0,1838631900.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,93.0,93,,,,,94.0,94,Period 3,-1.0,A,2018-04-06T11:05 (15)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,32.0,END OF TREATMENT,21281.0,38700.0,1838717100.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,,96.0,96,EOT/ET/Followup,-2.0,A,2018-04-07T10:45 (16)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21262.0,36000.0,1837072800.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,390.0,390,,,,Y,390.0,390,EOT/ET/Followup,nan,NA,2018-03-19T10:00 (-4)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21266.0,30900.0,1837413300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,399.0,399,,,,Y,399.0,399,Period 1,nan,B,2018-03-23T08:35 (1)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,35.0,TREATMENT,21266.0,39900.0,1837422300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,416.0,416,,,,,399.0,399,Period 1,17.0,B,2018-03-23T11:05 (1)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,36.0,TREATMENT,21273.0,30900.0,1838018100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,398.0,398,,,,Y,398.0,398,Period 2,nan,C,2018-03-30T08:35 (8)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,37.0,TREATMENT,21273.0,39900.0,1838027100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,408.0,408,,,,,398.0,398,Period 2,10.0,C,2018-03-30T11:05 (8)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,38.0,TREATMENT,21280.0,30900.0,1838622900.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,390.0,390,,,,Y,390.0,390,Period 3,nan,A,2018-04-06T08:35 (15)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,39.0,TREATMENT,21280.0,39900.0,1838631900.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,390.0,390,,,,,390.0,390,Period 3,0.0,A,2018-04-06T11:05 (15)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,40.0,END OF TREATMENT,21281.0,38700.0,1838717100.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,382.0,382,,,,,390.0,390,EOT/ET/Followup,-8.0,A,2018-04-07T10:45 (16)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21262.0,36000.0,1837072800.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,406.0,406,,,,Y,406.0,406,EOT/ET/Followup,nan,NA,2018-03-19T10:00 (-4)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,42.0,TREATMENT,21266.0,30900.0,1837413300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,413.0,413,,,,Y,413.0,413,Period 1,nan,B,2018-03-23T08:35 (1)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,43.0,TREATMENT,21266.0,39900.0,1837422300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,382.0,382,,,,,413.0,413,Period 1,-31.0,B,2018-03-23T11:05 (1)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,44.0,TREATMENT,21273.0,30900.0,1838018100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,381.0,381,,,,Y,381.0,381,Period 2,nan,C,2018-03-30T08:35 (8)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,45.0,TREATMENT,21273.0,39900.0,1838027100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,386.0,386,,,,,381.0,381,Period 2,5.0,C,2018-03-30T11:05 (8)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,46.0,TREATMENT,21280.0,30900.0,1838622900.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,396.0,396,,,,Y,396.0,396,Period 3,nan,A,2018-04-06T08:35 (15)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,47.0,TREATMENT,21280.0,39900.0,1838631900.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,377.0,377,,,,,396.0,396,Period 3,-19.0,A,2018-04-06T11:05 (15)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,48.0,END OF TREATMENT,21281.0,38700.0,1838717100.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,384.0,384,,,,,406.0,406,EOT/ET/Followup,-22.0,A,2018-04-07T10:45 (16)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21262.0,36000.0,1837072800.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,400.0,400,,,,Y,400.0,400,EOT/ET/Followup,nan,NA,2018-03-19T10:00 (-4)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,50.0,TREATMENT,21266.0,30900.0,1837413300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,408.0,408,,,,Y,408.0,408,Period 1,nan,B,2018-03-23T08:35 (1)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,51.0,TREATMENT,21266.0,39900.0,1837422300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,393.0,393,,,,,408.0,408,Period 1,-15.0,B,2018-03-23T11:05 (1)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,52.0,TREATMENT,21273.0,30900.0,1838018100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,387.0,387,,,,Y,387.0,387,Period 2,nan,C,2018-03-30T08:35 (8)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,53.0,TREATMENT,21273.0,39900.0,1838027100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,393.0,393,,,,,387.0,387,Period 2,6.0,C,2018-03-30T11:05 (8)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,54.0,TREATMENT,21280.0,30900.0,1838622900.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,394.0,394,,,,Y,394.0,394,Period 3,nan,A,2018-04-06T08:35 (15)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,55.0,TREATMENT,21280.0,39900.0,1838631900.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,381.0,381,,,,,394.0,394,Period 3,-13.0,A,2018-04-06T11:05 (15)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,56.0,END OF TREATMENT,21281.0,38700.0,1838717100.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,383.0,383,,,,,400.0,400,EOT/ET/Followup,-17.0,A,2018-04-07T10:45 (16)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21262.0,36000.0,1837072800.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,922.0,922,,,,Y,922.0,922,EOT/ET/Followup,nan,NA,2018-03-19T10:00 (-4)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,58.0,TREATMENT,21266.0,30900.0,1837413300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,932.0,932,,,,Y,932.0,932,Period 1,nan,B,2018-03-23T08:35 (1)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,59.0,TREATMENT,21266.0,39900.0,1837422300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1184.0,1184,,,,,932.0,932,Period 1,252.0,B,2018-03-23T11:05 (1)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,60.0,TREATMENT,21273.0,30900.0,1838018100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1087.0,1087,,,,Y,1087.0,1087,Period 2,nan,C,2018-03-30T08:35 (8)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,61.0,TREATMENT,21273.0,39900.0,1838027100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1116.0,1116,,,,,1087.0,1087,Period 2,29.0,C,2018-03-30T11:05 (8)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,62.0,TREATMENT,21280.0,30900.0,1838622900.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,966.0,966,,,,Y,966.0,966,Period 3,nan,A,2018-04-06T08:35 (15)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,63.0,TREATMENT,21280.0,39900.0,1838631900.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1067.0,1067,,,,,966.0,966,Period 3,101.0,A,2018-04-06T11:05 (15)
3110-103-002,3110-103-002.103001141,103001141,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,64.0,END OF TREATMENT,21281.0,38700.0,1838717100.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,987.0,987,,,,,922.0,922,EOT/ET/Followup,65.0,A,2018-04-07T10:45 (16)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21262.0,39660.0,1837076460.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,74.0,74,,,,Y,74.0,74,EOT/ET/Followup,nan,NA,2018-03-19T11:01 (-4)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21266.0,32171.0,1837414571.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,81.0,81,,,,Y,81.0,81,Period 1,nan,C,2018-03-23T08:56 (1)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21266.0,41160.0,1837423560.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,78.0,78,,,,,81.0,81,Period 1,-3.0,C,2018-03-23T11:26 (1)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,4.0,TREATMENT,21273.0,32160.0,1838019360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,69.0,69,,,,Y,69.0,69,Period 2,nan,B,2018-03-30T08:56 (8)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21273.0,41160.0,1838028360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,70.0,70,,,,,69.0,69,Period 2,1.0,B,2018-03-30T11:26 (8)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,6.0,TREATMENT,21280.0,32160.0,1838624160.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,69.0,69,,,,Y,69.0,69,Period 3,nan,A,2018-04-06T08:56 (15)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,7.0,TREATMENT,21280.0,41160.0,1838633160.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,66.0,66,,,,,69.0,69,Period 3,-3.0,A,2018-04-06T11:26 (15)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,8.0,END OF TREATMENT,21281.0,39960.0,1838718360.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,70.0,70,,,,,74.0,74,EOT/ET/Followup,-4.0,A,2018-04-07T11:06 (16)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21262.0,39660.0,1837076460.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-19T11:01 (-4)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21266.0,32171.0,1837414571.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,C,2018-03-23T08:56 (1)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,TREATMENT,21266.0,41160.0,1837423560.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,C,2018-03-23T11:26 (1)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,12.0,TREATMENT,21273.0,32160.0,1838019360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,B,2018-03-30T08:56 (8)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,13.0,TREATMENT,21273.0,41160.0,1838028360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,B,2018-03-30T11:26 (8)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,14.0,TREATMENT,21280.0,32160.0,1838624160.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,A,2018-04-06T08:56 (15)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,15.0,TREATMENT,21280.0,41160.0,1838633160.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,A,2018-04-06T11:26 (15)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,16.0,END OF TREATMENT,21281.0,39960.0,1838718360.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,A,2018-04-07T11:06 (16)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21262.0,39660.0,1837076460.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,174.0,174,,,,Y,174.0,174,EOT/ET/Followup,nan,NA,2018-03-19T11:01 (-4)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21266.0,32171.0,1837414571.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,176.0,176,,,,Y,176.0,176,Period 1,nan,C,2018-03-23T08:56 (1)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21266.0,41160.0,1837423560.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,186.0,186,,,,,176.0,176,Period 1,10.0,C,2018-03-23T11:26 (1)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21273.0,32160.0,1838019360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,192.0,192,,,,Y,192.0,192,Period 2,nan,B,2018-03-30T08:56 (8)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21.0,TREATMENT,21273.0,41160.0,1838028360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,186.0,186,,,,,192.0,192,Period 2,-6.0,B,2018-03-30T11:26 (8)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,22.0,TREATMENT,21280.0,32160.0,1838624160.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,198.0,198,,,,Y,198.0,198,Period 3,nan,A,2018-04-06T08:56 (15)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,23.0,TREATMENT,21280.0,41160.0,1838633160.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,197.0,197,,,,,198.0,198,Period 3,-1.0,A,2018-04-06T11:26 (15)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,24.0,END OF TREATMENT,21281.0,39960.0,1838718360.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,178.0,178,,,,,174.0,174,EOT/ET/Followup,4.0,A,2018-04-07T11:06 (16)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21262.0,39660.0,1837076460.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,85.0,85,,,,Y,85.0,85,EOT/ET/Followup,nan,NA,2018-03-19T11:01 (-4)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,26.0,TREATMENT,21266.0,32171.0,1837414571.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,83.0,83,,,,Y,83.0,83,Period 1,nan,C,2018-03-23T08:56 (1)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,27.0,TREATMENT,21266.0,41160.0,1837423560.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,81.0,81,,,,,83.0,83,Period 1,-2.0,C,2018-03-23T11:26 (1)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,28.0,TREATMENT,21273.0,32160.0,1838019360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,84.0,84,,,,Y,84.0,84,Period 2,nan,B,2018-03-30T08:56 (8)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,29.0,TREATMENT,21273.0,41160.0,1838028360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,83.0,83,,,,,84.0,84,Period 2,-1.0,B,2018-03-30T11:26 (8)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,30.0,TREATMENT,21280.0,32160.0,1838624160.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,83.0,83,,,,Y,83.0,83,Period 3,nan,A,2018-04-06T08:56 (15)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,31.0,TREATMENT,21280.0,41160.0,1838633160.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,80.0,80,,,,,83.0,83,Period 3,-3.0,A,2018-04-06T11:26 (15)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,32.0,END OF TREATMENT,21281.0,39960.0,1838718360.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,83.0,83,,,,,85.0,85,EOT/ET/Followup,-2.0,A,2018-04-07T11:06 (16)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21262.0,39660.0,1837076460.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,400.0,400,,,,Y,400.0,400,EOT/ET/Followup,nan,NA,2018-03-19T11:01 (-4)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,34.0,TREATMENT,21266.0,32171.0,1837414571.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,397.0,397,,,,Y,397.0,397,Period 1,nan,C,2018-03-23T08:56 (1)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,35.0,TREATMENT,21266.0,41160.0,1837423560.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,388.0,388,,,,,397.0,397,Period 1,-9.0,C,2018-03-23T11:26 (1)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,TREATMENT,21273.0,32160.0,1838019360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,421.0,421,,,,Y,421.0,421,Period 2,nan,B,2018-03-30T08:56 (8)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,37.0,TREATMENT,21273.0,41160.0,1838028360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,421.0,421,,,,,421.0,421,Period 2,0.0,B,2018-03-30T11:26 (8)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,38.0,TREATMENT,21280.0,32160.0,1838624160.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,421.0,421,,,,Y,421.0,421,Period 3,nan,A,2018-04-06T08:56 (15)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,39.0,TREATMENT,21280.0,41160.0,1838633160.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,421.0,421,,,,,421.0,421,Period 3,0.0,A,2018-04-06T11:26 (15)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,40.0,END OF TREATMENT,21281.0,39960.0,1838718360.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,412.0,412,,,,,400.0,400,EOT/ET/Followup,12.0,A,2018-04-07T11:06 (16)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21262.0,39660.0,1837076460.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,445.0,445,,,,Y,445.0,445,EOT/ET/Followup,nan,NA,2018-03-19T11:01 (-4)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,42.0,TREATMENT,21266.0,32171.0,1837414571.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,462.0,462,,,,Y,462.0,462,Period 1,nan,C,2018-03-23T08:56 (1)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,43.0,TREATMENT,21266.0,41160.0,1837423560.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,443.0,443,,,,,462.0,462,Period 1,-19.0,C,2018-03-23T11:26 (1)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,44.0,TREATMENT,21273.0,32160.0,1838019360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,454.0,454,,,,Y,454.0,454,Period 2,nan,B,2018-03-30T08:56 (8)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,45.0,TREATMENT,21273.0,41160.0,1838028360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,455.0,455,,,,,454.0,454,Period 2,1.0,B,2018-03-30T11:26 (8)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,46.0,TREATMENT,21280.0,32160.0,1838624160.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,452.0,452,,,,Y,452.0,452,Period 3,nan,A,2018-04-06T08:56 (15)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,47.0,TREATMENT,21280.0,41160.0,1838633160.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,443.0,443,,,,,452.0,452,Period 3,-9.0,A,2018-04-06T11:26 (15)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,48.0,END OF TREATMENT,21281.0,39960.0,1838718360.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,445.0,445,,,,,445.0,445,EOT/ET/Followup,0.0,A,2018-04-07T11:06 (16)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21262.0,39660.0,1837076460.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,429.0,429,,,,Y,429.0,429,EOT/ET/Followup,nan,NA,2018-03-19T11:01 (-4)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,50.0,TREATMENT,21266.0,32171.0,1837414571.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,439.0,439,,,,Y,439.0,439,Period 1,nan,C,2018-03-23T08:56 (1)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,51.0,TREATMENT,21266.0,41160.0,1837423560.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,424.0,424,,,,,439.0,439,Period 1,-15.0,C,2018-03-23T11:26 (1)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,52.0,TREATMENT,21273.0,32160.0,1838019360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,443.0,443,,,,Y,443.0,443,Period 2,nan,B,2018-03-30T08:56 (8)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,53.0,TREATMENT,21273.0,41160.0,1838028360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,443.0,443,,,,,443.0,443,Period 2,0.0,B,2018-03-30T11:26 (8)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,54.0,TREATMENT,21280.0,32160.0,1838624160.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,442.0,442,,,,Y,442.0,442,Period 3,nan,A,2018-04-06T08:56 (15)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,55.0,TREATMENT,21280.0,41160.0,1838633160.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,435.0,435,,,,,442.0,442,Period 3,-7.0,A,2018-04-06T11:26 (15)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,56.0,END OF TREATMENT,21281.0,39960.0,1838718360.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,434.0,434,,,,,429.0,429,EOT/ET/Followup,5.0,A,2018-04-07T11:06 (16)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21262.0,39660.0,1837076460.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,806.0,806,,,,Y,806.0,806,EOT/ET/Followup,nan,NA,2018-03-19T11:01 (-4)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,58.0,TREATMENT,21266.0,32171.0,1837414571.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,737.0,737,,,,Y,737.0,737,Period 1,nan,C,2018-03-23T08:56 (1)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,59.0,TREATMENT,21266.0,41160.0,1837423560.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,764.0,764,,,,,737.0,737,Period 1,27.0,C,2018-03-23T11:26 (1)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,60.0,TREATMENT,21273.0,32160.0,1838019360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,858.0,858,,,,Y,858.0,858,Period 2,nan,B,2018-03-30T08:56 (8)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,61.0,TREATMENT,21273.0,41160.0,1838028360.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,853.0,853,,,,,858.0,858,Period 2,-5.0,B,2018-03-30T11:26 (8)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,62.0,TREATMENT,21280.0,32160.0,1838624160.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,864.0,864,,,,Y,864.0,864,Period 3,nan,A,2018-04-06T08:56 (15)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,63.0,TREATMENT,21280.0,41160.0,1838633160.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,901.0,901,,,,,864.0,864,Period 3,37.0,A,2018-04-06T11:26 (15)
3110-103-002,3110-103-002.103001149,103001149,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,64.0,END OF TREATMENT,21281.0,39960.0,1838718360.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,854.0,854,,,,,806.0,806,EOT/ET/Followup,48.0,A,2018-04-07T11:06 (16)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21262.0,36725.0,1837073525.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,59.0,59,,,,Y,59.0,59,EOT/ET/Followup,nan,NA,2018-03-19T10:12 (-4)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21266.0,32760.0,1837415160.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,58.0,58,,,,Y,58.0,58,Period 1,nan,C,2018-03-23T09:06 (1)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21266.0,41760.0,1837424160.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,50.0,50,,,,,58.0,58,Period 1,-8.0,C,2018-03-23T11:36 (1)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,4.0,TREATMENT,21273.0,32760.0,1838019960.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,64.0,64,,,,Y,64.0,64,Period 2,nan,B,2018-03-30T09:06 (8)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21273.0,41760.0,1838028960.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,51.0,51,,,,,64.0,64,Period 2,-13.0,B,2018-03-30T11:36 (8)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,6.0,TREATMENT,21280.0,32869.0,1838624869.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,57.0,57,,,,Y,57.0,57,Period 3,nan,A,2018-04-06T09:07 (15)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,7.0,TREATMENT,21280.0,41760.0,1838633760.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,48.0,48,,,,,57.0,57,Period 3,-9.0,A,2018-04-06T11:36 (15)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,8.0,END OF TREATMENT,21281.0,40560.0,1838718960.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,53.0,53,,,,,59.0,59,EOT/ET/Followup,-6.0,A,2018-04-07T11:16 (16)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21262.0,36725.0,1837073525.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-19T10:12 (-4)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21266.0,32760.0,1837415160.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,C,2018-03-23T09:06 (1)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,TREATMENT,21266.0,41760.0,1837424160.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,C,2018-03-23T11:36 (1)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,12.0,TREATMENT,21273.0,32760.0,1838019960.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,B,2018-03-30T09:06 (8)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,13.0,TREATMENT,21273.0,41760.0,1838028960.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,B,2018-03-30T11:36 (8)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,14.0,TREATMENT,21280.0,32869.0,1838624869.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,A,2018-04-06T09:07 (15)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,15.0,TREATMENT,21280.0,41760.0,1838633760.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,,nan,Normal,Period 3,nan,A,2018-04-06T11:36 (15)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,16.0,END OF TREATMENT,21281.0,40560.0,1838718960.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,A,2018-04-07T11:16 (16)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21262.0,36725.0,1837073525.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,160.0,160,,,,Y,160.0,160,EOT/ET/Followup,nan,NA,2018-03-19T10:12 (-4)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21266.0,32760.0,1837415160.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,153.0,153,,,,Y,153.0,153,Period 1,nan,C,2018-03-23T09:06 (1)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21266.0,41760.0,1837424160.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,144.0,144,,,,,153.0,153,Period 1,-9.0,C,2018-03-23T11:36 (1)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21273.0,32760.0,1838019960.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,152.0,152,,,,Y,152.0,152,Period 2,nan,B,2018-03-30T09:06 (8)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21.0,TREATMENT,21273.0,41760.0,1838028960.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,146.0,146,,,,,152.0,152,Period 2,-6.0,B,2018-03-30T11:36 (8)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,22.0,TREATMENT,21280.0,32869.0,1838624869.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,159.0,159,,,,Y,159.0,159,Period 3,nan,A,2018-04-06T09:07 (15)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,23.0,TREATMENT,21280.0,41760.0,1838633760.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,151.0,151,,,,,159.0,159,Period 3,-8.0,A,2018-04-06T11:36 (15)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,24.0,END OF TREATMENT,21281.0,40560.0,1838718960.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,146.0,146,,,,,160.0,160,EOT/ET/Followup,-14.0,A,2018-04-07T11:16 (16)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21262.0,36725.0,1837073525.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,81.0,81,,,,Y,81.0,81,EOT/ET/Followup,nan,NA,2018-03-19T10:12 (-4)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,26.0,TREATMENT,21266.0,32760.0,1837415160.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,82.0,82,,,,Y,82.0,82,Period 1,nan,C,2018-03-23T09:06 (1)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,27.0,TREATMENT,21266.0,41760.0,1837424160.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,,82.0,82,Period 1,12.0,C,2018-03-23T11:36 (1)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,28.0,TREATMENT,21273.0,32760.0,1838019960.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,85.0,85,,,,Y,85.0,85,Period 2,nan,B,2018-03-30T09:06 (8)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,29.0,TREATMENT,21273.0,41760.0,1838028960.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,77.0,77,,,,,85.0,85,Period 2,-8.0,B,2018-03-30T11:36 (8)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,30.0,TREATMENT,21280.0,32869.0,1838624869.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,90.0,90,,,,Y,90.0,90,Period 3,nan,A,2018-04-06T09:07 (15)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,31.0,TREATMENT,21280.0,41760.0,1838633760.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,93.0,93,,,,,90.0,90,Period 3,3.0,A,2018-04-06T11:36 (15)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,32.0,END OF TREATMENT,21281.0,40560.0,1838718960.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,,81.0,81,EOT/ET/Followup,13.0,A,2018-04-07T11:16 (16)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21262.0,36725.0,1837073525.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,401.0,401,,,,Y,401.0,401,EOT/ET/Followup,nan,NA,2018-03-19T10:12 (-4)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,34.0,TREATMENT,21266.0,32760.0,1837415160.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,395.0,395,,,,Y,395.0,395,Period 1,nan,C,2018-03-23T09:06 (1)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,35.0,TREATMENT,21266.0,41760.0,1837424160.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,419.0,419,,,,,395.0,395,Period 1,24.0,C,2018-03-23T11:36 (1)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,TREATMENT,21273.0,32760.0,1838019960.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,380.0,380,,,,Y,380.0,380,Period 2,nan,B,2018-03-30T09:06 (8)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,37.0,TREATMENT,21273.0,41760.0,1838028960.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,401.0,401,,,,,380.0,380,Period 2,21.0,B,2018-03-30T11:36 (8)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,38.0,TREATMENT,21280.0,32869.0,1838624869.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,404.0,404,,,,Y,404.0,404,Period 3,nan,A,2018-04-06T09:07 (15)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,39.0,TREATMENT,21280.0,41760.0,1838633760.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,420.0,420,,,,,404.0,404,Period 3,16.0,A,2018-04-06T11:36 (15)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,40.0,END OF TREATMENT,21281.0,40560.0,1838718960.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,409.0,409,,,,,401.0,401,EOT/ET/Followup,8.0,A,2018-04-07T11:16 (16)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21262.0,36725.0,1837073525.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,400.0,400,,,,Y,400.0,400,EOT/ET/Followup,nan,NA,2018-03-19T10:12 (-4)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,42.0,TREATMENT,21266.0,32760.0,1837415160.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,389.0,389,,,,Y,389.0,389,Period 1,nan,C,2018-03-23T09:06 (1)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,43.0,TREATMENT,21266.0,41760.0,1837424160.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,383.0,383,,,,,389.0,389,Period 1,-6.0,C,2018-03-23T11:36 (1)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,44.0,TREATMENT,21273.0,32760.0,1838019960.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,392.0,392,,,,Y,392.0,392,Period 2,nan,B,2018-03-30T09:06 (8)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,45.0,TREATMENT,21273.0,41760.0,1838028960.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,370.0,370,,,,,392.0,392,Period 2,-22.0,B,2018-03-30T11:36 (8)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,46.0,TREATMENT,21280.0,32869.0,1838624869.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,395.0,395,,,,Y,395.0,395,Period 3,nan,A,2018-04-06T09:07 (15)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,47.0,TREATMENT,21280.0,41760.0,1838633760.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,378.0,378,,,,,395.0,395,Period 3,-17.0,A,2018-04-06T11:36 (15)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,48.0,END OF TREATMENT,21281.0,40560.0,1838718960.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,386.0,386,,,,,400.0,400,EOT/ET/Followup,-14.0,A,2018-04-07T11:16 (16)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21262.0,36725.0,1837073525.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,400.0,400,,,,Y,400.0,400,EOT/ET/Followup,nan,NA,2018-03-19T10:12 (-4)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,50.0,TREATMENT,21266.0,32760.0,1837415160.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,391.0,391,,,,Y,391.0,391,Period 1,nan,C,2018-03-23T09:06 (1)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,51.0,TREATMENT,21266.0,41760.0,1837424160.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,394.0,394,,,,,391.0,391,Period 1,3.0,C,2018-03-23T11:36 (1)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,52.0,TREATMENT,21273.0,32760.0,1838019960.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,388.0,388,,,,Y,388.0,388,Period 2,nan,B,2018-03-30T09:06 (8)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,53.0,TREATMENT,21273.0,41760.0,1838028960.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,380.0,380,,,,,388.0,388,Period 2,-8.0,B,2018-03-30T11:36 (8)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,54.0,TREATMENT,21280.0,32869.0,1838624869.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,398.0,398,,,,Y,398.0,398,Period 3,nan,A,2018-04-06T09:07 (15)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,55.0,TREATMENT,21280.0,41760.0,1838633760.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,391.0,391,,,,,398.0,398,Period 3,-7.0,A,2018-04-06T11:36 (15)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,56.0,END OF TREATMENT,21281.0,40560.0,1838718960.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,393.0,393,,,,,400.0,400,EOT/ET/Followup,-7.0,A,2018-04-07T11:16 (16)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21262.0,36725.0,1837073525.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,1004.0,1004,,,,Y,1004.0,1004,EOT/ET/Followup,nan,NA,2018-03-19T10:12 (-4)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,58.0,TREATMENT,21266.0,32760.0,1837415160.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1026.0,1026,,,,Y,1026.0,1026,Period 1,nan,C,2018-03-23T09:06 (1)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,59.0,TREATMENT,21266.0,41760.0,1837424160.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1194.0,1194,,,,,1026.0,1026,Period 1,168.0,C,2018-03-23T11:36 (1)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,60.0,TREATMENT,21273.0,32760.0,1838019960.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,935.0,935,,,,Y,935.0,935,Period 2,nan,B,2018-03-30T09:06 (8)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,61.0,TREATMENT,21273.0,41760.0,1838028960.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1170.0,1170,,,,,935.0,935,Period 2,235.0,B,2018-03-30T11:36 (8)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,62.0,TREATMENT,21280.0,32869.0,1838624869.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1042.0,1042,,,,Y,1042.0,1042,Period 3,nan,A,2018-04-06T09:07 (15)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,63.0,TREATMENT,21280.0,41760.0,1838633760.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1232.0,1232,,,,,1042.0,1042,Period 3,190.0,A,2018-04-06T11:36 (15)
3110-103-002,3110-103-002.103001150,103001150,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,64.0,END OF TREATMENT,21281.0,40560.0,1838718960.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1121.0,1121,,,,,1004.0,1004,EOT/ET/Followup,117.0,A,2018-04-07T11:16 (16)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21262.0,44920.0,1837081720.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,63.0,63,,,,Y,63.0,63,EOT/ET/Followup,nan,NA,2018-03-19T12:28 (-4)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,2.0,TREATMENT,21266.0,32340.0,1837414740.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,71.0,71,,,,Y,71.0,71,Period 1,nan,B,2018-03-23T08:59 (1)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,3.0,TREATMENT,21266.0,41340.0,1837423740.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,65.0,65,,,,,71.0,71,Period 1,-6.0,B,2018-03-23T11:29 (1)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,TREATMENT,21273.0,32340.0,1838019540.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,66.0,66,,,,Y,66.0,66,Period 2,nan,C,2018-03-30T08:59 (8)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,5.0,TREATMENT,21273.0,41340.0,1838028540.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,63.0,63,,,,,66.0,66,Period 2,-3.0,C,2018-03-30T11:29 (8)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,6.0,TREATMENT,21280.0,32340.0,1838624340.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,69.0,69,,,,Y,69.0,69,Period 3,nan,A,2018-04-06T08:59 (15)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,7.0,TREATMENT,21280.0,41340.0,1838633340.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,62.0,62,,,,,69.0,69,Period 3,-7.0,A,2018-04-06T11:29 (15)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,8.0,END OF TREATMENT,21281.0,40140.0,1838718540.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,63.0,63,,,,,63.0,63,EOT/ET/Followup,0.0,A,2018-04-07T11:09 (16)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21262.0,44920.0,1837081720.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-19T12:28 (-4)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,10.0,TREATMENT,21266.0,32340.0,1837414740.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,B,2018-03-23T08:59 (1)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,11.0,TREATMENT,21266.0,41340.0,1837423740.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,B,2018-03-23T11:29 (1)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,12.0,TREATMENT,21273.0,32340.0,1838019540.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,C,2018-03-30T08:59 (8)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,13.0,TREATMENT,21273.0,41340.0,1838028540.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,C,2018-03-30T11:29 (8)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,14.0,TREATMENT,21280.0,32340.0,1838624340.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,A,2018-04-06T08:59 (15)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,15.0,TREATMENT,21280.0,41340.0,1838633340.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,A,2018-04-06T11:29 (15)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,16.0,END OF TREATMENT,21281.0,40140.0,1838718540.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,A,2018-04-07T11:09 (16)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21262.0,44920.0,1837081720.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,157.0,157,,,,Y,157.0,157,EOT/ET/Followup,nan,NA,2018-03-19T12:28 (-4)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,18.0,TREATMENT,21266.0,32340.0,1837414740.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,183.0,183,,,,Y,183.0,183,Period 1,nan,B,2018-03-23T08:59 (1)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21266.0,41340.0,1837423740.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,182.0,182,,,,,183.0,183,Period 1,-1.0,B,2018-03-23T11:29 (1)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,TREATMENT,21273.0,32340.0,1838019540.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,162.0,162,,,,Y,162.0,162,Period 2,nan,C,2018-03-30T08:59 (8)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21.0,TREATMENT,21273.0,41340.0,1838028540.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,157.0,157,,,,,162.0,162,Period 2,-5.0,C,2018-03-30T11:29 (8)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,22.0,TREATMENT,21280.0,32340.0,1838624340.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,145.0,145,,,,Y,145.0,145,Period 3,nan,A,2018-04-06T08:59 (15)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,23.0,TREATMENT,21280.0,41340.0,1838633340.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,145.0,145,,,,,145.0,145,Period 3,0.0,A,2018-04-06T11:29 (15)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,24.0,END OF TREATMENT,21281.0,40140.0,1838718540.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,146.0,146,,,,,157.0,157,EOT/ET/Followup,-11.0,A,2018-04-07T11:09 (16)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21262.0,44920.0,1837081720.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,Y,99.0,99,EOT/ET/Followup,nan,NA,2018-03-19T12:28 (-4)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,26.0,TREATMENT,21266.0,32340.0,1837414740.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,Y,96.0,96,Period 1,nan,B,2018-03-23T08:59 (1)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,27.0,TREATMENT,21266.0,41340.0,1837423740.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,,96.0,96,Period 1,1.0,B,2018-03-23T11:29 (1)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,28.0,TREATMENT,21273.0,32340.0,1838019540.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,Y,99.0,99,Period 2,nan,C,2018-03-30T08:59 (8)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,29.0,TREATMENT,21273.0,41340.0,1838028540.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,95.0,95,,,,,99.0,99,Period 2,-4.0,C,2018-03-30T11:29 (8)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,30.0,TREATMENT,21280.0,32340.0,1838624340.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,Y,97.0,97,Period 3,nan,A,2018-04-06T08:59 (15)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,31.0,TREATMENT,21280.0,41340.0,1838633340.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,,97.0,97,Period 3,2.0,A,2018-04-06T11:29 (15)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,32.0,END OF TREATMENT,21281.0,40140.0,1838718540.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,,99.0,99,EOT/ET/Followup,-3.0,A,2018-04-07T11:09 (16)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21262.0,44920.0,1837081720.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,417.0,417,,,,Y,417.0,417,EOT/ET/Followup,nan,NA,2018-03-19T12:28 (-4)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21266.0,32340.0,1837414740.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,392.0,392,,,,Y,392.0,392,Period 1,nan,B,2018-03-23T08:59 (1)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,35.0,TREATMENT,21266.0,41340.0,1837423740.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,404.0,404,,,,,392.0,392,Period 1,12.0,B,2018-03-23T11:29 (1)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,36.0,TREATMENT,21273.0,32340.0,1838019540.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,421.0,421,,,,Y,421.0,421,Period 2,nan,C,2018-03-30T08:59 (8)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,37.0,TREATMENT,21273.0,41340.0,1838028540.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,411.0,411,,,,,421.0,421,Period 2,-10.0,C,2018-03-30T11:29 (8)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,38.0,TREATMENT,21280.0,32340.0,1838624340.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,402.0,402,,,,Y,402.0,402,Period 3,nan,A,2018-04-06T08:59 (15)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,39.0,TREATMENT,21280.0,41340.0,1838633340.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,418.0,418,,,,,402.0,402,Period 3,16.0,A,2018-04-06T11:29 (15)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,40.0,END OF TREATMENT,21281.0,40140.0,1838718540.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,396.0,396,,,,,417.0,417,EOT/ET/Followup,-21.0,A,2018-04-07T11:09 (16)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21262.0,44920.0,1837081720.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,428.0,428,,,,Y,428.0,428,EOT/ET/Followup,nan,NA,2018-03-19T12:28 (-4)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,42.0,TREATMENT,21266.0,32340.0,1837414740.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,426.0,426,,,,Y,426.0,426,Period 1,nan,B,2018-03-23T08:59 (1)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,43.0,TREATMENT,21266.0,41340.0,1837423740.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,423.0,423,,,,,426.0,426,Period 1,-3.0,B,2018-03-23T11:29 (1)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,44.0,TREATMENT,21273.0,32340.0,1838019540.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,443.0,443,,,,Y,443.0,443,Period 2,nan,C,2018-03-30T08:59 (8)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,45.0,TREATMENT,21273.0,41340.0,1838028540.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,422.0,422,,,,,443.0,443,Period 2,-21.0,C,2018-03-30T11:29 (8)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,46.0,TREATMENT,21280.0,32340.0,1838624340.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,431.0,431,,,,Y,431.0,431,Period 3,nan,A,2018-04-06T08:59 (15)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,47.0,TREATMENT,21280.0,41340.0,1838633340.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,426.0,426,,,,,431.0,431,Period 3,-5.0,A,2018-04-06T11:29 (15)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,48.0,END OF TREATMENT,21281.0,40140.0,1838718540.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,408.0,408,,,,,428.0,428,EOT/ET/Followup,-20.0,A,2018-04-07T11:09 (16)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21262.0,44920.0,1837081720.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,424.0,424,,,,Y,424.0,424,EOT/ET/Followup,nan,NA,2018-03-19T12:28 (-4)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,50.0,TREATMENT,21266.0,32340.0,1837414740.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,414.0,414,,,,Y,414.0,414,Period 1,nan,B,2018-03-23T08:59 (1)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,51.0,TREATMENT,21266.0,41340.0,1837423740.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,416.0,416,,,,,414.0,414,Period 1,2.0,B,2018-03-23T11:29 (1)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,52.0,TREATMENT,21273.0,32340.0,1838019540.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,435.0,435,,,,Y,435.0,435,Period 2,nan,C,2018-03-30T08:59 (8)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,53.0,TREATMENT,21273.0,41340.0,1838028540.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,418.0,418,,,,,435.0,435,Period 2,-17.0,C,2018-03-30T11:29 (8)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,54.0,TREATMENT,21280.0,32340.0,1838624340.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,421.0,421,,,,Y,421.0,421,Period 3,nan,A,2018-04-06T08:59 (15)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,55.0,TREATMENT,21280.0,41340.0,1838633340.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,423.0,423,,,,,421.0,421,Period 3,2.0,A,2018-04-06T11:29 (15)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,56.0,END OF TREATMENT,21281.0,40140.0,1838718540.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,404.0,404,,,,,424.0,424,EOT/ET/Followup,-20.0,A,2018-04-07T11:09 (16)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21262.0,44920.0,1837081720.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,946.0,946,,,,Y,946.0,946,EOT/ET/Followup,nan,NA,2018-03-19T12:28 (-4)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,58.0,TREATMENT,21266.0,32340.0,1837414740.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,845.0,845,,,,Y,845.0,845,Period 1,nan,B,2018-03-23T08:59 (1)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,59.0,TREATMENT,21266.0,41340.0,1837423740.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,912.0,912,,,,,845.0,845,Period 1,67.0,B,2018-03-23T11:29 (1)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,60.0,TREATMENT,21273.0,32340.0,1838019540.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,903.0,903,,,,Y,903.0,903,Period 2,nan,C,2018-03-30T08:59 (8)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,61.0,TREATMENT,21273.0,41340.0,1838028540.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,947.0,947,,,,,903.0,903,Period 2,44.0,C,2018-03-30T11:29 (8)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,62.0,TREATMENT,21280.0,32340.0,1838624340.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,867.0,867,,,,Y,867.0,867,Period 3,nan,A,2018-04-06T08:59 (15)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,63.0,TREATMENT,21280.0,41340.0,1838633340.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,961.0,961,,,,,867.0,867,Period 3,94.0,A,2018-04-06T11:29 (15)
3110-103-002,3110-103-002.103001155,103001155,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,64.0,END OF TREATMENT,21281.0,40140.0,1838718540.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,939.0,939,,,,,946.0,946,EOT/ET/Followup,-7.0,A,2018-04-07T11:09 (16)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21262.0,46200.0,1837083000.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,58.0,58,,,,Y,58.0,58,EOT/ET/Followup,nan,NA,2018-03-19T12:50 (-4)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,2.0,TREATMENT,21266.0,31980.0,1837414380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,56.0,56,,,,Y,56.0,56,Period 1,nan,B,2018-03-23T08:53 (1)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,3.0,TREATMENT,21266.0,40983.0,1837423383.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,50.0,50,,,,,56.0,56,Period 1,-6.0,B,2018-03-23T11:23 (1)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,4.0,END OF TREATMENT,21272.0,60783.0,1837961583.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,72.0,72,,,,,58.0,58,EOT/ET/Followup,14.0,B,2018-03-29T16:53 (7)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,5.0,SCREENING,21262.0,46200.0,1837083000.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-19T12:50 (-4)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21266.0,31980.0,1837414380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,B,2018-03-23T08:53 (1)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,7.0,TREATMENT,21266.0,40983.0,1837423383.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,B,2018-03-23T11:23 (1)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,8.0,END OF TREATMENT,21272.0,60783.0,1837961583.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,B,2018-03-29T16:53 (7)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21262.0,46200.0,1837083000.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,127.0,127,,,,Y,127.0,127,EOT/ET/Followup,nan,NA,2018-03-19T12:50 (-4)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,10.0,TREATMENT,21266.0,31980.0,1837414380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,136.0,136,,,,Y,136.0,136,Period 1,nan,B,2018-03-23T08:53 (1)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,11.0,TREATMENT,21266.0,40983.0,1837423383.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,138.0,138,,,,,136.0,136,Period 1,2.0,B,2018-03-23T11:23 (1)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,12.0,END OF TREATMENT,21272.0,60783.0,1837961583.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,138.0,138,,,,,127.0,127,EOT/ET/Followup,11.0,B,2018-03-29T16:53 (7)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,13.0,SCREENING,21262.0,46200.0,1837083000.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,91.0,91,,,,Y,91.0,91,EOT/ET/Followup,nan,NA,2018-03-19T12:50 (-4)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,14.0,TREATMENT,21266.0,31980.0,1837414380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,92.0,92,,,,Y,92.0,92,Period 1,nan,B,2018-03-23T08:53 (1)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,15.0,TREATMENT,21266.0,40983.0,1837423383.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,93.0,93,,,,,92.0,92,Period 1,1.0,B,2018-03-23T11:23 (1)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,16.0,END OF TREATMENT,21272.0,60783.0,1837961583.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,93.0,93,,,,,91.0,91,EOT/ET/Followup,2.0,B,2018-03-29T16:53 (7)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21262.0,46200.0,1837083000.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,392.0,392,,,,Y,392.0,392,EOT/ET/Followup,nan,NA,2018-03-19T12:50 (-4)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,18.0,TREATMENT,21266.0,31980.0,1837414380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,395.0,395,,,,Y,395.0,395,Period 1,nan,B,2018-03-23T08:53 (1)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21266.0,40983.0,1837423383.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,398.0,398,,,,,395.0,395,Period 1,3.0,B,2018-03-23T11:23 (1)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,END OF TREATMENT,21272.0,60783.0,1837961583.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,366.0,366,,,,,392.0,392,EOT/ET/Followup,-26.0,B,2018-03-29T16:53 (7)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,21.0,SCREENING,21262.0,46200.0,1837083000.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,387.0,387,,,,Y,387.0,387,EOT/ET/Followup,nan,NA,2018-03-19T12:50 (-4)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,22.0,TREATMENT,21266.0,31980.0,1837414380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,383.0,383,,,,Y,383.0,383,Period 1,nan,B,2018-03-23T08:53 (1)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,23.0,TREATMENT,21266.0,40983.0,1837423383.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,364.0,364,,,,,383.0,383,Period 1,-19.0,B,2018-03-23T11:23 (1)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,24.0,END OF TREATMENT,21272.0,60783.0,1837961583.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,402.0,402,,,,,387.0,387,EOT/ET/Followup,15.0,B,2018-03-29T16:53 (7)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21262.0,46200.0,1837083000.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,389.0,389,,,,Y,389.0,389,EOT/ET/Followup,nan,NA,2018-03-19T12:50 (-4)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,26.0,TREATMENT,21266.0,31980.0,1837414380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,387.0,387,,,,Y,387.0,387,Period 1,nan,B,2018-03-23T08:53 (1)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,27.0,TREATMENT,21266.0,40983.0,1837423383.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,375.0,375,,,,,387.0,387,Period 1,-12.0,B,2018-03-23T11:23 (1)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,28.0,END OF TREATMENT,21272.0,60783.0,1837961583.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,389.0,389,,,,,389.0,389,EOT/ET/Followup,0.0,B,2018-03-29T16:53 (7)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,29.0,SCREENING,21262.0,46200.0,1837083000.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,1021.0,1021,,,,Y,1021.0,1021,EOT/ET/Followup,nan,NA,2018-03-19T12:50 (-4)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,30.0,TREATMENT,21266.0,31980.0,1837414380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1062.0,1062,,,,Y,1062.0,1062,Period 1,nan,B,2018-03-23T08:53 (1)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,31.0,TREATMENT,21266.0,40983.0,1837423383.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1195.0,1195,,,,,1062.0,1062,Period 1,133.0,B,2018-03-23T11:23 (1)
3110-103-002,3110-103-002.103001156,103001156,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,32.0,END OF TREATMENT,21272.0,60783.0,1837961583.0,7.0,EOT/ET,99.0,Early Term,,nan,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,828.0,828,,,,,1021.0,1021,EOT/ET/Followup,-193.0,B,2018-03-29T16:53 (7)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21264.0,34410.0,1837244010.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,61.0,61,,,,Y,61.0,61,EOT/ET/Followup,nan,NA,2018-03-21T09:33 (-2)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,2.0,TREATMENT,21266.0,32280.0,1837414680.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,57.0,57,,,,Y,57.0,57,Period 1,nan,A,2018-03-23T08:58 (1)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21266.0,41280.0,1837423680.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,55.0,55,,,,,57.0,57,Period 1,-2.0,A,2018-03-23T11:28 (1)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,TREATMENT,21273.0,32280.0,1838019480.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,59.0,59,,,,Y,59.0,59,Period 2,nan,C,2018-03-30T08:58 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,5.0,TREATMENT,21273.0,41280.0,1838028480.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,60.0,60,,,,,59.0,59,Period 2,1.0,C,2018-03-30T11:28 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21280.0,32280.0,1838624280.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,55.0,55,,,,Y,55.0,55,Period 3,nan,B,2018-04-06T08:58 (15)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,7.0,TREATMENT,21280.0,41280.0,1838633280.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,55.0,55,,,,,55.0,55,Period 3,0.0,B,2018-04-06T11:28 (15)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,8.0,END OF TREATMENT,21281.0,40080.0,1838718480.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,60.0,60,,,,,61.0,61,EOT/ET/Followup,-1.0,B,2018-04-07T11:08 (16)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21264.0,34410.0,1837244010.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-21T09:33 (-2)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,10.0,TREATMENT,21266.0,32280.0,1837414680.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,A,2018-03-23T08:58 (1)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,11.0,TREATMENT,21266.0,41280.0,1837423680.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,A,2018-03-23T11:28 (1)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,12.0,TREATMENT,21273.0,32280.0,1838019480.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,C,2018-03-30T08:58 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,13.0,TREATMENT,21273.0,41280.0,1838028480.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,C,2018-03-30T11:28 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,14.0,TREATMENT,21280.0,32280.0,1838624280.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,B,2018-04-06T08:58 (15)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,15.0,TREATMENT,21280.0,41280.0,1838633280.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,B,2018-04-06T11:28 (15)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,16.0,END OF TREATMENT,21281.0,40080.0,1838718480.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,B,2018-04-07T11:08 (16)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21264.0,34410.0,1837244010.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,162.0,162,,,,Y,162.0,162,EOT/ET/Followup,nan,NA,2018-03-21T09:33 (-2)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,18.0,TREATMENT,21266.0,32280.0,1837414680.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,157.0,157,,,,Y,157.0,157,Period 1,nan,A,2018-03-23T08:58 (1)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,19.0,TREATMENT,21266.0,41280.0,1837423680.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,165.0,165,,,,,157.0,157,Period 1,8.0,A,2018-03-23T11:28 (1)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,TREATMENT,21273.0,32280.0,1838019480.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,164.0,164,,,,Y,164.0,164,Period 2,nan,C,2018-03-30T08:58 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21.0,TREATMENT,21273.0,41280.0,1838028480.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,162.0,162,,,,,164.0,164,Period 2,-2.0,C,2018-03-30T11:28 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,22.0,TREATMENT,21280.0,32280.0,1838624280.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,170.0,170,,,,Y,170.0,170,Period 3,nan,B,2018-04-06T08:58 (15)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,23.0,TREATMENT,21280.0,41280.0,1838633280.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,176.0,176,,,,,170.0,170,Period 3,6.0,B,2018-04-06T11:28 (15)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,24.0,END OF TREATMENT,21281.0,40080.0,1838718480.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,166.0,166,,,,,162.0,162,EOT/ET/Followup,4.0,B,2018-04-07T11:08 (16)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21264.0,34410.0,1837244010.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,78.0,78,,,,Y,78.0,78,EOT/ET/Followup,nan,NA,2018-03-21T09:33 (-2)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,26.0,TREATMENT,21266.0,32280.0,1837414680.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,85.0,85,,,,Y,85.0,85,Period 1,nan,A,2018-03-23T08:58 (1)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,TREATMENT,21266.0,41280.0,1837423680.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,81.0,81,,,,,85.0,85,Period 1,-4.0,A,2018-03-23T11:28 (1)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,28.0,TREATMENT,21273.0,32280.0,1838019480.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,86.0,86,,,,Y,86.0,86,Period 2,nan,C,2018-03-30T08:58 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,29.0,TREATMENT,21273.0,41280.0,1838028480.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,78.0,78,,,,,86.0,86,Period 2,-8.0,C,2018-03-30T11:28 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,30.0,TREATMENT,21280.0,32280.0,1838624280.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,80.0,80,,,,Y,80.0,80,Period 3,nan,B,2018-04-06T08:58 (15)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,31.0,TREATMENT,21280.0,41280.0,1838633280.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,73.0,73,,,,,80.0,80,Period 3,-7.0,B,2018-04-06T11:28 (15)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,32.0,END OF TREATMENT,21281.0,40080.0,1838718480.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,83.0,83,,,,,78.0,78,EOT/ET/Followup,5.0,B,2018-04-07T11:08 (16)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21264.0,34410.0,1837244010.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,412.0,412,,,,Y,412.0,412,EOT/ET/Followup,nan,NA,2018-03-21T09:33 (-2)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,34.0,TREATMENT,21266.0,32280.0,1837414680.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,433.0,433,,,,Y,433.0,433,Period 1,nan,A,2018-03-23T08:58 (1)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,35.0,TREATMENT,21266.0,41280.0,1837423680.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,430.0,430,,,,,433.0,433,Period 1,-3.0,A,2018-03-23T11:28 (1)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,36.0,TREATMENT,21273.0,32280.0,1838019480.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,420.0,420,,,,Y,420.0,420,Period 2,nan,C,2018-03-30T08:58 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,37.0,TREATMENT,21273.0,41280.0,1838028480.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,414.0,414,,,,,420.0,420,Period 2,-6.0,C,2018-03-30T11:28 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,38.0,TREATMENT,21280.0,32280.0,1838624280.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,435.0,435,,,,Y,435.0,435,Period 3,nan,B,2018-04-06T08:58 (15)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,39.0,TREATMENT,21280.0,41280.0,1838633280.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,438.0,438,,,,,435.0,435,Period 3,3.0,B,2018-04-06T11:28 (15)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,40.0,END OF TREATMENT,21281.0,40080.0,1838718480.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,429.0,429,,,,,412.0,412,EOT/ET/Followup,17.0,B,2018-04-07T11:08 (16)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21264.0,34410.0,1837244010.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,415.0,415,,,,Y,415.0,415,EOT/ET/Followup,nan,NA,2018-03-21T09:33 (-2)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,42.0,TREATMENT,21266.0,32280.0,1837414680.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,422.0,422,,,,Y,422.0,422,Period 1,nan,A,2018-03-23T08:58 (1)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,43.0,TREATMENT,21266.0,41280.0,1837423680.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,414.0,414,,,,,422.0,422,Period 1,-8.0,A,2018-03-23T11:28 (1)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,44.0,TREATMENT,21273.0,32280.0,1838019480.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,418.0,418,,,,Y,418.0,418,Period 2,nan,C,2018-03-30T08:58 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,45.0,TREATMENT,21273.0,41280.0,1838028480.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,416.0,416,,,,,418.0,418,Period 2,-2.0,C,2018-03-30T11:28 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,46.0,TREATMENT,21280.0,32280.0,1838624280.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,417.0,417,,,,Y,417.0,417,Period 3,nan,B,2018-04-06T08:58 (15)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,47.0,TREATMENT,21280.0,41280.0,1838633280.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,422.0,422,,,,,417.0,417,Period 3,5.0,B,2018-04-06T11:28 (15)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,48.0,END OF TREATMENT,21281.0,40080.0,1838718480.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,429.0,429,,,,,415.0,415,EOT/ET/Followup,14.0,B,2018-04-07T11:08 (16)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21264.0,34410.0,1837244010.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,414.0,414,,,,Y,414.0,414,EOT/ET/Followup,nan,NA,2018-03-21T09:33 (-2)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,50.0,TREATMENT,21266.0,32280.0,1837414680.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,426.0,426,,,,Y,426.0,426,Period 1,nan,A,2018-03-23T08:58 (1)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,51.0,TREATMENT,21266.0,41280.0,1837423680.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,419.0,419,,,,,426.0,426,Period 1,-7.0,A,2018-03-23T11:28 (1)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,52.0,TREATMENT,21273.0,32280.0,1838019480.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,419.0,419,,,,Y,419.0,419,Period 2,nan,C,2018-03-30T08:58 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,53.0,TREATMENT,21273.0,41280.0,1838028480.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,415.0,415,,,,,419.0,419,Period 2,-4.0,C,2018-03-30T11:28 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,54.0,TREATMENT,21280.0,32280.0,1838624280.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,423.0,423,,,,Y,423.0,423,Period 3,nan,B,2018-04-06T08:58 (15)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,55.0,TREATMENT,21280.0,41280.0,1838633280.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,427.0,427,,,,,423.0,423,Period 3,4.0,B,2018-04-06T11:28 (15)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,56.0,END OF TREATMENT,21281.0,40080.0,1838718480.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,429.0,429,,,,,414.0,414,EOT/ET/Followup,15.0,B,2018-04-07T11:08 (16)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21264.0,34410.0,1837244010.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,982.0,982,,,,Y,982.0,982,EOT/ET/Followup,nan,NA,2018-03-21T09:33 (-2)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,58.0,TREATMENT,21266.0,32280.0,1837414680.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1050.0,1050,,,,Y,1050.0,1050,Period 1,nan,A,2018-03-23T08:58 (1)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,59.0,TREATMENT,21266.0,41280.0,1837423680.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1074.0,1074,,,,,1050.0,1050,Period 1,24.0,A,2018-03-23T11:28 (1)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,60.0,TREATMENT,21273.0,32280.0,1838019480.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1005.0,1005,,,,Y,1005.0,1005,Period 2,nan,C,2018-03-30T08:58 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,61.0,TREATMENT,21273.0,41280.0,1838028480.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,987.0,987,,,,,1005.0,1005,Period 2,-18.0,C,2018-03-30T11:28 (8)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,62.0,TREATMENT,21280.0,32280.0,1838624280.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1083.0,1083,,,,Y,1083.0,1083,Period 3,nan,B,2018-04-06T08:58 (15)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,63.0,TREATMENT,21280.0,41280.0,1838633280.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1075.0,1075,,,,,1083.0,1083,Period 3,-8.0,B,2018-04-06T11:28 (15)
3110-103-002,3110-103-002.103001193,103001193,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,64.0,END OF TREATMENT,21281.0,40080.0,1838718480.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,997.0,997,,,,,982.0,982,EOT/ET/Followup,15.0,B,2018-04-07T11:08 (16)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21264.0,38100.0,1837247700.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,63.0,63,,,,Y,63.0,63,EOT/ET/Followup,nan,NA,2018-03-21T10:35 (-2)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21266.0,30300.0,1837412700.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,76.0,76,,,,Y,76.0,76,Period 1,nan,C,2018-03-23T08:25 (1)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21266.0,39300.0,1837421700.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,68.0,68,,,,,76.0,76,Period 1,-8.0,C,2018-03-23T10:55 (1)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,4.0,TREATMENT,21273.0,30300.0,1838017500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,72.0,72,,,,Y,72.0,72,Period 2,nan,A,2018-03-30T08:25 (8)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,5.0,TREATMENT,21273.0,39300.0,1838026500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,62.0,62,,,,,72.0,72,Period 2,-10.0,A,2018-03-30T10:55 (8)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21280.0,30300.0,1838622300.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,67.0,67,,,,Y,67.0,67,Period 3,nan,B,2018-04-06T08:25 (15)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,7.0,TREATMENT,21280.0,39300.0,1838631300.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,65.0,65,,,,,67.0,67,Period 3,-2.0,B,2018-04-06T10:55 (15)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,8.0,END OF TREATMENT,21281.0,38100.0,1838716500.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,64.0,64,,,,,63.0,63,EOT/ET/Followup,1.0,B,2018-04-07T10:35 (16)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21264.0,38100.0,1837247700.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-03-21T10:35 (-2)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21266.0,30300.0,1837412700.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,C,2018-03-23T08:25 (1)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,TREATMENT,21266.0,39300.0,1837421700.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,C,2018-03-23T10:55 (1)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,12.0,TREATMENT,21273.0,30300.0,1838017500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,A,2018-03-30T08:25 (8)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,13.0,TREATMENT,21273.0,39300.0,1838026500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,A,2018-03-30T10:55 (8)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,14.0,TREATMENT,21280.0,30300.0,1838622300.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,B,2018-04-06T08:25 (15)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,15.0,TREATMENT,21280.0,39300.0,1838631300.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,B,2018-04-06T10:55 (15)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,16.0,END OF TREATMENT,21281.0,38100.0,1838716500.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,B,2018-04-07T10:35 (16)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21264.0,38100.0,1837247700.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,160.0,160,,,,Y,160.0,160,EOT/ET/Followup,nan,NA,2018-03-21T10:35 (-2)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21266.0,30300.0,1837412700.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,160.0,160,,,,Y,160.0,160,Period 1,nan,C,2018-03-23T08:25 (1)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21266.0,39300.0,1837421700.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,150.0,150,,,,,160.0,160,Period 1,-10.0,C,2018-03-23T10:55 (1)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,20.0,TREATMENT,21273.0,30300.0,1838017500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,164.0,164,,,,Y,164.0,164,Period 2,nan,A,2018-03-30T08:25 (8)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21.0,TREATMENT,21273.0,39300.0,1838026500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,149.0,149,,,,,164.0,164,Period 2,-15.0,A,2018-03-30T10:55 (8)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,22.0,TREATMENT,21280.0,30300.0,1838622300.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,170.0,170,,,,Y,170.0,170,Period 3,nan,B,2018-04-06T08:25 (15)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,23.0,TREATMENT,21280.0,39300.0,1838631300.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,158.0,158,,,,,170.0,170,Period 3,-12.0,B,2018-04-06T10:55 (15)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,24.0,END OF TREATMENT,21281.0,38100.0,1838716500.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,167.0,167,,,,,160.0,160,EOT/ET/Followup,7.0,B,2018-04-07T10:35 (16)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21264.0,38100.0,1837247700.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,Y,98.0,98,EOT/ET/Followup,nan,NA,2018-03-21T10:35 (-2)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,26.0,TREATMENT,21266.0,30300.0,1837412700.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,Y,96.0,96,Period 1,nan,C,2018-03-23T08:25 (1)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,27.0,TREATMENT,21266.0,39300.0,1837421700.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,,96.0,96,Period 1,3.0,C,2018-03-23T10:55 (1)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,28.0,TREATMENT,21273.0,30300.0,1838017500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,Y,99.0,99,Period 2,nan,A,2018-03-30T08:25 (8)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,TREATMENT,21273.0,39300.0,1838026500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,,99.0,99,Period 2,0.0,A,2018-03-30T10:55 (8)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,30.0,TREATMENT,21280.0,30300.0,1838622300.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,Y,99.0,99,Period 3,nan,B,2018-04-06T08:25 (15)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,31.0,TREATMENT,21280.0,39300.0,1838631300.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,,99.0,99,Period 3,0.0,B,2018-04-06T10:55 (15)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,32.0,END OF TREATMENT,21281.0,38100.0,1838716500.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,,98.0,98,EOT/ET/Followup,1.0,B,2018-04-07T10:35 (16)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21264.0,38100.0,1837247700.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,384.0,384,,,,Y,384.0,384,EOT/ET/Followup,nan,NA,2018-03-21T10:35 (-2)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,34.0,TREATMENT,21266.0,30300.0,1837412700.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,380.0,380,,,,Y,380.0,380,Period 1,nan,C,2018-03-23T08:25 (1)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,35.0,TREATMENT,21266.0,39300.0,1837421700.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,393.0,393,,,,,380.0,380,Period 1,13.0,C,2018-03-23T10:55 (1)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,36.0,TREATMENT,21273.0,30300.0,1838017500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,387.0,387,,,,Y,387.0,387,Period 2,nan,A,2018-03-30T08:25 (8)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,37.0,TREATMENT,21273.0,39300.0,1838026500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,404.0,404,,,,,387.0,387,Period 2,17.0,A,2018-03-30T10:55 (8)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,38.0,TREATMENT,21280.0,30300.0,1838622300.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,386.0,386,,,,Y,386.0,386,Period 3,nan,B,2018-04-06T08:25 (15)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,39.0,TREATMENT,21280.0,39300.0,1838631300.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,387.0,387,,,,,386.0,386,Period 3,1.0,B,2018-04-06T10:55 (15)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,40.0,END OF TREATMENT,21281.0,38100.0,1838716500.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,382.0,382,,,,,384.0,384,EOT/ET/Followup,-2.0,B,2018-04-07T10:35 (16)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21264.0,38100.0,1837247700.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,395.0,395,,,,Y,395.0,395,EOT/ET/Followup,nan,NA,2018-03-21T10:35 (-2)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,42.0,TREATMENT,21266.0,30300.0,1837412700.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,427.0,427,,,,Y,427.0,427,Period 1,nan,C,2018-03-23T08:25 (1)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,43.0,TREATMENT,21266.0,39300.0,1837421700.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,421.0,421,,,,,427.0,427,Period 1,-6.0,C,2018-03-23T10:55 (1)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,44.0,TREATMENT,21273.0,30300.0,1838017500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,425.0,425,,,,Y,425.0,425,Period 2,nan,A,2018-03-30T08:25 (8)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,45.0,TREATMENT,21273.0,39300.0,1838026500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,413.0,413,,,,,425.0,425,Period 2,-12.0,A,2018-03-30T10:55 (8)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,46.0,TREATMENT,21280.0,30300.0,1838622300.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,408.0,408,,,,Y,408.0,408,Period 3,nan,B,2018-04-06T08:25 (15)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,47.0,TREATMENT,21280.0,39300.0,1838631300.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,404.0,404,,,,,408.0,408,Period 3,-4.0,B,2018-04-06T10:55 (15)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,48.0,END OF TREATMENT,21281.0,38100.0,1838716500.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,396.0,396,,,,,395.0,395,EOT/ET/Followup,1.0,B,2018-04-07T10:35 (16)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21264.0,38100.0,1837247700.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,391.0,391,,,,Y,391.0,391,EOT/ET/Followup,nan,NA,2018-03-21T10:35 (-2)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,50.0,TREATMENT,21266.0,30300.0,1837412700.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,411.0,411,,,,Y,411.0,411,Period 1,nan,C,2018-03-23T08:25 (1)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,51.0,TREATMENT,21266.0,39300.0,1837421700.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,411.0,411,,,,,411.0,411,Period 1,0.0,C,2018-03-23T10:55 (1)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,52.0,TREATMENT,21273.0,30300.0,1838017500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,412.0,412,,,,Y,412.0,412,Period 2,nan,A,2018-03-30T08:25 (8)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,53.0,TREATMENT,21273.0,39300.0,1838026500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,410.0,410,,,,,412.0,412,Period 2,-2.0,A,2018-03-30T10:55 (8)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,54.0,TREATMENT,21280.0,30300.0,1838622300.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,401.0,401,,,,Y,401.0,401,Period 3,nan,B,2018-04-06T08:25 (15)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,55.0,TREATMENT,21280.0,39300.0,1838631300.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,398.0,398,,,,,401.0,401,Period 3,-3.0,B,2018-04-06T10:55 (15)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,56.0,END OF TREATMENT,21281.0,38100.0,1838716500.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,391.0,391,,,,,391.0,391,EOT/ET/Followup,0.0,B,2018-04-07T10:35 (16)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21264.0,38100.0,1837247700.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,941.0,941,,,,Y,941.0,941,EOT/ET/Followup,nan,NA,2018-03-21T10:35 (-2)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,58.0,TREATMENT,21266.0,30300.0,1837412700.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,789.0,789,,,,Y,789.0,789,Period 1,nan,C,2018-03-23T08:25 (1)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,59.0,TREATMENT,21266.0,39300.0,1837421700.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,870.0,870,,,,,789.0,789,Period 1,81.0,C,2018-03-23T10:55 (1)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,60.0,TREATMENT,21273.0,30300.0,1838017500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,828.0,828,,,,Y,828.0,828,Period 2,nan,A,2018-03-30T08:25 (8)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,61.0,TREATMENT,21273.0,39300.0,1838026500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,954.0,954,,,,,828.0,828,Period 2,126.0,A,2018-03-30T10:55 (8)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,62.0,TREATMENT,21280.0,30300.0,1838622300.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,891.0,891,,,,Y,891.0,891,Period 3,nan,B,2018-04-06T08:25 (15)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,63.0,TREATMENT,21280.0,39300.0,1838631300.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,914.0,914,,,,,891.0,891,Period 3,23.0,B,2018-04-06T10:55 (15)
3110-103-002,3110-103-002.103001201,103001201,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,64.0,END OF TREATMENT,21281.0,38100.0,1838716500.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,929.0,929,,,,,941.0,941,EOT/ET/Followup,-12.0,B,2018-04-07T10:35 (16)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21264.0,43206.0,1837252806.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,44.0,44,,,,Y,44.0,44,EOT/ET/Followup,nan,NA,2018-03-21T12:00 (-2)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,2.0,TREATMENT,21266.0,30360.0,1837412760.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,48.0,48,,,,Y,48.0,48,Period 1,nan,B,2018-03-23T08:26 (1)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,3.0,TREATMENT,21266.0,39360.0,1837421760.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,46.0,46,,,,,48.0,48,Period 1,-2.0,B,2018-03-23T10:56 (1)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,TREATMENT,21273.0,30360.0,1838017560.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,45.0,45,,,,Y,45.0,45,Period 2,nan,C,2018-03-30T08:26 (8)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,5.0,TREATMENT,21273.0,39360.0,1838026560.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,46.0,46,,,,,45.0,45,Period 2,1.0,C,2018-03-30T10:56 (8)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,6.0,TREATMENT,21280.0,30360.0,1838622360.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,49.0,49,,,,Y,49.0,49,Period 3,nan,A,2018-04-06T08:26 (15)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,7.0,TREATMENT,21280.0,39360.0,1838631360.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,48.0,48,,,,,49.0,49,Period 3,-1.0,A,2018-04-06T10:56 (15)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,8.0,END OF TREATMENT,21281.0,38160.0,1838716560.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,51.0,51,,,,,44.0,44,EOT/ET/Followup,7.0,A,2018-04-07T10:36 (16)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21264.0,43206.0,1837252806.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Abnormal, NCS,,,SINUS BRADYCARDIA,Y,nan,Abnormal, NCS,EOT/ET/Followup,nan,NA,2018-03-21T12:00 (-2)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,10.0,TREATMENT,21266.0,30360.0,1837412760.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,Y,nan,Normal,Period 1,nan,B,2018-03-23T08:26 (1)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,11.0,TREATMENT,21266.0,39360.0,1837421760.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,,nan,Normal,Period 1,nan,B,2018-03-23T10:56 (1)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,12.0,TREATMENT,21273.0,30360.0,1838017560.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,Y,nan,Normal,Period 2,nan,C,2018-03-30T08:26 (8)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,13.0,TREATMENT,21273.0,39360.0,1838026560.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,,nan,Normal,Period 2,nan,C,2018-03-30T10:56 (8)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,14.0,TREATMENT,21280.0,30360.0,1838622360.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,Y,nan,Normal,Period 3,nan,A,2018-04-06T08:26 (15)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,15.0,TREATMENT,21280.0,39360.0,1838631360.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,,nan,Normal,Period 3,nan,A,2018-04-06T10:56 (15)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,16.0,END OF TREATMENT,21281.0,38160.0,1838716560.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Abnormal, NCS,EOT/ET/Followup,nan,A,2018-04-07T10:36 (16)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21264.0,43206.0,1837252806.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,164.0,164,,,,Y,164.0,164,EOT/ET/Followup,nan,NA,2018-03-21T12:00 (-2)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,18.0,TREATMENT,21266.0,30360.0,1837412760.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,184.0,184,,,,Y,184.0,184,Period 1,nan,B,2018-03-23T08:26 (1)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21266.0,39360.0,1837421760.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,164.0,164,,,,,184.0,184,Period 1,-20.0,B,2018-03-23T10:56 (1)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,TREATMENT,21273.0,30360.0,1838017560.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,170.0,170,,,,Y,170.0,170,Period 2,nan,C,2018-03-30T08:26 (8)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21.0,TREATMENT,21273.0,39360.0,1838026560.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,175.0,175,,,,,170.0,170,Period 2,5.0,C,2018-03-30T10:56 (8)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,22.0,TREATMENT,21280.0,30360.0,1838622360.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,183.0,183,,,,Y,183.0,183,Period 3,nan,A,2018-04-06T08:26 (15)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,23.0,TREATMENT,21280.0,39360.0,1838631360.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,175.0,175,,,,,183.0,183,Period 3,-8.0,A,2018-04-06T10:56 (15)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,24.0,END OF TREATMENT,21281.0,38160.0,1838716560.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,167.0,167,,,,,164.0,164,EOT/ET/Followup,3.0,A,2018-04-07T10:36 (16)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21264.0,43206.0,1837252806.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,92.0,92,,,,Y,92.0,92,EOT/ET/Followup,nan,NA,2018-03-21T12:00 (-2)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,26.0,TREATMENT,21266.0,30360.0,1837412760.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,Y,97.0,97,Period 1,nan,B,2018-03-23T08:26 (1)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,27.0,TREATMENT,21266.0,39360.0,1837421760.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,,97.0,97,Period 1,2.0,B,2018-03-23T10:56 (1)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,28.0,TREATMENT,21273.0,30360.0,1838017560.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,90.0,90,,,,Y,90.0,90,Period 2,nan,C,2018-03-30T08:26 (8)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,29.0,TREATMENT,21273.0,39360.0,1838026560.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,93.0,93,,,,,90.0,90,Period 2,3.0,C,2018-03-30T10:56 (8)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,30.0,TREATMENT,21280.0,30360.0,1838622360.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,95.0,95,,,,Y,95.0,95,Period 3,nan,A,2018-04-06T08:26 (15)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,31.0,TREATMENT,21280.0,39360.0,1838631360.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,,95.0,95,Period 3,1.0,A,2018-04-06T10:56 (15)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,32.0,END OF TREATMENT,21281.0,38160.0,1838716560.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,,92.0,92,EOT/ET/Followup,5.0,A,2018-04-07T10:36 (16)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21264.0,43206.0,1837252806.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,432.0,432,,,,Y,432.0,432,EOT/ET/Followup,nan,NA,2018-03-21T12:00 (-2)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21266.0,30360.0,1837412760.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,430.0,430,,,,Y,430.0,430,Period 1,nan,B,2018-03-23T08:26 (1)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,35.0,TREATMENT,21266.0,39360.0,1837421760.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,442.0,442,,,,,430.0,430,Period 1,12.0,B,2018-03-23T10:56 (1)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,36.0,TREATMENT,21273.0,30360.0,1838017560.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,451.0,451,,,,Y,451.0,451,Period 2,nan,C,2018-03-30T08:26 (8)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,37.0,TREATMENT,21273.0,39360.0,1838026560.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,447.0,447,,,,,451.0,451,Period 2,-4.0,C,2018-03-30T10:56 (8)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,38.0,TREATMENT,21280.0,30360.0,1838622360.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,435.0,435,,,,Y,435.0,435,Period 3,nan,A,2018-04-06T08:26 (15)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,39.0,TREATMENT,21280.0,39360.0,1838631360.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,433.0,433,,,,,435.0,435,Period 3,-2.0,A,2018-04-06T10:56 (15)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,40.0,END OF TREATMENT,21281.0,38160.0,1838716560.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,427.0,427,,,,,432.0,432,EOT/ET/Followup,-5.0,A,2018-04-07T10:36 (16)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21264.0,43206.0,1837252806.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,370.0,370,,,,Y,370.0,370,EOT/ET/Followup,nan,NA,2018-03-21T12:00 (-2)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,42.0,TREATMENT,21266.0,30360.0,1837412760.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,385.0,385,,,,Y,385.0,385,Period 1,nan,B,2018-03-23T08:26 (1)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,43.0,TREATMENT,21266.0,39360.0,1837421760.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,389.0,389,,,,,385.0,385,Period 1,4.0,B,2018-03-23T10:56 (1)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,44.0,TREATMENT,21273.0,30360.0,1838017560.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,392.0,392,,,,Y,392.0,392,Period 2,nan,C,2018-03-30T08:26 (8)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,45.0,TREATMENT,21273.0,39360.0,1838026560.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,392.0,392,,,,,392.0,392,Period 2,0.0,C,2018-03-30T10:56 (8)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,46.0,TREATMENT,21280.0,30360.0,1838622360.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,394.0,394,,,,Y,394.0,394,Period 3,nan,A,2018-04-06T08:26 (15)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,47.0,TREATMENT,21280.0,39360.0,1838631360.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,390.0,390,,,,,394.0,394,Period 3,-4.0,A,2018-04-06T10:56 (15)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,48.0,END OF TREATMENT,21281.0,38160.0,1838716560.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,396.0,396,,,,,370.0,370,EOT/ET/Followup,26.0,A,2018-04-07T10:36 (16)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21264.0,43206.0,1837252806.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,389.0,389,,,,Y,389.0,389,EOT/ET/Followup,nan,NA,2018-03-21T12:00 (-2)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,50.0,TREATMENT,21266.0,30360.0,1837412760.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,400.0,400,,,,Y,400.0,400,Period 1,nan,B,2018-03-23T08:26 (1)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,51.0,TREATMENT,21266.0,39360.0,1837421760.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,406.0,406,,,,,400.0,400,Period 1,6.0,B,2018-03-23T10:56 (1)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,52.0,TREATMENT,21273.0,30360.0,1838017560.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,411.0,411,,,,Y,411.0,411,Period 2,nan,C,2018-03-30T08:26 (8)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,53.0,TREATMENT,21273.0,39360.0,1838026560.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,409.0,409,,,,,411.0,411,Period 2,-2.0,C,2018-03-30T10:56 (8)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,54.0,TREATMENT,21280.0,30360.0,1838622360.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,407.0,407,,,,Y,407.0,407,Period 3,nan,A,2018-04-06T08:26 (15)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,55.0,TREATMENT,21280.0,39360.0,1838631360.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,404.0,404,,,,,407.0,407,Period 3,-3.0,A,2018-04-06T10:56 (15)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,56.0,END OF TREATMENT,21281.0,38160.0,1838716560.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,406.0,406,,,,,389.0,389,EOT/ET/Followup,17.0,A,2018-04-07T10:36 (16)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21264.0,43206.0,1837252806.0,-2.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,1363.0,1363,,,,Y,1363.0,1363,EOT/ET/Followup,nan,NA,2018-03-21T12:00 (-2)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,58.0,TREATMENT,21266.0,30360.0,1837412760.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1242.0,1242,,,,Y,1242.0,1242,Period 1,nan,B,2018-03-23T08:26 (1)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,59.0,TREATMENT,21266.0,39360.0,1837421760.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1285.0,1285,,,,,1242.0,1242,Period 1,43.0,B,2018-03-23T10:56 (1)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,60.0,TREATMENT,21273.0,30360.0,1838017560.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1321.0,1321,,,,Y,1321.0,1321,Period 2,nan,C,2018-03-30T08:26 (8)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,61.0,TREATMENT,21273.0,39360.0,1838026560.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1298.0,1298,,,,,1321.0,1321,Period 2,-23.0,C,2018-03-30T10:56 (8)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,62.0,TREATMENT,21280.0,30360.0,1838622360.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1218.0,1218,,,,Y,1218.0,1218,Period 3,nan,A,2018-04-06T08:26 (15)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,63.0,TREATMENT,21280.0,39360.0,1838631360.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1231.0,1231,,,,,1218.0,1218,Period 3,13.0,A,2018-04-06T10:56 (15)
3110-103-002,3110-103-002.103001211,103001211,001,Y,1.0,4: BCA,4.0,4: BCA,4.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,64.0,END OF TREATMENT,21281.0,38160.0,1838716560.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1162.0,1162,,,,,1363.0,1363,EOT/ET/Followup,-201.0,A,2018-04-07T10:36 (16)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21280.0,47462.0,1838639462.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,50.0,50,,,,Y,50.0,50,EOT/ET/Followup,nan,NA,2018-04-06T13:11 (-12)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21292.0,25980.0,1839654780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,66.0,66,,,,Y,66.0,66,Period 1,nan,C,2018-04-18T07:13 (1)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21292.0,34980.0,1839663780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,59.0,59,,,,,66.0,66,Period 1,-7.0,C,2018-04-18T09:43 (1)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,4.0,TREATMENT,21299.0,25980.0,1840259580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,73.0,73,,,,Y,73.0,73,Period 2,nan,A,2018-04-25T07:13 (8)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,5.0,TREATMENT,21299.0,34980.0,1840268580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,55.0,55,,,,,73.0,73,Period 2,-18.0,A,2018-04-25T09:43 (8)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21306.0,25980.0,1840864380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,60.0,60,,,,Y,60.0,60,Period 3,nan,B,2018-05-02T07:13 (15)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,7.0,TREATMENT,21306.0,34997.0,1840873397.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,77.0,77,,,,,60.0,60,Period 3,17.0,B,2018-05-02T09:43 (15)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,8.0,END OF TREATMENT,21307.0,32400.0,1840957200.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,70.0,70,,,,,50.0,50,EOT/ET/Followup,20.0,B,2018-05-03T09:00 (16)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21280.0,47462.0,1838639462.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-04-06T13:11 (-12)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21292.0,25980.0,1839654780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,C,2018-04-18T07:13 (1)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,TREATMENT,21292.0,34980.0,1839663780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,C,2018-04-18T09:43 (1)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,12.0,TREATMENT,21299.0,25980.0,1840259580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,A,2018-04-25T07:13 (8)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,13.0,TREATMENT,21299.0,34980.0,1840268580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,A,2018-04-25T09:43 (8)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,14.0,TREATMENT,21306.0,25980.0,1840864380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,B,2018-05-02T07:13 (15)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,15.0,TREATMENT,21306.0,34997.0,1840873397.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,B,2018-05-02T09:43 (15)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,16.0,END OF TREATMENT,21307.0,32400.0,1840957200.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,B,2018-05-03T09:00 (16)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21280.0,47462.0,1838639462.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,125.0,125,,,,Y,125.0,125,EOT/ET/Followup,nan,NA,2018-04-06T13:11 (-12)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21292.0,25980.0,1839654780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,121.0,121,,,,Y,121.0,121,Period 1,nan,C,2018-04-18T07:13 (1)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21292.0,34980.0,1839663780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,120.0,120,,,,,121.0,121,Period 1,-1.0,C,2018-04-18T09:43 (1)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,20.0,TREATMENT,21299.0,25980.0,1840259580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,122.0,122,,,,Y,122.0,122,Period 2,nan,A,2018-04-25T07:13 (8)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21.0,TREATMENT,21299.0,34980.0,1840268580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,119.0,119,,,,,122.0,122,Period 2,-3.0,A,2018-04-25T09:43 (8)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,22.0,TREATMENT,21306.0,25980.0,1840864380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,120.0,120,,,,Y,120.0,120,Period 3,nan,B,2018-05-02T07:13 (15)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,23.0,TREATMENT,21306.0,34997.0,1840873397.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,122.0,122,,,,,120.0,120,Period 3,2.0,B,2018-05-02T09:43 (15)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,24.0,END OF TREATMENT,21307.0,32400.0,1840957200.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,124.0,124,,,,,125.0,125,EOT/ET/Followup,-1.0,B,2018-05-03T09:00 (16)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21280.0,47462.0,1838639462.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,Y,94.0,94,EOT/ET/Followup,nan,NA,2018-04-06T13:11 (-12)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,26.0,TREATMENT,21292.0,25980.0,1839654780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,86.0,86,,,,Y,86.0,86,Period 1,nan,C,2018-04-18T07:13 (1)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,27.0,TREATMENT,21292.0,34980.0,1839663780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,92.0,92,,,,,86.0,86,Period 1,6.0,C,2018-04-18T09:43 (1)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,28.0,TREATMENT,21299.0,25980.0,1840259580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,90.0,90,,,,Y,90.0,90,Period 2,nan,A,2018-04-25T07:13 (8)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,TREATMENT,21299.0,34980.0,1840268580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,91.0,91,,,,,90.0,90,Period 2,1.0,A,2018-04-25T09:43 (8)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,30.0,TREATMENT,21306.0,25980.0,1840864380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,92.0,92,,,,Y,92.0,92,Period 3,nan,B,2018-05-02T07:13 (15)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,31.0,TREATMENT,21306.0,34997.0,1840873397.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,90.0,90,,,,,92.0,92,Period 3,-2.0,B,2018-05-02T09:43 (15)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,32.0,END OF TREATMENT,21307.0,32400.0,1840957200.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,87.0,87,,,,,94.0,94,EOT/ET/Followup,-7.0,B,2018-05-03T09:00 (16)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21280.0,47462.0,1838639462.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,396.0,396,,,,Y,396.0,396,EOT/ET/Followup,nan,NA,2018-04-06T13:11 (-12)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,34.0,TREATMENT,21292.0,25980.0,1839654780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,357.0,357,,,,Y,357.0,357,Period 1,nan,C,2018-04-18T07:13 (1)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,35.0,TREATMENT,21292.0,34980.0,1839663780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,376.0,376,,,,,357.0,357,Period 1,19.0,C,2018-04-18T09:43 (1)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,36.0,TREATMENT,21299.0,25980.0,1840259580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,378.0,378,,,,Y,378.0,378,Period 2,nan,A,2018-04-25T07:13 (8)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,37.0,TREATMENT,21299.0,34980.0,1840268580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,416.0,416,,,,,378.0,378,Period 2,38.0,A,2018-04-25T09:43 (8)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,38.0,TREATMENT,21306.0,25980.0,1840864380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,379.0,379,,,,Y,379.0,379,Period 3,nan,B,2018-05-02T07:13 (15)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,39.0,TREATMENT,21306.0,34997.0,1840873397.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,368.0,368,,,,,379.0,379,Period 3,-11.0,B,2018-05-02T09:43 (15)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,40.0,END OF TREATMENT,21307.0,32400.0,1840957200.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,379.0,379,,,,,396.0,396,EOT/ET/Followup,-17.0,B,2018-05-03T09:00 (16)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21280.0,47462.0,1838639462.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,364.0,364,,,,Y,364.0,364,EOT/ET/Followup,nan,NA,2018-04-06T13:11 (-12)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,42.0,TREATMENT,21292.0,25980.0,1839654780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,375.0,375,,,,Y,375.0,375,Period 1,nan,C,2018-04-18T07:13 (1)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,43.0,TREATMENT,21292.0,34980.0,1839663780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,375.0,375,,,,,375.0,375,Period 1,0.0,C,2018-04-18T09:43 (1)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,44.0,TREATMENT,21299.0,25980.0,1840259580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,419.0,419,,,,Y,419.0,419,Period 2,nan,A,2018-04-25T07:13 (8)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,45.0,TREATMENT,21299.0,34980.0,1840268580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,400.0,400,,,,,419.0,419,Period 2,-19.0,A,2018-04-25T09:43 (8)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,46.0,TREATMENT,21306.0,25980.0,1840864380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,380.0,380,,,,Y,380.0,380,Period 3,nan,B,2018-05-02T07:13 (15)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,47.0,TREATMENT,21306.0,34997.0,1840873397.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,418.0,418,,,,,380.0,380,Period 3,38.0,B,2018-05-02T09:43 (15)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,48.0,END OF TREATMENT,21307.0,32400.0,1840957200.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,411.0,411,,,,,364.0,364,EOT/ET/Followup,47.0,B,2018-05-03T09:00 (16)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21280.0,47462.0,1838639462.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,374.0,374,,,,Y,374.0,374,EOT/ET/Followup,nan,NA,2018-04-06T13:11 (-12)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,50.0,TREATMENT,21292.0,25980.0,1839654780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,369.0,369,,,,Y,369.0,369,Period 1,nan,C,2018-04-18T07:13 (1)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,51.0,TREATMENT,21292.0,34980.0,1839663780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,375.0,375,,,,,369.0,369,Period 1,6.0,C,2018-04-18T09:43 (1)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,52.0,TREATMENT,21299.0,25980.0,1840259580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,405.0,405,,,,Y,405.0,405,Period 2,nan,A,2018-04-25T07:13 (8)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,53.0,TREATMENT,21299.0,34980.0,1840268580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,405.0,405,,,,,405.0,405,Period 2,0.0,A,2018-04-25T09:43 (8)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,54.0,TREATMENT,21306.0,25980.0,1840864380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,379.0,379,,,,Y,379.0,379,Period 3,nan,B,2018-05-02T07:13 (15)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,55.0,TREATMENT,21306.0,34997.0,1840873397.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,400.0,400,,,,,379.0,379,Period 3,21.0,B,2018-05-02T09:43 (15)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,56.0,END OF TREATMENT,21307.0,32400.0,1840957200.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,400.0,400,,,,,374.0,374,EOT/ET/Followup,26.0,B,2018-05-03T09:00 (16)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21280.0,47462.0,1838639462.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,1181.0,1181,,,,Y,1181.0,1181,EOT/ET/Followup,nan,NA,2018-04-06T13:11 (-12)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,58.0,TREATMENT,21292.0,25980.0,1839654780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,904.0,904,,,,Y,904.0,904,Period 1,nan,C,2018-04-18T07:13 (1)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,59.0,TREATMENT,21292.0,34980.0,1839663780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1002.0,1002,,,,,904.0,904,Period 1,98.0,C,2018-04-18T09:43 (1)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,60.0,TREATMENT,21299.0,25980.0,1840259580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,812.0,812,,,,Y,812.0,812,Period 2,nan,A,2018-04-25T07:13 (8)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,61.0,TREATMENT,21299.0,34980.0,1840268580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1079.0,1079,,,,,812.0,812,Period 2,267.0,A,2018-04-25T09:43 (8)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,62.0,TREATMENT,21306.0,25980.0,1840864380.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,994.0,994,,,,Y,994.0,994,Period 3,nan,B,2018-05-02T07:13 (15)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,63.0,TREATMENT,21306.0,34997.0,1840873397.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,775.0,775,,,,,994.0,994,Period 3,-219.0,B,2018-05-02T09:43 (15)
3110-103-002,3110-103-002.103001218,103001218,001,Y,1.0,5: CAB,5.0,5: CAB,5.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,64.0,END OF TREATMENT,21307.0,32400.0,1840957200.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,848.0,848,,,,,1181.0,1181,EOT/ET/Followup,-333.0,B,2018-05-03T09:00 (16)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21280.0,47105.0,1838639105.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,65.0,65,,,,Y,65.0,65,EOT/ET/Followup,nan,NA,2018-04-06T13:05 (-12)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,2.0,TREATMENT,21292.0,26110.0,1839654910.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,58.0,58,,,,Y,58.0,58,Period 1,nan,A,2018-04-18T07:15 (1)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21292.0,35100.0,1839663900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,64.0,64,,,,,58.0,58,Period 1,6.0,A,2018-04-18T09:45 (1)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,4.0,TREATMENT,21299.0,26100.0,1840259700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,63.0,63,,,,Y,63.0,63,Period 2,nan,C,2018-04-25T07:15 (8)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,5.0,TREATMENT,21299.0,35100.0,1840268700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,66.0,66,,,,,63.0,63,Period 2,3.0,C,2018-04-25T09:45 (8)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,6.0,TREATMENT,21306.0,26100.0,1840864500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,57.0,57,,,,Y,57.0,57,Period 3,nan,B,2018-05-02T07:15 (15)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,7.0,TREATMENT,21306.0,35100.0,1840873500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,62.0,62,,,,,57.0,57,Period 3,5.0,B,2018-05-02T09:45 (15)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,8.0,END OF TREATMENT,21307.0,32460.0,1840957260.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,61.0,61,,,,,65.0,65,EOT/ET/Followup,-4.0,B,2018-05-03T09:01 (16)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21280.0,47105.0,1838639105.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-04-06T13:05 (-12)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,10.0,TREATMENT,21292.0,26110.0,1839654910.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,A,2018-04-18T07:15 (1)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,11.0,TREATMENT,21292.0,35100.0,1839663900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,A,2018-04-18T09:45 (1)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,12.0,TREATMENT,21299.0,26100.0,1840259700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,C,2018-04-25T07:15 (8)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,13.0,TREATMENT,21299.0,35100.0,1840268700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,C,2018-04-25T09:45 (8)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,14.0,TREATMENT,21306.0,26100.0,1840864500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,B,2018-05-02T07:15 (15)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,15.0,TREATMENT,21306.0,35100.0,1840873500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,B,2018-05-02T09:45 (15)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,16.0,END OF TREATMENT,21307.0,32460.0,1840957260.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,B,2018-05-03T09:01 (16)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21280.0,47105.0,1838639105.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,158.0,158,,,,Y,158.0,158,EOT/ET/Followup,nan,NA,2018-04-06T13:05 (-12)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,18.0,TREATMENT,21292.0,26110.0,1839654910.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,185.0,185,,,,Y,185.0,185,Period 1,nan,A,2018-04-18T07:15 (1)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,19.0,TREATMENT,21292.0,35100.0,1839663900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,171.0,171,,,,,185.0,185,Period 1,-14.0,A,2018-04-18T09:45 (1)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,20.0,TREATMENT,21299.0,26100.0,1840259700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,178.0,178,,,,Y,178.0,178,Period 2,nan,C,2018-04-25T07:15 (8)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,21.0,TREATMENT,21299.0,35100.0,1840268700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,185.0,185,,,,,178.0,178,Period 2,7.0,C,2018-04-25T09:45 (8)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,22.0,TREATMENT,21306.0,26100.0,1840864500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,177.0,177,,,,Y,177.0,177,Period 3,nan,B,2018-05-02T07:15 (15)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,23.0,TREATMENT,21306.0,35100.0,1840873500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,188.0,188,,,,,177.0,177,Period 3,11.0,B,2018-05-02T09:45 (15)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,24.0,END OF TREATMENT,21307.0,32460.0,1840957260.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,180.0,180,,,,,158.0,158,EOT/ET/Followup,22.0,B,2018-05-03T09:01 (16)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21280.0,47105.0,1838639105.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,101.0,101,,,,Y,101.0,101,EOT/ET/Followup,nan,NA,2018-04-06T13:05 (-12)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,26.0,TREATMENT,21292.0,26110.0,1839654910.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,Y,99.0,99,Period 1,nan,A,2018-04-18T07:15 (1)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,TREATMENT,21292.0,35100.0,1839663900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,,99.0,99,Period 1,0.0,A,2018-04-18T09:45 (1)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,28.0,TREATMENT,21299.0,26100.0,1840259700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,Y,97.0,97,Period 2,nan,C,2018-04-25T07:15 (8)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,29.0,TREATMENT,21299.0,35100.0,1840268700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,,97.0,97,Period 2,0.0,C,2018-04-25T09:45 (8)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,30.0,TREATMENT,21306.0,26100.0,1840864500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,92.0,92,,,,Y,92.0,92,Period 3,nan,B,2018-05-02T07:15 (15)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,31.0,TREATMENT,21306.0,35100.0,1840873500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,,92.0,92,Period 3,5.0,B,2018-05-02T09:45 (15)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,32.0,END OF TREATMENT,21307.0,32460.0,1840957260.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,,101.0,101,EOT/ET/Followup,-3.0,B,2018-05-03T09:01 (16)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21280.0,47105.0,1838639105.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,415.0,415,,,,Y,415.0,415,EOT/ET/Followup,nan,NA,2018-04-06T13:05 (-12)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,34.0,TREATMENT,21292.0,26110.0,1839654910.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,431.0,431,,,,Y,431.0,431,Period 1,nan,A,2018-04-18T07:15 (1)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,35.0,TREATMENT,21292.0,35100.0,1839663900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,410.0,410,,,,,431.0,431,Period 1,-21.0,A,2018-04-18T09:45 (1)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,36.0,TREATMENT,21299.0,26100.0,1840259700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,420.0,420,,,,Y,420.0,420,Period 2,nan,C,2018-04-25T07:15 (8)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,37.0,TREATMENT,21299.0,35100.0,1840268700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,422.0,422,,,,,420.0,420,Period 2,2.0,C,2018-04-25T09:45 (8)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,38.0,TREATMENT,21306.0,26100.0,1840864500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,441.0,441,,,,Y,441.0,441,Period 3,nan,B,2018-05-02T07:15 (15)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,39.0,TREATMENT,21306.0,35100.0,1840873500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,432.0,432,,,,,441.0,441,Period 3,-9.0,B,2018-05-02T09:45 (15)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,40.0,END OF TREATMENT,21307.0,32460.0,1840957260.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,418.0,418,,,,,415.0,415,EOT/ET/Followup,3.0,B,2018-05-03T09:01 (16)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21280.0,47105.0,1838639105.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,435.0,435,,,,Y,435.0,435,EOT/ET/Followup,nan,NA,2018-04-06T13:05 (-12)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,42.0,TREATMENT,21292.0,26110.0,1839654910.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,427.0,427,,,,Y,427.0,427,Period 1,nan,A,2018-04-18T07:15 (1)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,43.0,TREATMENT,21292.0,35100.0,1839663900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,425.0,425,,,,,427.0,427,Period 1,-2.0,A,2018-04-18T09:45 (1)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,44.0,TREATMENT,21299.0,26100.0,1840259700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,432.0,432,,,,Y,432.0,432,Period 2,nan,C,2018-04-25T07:15 (8)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,45.0,TREATMENT,21299.0,35100.0,1840268700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,442.0,442,,,,,432.0,432,Period 2,10.0,C,2018-04-25T09:45 (8)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,46.0,TREATMENT,21306.0,26100.0,1840864500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,433.0,433,,,,Y,433.0,433,Period 3,nan,B,2018-05-02T07:15 (15)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,47.0,TREATMENT,21306.0,35100.0,1840873500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,439.0,439,,,,,433.0,433,Period 3,6.0,B,2018-05-02T09:45 (15)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,48.0,END OF TREATMENT,21307.0,32460.0,1840957260.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,421.0,421,,,,,435.0,435,EOT/ET/Followup,-14.0,B,2018-05-03T09:01 (16)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21280.0,47105.0,1838639105.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,428.0,428,,,,Y,428.0,428,EOT/ET/Followup,nan,NA,2018-04-06T13:05 (-12)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,50.0,TREATMENT,21292.0,26110.0,1839654910.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,428.0,428,,,,Y,428.0,428,Period 1,nan,A,2018-04-18T07:15 (1)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,51.0,TREATMENT,21292.0,35100.0,1839663900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,420.0,420,,,,,428.0,428,Period 1,-8.0,A,2018-04-18T09:45 (1)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,52.0,TREATMENT,21299.0,26100.0,1840259700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,427.0,427,,,,Y,427.0,427,Period 2,nan,C,2018-04-25T07:15 (8)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,53.0,TREATMENT,21299.0,35100.0,1840268700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,435.0,435,,,,,427.0,427,Period 2,8.0,C,2018-04-25T09:45 (8)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,54.0,TREATMENT,21306.0,26100.0,1840864500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,435.0,435,,,,Y,435.0,435,Period 3,nan,B,2018-05-02T07:15 (15)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,55.0,TREATMENT,21306.0,35100.0,1840873500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,437.0,437,,,,,435.0,435,Period 3,2.0,B,2018-05-02T09:45 (15)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,56.0,END OF TREATMENT,21307.0,32460.0,1840957260.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,420.0,420,,,,,428.0,428,EOT/ET/Followup,-8.0,B,2018-05-03T09:01 (16)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21280.0,47105.0,1838639105.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,910.0,910,,,,Y,910.0,910,EOT/ET/Followup,nan,NA,2018-04-06T13:05 (-12)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,58.0,TREATMENT,21292.0,26110.0,1839654910.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1018.0,1018,,,,Y,1018.0,1018,Period 1,nan,A,2018-04-18T07:15 (1)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,59.0,TREATMENT,21292.0,35100.0,1839663900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,927.0,927,,,,,1018.0,1018,Period 1,-91.0,A,2018-04-18T09:45 (1)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,60.0,TREATMENT,21299.0,26100.0,1840259700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,945.0,945,,,,Y,945.0,945,Period 2,nan,C,2018-04-25T07:15 (8)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,61.0,TREATMENT,21299.0,35100.0,1840268700.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,908.0,908,,,,,945.0,945,Period 2,-37.0,C,2018-04-25T09:45 (8)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,62.0,TREATMENT,21306.0,26100.0,1840864500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1036.0,1036,,,,Y,1036.0,1036,Period 3,nan,B,2018-05-02T07:15 (15)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,63.0,TREATMENT,21306.0,35100.0,1840873500.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,964.0,964,,,,,1036.0,1036,Period 3,-72.0,B,2018-05-02T09:45 (15)
3110-103-002,3110-103-002.103001220,103001220,001,Y,1.0,2: ACB,2.0,2: ACB,2.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,64.0,END OF TREATMENT,21307.0,32460.0,1840957260.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,983.0,983,,,,,910.0,910,EOT/ET/Followup,73.0,B,2018-05-03T09:01 (16)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21280.0,49202.0,1838641202.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,75.0,75,,,,Y,75.0,75,EOT/ET/Followup,nan,NA,2018-04-06T13:40 (-12)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,2.0,TREATMENT,21292.0,26340.0,1839655140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,63.0,63,,,,Y,63.0,63,Period 1,nan,A,2018-04-18T07:19 (1)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,3.0,TREATMENT,21292.0,35340.0,1839664140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,73.0,73,,,,,63.0,63,Period 1,10.0,A,2018-04-18T09:49 (1)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,4.0,TREATMENT,21299.0,26340.0,1840259940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,62.0,62,,,,Y,62.0,62,Period 2,nan,B,2018-04-25T07:19 (8)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21299.0,35347.0,1840268947.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,82.0,82,,,,,62.0,62,Period 2,20.0,B,2018-04-25T09:49 (8)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,6.0,TREATMENT,21306.0,26340.0,1840864740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,66.0,66,,,,Y,66.0,66,Period 3,nan,C,2018-05-02T07:19 (15)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,TREATMENT,21306.0,35340.0,1840873740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,62.0,62,,,,,66.0,66,Period 3,-4.0,C,2018-05-02T09:49 (15)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,END OF TREATMENT,21307.0,32640.0,1840957440.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,69.0,69,,,,,75.0,75,EOT/ET/Followup,-6.0,C,2018-05-03T09:04 (16)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21280.0,49202.0,1838641202.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-04-06T13:40 (-12)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,10.0,TREATMENT,21292.0,26340.0,1839655140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,A,2018-04-18T07:19 (1)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,11.0,TREATMENT,21292.0,35340.0,1839664140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,A,2018-04-18T09:49 (1)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,12.0,TREATMENT,21299.0,26340.0,1840259940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,B,2018-04-25T07:19 (8)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,13.0,TREATMENT,21299.0,35347.0,1840268947.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,B,2018-04-25T09:49 (8)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,14.0,TREATMENT,21306.0,26340.0,1840864740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,C,2018-05-02T07:19 (15)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,15.0,TREATMENT,21306.0,35340.0,1840873740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,C,2018-05-02T09:49 (15)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,16.0,END OF TREATMENT,21307.0,32640.0,1840957440.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,C,2018-05-03T09:04 (16)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21280.0,49202.0,1838641202.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,144.0,144,,,,Y,144.0,144,EOT/ET/Followup,nan,NA,2018-04-06T13:40 (-12)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,18.0,TREATMENT,21292.0,26340.0,1839655140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,154.0,154,,,,Y,154.0,154,Period 1,nan,A,2018-04-18T07:19 (1)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,19.0,TREATMENT,21292.0,35340.0,1839664140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,141.0,141,,,,,154.0,154,Period 1,-13.0,A,2018-04-18T09:49 (1)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21299.0,26340.0,1840259940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,164.0,164,,,,Y,164.0,164,Period 2,nan,B,2018-04-25T07:19 (8)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21.0,TREATMENT,21299.0,35347.0,1840268947.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,148.0,148,,,,,164.0,164,Period 2,-16.0,B,2018-04-25T09:49 (8)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,TREATMENT,21306.0,26340.0,1840864740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,148.0,148,,,,Y,148.0,148,Period 3,nan,C,2018-05-02T07:19 (15)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,23.0,TREATMENT,21306.0,35340.0,1840873740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,148.0,148,,,,,148.0,148,Period 3,0.0,C,2018-05-02T09:49 (15)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,24.0,END OF TREATMENT,21307.0,32640.0,1840957440.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,148.0,148,,,,,144.0,144,EOT/ET/Followup,4.0,C,2018-05-03T09:04 (16)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21280.0,49202.0,1838641202.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,93.0,93,,,,Y,93.0,93,EOT/ET/Followup,nan,NA,2018-04-06T13:40 (-12)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,26.0,TREATMENT,21292.0,26340.0,1839655140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,90.0,90,,,,Y,90.0,90,Period 1,nan,A,2018-04-18T07:19 (1)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,27.0,TREATMENT,21292.0,35340.0,1839664140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,90.0,90,,,,,90.0,90,Period 1,0.0,A,2018-04-18T09:49 (1)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,28.0,TREATMENT,21299.0,26340.0,1840259940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,Y,98.0,98,Period 2,nan,B,2018-04-25T07:19 (8)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,29.0,TREATMENT,21299.0,35347.0,1840268947.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,,98.0,98,Period 2,-1.0,B,2018-04-25T09:49 (8)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,30.0,TREATMENT,21306.0,26340.0,1840864740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,Y,97.0,97,Period 3,nan,C,2018-05-02T07:19 (15)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,31.0,TREATMENT,21306.0,35340.0,1840873740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,,97.0,97,Period 3,1.0,C,2018-05-02T09:49 (15)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,32.0,END OF TREATMENT,21307.0,32640.0,1840957440.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,95.0,95,,,,,93.0,93,EOT/ET/Followup,2.0,C,2018-05-03T09:04 (16)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21280.0,49202.0,1838641202.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,356.0,356,,,,Y,356.0,356,EOT/ET/Followup,nan,NA,2018-04-06T13:40 (-12)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,34.0,TREATMENT,21292.0,26340.0,1839655140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,391.0,391,,,,Y,391.0,391,Period 1,nan,A,2018-04-18T07:19 (1)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,35.0,TREATMENT,21292.0,35340.0,1839664140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,361.0,361,,,,,391.0,391,Period 1,-30.0,A,2018-04-18T09:49 (1)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,TREATMENT,21299.0,26340.0,1840259940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,395.0,395,,,,Y,395.0,395,Period 2,nan,B,2018-04-25T07:19 (8)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,37.0,TREATMENT,21299.0,35347.0,1840268947.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,383.0,383,,,,,395.0,395,Period 2,-12.0,B,2018-04-25T09:49 (8)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,38.0,TREATMENT,21306.0,26340.0,1840864740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,387.0,387,,,,Y,387.0,387,Period 3,nan,C,2018-05-02T07:19 (15)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,39.0,TREATMENT,21306.0,35340.0,1840873740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,388.0,388,,,,,387.0,387,Period 3,1.0,C,2018-05-02T09:49 (15)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,40.0,END OF TREATMENT,21307.0,32640.0,1840957440.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,371.0,371,,,,,356.0,356,EOT/ET/Followup,15.0,C,2018-05-03T09:04 (16)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21280.0,49202.0,1838641202.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,400.0,400,,,,Y,400.0,400,EOT/ET/Followup,nan,NA,2018-04-06T13:40 (-12)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,42.0,TREATMENT,21292.0,26340.0,1839655140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,403.0,403,,,,Y,403.0,403,Period 1,nan,A,2018-04-18T07:19 (1)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,43.0,TREATMENT,21292.0,35340.0,1839664140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,400.0,400,,,,,403.0,403,Period 1,-3.0,A,2018-04-18T09:49 (1)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,44.0,TREATMENT,21299.0,26340.0,1840259940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,402.0,402,,,,Y,402.0,402,Period 2,nan,B,2018-04-25T07:19 (8)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,45.0,TREATMENT,21299.0,35347.0,1840268947.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,447.0,447,,,,,402.0,402,Period 2,45.0,B,2018-04-25T09:49 (8)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,46.0,TREATMENT,21306.0,26340.0,1840864740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,408.0,408,,,,Y,408.0,408,Period 3,nan,C,2018-05-02T07:19 (15)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,47.0,TREATMENT,21306.0,35340.0,1840873740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,394.0,394,,,,,408.0,408,Period 3,-14.0,C,2018-05-02T09:49 (15)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,48.0,END OF TREATMENT,21307.0,32640.0,1840957440.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,398.0,398,,,,,400.0,400,EOT/ET/Followup,-2.0,C,2018-05-03T09:04 (16)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21280.0,49202.0,1838641202.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,384.0,384,,,,Y,384.0,384,EOT/ET/Followup,nan,NA,2018-04-06T13:40 (-12)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,50.0,TREATMENT,21292.0,26340.0,1839655140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,399.0,399,,,,Y,399.0,399,Period 1,nan,A,2018-04-18T07:19 (1)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,51.0,TREATMENT,21292.0,35340.0,1839664140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,386.0,386,,,,,399.0,399,Period 1,-13.0,A,2018-04-18T09:49 (1)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,52.0,TREATMENT,21299.0,26340.0,1840259940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,400.0,400,,,,Y,400.0,400,Period 2,nan,B,2018-04-25T07:19 (8)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,53.0,TREATMENT,21299.0,35347.0,1840268947.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,425.0,425,,,,,400.0,400,Period 2,25.0,B,2018-04-25T09:49 (8)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,54.0,TREATMENT,21306.0,26340.0,1840864740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,401.0,401,,,,Y,401.0,401,Period 3,nan,C,2018-05-02T07:19 (15)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,55.0,TREATMENT,21306.0,35340.0,1840873740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,392.0,392,,,,,401.0,401,Period 3,-9.0,C,2018-05-02T09:49 (15)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,56.0,END OF TREATMENT,21307.0,32640.0,1840957440.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,389.0,389,,,,,384.0,384,EOT/ET/Followup,5.0,C,2018-05-03T09:04 (16)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21280.0,49202.0,1838641202.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,791.0,791,,,,Y,791.0,791,EOT/ET/Followup,nan,NA,2018-04-06T13:40 (-12)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,58.0,TREATMENT,21292.0,26340.0,1839655140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,939.0,939,,,,Y,939.0,939,Period 1,nan,A,2018-04-18T07:19 (1)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,59.0,TREATMENT,21292.0,35340.0,1839664140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,812.0,812,,,,,939.0,939,Period 1,-127.0,A,2018-04-18T09:49 (1)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,60.0,TREATMENT,21299.0,26340.0,1840259940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,961.0,961,,,,Y,961.0,961,Period 2,nan,B,2018-04-25T07:19 (8)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,61.0,TREATMENT,21299.0,35347.0,1840268947.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,731.0,731,,,,,961.0,961,Period 2,-230.0,B,2018-04-25T09:49 (8)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,62.0,TREATMENT,21306.0,26340.0,1840864740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,896.0,896,,,,Y,896.0,896,Period 3,nan,C,2018-05-02T07:19 (15)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,63.0,TREATMENT,21306.0,35340.0,1840873740.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,967.0,967,,,,,896.0,896,Period 3,71.0,C,2018-05-02T09:49 (15)
3110-103-002,3110-103-002.103001222,103001222,001,Y,1.0,1: ABC,1.0,1: ABC,1.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,64.0,END OF TREATMENT,21307.0,32640.0,1840957440.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,865.0,865,,,,,791.0,791,EOT/ET/Followup,74.0,C,2018-05-03T09:04 (16)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21280.0,48547.0,1838640547.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,43.0,43,,,,Y,43.0,43,EOT/ET/Followup,nan,NA,2018-04-06T13:29 (-12)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,2.0,TREATMENT,21292.0,25020.0,1839653820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,45.0,45,,,,Y,45.0,45,Period 1,nan,D,2018-04-18T06:57 (1)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,3.0,TREATMENT,21292.0,34020.0,1839662820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,43.0,43,,,,,45.0,45,Period 1,-2.0,D,2018-04-18T09:27 (1)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,4.0,TREATMENT,21299.0,25021.0,1840258621.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,42.0,42,,,,Y,42.0,42,Period 2,nan,E,2018-04-25T06:57 (8)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,5.0,TREATMENT,21299.0,34036.0,1840267636.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,48.0,48,,,,,42.0,42,Period 2,6.0,E,2018-04-25T09:27 (8)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,6.0,END OF TREATMENT,21300.0,32820.0,1840352820.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,44.0,44,,,,,43.0,43,EOT/ET/Followup,1.0,E,2018-04-26T09:07 (9)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,7.0,SCREENING,21280.0,48547.0,1838640547.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Abnormal, NCS,,,SINUS BRADYCARDIA,Y,nan,Abnormal, NCS,EOT/ET/Followup,nan,NA,2018-04-06T13:29 (-12)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,8.0,TREATMENT,21292.0,25020.0,1839653820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,Y,nan,Normal,Period 1,nan,D,2018-04-18T06:57 (1)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,9.0,TREATMENT,21292.0,34020.0,1839662820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Abnormal, NCS,,,SINUS BRADYCARDIA,,nan,Normal,Period 1,nan,D,2018-04-18T09:27 (1)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,10.0,TREATMENT,21299.0,25021.0,1840258621.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Abnormal, NCS,,,SINUS BRADYCARDIA,Y,nan,Abnormal, NCS,Period 2,nan,E,2018-04-25T06:57 (8)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,11.0,TREATMENT,21299.0,34036.0,1840267636.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,,nan,Abnormal, NCS,Period 2,nan,E,2018-04-25T09:27 (8)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,12.0,END OF TREATMENT,21300.0,32820.0,1840352820.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Abnormal, NCS,,,SINUS BRADYCARDIA,,nan,Abnormal, NCS,EOT/ET/Followup,nan,E,2018-04-26T09:07 (9)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,13.0,SCREENING,21280.0,48547.0,1838640547.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,166.0,166,,,,Y,166.0,166,EOT/ET/Followup,nan,NA,2018-04-06T13:29 (-12)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,14.0,TREATMENT,21292.0,25020.0,1839653820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,173.0,173,,,,Y,173.0,173,Period 1,nan,D,2018-04-18T06:57 (1)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,15.0,TREATMENT,21292.0,34020.0,1839662820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,162.0,162,,,,,173.0,173,Period 1,-11.0,D,2018-04-18T09:27 (1)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,16.0,TREATMENT,21299.0,25021.0,1840258621.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,171.0,171,,,,Y,171.0,171,Period 2,nan,E,2018-04-25T06:57 (8)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,17.0,TREATMENT,21299.0,34036.0,1840267636.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,168.0,168,,,,,171.0,171,Period 2,-3.0,E,2018-04-25T09:27 (8)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,18.0,END OF TREATMENT,21300.0,32820.0,1840352820.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,168.0,168,,,,,166.0,166,EOT/ET/Followup,2.0,E,2018-04-26T09:07 (9)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,19.0,SCREENING,21280.0,48547.0,1838640547.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,88.0,88,,,,Y,88.0,88,EOT/ET/Followup,nan,NA,2018-04-06T13:29 (-12)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,20.0,TREATMENT,21292.0,25020.0,1839653820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,92.0,92,,,,Y,92.0,92,Period 1,nan,D,2018-04-18T06:57 (1)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21.0,TREATMENT,21292.0,34020.0,1839662820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,,92.0,92,Period 1,2.0,D,2018-04-18T09:27 (1)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,22.0,TREATMENT,21299.0,25021.0,1840258621.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,86.0,86,,,,Y,86.0,86,Period 2,nan,E,2018-04-25T06:57 (8)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,23.0,TREATMENT,21299.0,34036.0,1840267636.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,88.0,88,,,,,86.0,86,Period 2,2.0,E,2018-04-25T09:27 (8)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,24.0,END OF TREATMENT,21300.0,32820.0,1840352820.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,88.0,88,,,,,88.0,88,EOT/ET/Followup,0.0,E,2018-04-26T09:07 (9)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,25.0,SCREENING,21280.0,48547.0,1838640547.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,420.0,420,,,,Y,420.0,420,EOT/ET/Followup,nan,NA,2018-04-06T13:29 (-12)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,26.0,TREATMENT,21292.0,25020.0,1839653820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,441.0,441,,,,Y,441.0,441,Period 1,nan,D,2018-04-18T06:57 (1)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,27.0,TREATMENT,21292.0,34020.0,1839662820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,425.0,425,,,,,441.0,441,Period 1,-16.0,D,2018-04-18T09:27 (1)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,28.0,TREATMENT,21299.0,25021.0,1840258621.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,446.0,446,,,,Y,446.0,446,Period 2,nan,E,2018-04-25T06:57 (8)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,29.0,TREATMENT,21299.0,34036.0,1840267636.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,439.0,439,,,,,446.0,446,Period 2,-7.0,E,2018-04-25T09:27 (8)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,30.0,END OF TREATMENT,21300.0,32820.0,1840352820.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,420.0,420,,,,,420.0,420,EOT/ET/Followup,0.0,E,2018-04-26T09:07 (9)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,31.0,SCREENING,21280.0,48547.0,1838640547.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,356.0,356,,,,Y,356.0,356,EOT/ET/Followup,nan,NA,2018-04-06T13:29 (-12)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,32.0,TREATMENT,21292.0,25020.0,1839653820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,384.0,384,,,,Y,384.0,384,Period 1,nan,D,2018-04-18T06:57 (1)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,33.0,TREATMENT,21292.0,34020.0,1839662820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,361.0,361,,,,,384.0,384,Period 1,-23.0,D,2018-04-18T09:27 (1)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,34.0,TREATMENT,21299.0,25021.0,1840258621.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,377.0,377,,,,Y,377.0,377,Period 2,nan,E,2018-04-25T06:57 (8)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,35.0,TREATMENT,21299.0,34036.0,1840267636.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,392.0,392,,,,,377.0,377,Period 2,15.0,E,2018-04-25T09:27 (8)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,36.0,END OF TREATMENT,21300.0,32820.0,1840352820.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,361.0,361,,,,,356.0,356,EOT/ET/Followup,5.0,E,2018-04-26T09:07 (9)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,37.0,SCREENING,21280.0,48547.0,1838640547.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,376.0,376,,,,Y,376.0,376,EOT/ET/Followup,nan,NA,2018-04-06T13:29 (-12)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,38.0,TREATMENT,21292.0,25020.0,1839653820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,402.0,402,,,,Y,402.0,402,Period 1,nan,D,2018-04-18T06:57 (1)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,39.0,TREATMENT,21292.0,34020.0,1839662820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,381.0,381,,,,,402.0,402,Period 1,-21.0,D,2018-04-18T09:27 (1)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,40.0,TREATMENT,21299.0,25021.0,1840258621.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,398.0,398,,,,Y,398.0,398,Period 2,nan,E,2018-04-25T06:57 (8)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,41.0,TREATMENT,21299.0,34036.0,1840267636.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,407.0,407,,,,,398.0,398,Period 2,9.0,E,2018-04-25T09:27 (8)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,42.0,END OF TREATMENT,21300.0,32820.0,1840352820.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,380.0,380,,,,,376.0,376,EOT/ET/Followup,4.0,E,2018-04-26T09:07 (9)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,43.0,SCREENING,21280.0,48547.0,1838640547.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,1385.0,1385,,,,Y,1385.0,1385,EOT/ET/Followup,nan,NA,2018-04-06T13:29 (-12)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,44.0,TREATMENT,21292.0,25020.0,1839653820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1315.0,1315,,,,Y,1315.0,1315,Period 1,nan,D,2018-04-18T06:57 (1)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,45.0,TREATMENT,21292.0,34020.0,1839662820.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1384.0,1384,,,,,1315.0,1315,Period 1,69.0,D,2018-04-18T09:27 (1)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,46.0,TREATMENT,21299.0,25021.0,1840258621.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1398.0,1398,,,,Y,1398.0,1398,Period 2,nan,E,2018-04-25T06:57 (8)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,47.0,TREATMENT,21299.0,34036.0,1840267636.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1248.0,1248,,,,,1398.0,1398,Period 2,-150.0,E,2018-04-25T09:27 (8)
3110-103-002,3110-103-002.103001225,103001225,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,48.0,END OF TREATMENT,21300.0,32820.0,1840352820.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1347.0,1347,,,,,1385.0,1385,EOT/ET/Followup,-38.0,E,2018-04-26T09:07 (9)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21280.0,52201.0,1838644201.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,63.0,63,,,,Y,63.0,63,EOT/ET/Followup,nan,NA,2018-04-06T14:30 (-12)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,2.0,TREATMENT,21292.0,25165.0,1839653965.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,76.0,76,,,,Y,76.0,76,Period 1,nan,E,2018-04-18T06:59 (1)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,3.0,TREATMENT,21292.0,34140.0,1839662940.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,76.0,76,,,,,76.0,76,Period 1,0.0,E,2018-04-18T09:29 (1)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,4.0,TREATMENT,21299.0,25155.0,1840258755.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,71.0,71,,,,Y,71.0,71,Period 2,nan,D,2018-04-25T06:59 (8)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,5.0,TREATMENT,21299.0,34140.0,1840267740.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,74.0,74,,,,,71.0,71,Period 2,3.0,D,2018-04-25T09:29 (8)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,6.0,END OF TREATMENT,21300.0,32940.0,1840352940.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,71.0,71,,,,,63.0,63,EOT/ET/Followup,8.0,D,2018-04-26T09:09 (9)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,7.0,SCREENING,21280.0,52201.0,1838644201.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-04-06T14:30 (-12)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,8.0,TREATMENT,21292.0,25165.0,1839653965.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,E,2018-04-18T06:59 (1)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,9.0,TREATMENT,21292.0,34140.0,1839662940.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,E,2018-04-18T09:29 (1)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,10.0,TREATMENT,21299.0,25155.0,1840258755.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,D,2018-04-25T06:59 (8)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,11.0,TREATMENT,21299.0,34140.0,1840267740.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,D,2018-04-25T09:29 (8)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,12.0,END OF TREATMENT,21300.0,32940.0,1840352940.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,D,2018-04-26T09:09 (9)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,13.0,SCREENING,21280.0,52201.0,1838644201.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,180.0,180,,,,Y,180.0,180,EOT/ET/Followup,nan,NA,2018-04-06T14:30 (-12)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,14.0,TREATMENT,21292.0,25165.0,1839653965.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,165.0,165,,,,Y,165.0,165,Period 1,nan,E,2018-04-18T06:59 (1)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,15.0,TREATMENT,21292.0,34140.0,1839662940.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,170.0,170,,,,,165.0,165,Period 1,5.0,E,2018-04-18T09:29 (1)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,16.0,TREATMENT,21299.0,25155.0,1840258755.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,170.0,170,,,,Y,170.0,170,Period 2,nan,D,2018-04-25T06:59 (8)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,17.0,TREATMENT,21299.0,34140.0,1840267740.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,158.0,158,,,,,170.0,170,Period 2,-12.0,D,2018-04-25T09:29 (8)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,18.0,END OF TREATMENT,21300.0,32940.0,1840352940.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,168.0,168,,,,,180.0,180,EOT/ET/Followup,-12.0,D,2018-04-26T09:09 (9)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,19.0,SCREENING,21280.0,52201.0,1838644201.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,78.0,78,,,,Y,78.0,78,EOT/ET/Followup,nan,NA,2018-04-06T14:30 (-12)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,20.0,TREATMENT,21292.0,25165.0,1839653965.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,78.0,78,,,,Y,78.0,78,Period 1,nan,E,2018-04-18T06:59 (1)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21.0,TREATMENT,21292.0,34140.0,1839662940.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,73.0,73,,,,,78.0,78,Period 1,-5.0,E,2018-04-18T09:29 (1)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,22.0,TREATMENT,21299.0,25155.0,1840258755.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,77.0,77,,,,Y,77.0,77,Period 2,nan,D,2018-04-25T06:59 (8)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,23.0,TREATMENT,21299.0,34140.0,1840267740.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,72.0,72,,,,,77.0,77,Period 2,-5.0,D,2018-04-25T09:29 (8)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,24.0,END OF TREATMENT,21300.0,32940.0,1840352940.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,77.0,77,,,,,78.0,78,EOT/ET/Followup,-1.0,D,2018-04-26T09:09 (9)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,25.0,SCREENING,21280.0,52201.0,1838644201.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,376.0,376,,,,Y,376.0,376,EOT/ET/Followup,nan,NA,2018-04-06T14:30 (-12)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,26.0,TREATMENT,21292.0,25165.0,1839653965.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,372.0,372,,,,Y,372.0,372,Period 1,nan,E,2018-04-18T06:59 (1)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,27.0,TREATMENT,21292.0,34140.0,1839662940.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,359.0,359,,,,,372.0,372,Period 1,-13.0,E,2018-04-18T09:29 (1)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,28.0,TREATMENT,21299.0,25155.0,1840258755.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,374.0,374,,,,Y,374.0,374,Period 2,nan,D,2018-04-25T06:59 (8)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,29.0,TREATMENT,21299.0,34140.0,1840267740.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,356.0,356,,,,,374.0,374,Period 2,-18.0,D,2018-04-25T09:29 (8)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,30.0,END OF TREATMENT,21300.0,32940.0,1840352940.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,364.0,364,,,,,376.0,376,EOT/ET/Followup,-12.0,D,2018-04-26T09:09 (9)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,31.0,SCREENING,21280.0,52201.0,1838644201.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,388.0,388,,,,Y,388.0,388,EOT/ET/Followup,nan,NA,2018-04-06T14:30 (-12)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,32.0,TREATMENT,21292.0,25165.0,1839653965.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,420.0,420,,,,Y,420.0,420,Period 1,nan,E,2018-04-18T06:59 (1)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,33.0,TREATMENT,21292.0,34140.0,1839662940.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,405.0,405,,,,,420.0,420,Period 1,-15.0,E,2018-04-18T09:29 (1)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,34.0,TREATMENT,21299.0,25155.0,1840258755.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,407.0,407,,,,Y,407.0,407,Period 2,nan,D,2018-04-25T06:59 (8)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,35.0,TREATMENT,21299.0,34140.0,1840267740.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,396.0,396,,,,,407.0,407,Period 2,-11.0,D,2018-04-25T09:29 (8)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,36.0,END OF TREATMENT,21300.0,32940.0,1840352940.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,397.0,397,,,,,388.0,388,EOT/ET/Followup,9.0,D,2018-04-26T09:09 (9)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,37.0,SCREENING,21280.0,52201.0,1838644201.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,383.0,383,,,,Y,383.0,383,EOT/ET/Followup,nan,NA,2018-04-06T14:30 (-12)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,38.0,TREATMENT,21292.0,25165.0,1839653965.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,403.0,403,,,,Y,403.0,403,Period 1,nan,E,2018-04-18T06:59 (1)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,39.0,TREATMENT,21292.0,34140.0,1839662940.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,389.0,389,,,,,403.0,403,Period 1,-14.0,E,2018-04-18T09:29 (1)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,40.0,TREATMENT,21299.0,25155.0,1840258755.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,396.0,396,,,,Y,396.0,396,Period 2,nan,D,2018-04-25T06:59 (8)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,41.0,TREATMENT,21299.0,34140.0,1840267740.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,382.0,382,,,,,396.0,396,Period 2,-14.0,D,2018-04-25T09:29 (8)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,42.0,END OF TREATMENT,21300.0,32940.0,1840352940.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,385.0,385,,,,,383.0,383,EOT/ET/Followup,2.0,D,2018-04-26T09:09 (9)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,43.0,SCREENING,21280.0,52201.0,1838644201.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,939.0,939,,,,Y,939.0,939,EOT/ET/Followup,nan,NA,2018-04-06T14:30 (-12)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,44.0,TREATMENT,21292.0,25165.0,1839653965.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,783.0,783,,,,Y,783.0,783,Period 1,nan,E,2018-04-18T06:59 (1)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,45.0,TREATMENT,21292.0,34140.0,1839662940.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,783.0,783,,,,,783.0,783,Period 1,0.0,E,2018-04-18T09:29 (1)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,46.0,TREATMENT,21299.0,25155.0,1840258755.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,841.0,841,,,,Y,841.0,841,Period 2,nan,D,2018-04-25T06:59 (8)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,47.0,TREATMENT,21299.0,34140.0,1840267740.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,806.0,806,,,,,841.0,841,Period 2,-35.0,D,2018-04-25T09:29 (8)
3110-103-002,3110-103-002.103001233,103001233,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,48.0,END OF TREATMENT,21300.0,32940.0,1840352940.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,840.0,840,,,,,939.0,939,EOT/ET/Followup,-99.0,D,2018-04-26T09:09 (9)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21280.0,51601.0,1838643601.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,58.0,58,,,,Y,58.0,58,EOT/ET/Followup,nan,NA,2018-04-06T14:20 (-12)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,2.0,TREATMENT,21292.0,25420.0,1839654220.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,73.0,73,,,,Y,73.0,73,Period 1,nan,E,2018-04-18T07:03 (1)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,3.0,TREATMENT,21292.0,34380.0,1839663180.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,70.0,70,,,,,73.0,73,Period 1,-3.0,E,2018-04-18T09:33 (1)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,4.0,SCREENING,21280.0,51601.0,1838643601.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-04-06T14:20 (-12)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,5.0,TREATMENT,21292.0,25420.0,1839654220.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,E,2018-04-18T07:03 (1)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,6.0,TREATMENT,21292.0,34380.0,1839663180.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,E,2018-04-18T09:33 (1)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,7.0,SCREENING,21280.0,51601.0,1838643601.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,141.0,141,,,,Y,141.0,141,EOT/ET/Followup,nan,NA,2018-04-06T14:20 (-12)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,8.0,TREATMENT,21292.0,25420.0,1839654220.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,167.0,167,,,,Y,167.0,167,Period 1,nan,E,2018-04-18T07:03 (1)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,9.0,TREATMENT,21292.0,34380.0,1839663180.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,142.0,142,,,,,167.0,167,Period 1,-25.0,E,2018-04-18T09:33 (1)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,10.0,SCREENING,21280.0,51601.0,1838643601.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,Y,99.0,99,EOT/ET/Followup,nan,NA,2018-04-06T14:20 (-12)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,11.0,TREATMENT,21292.0,25420.0,1839654220.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,92.0,92,,,,Y,92.0,92,Period 1,nan,E,2018-04-18T07:03 (1)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,12.0,TREATMENT,21292.0,34380.0,1839663180.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,100.0,100,,,,,92.0,92,Period 1,8.0,E,2018-04-18T09:33 (1)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,13.0,SCREENING,21280.0,51601.0,1838643601.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,375.0,375,,,,Y,375.0,375,EOT/ET/Followup,nan,NA,2018-04-06T14:20 (-12)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,14.0,TREATMENT,21292.0,25420.0,1839654220.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,367.0,367,,,,Y,367.0,367,Period 1,nan,E,2018-04-18T07:03 (1)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,15.0,TREATMENT,21292.0,34380.0,1839663180.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,380.0,380,,,,,367.0,367,Period 1,13.0,E,2018-04-18T09:33 (1)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,16.0,SCREENING,21280.0,51601.0,1838643601.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,371.0,371,,,,Y,371.0,371,EOT/ET/Followup,nan,NA,2018-04-06T14:20 (-12)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,17.0,TREATMENT,21292.0,25420.0,1839654220.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,407.0,407,,,,Y,407.0,407,Period 1,nan,E,2018-04-18T07:03 (1)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,18.0,TREATMENT,21292.0,34380.0,1839663180.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,411.0,411,,,,,407.0,407,Period 1,4.0,E,2018-04-18T09:33 (1)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,19.0,SCREENING,21280.0,51601.0,1838643601.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,372.0,372,,,,Y,372.0,372,EOT/ET/Followup,nan,NA,2018-04-06T14:20 (-12)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,20.0,TREATMENT,21292.0,25420.0,1839654220.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,393.0,393,,,,Y,393.0,393,Period 1,nan,E,2018-04-18T07:03 (1)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21.0,TREATMENT,21292.0,34380.0,1839663180.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,400.0,400,,,,,393.0,393,Period 1,7.0,E,2018-04-18T09:33 (1)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,22.0,SCREENING,21280.0,51601.0,1838643601.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,1020.0,1020,,,,Y,1020.0,1020,EOT/ET/Followup,nan,NA,2018-04-06T14:20 (-12)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,23.0,TREATMENT,21292.0,25420.0,1839654220.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,813.0,813,,,,Y,813.0,813,Period 1,nan,E,2018-04-18T07:03 (1)
3110-103-002,3110-103-002.103001234,103001234,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,24.0,TREATMENT,21292.0,34380.0,1839663180.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,852.0,852,,,,,813.0,813,Period 1,39.0,E,2018-04-18T09:33 (1)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21280.0,54660.0,1838646660.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,72.0,72,,,,Y,72.0,72,EOT/ET/Followup,nan,NA,2018-04-06T15:11 (-12)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,2.0,TREATMENT,21292.0,25740.0,1839654540.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,62.0,62,,,,Y,62.0,62,Period 1,nan,E,2018-04-18T07:09 (1)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,3.0,TREATMENT,21292.0,34740.0,1839663540.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,55.0,55,,,,,62.0,62,Period 1,-7.0,E,2018-04-18T09:39 (1)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,4.0,TREATMENT,21299.0,25741.0,1840259341.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,59.0,59,,,,Y,59.0,59,Period 2,nan,D,2018-04-25T07:09 (8)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,5.0,TREATMENT,21299.0,34740.0,1840268340.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,65.0,65,,,,,59.0,59,Period 2,6.0,D,2018-04-25T09:39 (8)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,6.0,END OF TREATMENT,21300.0,33540.0,1840353540.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,63.0,63,,,,,72.0,72,EOT/ET/Followup,-9.0,D,2018-04-26T09:19 (9)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,7.0,SCREENING,21280.0,54660.0,1838646660.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-04-06T15:11 (-12)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,8.0,TREATMENT,21292.0,25740.0,1839654540.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,E,2018-04-18T07:09 (1)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,9.0,TREATMENT,21292.0,34740.0,1839663540.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,E,2018-04-18T09:39 (1)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,10.0,TREATMENT,21299.0,25741.0,1840259341.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,D,2018-04-25T07:09 (8)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,11.0,TREATMENT,21299.0,34740.0,1840268340.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,D,2018-04-25T09:39 (8)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,12.0,END OF TREATMENT,21300.0,33540.0,1840353540.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,D,2018-04-26T09:19 (9)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,13.0,SCREENING,21280.0,54660.0,1838646660.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,174.0,174,,,,Y,174.0,174,EOT/ET/Followup,nan,NA,2018-04-06T15:11 (-12)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,14.0,TREATMENT,21292.0,25740.0,1839654540.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,176.0,176,,,,Y,176.0,176,Period 1,nan,E,2018-04-18T07:09 (1)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,15.0,TREATMENT,21292.0,34740.0,1839663540.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,185.0,185,,,,,176.0,176,Period 1,9.0,E,2018-04-18T09:39 (1)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,16.0,TREATMENT,21299.0,25741.0,1840259341.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,169.0,169,,,,Y,169.0,169,Period 2,nan,D,2018-04-25T07:09 (8)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,17.0,TREATMENT,21299.0,34740.0,1840268340.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,183.0,183,,,,,169.0,169,Period 2,14.0,D,2018-04-25T09:39 (8)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,18.0,END OF TREATMENT,21300.0,33540.0,1840353540.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,174.0,174,,,,,174.0,174,EOT/ET/Followup,0.0,D,2018-04-26T09:19 (9)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,19.0,SCREENING,21280.0,54660.0,1838646660.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,Y,99.0,99,EOT/ET/Followup,nan,NA,2018-04-06T15:11 (-12)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,20.0,TREATMENT,21292.0,25740.0,1839654540.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,Y,98.0,98,Period 1,nan,E,2018-04-18T07:09 (1)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21.0,TREATMENT,21292.0,34740.0,1839663540.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,102.0,102,,,,,98.0,98,Period 1,4.0,E,2018-04-18T09:39 (1)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,22.0,TREATMENT,21299.0,25741.0,1840259341.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,90.0,90,,,,Y,90.0,90,Period 2,nan,D,2018-04-25T07:09 (8)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,23.0,TREATMENT,21299.0,34740.0,1840268340.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,102.0,102,,,,,90.0,90,Period 2,12.0,D,2018-04-25T09:39 (8)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,24.0,END OF TREATMENT,21300.0,33540.0,1840353540.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,,99.0,99,EOT/ET/Followup,-5.0,D,2018-04-26T09:19 (9)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,25.0,SCREENING,21280.0,54660.0,1838646660.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,366.0,366,,,,Y,366.0,366,EOT/ET/Followup,nan,NA,2018-04-06T15:11 (-12)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,26.0,TREATMENT,21292.0,25740.0,1839654540.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,387.0,387,,,,Y,387.0,387,Period 1,nan,E,2018-04-18T07:09 (1)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,27.0,TREATMENT,21292.0,34740.0,1839663540.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,395.0,395,,,,,387.0,387,Period 1,8.0,E,2018-04-18T09:39 (1)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,28.0,TREATMENT,21299.0,25741.0,1840259341.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,388.0,388,,,,Y,388.0,388,Period 2,nan,D,2018-04-25T07:09 (8)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,29.0,TREATMENT,21299.0,34740.0,1840268340.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,396.0,396,,,,,388.0,388,Period 2,8.0,D,2018-04-25T09:39 (8)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,30.0,END OF TREATMENT,21300.0,33540.0,1840353540.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,376.0,376,,,,,366.0,366,EOT/ET/Followup,10.0,D,2018-04-26T09:19 (9)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,31.0,SCREENING,21280.0,54660.0,1838646660.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,402.0,402,,,,Y,402.0,402,EOT/ET/Followup,nan,NA,2018-04-06T15:11 (-12)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,32.0,TREATMENT,21292.0,25740.0,1839654540.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,396.0,396,,,,Y,396.0,396,Period 1,nan,E,2018-04-18T07:09 (1)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,33.0,TREATMENT,21292.0,34740.0,1839663540.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,379.0,379,,,,,396.0,396,Period 1,-17.0,E,2018-04-18T09:39 (1)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,34.0,TREATMENT,21299.0,25741.0,1840259341.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,385.0,385,,,,Y,385.0,385,Period 2,nan,D,2018-04-25T07:09 (8)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,35.0,TREATMENT,21299.0,34740.0,1840268340.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,413.0,413,,,,,385.0,385,Period 2,28.0,D,2018-04-25T09:39 (8)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,36.0,END OF TREATMENT,21300.0,33540.0,1840353540.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,386.0,386,,,,,402.0,402,EOT/ET/Followup,-16.0,D,2018-04-26T09:19 (9)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,37.0,SCREENING,21280.0,54660.0,1838646660.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,389.0,389,,,,Y,389.0,389,EOT/ET/Followup,nan,NA,2018-04-06T15:11 (-12)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,38.0,TREATMENT,21292.0,25740.0,1839654540.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,393.0,393,,,,Y,393.0,393,Period 1,nan,E,2018-04-18T07:09 (1)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,39.0,TREATMENT,21292.0,34740.0,1839663540.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,384.0,384,,,,,393.0,393,Period 1,-9.0,E,2018-04-18T09:39 (1)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,40.0,TREATMENT,21299.0,25741.0,1840259341.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,386.0,386,,,,Y,386.0,386,Period 2,nan,D,2018-04-25T07:09 (8)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,41.0,TREATMENT,21299.0,34740.0,1840268340.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,407.0,407,,,,,386.0,386,Period 2,21.0,D,2018-04-25T09:39 (8)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,42.0,END OF TREATMENT,21300.0,33540.0,1840353540.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,383.0,383,,,,,389.0,389,EOT/ET/Followup,-6.0,D,2018-04-26T09:19 (9)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,43.0,SCREENING,21280.0,54660.0,1838646660.0,-12.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,827.0,827,,,,Y,827.0,827,EOT/ET/Followup,nan,NA,2018-04-06T15:11 (-12)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,44.0,TREATMENT,21292.0,25740.0,1839654540.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,954.0,954,,,,Y,954.0,954,Period 1,nan,E,2018-04-18T07:09 (1)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,45.0,TREATMENT,21292.0,34740.0,1839663540.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1086.0,1086,,,,,954.0,954,Period 1,132.0,E,2018-04-18T09:39 (1)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,46.0,TREATMENT,21299.0,25741.0,1840259341.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1014.0,1014,,,,Y,1014.0,1014,Period 2,nan,D,2018-04-25T07:09 (8)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,47.0,TREATMENT,21299.0,34740.0,1840268340.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,919.0,919,,,,,1014.0,1014,Period 2,-95.0,D,2018-04-25T09:39 (8)
3110-103-002,3110-103-002.103001241,103001241,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,48.0,END OF TREATMENT,21300.0,33540.0,1840353540.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,946.0,946,,,,,827.0,827,EOT/ET/Followup,119.0,D,2018-04-26T09:19 (9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21283.0,48970.0,1838900170.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,72.0,72,,,,Y,72.0,72,EOT/ET/Followup,nan,NA,2018-04-09T13:36 (-9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,2.0,TREATMENT,21292.0,25268.0,1839654068.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,62.0,62,,,,Y,62.0,62,Period 1,nan,D,2018-04-18T07:01 (1)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,3.0,TREATMENT,21292.0,34260.0,1839663060.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,78.0,78,,,,,62.0,62,Period 1,16.0,D,2018-04-18T09:31 (1)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,4.0,TREATMENT,21299.0,25261.0,1840258861.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,70.0,70,,,,Y,70.0,70,Period 2,nan,E,2018-04-25T07:01 (8)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,5.0,TREATMENT,21299.0,34260.0,1840267860.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,63.0,63,,,,,70.0,70,Period 2,-7.0,E,2018-04-25T09:31 (8)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,6.0,END OF TREATMENT,21300.0,33060.0,1840353060.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,68.0,68,,,,,72.0,72,EOT/ET/Followup,-4.0,E,2018-04-26T09:11 (9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,7.0,SCREENING,21283.0,48970.0,1838900170.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-04-09T13:36 (-9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,8.0,TREATMENT,21292.0,25268.0,1839654068.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,D,2018-04-18T07:01 (1)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,9.0,TREATMENT,21292.0,34260.0,1839663060.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,D,2018-04-18T09:31 (1)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,10.0,TREATMENT,21299.0,25261.0,1840258861.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,E,2018-04-25T07:01 (8)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,11.0,TREATMENT,21299.0,34260.0,1840267860.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,E,2018-04-25T09:31 (8)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,12.0,END OF TREATMENT,21300.0,33060.0,1840353060.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,E,2018-04-26T09:11 (9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,13.0,SCREENING,21283.0,48970.0,1838900170.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,155.0,155,,,,Y,155.0,155,EOT/ET/Followup,nan,NA,2018-04-09T13:36 (-9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,14.0,TREATMENT,21292.0,25268.0,1839654068.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,133.0,133,,,,Y,133.0,133,Period 1,nan,D,2018-04-18T07:01 (1)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,15.0,TREATMENT,21292.0,34260.0,1839663060.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,135.0,135,,,,,133.0,133,Period 1,2.0,D,2018-04-18T09:31 (1)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,16.0,TREATMENT,21299.0,25261.0,1840258861.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,137.0,137,,,,Y,137.0,137,Period 2,nan,E,2018-04-25T07:01 (8)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,17.0,TREATMENT,21299.0,34260.0,1840267860.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,132.0,132,,,,,137.0,137,Period 2,-5.0,E,2018-04-25T09:31 (8)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,18.0,END OF TREATMENT,21300.0,33060.0,1840353060.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,137.0,137,,,,,155.0,155,EOT/ET/Followup,-18.0,E,2018-04-26T09:11 (9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,19.0,SCREENING,21283.0,48970.0,1838900170.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,91.0,91,,,,Y,91.0,91,EOT/ET/Followup,nan,NA,2018-04-09T13:36 (-9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,20.0,TREATMENT,21292.0,25268.0,1839654068.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,89.0,89,,,,Y,89.0,89,Period 1,nan,D,2018-04-18T07:01 (1)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21.0,TREATMENT,21292.0,34260.0,1839663060.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,86.0,86,,,,,89.0,89,Period 1,-3.0,D,2018-04-18T09:31 (1)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,22.0,TREATMENT,21299.0,25261.0,1840258861.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,Y,96.0,96,Period 2,nan,E,2018-04-25T07:01 (8)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,23.0,TREATMENT,21299.0,34260.0,1840267860.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,89.0,89,,,,,96.0,96,Period 2,-7.0,E,2018-04-25T09:31 (8)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,24.0,END OF TREATMENT,21300.0,33060.0,1840353060.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,93.0,93,,,,,91.0,91,EOT/ET/Followup,2.0,E,2018-04-26T09:11 (9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,25.0,SCREENING,21283.0,48970.0,1838900170.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,382.0,382,,,,Y,382.0,382,EOT/ET/Followup,nan,NA,2018-04-09T13:36 (-9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,26.0,TREATMENT,21292.0,25268.0,1839654068.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,389.0,389,,,,Y,389.0,389,Period 1,nan,D,2018-04-18T07:01 (1)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,27.0,TREATMENT,21292.0,34260.0,1839663060.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,364.0,364,,,,,389.0,389,Period 1,-25.0,D,2018-04-18T09:31 (1)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,28.0,TREATMENT,21299.0,25261.0,1840258861.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,382.0,382,,,,Y,382.0,382,Period 2,nan,E,2018-04-25T07:01 (8)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,29.0,TREATMENT,21299.0,34260.0,1840267860.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,387.0,387,,,,,382.0,382,Period 2,5.0,E,2018-04-25T09:31 (8)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,30.0,END OF TREATMENT,21300.0,33060.0,1840353060.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,378.0,378,,,,,382.0,382,EOT/ET/Followup,-4.0,E,2018-04-26T09:11 (9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,31.0,SCREENING,21283.0,48970.0,1838900170.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,421.0,421,,,,Y,421.0,421,EOT/ET/Followup,nan,NA,2018-04-09T13:36 (-9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,32.0,TREATMENT,21292.0,25268.0,1839654068.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,398.0,398,,,,Y,398.0,398,Period 1,nan,D,2018-04-18T07:01 (1)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,33.0,TREATMENT,21292.0,34260.0,1839663060.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,416.0,416,,,,,398.0,398,Period 1,18.0,D,2018-04-18T09:31 (1)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,34.0,TREATMENT,21299.0,25261.0,1840258861.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,412.0,412,,,,Y,412.0,412,Period 2,nan,E,2018-04-25T07:01 (8)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,35.0,TREATMENT,21299.0,34260.0,1840267860.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,398.0,398,,,,,412.0,412,Period 2,-14.0,E,2018-04-25T09:31 (8)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,36.0,END OF TREATMENT,21300.0,33060.0,1840353060.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,404.0,404,,,,,421.0,421,EOT/ET/Followup,-17.0,E,2018-04-26T09:11 (9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,37.0,SCREENING,21283.0,48970.0,1838900170.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,407.0,407,,,,Y,407.0,407,EOT/ET/Followup,nan,NA,2018-04-09T13:36 (-9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,38.0,TREATMENT,21292.0,25268.0,1839654068.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,395.0,395,,,,Y,395.0,395,Period 1,nan,D,2018-04-18T07:01 (1)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,39.0,TREATMENT,21292.0,34260.0,1839663060.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,398.0,398,,,,,395.0,395,Period 1,3.0,D,2018-04-18T09:31 (1)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,40.0,TREATMENT,21299.0,25261.0,1840258861.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,402.0,402,,,,Y,402.0,402,Period 2,nan,E,2018-04-25T07:01 (8)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,41.0,TREATMENT,21299.0,34260.0,1840267860.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,394.0,394,,,,,402.0,402,Period 2,-8.0,E,2018-04-25T09:31 (8)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,42.0,END OF TREATMENT,21300.0,33060.0,1840353060.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,395.0,395,,,,,407.0,407,EOT/ET/Followup,-12.0,E,2018-04-26T09:11 (9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,43.0,SCREENING,21283.0,48970.0,1838900170.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,822.0,822,,,,Y,822.0,822,EOT/ET/Followup,nan,NA,2018-04-09T13:36 (-9)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,44.0,TREATMENT,21292.0,25268.0,1839654068.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,953.0,953,,,,Y,953.0,953,Period 1,nan,D,2018-04-18T07:01 (1)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,45.0,TREATMENT,21292.0,34260.0,1839663060.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,762.0,762,,,,,953.0,953,Period 1,-191.0,D,2018-04-18T09:31 (1)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,46.0,TREATMENT,21299.0,25261.0,1840258861.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,856.0,856,,,,Y,856.0,856,Period 2,nan,E,2018-04-25T07:01 (8)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,47.0,TREATMENT,21299.0,34260.0,1840267860.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,941.0,941,,,,,856.0,856,Period 2,85.0,E,2018-04-25T09:31 (8)
3110-103-002,3110-103-002.103001248,103001248,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,48.0,END OF TREATMENT,21300.0,33060.0,1840353060.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,872.0,872,,,,,822.0,822,EOT/ET/Followup,50.0,E,2018-04-26T09:11 (9)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21279.0,41678.0,1838547278.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,58.0,58,,,,Y,58.0,58,EOT/ET/Followup,nan,NA,2018-04-05T11:34 (-13)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,2.0,TREATMENT,21292.0,25500.0,1839654300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,57.0,57,,,,Y,57.0,57,Period 1,nan,D,2018-04-18T07:05 (1)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,3.0,TREATMENT,21292.0,34500.0,1839663300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,66.0,66,,,,,57.0,57,Period 1,9.0,D,2018-04-18T09:35 (1)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,4.0,TREATMENT,21299.0,25501.0,1840259101.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,60.0,60,,,,Y,60.0,60,Period 2,nan,E,2018-04-25T07:05 (8)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,5.0,TREATMENT,21299.0,34500.0,1840268100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,58.0,58,,,,,60.0,60,Period 2,-2.0,E,2018-04-25T09:35 (8)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,6.0,END OF TREATMENT,21300.0,33300.0,1840353300.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,65.0,65,,,,,58.0,58,EOT/ET/Followup,7.0,E,2018-04-26T09:15 (9)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,7.0,SCREENING,21279.0,41678.0,1838547278.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-04-05T11:34 (-13)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,8.0,TREATMENT,21292.0,25500.0,1839654300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,D,2018-04-18T07:05 (1)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,9.0,TREATMENT,21292.0,34500.0,1839663300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,D,2018-04-18T09:35 (1)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,10.0,TREATMENT,21299.0,25501.0,1840259101.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,E,2018-04-25T07:05 (8)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,11.0,TREATMENT,21299.0,34500.0,1840268100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,E,2018-04-25T09:35 (8)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,12.0,END OF TREATMENT,21300.0,33300.0,1840353300.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,E,2018-04-26T09:15 (9)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,13.0,SCREENING,21279.0,41678.0,1838547278.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,159.0,159,,,,Y,159.0,159,EOT/ET/Followup,nan,NA,2018-04-05T11:34 (-13)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,14.0,TREATMENT,21292.0,25500.0,1839654300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,170.0,170,,,,Y,170.0,170,Period 1,nan,D,2018-04-18T07:05 (1)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,15.0,TREATMENT,21292.0,34500.0,1839663300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,165.0,165,,,,,170.0,170,Period 1,-5.0,D,2018-04-18T09:35 (1)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,16.0,TREATMENT,21299.0,25501.0,1840259101.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,178.0,178,,,,Y,178.0,178,Period 2,nan,E,2018-04-25T07:05 (8)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,17.0,TREATMENT,21299.0,34500.0,1840268100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,166.0,166,,,,,178.0,178,Period 2,-12.0,E,2018-04-25T09:35 (8)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,18.0,END OF TREATMENT,21300.0,33300.0,1840353300.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,157.0,157,,,,,159.0,159,EOT/ET/Followup,-2.0,E,2018-04-26T09:15 (9)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,19.0,SCREENING,21279.0,41678.0,1838547278.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,Y,98.0,98,EOT/ET/Followup,nan,NA,2018-04-05T11:34 (-13)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,20.0,TREATMENT,21292.0,25500.0,1839654300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,Y,98.0,98,Period 1,nan,D,2018-04-18T07:05 (1)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21.0,TREATMENT,21292.0,34500.0,1839663300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,93.0,93,,,,,98.0,98,Period 1,-5.0,D,2018-04-18T09:35 (1)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,22.0,TREATMENT,21299.0,25501.0,1840259101.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,Y,98.0,98,Period 2,nan,E,2018-04-25T07:05 (8)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,23.0,TREATMENT,21299.0,34500.0,1840268100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,,98.0,98,Period 2,-4.0,E,2018-04-25T09:35 (8)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,24.0,END OF TREATMENT,21300.0,33300.0,1840353300.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,91.0,91,,,,,98.0,98,EOT/ET/Followup,-7.0,E,2018-04-26T09:15 (9)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,25.0,SCREENING,21279.0,41678.0,1838547278.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,406.0,406,,,,Y,406.0,406,EOT/ET/Followup,nan,NA,2018-04-05T11:34 (-13)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,26.0,TREATMENT,21292.0,25500.0,1839654300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,420.0,420,,,,Y,420.0,420,Period 1,nan,D,2018-04-18T07:05 (1)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,27.0,TREATMENT,21292.0,34500.0,1839663300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,406.0,406,,,,,420.0,420,Period 1,-14.0,D,2018-04-18T09:35 (1)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,28.0,TREATMENT,21299.0,25501.0,1840259101.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,424.0,424,,,,Y,424.0,424,Period 2,nan,E,2018-04-25T07:05 (8)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,29.0,TREATMENT,21299.0,34500.0,1840268100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,423.0,423,,,,,424.0,424,Period 2,-1.0,E,2018-04-25T09:35 (8)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,30.0,END OF TREATMENT,21300.0,33300.0,1840353300.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,407.0,407,,,,,406.0,406,EOT/ET/Followup,1.0,E,2018-04-26T09:15 (9)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,31.0,SCREENING,21279.0,41678.0,1838547278.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,400.0,400,,,,Y,400.0,400,EOT/ET/Followup,nan,NA,2018-04-05T11:34 (-13)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,32.0,TREATMENT,21292.0,25500.0,1839654300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,412.0,412,,,,Y,412.0,412,Period 1,nan,D,2018-04-18T07:05 (1)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,33.0,TREATMENT,21292.0,34500.0,1839663300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,426.0,426,,,,,412.0,412,Period 1,14.0,D,2018-04-18T09:35 (1)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,34.0,TREATMENT,21299.0,25501.0,1840259101.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,426.0,426,,,,Y,426.0,426,Period 2,nan,E,2018-04-25T07:05 (8)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,35.0,TREATMENT,21299.0,34500.0,1840268100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,418.0,418,,,,,426.0,426,Period 2,-8.0,E,2018-04-25T09:35 (8)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,36.0,END OF TREATMENT,21300.0,33300.0,1840353300.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,425.0,425,,,,,400.0,400,EOT/ET/Followup,25.0,E,2018-04-26T09:15 (9)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,37.0,SCREENING,21279.0,41678.0,1838547278.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,402.0,402,,,,Y,402.0,402,EOT/ET/Followup,nan,NA,2018-04-05T11:34 (-13)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,38.0,TREATMENT,21292.0,25500.0,1839654300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,414.0,414,,,,Y,414.0,414,Period 1,nan,D,2018-04-18T07:05 (1)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,39.0,TREATMENT,21292.0,34500.0,1839663300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,419.0,419,,,,,414.0,414,Period 1,5.0,D,2018-04-18T09:35 (1)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,40.0,TREATMENT,21299.0,25501.0,1840259101.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,425.0,425,,,,Y,425.0,425,Period 2,nan,E,2018-04-25T07:05 (8)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,41.0,TREATMENT,21299.0,34500.0,1840268100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,419.0,419,,,,,425.0,425,Period 2,-6.0,E,2018-04-25T09:35 (8)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,42.0,END OF TREATMENT,21300.0,33300.0,1840353300.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,419.0,419,,,,,402.0,402,EOT/ET/Followup,17.0,E,2018-04-26T09:15 (9)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,43.0,SCREENING,21279.0,41678.0,1838547278.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,1026.0,1026,,,,Y,1026.0,1026,EOT/ET/Followup,nan,NA,2018-04-05T11:34 (-13)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,44.0,TREATMENT,21292.0,25500.0,1839654300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1038.0,1038,,,,Y,1038.0,1038,Period 1,nan,D,2018-04-18T07:05 (1)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,45.0,TREATMENT,21292.0,34500.0,1839663300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,906.0,906,,,,,1038.0,1038,Period 1,-132.0,D,2018-04-18T09:35 (1)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,46.0,TREATMENT,21299.0,25501.0,1840259101.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,987.0,987,,,,Y,987.0,987,Period 2,nan,E,2018-04-25T07:05 (8)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,47.0,TREATMENT,21299.0,34500.0,1840268100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1024.0,1024,,,,,987.0,987,Period 2,37.0,E,2018-04-25T09:35 (8)
3110-103-002,3110-103-002.103001279,103001279,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,48.0,END OF TREATMENT,21300.0,33300.0,1840353300.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,913.0,913,,,,,1026.0,1026,EOT/ET/Followup,-113.0,E,2018-04-26T09:15 (9)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21279.0,41102.0,1838546702.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,75.0,75,,,,Y,75.0,75,EOT/ET/Followup,nan,NA,2018-04-05T11:25 (-13)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,2.0,TREATMENT,21292.0,24903.0,1839653703.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,64.0,64,,,,Y,64.0,64,Period 1,nan,E,2018-04-18T06:55 (1)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,3.0,TREATMENT,21292.0,33900.0,1839662700.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,63.0,63,,,,,64.0,64,Period 1,-1.0,E,2018-04-18T09:25 (1)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,4.0,TREATMENT,21299.0,24944.0,1840258544.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,65.0,65,,,,Y,65.0,65,Period 2,nan,D,2018-04-25T06:55 (8)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,5.0,TREATMENT,21299.0,33900.0,1840267500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,70.0,70,,,,,65.0,65,Period 2,5.0,D,2018-04-25T09:25 (8)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,6.0,END OF TREATMENT,21300.0,32700.0,1840352700.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,69.0,69,,,,,75.0,75,EOT/ET/Followup,-6.0,D,2018-04-26T09:05 (9)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,7.0,SCREENING,21279.0,41102.0,1838546702.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;Noise Noted;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-04-05T11:25 (-13)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,8.0,TREATMENT,21292.0,24903.0,1839653703.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,E,2018-04-18T06:55 (1)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,9.0,TREATMENT,21292.0,33900.0,1839662700.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,E,2018-04-18T09:25 (1)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,10.0,TREATMENT,21299.0,24944.0,1840258544.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,D,2018-04-25T06:55 (8)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,11.0,TREATMENT,21299.0,33900.0,1840267500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,D,2018-04-25T09:25 (8)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,12.0,END OF TREATMENT,21300.0,32700.0,1840352700.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,D,2018-04-26T09:05 (9)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,13.0,SCREENING,21279.0,41102.0,1838546702.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,174.0,174,,,,Y,174.0,174,EOT/ET/Followup,nan,NA,2018-04-05T11:25 (-13)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,14.0,TREATMENT,21292.0,24903.0,1839653703.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,171.0,171,,,,Y,171.0,171,Period 1,nan,E,2018-04-18T06:55 (1)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,15.0,TREATMENT,21292.0,33900.0,1839662700.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,182.0,182,,,,,171.0,171,Period 1,11.0,E,2018-04-18T09:25 (1)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,16.0,TREATMENT,21299.0,24944.0,1840258544.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,152.0,152,,,,Y,152.0,152,Period 2,nan,D,2018-04-25T06:55 (8)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,17.0,TREATMENT,21299.0,33900.0,1840267500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,156.0,156,,,,,152.0,152,Period 2,4.0,D,2018-04-25T09:25 (8)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,18.0,END OF TREATMENT,21300.0,32700.0,1840352700.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,166.0,166,,,,,174.0,174,EOT/ET/Followup,-8.0,D,2018-04-26T09:05 (9)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,19.0,SCREENING,21279.0,41102.0,1838546702.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,Y,98.0,98,EOT/ET/Followup,nan,NA,2018-04-05T11:25 (-13)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,20.0,TREATMENT,21292.0,24903.0,1839653703.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,Y,96.0,96,Period 1,nan,E,2018-04-18T06:55 (1)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21.0,TREATMENT,21292.0,33900.0,1839662700.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,,96.0,96,Period 1,-2.0,E,2018-04-18T09:25 (1)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,22.0,TREATMENT,21299.0,24944.0,1840258544.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,95.0,95,,,,Y,95.0,95,Period 2,nan,D,2018-04-25T06:55 (8)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,23.0,TREATMENT,21299.0,33900.0,1840267500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,,95.0,95,Period 2,2.0,D,2018-04-25T09:25 (8)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,24.0,END OF TREATMENT,21300.0,32700.0,1840352700.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,,98.0,98,EOT/ET/Followup,-2.0,D,2018-04-26T09:05 (9)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,25.0,SCREENING,21279.0,41102.0,1838546702.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,387.0,387,,,,Y,387.0,387,EOT/ET/Followup,nan,NA,2018-04-05T11:25 (-13)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,26.0,TREATMENT,21292.0,24903.0,1839653703.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,417.0,417,,,,Y,417.0,417,Period 1,nan,E,2018-04-18T06:55 (1)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,27.0,TREATMENT,21292.0,33900.0,1839662700.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,412.0,412,,,,,417.0,417,Period 1,-5.0,E,2018-04-18T09:25 (1)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,28.0,TREATMENT,21299.0,24944.0,1840258544.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,412.0,412,,,,Y,412.0,412,Period 2,nan,D,2018-04-25T06:55 (8)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,29.0,TREATMENT,21299.0,33900.0,1840267500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,391.0,391,,,,,412.0,412,Period 2,-21.0,D,2018-04-25T09:25 (8)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,30.0,END OF TREATMENT,21300.0,32700.0,1840352700.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,390.0,390,,,,,387.0,387,EOT/ET/Followup,3.0,D,2018-04-26T09:05 (9)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,31.0,SCREENING,21279.0,41102.0,1838546702.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,434.0,434,,,,Y,434.0,434,EOT/ET/Followup,nan,NA,2018-04-05T11:25 (-13)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,32.0,TREATMENT,21292.0,24903.0,1839653703.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,433.0,433,,,,Y,433.0,433,Period 1,nan,E,2018-04-18T06:55 (1)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,33.0,TREATMENT,21292.0,33900.0,1839662700.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,424.0,424,,,,,433.0,433,Period 1,-9.0,E,2018-04-18T09:25 (1)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,34.0,TREATMENT,21299.0,24944.0,1840258544.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,429.0,429,,,,Y,429.0,429,Period 2,nan,D,2018-04-25T06:55 (8)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,35.0,TREATMENT,21299.0,33900.0,1840267500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,425.0,425,,,,,429.0,429,Period 2,-4.0,D,2018-04-25T09:25 (8)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,36.0,END OF TREATMENT,21300.0,32700.0,1840352700.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,418.0,418,,,,,434.0,434,EOT/ET/Followup,-16.0,D,2018-04-26T09:05 (9)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,37.0,SCREENING,21279.0,41102.0,1838546702.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,417.0,417,,,,Y,417.0,417,EOT/ET/Followup,nan,NA,2018-04-05T11:25 (-13)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,38.0,TREATMENT,21292.0,24903.0,1839653703.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,428.0,428,,,,Y,428.0,428,Period 1,nan,E,2018-04-18T06:55 (1)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,39.0,TREATMENT,21292.0,33900.0,1839662700.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,420.0,420,,,,,428.0,428,Period 1,-8.0,E,2018-04-18T09:25 (1)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,40.0,TREATMENT,21299.0,24944.0,1840258544.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,423.0,423,,,,Y,423.0,423,Period 2,nan,D,2018-04-25T06:55 (8)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,41.0,TREATMENT,21299.0,33900.0,1840267500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,413.0,413,,,,,423.0,423,Period 2,-10.0,D,2018-04-25T09:25 (8)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,42.0,END OF TREATMENT,21300.0,32700.0,1840352700.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,408.0,408,,,,,417.0,417,EOT/ET/Followup,-9.0,D,2018-04-26T09:05 (9)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,43.0,SCREENING,21279.0,41102.0,1838546702.0,-13.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,794.0,794,,,,Y,794.0,794,EOT/ET/Followup,nan,NA,2018-04-05T11:25 (-13)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,44.0,TREATMENT,21292.0,24903.0,1839653703.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,924.0,924,,,,Y,924.0,924,Period 1,nan,E,2018-04-18T06:55 (1)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,45.0,TREATMENT,21292.0,33900.0,1839662700.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,940.0,940,,,,,924.0,924,Period 1,16.0,E,2018-04-18T09:25 (1)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,46.0,TREATMENT,21299.0,24944.0,1840258544.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,922.0,922,,,,Y,922.0,922,Period 2,nan,D,2018-04-25T06:55 (8)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,47.0,TREATMENT,21299.0,33900.0,1840267500.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,846.0,846,,,,,922.0,922,Period 2,-76.0,D,2018-04-25T09:25 (8)
3110-103-002,3110-103-002.103001284,103001284,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,48.0,END OF TREATMENT,21300.0,32700.0,1840352700.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,868.0,868,,,,,794.0,794,EOT/ET/Followup,74.0,D,2018-04-26T09:05 (9)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21285.0,35400.0,1839059400.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,46.0,46,,,,Y,46.0,46,EOT/ET/Followup,nan,NA,2018-04-11T09:50 (-7)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,2.0,TREATMENT,21292.0,25867.0,1839654667.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,45.0,45,,,,Y,45.0,45,Period 1,nan,C,2018-04-18T07:11 (1)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,3.0,TREATMENT,21292.0,34902.0,1839663702.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,43.0,43,,,,,45.0,45,Period 1,-2.0,C,2018-04-18T09:41 (1)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,4.0,TREATMENT,21299.0,25861.0,1840259461.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,50.0,50,,,,Y,50.0,50,Period 2,nan,B,2018-04-25T07:11 (8)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,5.0,TREATMENT,21299.0,34860.0,1840268460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,46.0,46,,,,,50.0,50,Period 2,-4.0,B,2018-04-25T09:41 (8)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,6.0,TREATMENT,21306.0,25860.0,1840864260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,46.0,46,,,,Y,46.0,46,Period 3,nan,A,2018-05-02T07:11 (15)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,7.0,TREATMENT,21306.0,34860.0,1840873260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,43.0,43,,,,,46.0,46,Period 3,-3.0,A,2018-05-02T09:41 (15)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,8.0,END OF TREATMENT,21307.0,32440.0,1840957240.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,43.0,43,,,,,46.0,46,EOT/ET/Followup,-3.0,A,2018-05-03T09:00 (16)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21285.0,35400.0,1839059400.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-04-11T09:50 (-7)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,10.0,TREATMENT,21292.0,25867.0,1839654667.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,Y,nan,Normal,Period 1,nan,C,2018-04-18T07:11 (1)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,11.0,TREATMENT,21292.0,34902.0,1839663702.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Abnormal, NCS,,,SINUS BRADYCARDIA,,nan,Normal,Period 1,nan,C,2018-04-18T09:41 (1)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,12.0,TREATMENT,21299.0,25861.0,1840259461.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,B,2018-04-25T07:11 (8)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,13.0,TREATMENT,21299.0,34860.0,1840268460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,,nan,Normal,Period 2,nan,B,2018-04-25T09:41 (8)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,14.0,TREATMENT,21306.0,25860.0,1840864260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,Y,nan,Normal,Period 3,nan,A,2018-05-02T07:11 (15)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,15.0,TREATMENT,21306.0,34860.0,1840873260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Abnormal, NCS,,,SINUS BRADYCARDIA,,nan,Normal,Period 3,nan,A,2018-05-02T09:41 (15)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,16.0,END OF TREATMENT,21307.0,32440.0,1840957240.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Abnormal, NCS,,,SINUS BRADYCARDIA;Noise Noted,,nan,Normal,EOT/ET/Followup,nan,A,2018-05-03T09:00 (16)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21285.0,35400.0,1839059400.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,152.0,152,,,,Y,152.0,152,EOT/ET/Followup,nan,NA,2018-04-11T09:50 (-7)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,18.0,TREATMENT,21292.0,25867.0,1839654667.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,177.0,177,,,,Y,177.0,177,Period 1,nan,C,2018-04-18T07:11 (1)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,19.0,TREATMENT,21292.0,34902.0,1839663702.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,168.0,168,,,,,177.0,177,Period 1,-9.0,C,2018-04-18T09:41 (1)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,20.0,TREATMENT,21299.0,25861.0,1840259461.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,151.0,151,,,,Y,151.0,151,Period 2,nan,B,2018-04-25T07:11 (8)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,21.0,TREATMENT,21299.0,34860.0,1840268460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,147.0,147,,,,,151.0,151,Period 2,-4.0,B,2018-04-25T09:41 (8)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,22.0,TREATMENT,21306.0,25860.0,1840864260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,156.0,156,,,,Y,156.0,156,Period 3,nan,A,2018-05-02T07:11 (15)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,23.0,TREATMENT,21306.0,34860.0,1840873260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,163.0,163,,,,,156.0,156,Period 3,7.0,A,2018-05-02T09:41 (15)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,24.0,END OF TREATMENT,21307.0,32440.0,1840957240.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,155.0,155,,,,,152.0,152,EOT/ET/Followup,3.0,A,2018-05-03T09:00 (16)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21285.0,35400.0,1839059400.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,Y,99.0,99,EOT/ET/Followup,nan,NA,2018-04-11T09:50 (-7)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,26.0,TREATMENT,21292.0,25867.0,1839654667.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,Y,96.0,96,Period 1,nan,C,2018-04-18T07:11 (1)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,27.0,TREATMENT,21292.0,34902.0,1839663702.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,90.0,90,,,,,96.0,96,Period 1,-6.0,C,2018-04-18T09:41 (1)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,28.0,TREATMENT,21299.0,25861.0,1840259461.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,Y,98.0,98,Period 2,nan,B,2018-04-25T07:11 (8)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,29.0,TREATMENT,21299.0,34860.0,1840268460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,,98.0,98,Period 2,0.0,B,2018-04-25T09:41 (8)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,30.0,TREATMENT,21306.0,25860.0,1840864260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,Y,97.0,97,Period 3,nan,A,2018-05-02T07:11 (15)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,31.0,TREATMENT,21306.0,34860.0,1840873260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,,97.0,97,Period 3,1.0,A,2018-05-02T09:41 (15)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,32.0,END OF TREATMENT,21307.0,32440.0,1840957240.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,,99.0,99,EOT/ET/Followup,-3.0,A,2018-05-03T09:00 (16)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21285.0,35400.0,1839059400.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,443.0,443,,,,Y,443.0,443,EOT/ET/Followup,nan,NA,2018-04-11T09:50 (-7)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,34.0,TREATMENT,21292.0,25867.0,1839654667.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,447.0,447,,,,Y,447.0,447,Period 1,nan,C,2018-04-18T07:11 (1)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,35.0,TREATMENT,21292.0,34902.0,1839663702.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,461.0,461,,,,,447.0,447,Period 1,14.0,C,2018-04-18T09:41 (1)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,36.0,TREATMENT,21299.0,25861.0,1840259461.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,444.0,444,,,,Y,444.0,444,Period 2,nan,B,2018-04-25T07:11 (8)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,37.0,TREATMENT,21299.0,34860.0,1840268460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,458.0,458,,,,,444.0,444,Period 2,14.0,B,2018-04-25T09:41 (8)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,38.0,TREATMENT,21306.0,25860.0,1840864260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,461.0,461,,,,Y,461.0,461,Period 3,nan,A,2018-05-02T07:11 (15)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,39.0,TREATMENT,21306.0,34860.0,1840873260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,460.0,460,,,,,461.0,461,Period 3,-1.0,A,2018-05-02T09:41 (15)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,40.0,END OF TREATMENT,21307.0,32440.0,1840957240.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,461.0,461,,,,,443.0,443,EOT/ET/Followup,18.0,A,2018-05-03T09:00 (16)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21285.0,35400.0,1839059400.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,389.0,389,,,,Y,389.0,389,EOT/ET/Followup,nan,NA,2018-04-11T09:50 (-7)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,42.0,TREATMENT,21292.0,25867.0,1839654667.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,388.0,388,,,,Y,388.0,388,Period 1,nan,C,2018-04-18T07:11 (1)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,43.0,TREATMENT,21292.0,34902.0,1839663702.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,392.0,392,,,,,388.0,388,Period 1,4.0,C,2018-04-18T09:41 (1)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,44.0,TREATMENT,21299.0,25861.0,1840259461.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,407.0,407,,,,Y,407.0,407,Period 2,nan,B,2018-04-25T07:11 (8)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,45.0,TREATMENT,21299.0,34860.0,1840268460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,402.0,402,,,,,407.0,407,Period 2,-5.0,B,2018-04-25T09:41 (8)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,46.0,TREATMENT,21306.0,25860.0,1840864260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,404.0,404,,,,Y,404.0,404,Period 3,nan,A,2018-05-02T07:11 (15)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,47.0,TREATMENT,21306.0,34860.0,1840873260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,392.0,392,,,,,404.0,404,Period 3,-12.0,A,2018-05-02T09:41 (15)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,48.0,END OF TREATMENT,21307.0,32440.0,1840957240.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,391.0,391,,,,,389.0,389,EOT/ET/Followup,2.0,A,2018-05-03T09:00 (16)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21285.0,35400.0,1839059400.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,406.0,406,,,,Y,406.0,406,EOT/ET/Followup,nan,NA,2018-04-11T09:50 (-7)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,50.0,TREATMENT,21292.0,25867.0,1839654667.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,407.0,407,,,,Y,407.0,407,Period 1,nan,C,2018-04-18T07:11 (1)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,51.0,TREATMENT,21292.0,34902.0,1839663702.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,414.0,414,,,,,407.0,407,Period 1,7.0,C,2018-04-18T09:41 (1)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,52.0,TREATMENT,21299.0,25861.0,1840259461.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,419.0,419,,,,Y,419.0,419,Period 2,nan,B,2018-04-25T07:11 (8)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,53.0,TREATMENT,21299.0,34860.0,1840268460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,419.0,419,,,,,419.0,419,Period 2,0.0,B,2018-04-25T09:41 (8)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,54.0,TREATMENT,21306.0,25860.0,1840864260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,422.0,422,,,,Y,422.0,422,Period 3,nan,A,2018-05-02T07:11 (15)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,55.0,TREATMENT,21306.0,34860.0,1840873260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,413.0,413,,,,,422.0,422,Period 3,-9.0,A,2018-05-02T09:41 (15)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,56.0,END OF TREATMENT,21307.0,32440.0,1840957240.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,413.0,413,,,,,406.0,406,EOT/ET/Followup,7.0,A,2018-05-03T09:00 (16)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21285.0,35400.0,1839059400.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,1292.0,1292,,,,Y,1292.0,1292,EOT/ET/Followup,nan,NA,2018-04-11T09:50 (-7)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,58.0,TREATMENT,21292.0,25867.0,1839654667.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1322.0,1322,,,,Y,1322.0,1322,Period 1,nan,C,2018-04-18T07:11 (1)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,59.0,TREATMENT,21292.0,34902.0,1839663702.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1377.0,1377,,,,,1322.0,1322,Period 1,55.0,C,2018-04-18T09:41 (1)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,60.0,TREATMENT,21299.0,25861.0,1840259461.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1189.0,1189,,,,Y,1189.0,1189,Period 2,nan,B,2018-04-25T07:11 (8)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,61.0,TREATMENT,21299.0,34860.0,1840268460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1298.0,1298,,,,,1189.0,1189,Period 2,109.0,B,2018-04-25T09:41 (8)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,62.0,TREATMENT,21306.0,25860.0,1840864260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1302.0,1302,,,,Y,1302.0,1302,Period 3,nan,A,2018-05-02T07:11 (15)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,63.0,TREATMENT,21306.0,34860.0,1840873260.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1375.0,1375,,,,,1302.0,1302,Period 3,73.0,A,2018-05-02T09:41 (15)
3110-103-002,3110-103-002.103001288,103001288,001,Y,1.0,6: CBA,6.0,6: CBA,6.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,64.0,END OF TREATMENT,21307.0,32440.0,1840957240.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1384.0,1384,,,,,1292.0,1292,EOT/ET/Followup,92.0,A,2018-05-03T09:00 (16)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,1.0,SCREENING,21285.0,35880.0,1839059880.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,57.0,57,,,,Y,57.0,57,EOT/ET/Followup,nan,NA,2018-04-11T09:58 (-7)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,2.0,TREATMENT,21292.0,26223.0,1839655023.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,54.0,54,,,,Y,54.0,54,Period 1,nan,B,2018-04-18T07:17 (1)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,3.0,TREATMENT,21292.0,35220.0,1839664020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,51.0,51,,,,,54.0,54,Period 1,-3.0,B,2018-04-18T09:47 (1)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,4.0,TREATMENT,21299.0,26220.0,1840259820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,54.0,54,,,,Y,54.0,54,Period 2,nan,A,2018-04-25T07:17 (8)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,5.0,TREATMENT,21299.0,35220.0,1840268820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,48.0,48,,,,,54.0,54,Period 2,-6.0,A,2018-04-25T09:47 (8)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,6.0,TREATMENT,21306.0,26220.0,1840864620.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,50.0,50,,,,Y,50.0,50,Period 3,nan,C,2018-05-02T07:17 (15)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,7.0,TREATMENT,21306.0,35220.0,1840873620.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,51.0,51,,,,,50.0,50,Period 3,1.0,C,2018-05-02T09:47 (15)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,8.0,END OF TREATMENT,21307.0,32580.0,1840957380.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,57.0,57,,,,,57.0,57,EOT/ET/Followup,0.0,C,2018-05-03T09:03 (16)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,9.0,SCREENING,21285.0,35880.0,1839059880.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-04-11T09:58 (-7)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,10.0,TREATMENT,21292.0,26223.0,1839655023.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,B,2018-04-18T07:17 (1)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,11.0,TREATMENT,21292.0,35220.0,1839664020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,B,2018-04-18T09:47 (1)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,12.0,TREATMENT,21299.0,26220.0,1840259820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,A,2018-04-25T07:17 (8)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,13.0,TREATMENT,21299.0,35220.0,1840268820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,,nan,Normal,Period 2,nan,A,2018-04-25T09:47 (8)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,14.0,TREATMENT,21306.0,26220.0,1840864620.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 3,nan,C,2018-05-02T07:17 (15)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,15.0,TREATMENT,21306.0,35220.0,1840873620.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 3,nan,C,2018-05-02T09:47 (15)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,16.0,END OF TREATMENT,21307.0,32580.0,1840957380.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,C,2018-05-03T09:03 (16)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,17.0,SCREENING,21285.0,35880.0,1839059880.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,173.0,173,,,,Y,173.0,173,EOT/ET/Followup,nan,NA,2018-04-11T09:58 (-7)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,18.0,TREATMENT,21292.0,26223.0,1839655023.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,168.0,168,,,,Y,168.0,168,Period 1,nan,B,2018-04-18T07:17 (1)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,19.0,TREATMENT,21292.0,35220.0,1839664020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,166.0,166,,,,,168.0,168,Period 1,-2.0,B,2018-04-18T09:47 (1)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,20.0,TREATMENT,21299.0,26220.0,1840259820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,158.0,158,,,,Y,158.0,158,Period 2,nan,A,2018-04-25T07:17 (8)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,21.0,TREATMENT,21299.0,35220.0,1840268820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,167.0,167,,,,,158.0,158,Period 2,9.0,A,2018-04-25T09:47 (8)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,22.0,TREATMENT,21306.0,26220.0,1840864620.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,160.0,160,,,,Y,160.0,160,Period 3,nan,C,2018-05-02T07:17 (15)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,23.0,TREATMENT,21306.0,35220.0,1840873620.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,156.0,156,,,,,160.0,160,Period 3,-4.0,C,2018-05-02T09:47 (15)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,24.0,END OF TREATMENT,21307.0,32580.0,1840957380.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,PR Interval, Aggregate (msec),PRAG,Safety ECG,161.0,161,,,,,173.0,173,EOT/ET/Followup,-12.0,C,2018-05-03T09:03 (16)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,25.0,SCREENING,21285.0,35880.0,1839059880.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,Y,99.0,99,EOT/ET/Followup,nan,NA,2018-04-11T09:58 (-7)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,26.0,TREATMENT,21292.0,26223.0,1839655023.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,84.0,84,,,,Y,84.0,84,Period 1,nan,B,2018-04-18T07:17 (1)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,27.0,TREATMENT,21292.0,35220.0,1839664020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,,84.0,84,Period 1,14.0,B,2018-04-18T09:47 (1)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,28.0,TREATMENT,21299.0,26220.0,1840259820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,Y,94.0,94,Period 2,nan,A,2018-04-25T07:17 (8)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,29.0,TREATMENT,21299.0,35220.0,1840268820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,,94.0,94,Period 2,3.0,A,2018-04-25T09:47 (8)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,30.0,TREATMENT,21306.0,26220.0,1840864620.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,Y,96.0,96,Period 3,nan,C,2018-05-02T07:17 (15)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,31.0,TREATMENT,21306.0,35220.0,1840873620.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,100.0,100,,,,,96.0,96,Period 3,4.0,C,2018-05-02T09:47 (15)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,32.0,END OF TREATMENT,21307.0,32580.0,1840957380.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,,99.0,99,EOT/ET/Followup,-1.0,C,2018-05-03T09:03 (16)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,33.0,SCREENING,21285.0,35880.0,1839059880.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,416.0,416,,,,Y,416.0,416,EOT/ET/Followup,nan,NA,2018-04-11T09:58 (-7)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,34.0,TREATMENT,21292.0,26223.0,1839655023.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,413.0,413,,,,Y,413.0,413,Period 1,nan,B,2018-04-18T07:17 (1)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,35.0,TREATMENT,21292.0,35220.0,1839664020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,411.0,411,,,,,413.0,413,Period 1,-2.0,B,2018-04-18T09:47 (1)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,36.0,TREATMENT,21299.0,26220.0,1840259820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,421.0,421,,,,Y,421.0,421,Period 2,nan,A,2018-04-25T07:17 (8)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,37.0,TREATMENT,21299.0,35220.0,1840268820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,428.0,428,,,,,421.0,421,Period 2,7.0,A,2018-04-25T09:47 (8)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,38.0,TREATMENT,21306.0,26220.0,1840864620.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,427.0,427,,,,Y,427.0,427,Period 3,nan,C,2018-05-02T07:17 (15)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,39.0,TREATMENT,21306.0,35220.0,1840873620.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,430.0,430,,,,,427.0,427,Period 3,3.0,C,2018-05-02T09:47 (15)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,40.0,END OF TREATMENT,21307.0,32580.0,1840957380.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QT Interval, Aggregate (msec),QTAG,Safety ECG,398.0,398,,,,,416.0,416,EOT/ET/Followup,-18.0,C,2018-05-03T09:03 (16)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,41.0,SCREENING,21285.0,35880.0,1839059880.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,408.0,408,,,,Y,408.0,408,EOT/ET/Followup,nan,NA,2018-04-11T09:58 (-7)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,42.0,TREATMENT,21292.0,26223.0,1839655023.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,394.0,394,,,,Y,394.0,394,Period 1,nan,B,2018-04-18T07:17 (1)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,43.0,TREATMENT,21292.0,35220.0,1839664020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,381.0,381,,,,,394.0,394,Period 1,-13.0,B,2018-04-18T09:47 (1)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,44.0,TREATMENT,21299.0,26220.0,1840259820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,400.0,400,,,,Y,400.0,400,Period 2,nan,A,2018-04-25T07:17 (8)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,45.0,TREATMENT,21299.0,35220.0,1840268820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,383.0,383,,,,,400.0,400,Period 2,-17.0,A,2018-04-25T09:47 (8)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,46.0,TREATMENT,21306.0,26220.0,1840864620.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,393.0,393,,,,Y,393.0,393,Period 3,nan,C,2018-05-02T07:17 (15)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,47.0,TREATMENT,21306.0,35220.0,1840873620.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,397.0,397,,,,,393.0,393,Period 3,4.0,C,2018-05-02T09:47 (15)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,48.0,END OF TREATMENT,21307.0,32580.0,1840957380.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,390.0,390,,,,,408.0,408,EOT/ET/Followup,-18.0,C,2018-05-03T09:03 (16)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,49.0,SCREENING,21285.0,35880.0,1839059880.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,410.0,410,,,,Y,410.0,410,EOT/ET/Followup,nan,NA,2018-04-11T09:58 (-7)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,50.0,TREATMENT,21292.0,26223.0,1839655023.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,400.0,400,,,,Y,400.0,400,Period 1,nan,B,2018-04-18T07:17 (1)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,51.0,TREATMENT,21292.0,35220.0,1839664020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,391.0,391,,,,,400.0,400,Period 1,-9.0,B,2018-04-18T09:47 (1)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,52.0,TREATMENT,21299.0,26220.0,1840259820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,407.0,407,,,,Y,407.0,407,Period 2,nan,A,2018-04-25T07:17 (8)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,53.0,TREATMENT,21299.0,35220.0,1840268820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,397.0,397,,,,,407.0,407,Period 2,-10.0,A,2018-04-25T09:47 (8)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,54.0,TREATMENT,21306.0,26220.0,1840864620.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,404.0,404,,,,Y,404.0,404,Period 3,nan,C,2018-05-02T07:17 (15)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,55.0,TREATMENT,21306.0,35220.0,1840873620.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,407.0,407,,,,,404.0,404,Period 3,3.0,C,2018-05-02T09:47 (15)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,56.0,END OF TREATMENT,21307.0,32580.0,1840957380.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,392.0,392,,,,,410.0,410,EOT/ET/Followup,-18.0,C,2018-05-03T09:03 (16)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,,nan,,nan,57.0,SCREENING,21285.0,35880.0,1839059880.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,1037.0,1037,,,,Y,1037.0,1037,EOT/ET/Followup,nan,NA,2018-04-11T09:58 (-7)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,58.0,TREATMENT,21292.0,26223.0,1839655023.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1096.0,1096,,,,Y,1096.0,1096,Period 1,nan,B,2018-04-18T07:17 (1)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,TBM Ubrogepant 2 x 50 mg (Test 2),2.0,59.0,TREATMENT,21292.0,35220.0,1839664020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1160.0,1160,,,,,1096.0,1096,Period 1,64.0,B,2018-04-18T09:47 (1)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,60.0,TREATMENT,21299.0,26220.0,1840259820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1103.0,1103,,,,Y,1103.0,1103,Period 2,nan,A,2018-04-25T07:17 (8)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,TBM Ubrogepant 1 x 100 mg (Test 1),1.0,61.0,TREATMENT,21299.0,35220.0,1840268820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1247.0,1247,,,,,1103.0,1103,Period 2,144.0,A,2018-04-25T09:47 (8)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,62.0,TREATMENT,21306.0,26220.0,1840864620.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (Predose),Predose,0.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1179.0,1179,,,,Y,1179.0,1179,Period 3,nan,C,2018-05-02T07:17 (15)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,63.0,TREATMENT,21306.0,35220.0,1840873620.0,15.0,Period 3 Day 15,25.0,Period 3 Day 15 (2 h),2 h,2.0,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1173.0,1173,,,,,1179.0,1179,Period 3,-6.0,C,2018-05-02T09:47 (15)
3110-103-002,3110-103-002.103001290,103001290,001,Y,1.0,3: BAC,3.0,3: BAC,3.0,Part A,1.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,CT Ubrogepant 2 x 50 mg (Reference 1),3.0,64.0,END OF TREATMENT,21307.0,32580.0,1840957380.0,16.0,EOT/ET,99.0,End of Treatment,,nan,3.0,Period 3,RR Interval, Aggregate (msec),RRAG,Safety ECG,1040.0,1040,,,,,1037.0,1037,EOT/ET/Followup,3.0,C,2018-05-03T09:03 (16)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21285.0,37380.0,1839061380.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,67.0,67,,,,Y,67.0,67,EOT/ET/Followup,nan,NA,2018-04-11T10:23 (-7)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,2.0,TREATMENT,21292.0,25620.0,1839654420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,65.0,65,,,,Y,65.0,65,Period 1,nan,D,2018-04-18T07:07 (1)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,3.0,TREATMENT,21292.0,34620.0,1839663420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,70.0,70,,,,,65.0,65,Period 1,5.0,D,2018-04-18T09:37 (1)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,4.0,TREATMENT,21299.0,25621.0,1840259221.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,67.0,67,,,,Y,67.0,67,Period 2,nan,E,2018-04-25T07:07 (8)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,5.0,TREATMENT,21299.0,34620.0,1840268220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,55.0,55,,,,,67.0,67,Period 2,-12.0,E,2018-04-25T09:37 (8)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,6.0,END OF TREATMENT,21300.0,33420.0,1840353420.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,61.0,61,,,,,67.0,67,EOT/ET/Followup,-6.0,E,2018-04-26T09:17 (9)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,7.0,SCREENING,21285.0,37380.0,1839061380.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-04-11T10:23 (-7)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,8.0,TREATMENT,21292.0,25620.0,1839654420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,D,2018-04-18T07:07 (1)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,9.0,TREATMENT,21292.0,34620.0,1839663420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,D,2018-04-18T09:37 (1)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,10.0,TREATMENT,21299.0,25621.0,1840259221.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,E,2018-04-25T07:07 (8)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,11.0,TREATMENT,21299.0,34620.0,1840268220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,E,2018-04-25T09:37 (8)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,12.0,END OF TREATMENT,21300.0,33420.0,1840353420.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,E,2018-04-26T09:17 (9)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,13.0,SCREENING,21285.0,37380.0,1839061380.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,162.0,162,,,,Y,162.0,162,EOT/ET/Followup,nan,NA,2018-04-11T10:23 (-7)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,14.0,TREATMENT,21292.0,25620.0,1839654420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,155.0,155,,,,Y,155.0,155,Period 1,nan,D,2018-04-18T07:07 (1)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,15.0,TREATMENT,21292.0,34620.0,1839663420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,164.0,164,,,,,155.0,155,Period 1,9.0,D,2018-04-18T09:37 (1)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,16.0,TREATMENT,21299.0,25621.0,1840259221.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,136.0,136,,,,Y,136.0,136,Period 2,nan,E,2018-04-25T07:07 (8)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,17.0,TREATMENT,21299.0,34620.0,1840268220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,157.0,157,,,,,136.0,136,Period 2,21.0,E,2018-04-25T09:37 (8)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,18.0,END OF TREATMENT,21300.0,33420.0,1840353420.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,143.0,143,,,,,162.0,162,EOT/ET/Followup,-19.0,E,2018-04-26T09:17 (9)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,19.0,SCREENING,21285.0,37380.0,1839061380.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,Y,98.0,98,EOT/ET/Followup,nan,NA,2018-04-11T10:23 (-7)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,20.0,TREATMENT,21292.0,25620.0,1839654420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,95.0,95,,,,Y,95.0,95,Period 1,nan,D,2018-04-18T07:07 (1)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21.0,TREATMENT,21292.0,34620.0,1839663420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,,95.0,95,Period 1,3.0,D,2018-04-18T09:37 (1)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,22.0,TREATMENT,21299.0,25621.0,1840259221.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,95.0,95,,,,Y,95.0,95,Period 2,nan,E,2018-04-25T07:07 (8)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,23.0,TREATMENT,21299.0,34620.0,1840268220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,,95.0,95,Period 2,3.0,E,2018-04-25T09:37 (8)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,24.0,END OF TREATMENT,21300.0,33420.0,1840353420.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,93.0,93,,,,,98.0,98,EOT/ET/Followup,-5.0,E,2018-04-26T09:17 (9)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,25.0,SCREENING,21285.0,37380.0,1839061380.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,408.0,408,,,,Y,408.0,408,EOT/ET/Followup,nan,NA,2018-04-11T10:23 (-7)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,26.0,TREATMENT,21292.0,25620.0,1839654420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,398.0,398,,,,Y,398.0,398,Period 1,nan,D,2018-04-18T07:07 (1)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,27.0,TREATMENT,21292.0,34620.0,1839663420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,383.0,383,,,,,398.0,398,Period 1,-15.0,D,2018-04-18T09:37 (1)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,28.0,TREATMENT,21299.0,25621.0,1840259221.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,388.0,388,,,,Y,388.0,388,Period 2,nan,E,2018-04-25T07:07 (8)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,29.0,TREATMENT,21299.0,34620.0,1840268220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,411.0,411,,,,,388.0,388,Period 2,23.0,E,2018-04-25T09:37 (8)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,30.0,END OF TREATMENT,21300.0,33420.0,1840353420.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,389.0,389,,,,,408.0,408,EOT/ET/Followup,-19.0,E,2018-04-26T09:17 (9)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,31.0,SCREENING,21285.0,37380.0,1839061380.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,432.0,432,,,,Y,432.0,432,EOT/ET/Followup,nan,NA,2018-04-11T10:23 (-7)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,32.0,TREATMENT,21292.0,25620.0,1839654420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,415.0,415,,,,Y,415.0,415,Period 1,nan,D,2018-04-18T07:07 (1)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,33.0,TREATMENT,21292.0,34620.0,1839663420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,415.0,415,,,,,415.0,415,Period 1,0.0,D,2018-04-18T09:37 (1)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,34.0,TREATMENT,21299.0,25621.0,1840259221.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,411.0,411,,,,Y,411.0,411,Period 2,nan,E,2018-04-25T07:07 (8)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,35.0,TREATMENT,21299.0,34620.0,1840268220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,395.0,395,,,,,411.0,411,Period 2,-16.0,E,2018-04-25T09:37 (8)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,36.0,END OF TREATMENT,21300.0,33420.0,1840353420.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,393.0,393,,,,,432.0,432,EOT/ET/Followup,-39.0,E,2018-04-26T09:17 (9)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,37.0,SCREENING,21285.0,37380.0,1839061380.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,424.0,424,,,,Y,424.0,424,EOT/ET/Followup,nan,NA,2018-04-11T10:23 (-7)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,38.0,TREATMENT,21292.0,25620.0,1839654420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,409.0,409,,,,Y,409.0,409,Period 1,nan,D,2018-04-18T07:07 (1)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,39.0,TREATMENT,21292.0,34620.0,1839663420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,404.0,404,,,,,409.0,409,Period 1,-5.0,D,2018-04-18T09:37 (1)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,40.0,TREATMENT,21299.0,25621.0,1840259221.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,403.0,403,,,,Y,403.0,403,Period 2,nan,E,2018-04-25T07:07 (8)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,41.0,TREATMENT,21299.0,34620.0,1840268220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,400.0,400,,,,,403.0,403,Period 2,-3.0,E,2018-04-25T09:37 (8)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,42.0,END OF TREATMENT,21300.0,33420.0,1840353420.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,392.0,392,,,,,424.0,424,EOT/ET/Followup,-32.0,E,2018-04-26T09:17 (9)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,43.0,SCREENING,21285.0,37380.0,1839061380.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,888.0,888,,,,Y,888.0,888,EOT/ET/Followup,nan,NA,2018-04-11T10:23 (-7)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,44.0,TREATMENT,21292.0,25620.0,1839654420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,916.0,916,,,,Y,916.0,916,Period 1,nan,D,2018-04-18T07:07 (1)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,45.0,TREATMENT,21292.0,34620.0,1839663420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,849.0,849,,,,,916.0,916,Period 1,-67.0,D,2018-04-18T09:37 (1)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,46.0,TREATMENT,21299.0,25621.0,1840259221.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,890.0,890,,,,Y,890.0,890,Period 2,nan,E,2018-04-25T07:07 (8)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,47.0,TREATMENT,21299.0,34620.0,1840268220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1081.0,1081,,,,,890.0,890,Period 2,191.0,E,2018-04-25T09:37 (8)
3110-103-002,3110-103-002.103001303,103001303,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,48.0,END OF TREATMENT,21300.0,33420.0,1840353420.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,977.0,977,,,,,888.0,888,EOT/ET/Followup,89.0,E,2018-04-26T09:17 (9)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21292.0,50760.0,1839679560.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,58.0,58,,,,Y,58.0,58,EOT/ET/Followup,nan,NA,2018-04-18T14:06 (-9)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,2.0,TREATMENT,21301.0,25500.0,1840431900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,60.0,60,,,,Y,60.0,60,Period 1,nan,E,2018-04-27T07:05 (1)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,3.0,TREATMENT,21301.0,34500.0,1840440900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,57.0,57,,,,,60.0,60,Period 1,-3.0,E,2018-04-27T09:35 (1)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,4.0,TREATMENT,21315.0,25500.0,1841641500.0,15.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,63.0,63,,,,Y,63.0,63,Period 2,nan,D,2018-05-11T07:05 (15)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,5.0,TREATMENT,21315.0,34500.0,1841650500.0,15.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,63.0,63,,,,,63.0,63,Period 2,0.0,D,2018-05-11T09:35 (15)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,6.0,END OF TREATMENT,21316.0,32700.0,1841735100.0,16.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,63.0,63,,,,,58.0,58,EOT/ET/Followup,5.0,D,2018-05-12T09:05 (16)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,7.0,SCREENING,21292.0,50760.0,1839679560.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-04-18T14:06 (-9)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,8.0,TREATMENT,21301.0,25500.0,1840431900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,E,2018-04-27T07:05 (1)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,9.0,TREATMENT,21301.0,34500.0,1840440900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,E,2018-04-27T09:35 (1)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,10.0,TREATMENT,21315.0,25500.0,1841641500.0,15.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,D,2018-05-11T07:05 (15)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,11.0,TREATMENT,21315.0,34500.0,1841650500.0,15.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,D,2018-05-11T09:35 (15)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,12.0,END OF TREATMENT,21316.0,32700.0,1841735100.0,16.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,D,2018-05-12T09:05 (16)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,13.0,SCREENING,21292.0,50760.0,1839679560.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,182.0,182,,,,Y,182.0,182,EOT/ET/Followup,nan,NA,2018-04-18T14:06 (-9)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,14.0,TREATMENT,21301.0,25500.0,1840431900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,183.0,183,,,,Y,183.0,183,Period 1,nan,E,2018-04-27T07:05 (1)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,15.0,TREATMENT,21301.0,34500.0,1840440900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,189.0,189,,,,,183.0,183,Period 1,6.0,E,2018-04-27T09:35 (1)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,16.0,TREATMENT,21315.0,25500.0,1841641500.0,15.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,157.0,157,,,,Y,157.0,157,Period 2,nan,D,2018-05-11T07:05 (15)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,17.0,TREATMENT,21315.0,34500.0,1841650500.0,15.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,172.0,172,,,,,157.0,157,Period 2,15.0,D,2018-05-11T09:35 (15)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,18.0,END OF TREATMENT,21316.0,32700.0,1841735100.0,16.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,179.0,179,,,,,182.0,182,EOT/ET/Followup,-3.0,D,2018-05-12T09:05 (16)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,19.0,SCREENING,21292.0,50760.0,1839679560.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,90.0,90,,,,Y,90.0,90,EOT/ET/Followup,nan,NA,2018-04-18T14:06 (-9)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,20.0,TREATMENT,21301.0,25500.0,1840431900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,Y,94.0,94,Period 1,nan,E,2018-04-27T07:05 (1)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21.0,TREATMENT,21301.0,34500.0,1840440900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,88.0,88,,,,,94.0,94,Period 1,-6.0,E,2018-04-27T09:35 (1)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,22.0,TREATMENT,21315.0,25500.0,1841641500.0,15.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,88.0,88,,,,Y,88.0,88,Period 2,nan,D,2018-05-11T07:05 (15)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,23.0,TREATMENT,21315.0,34500.0,1841650500.0,15.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,,88.0,88,Period 2,6.0,D,2018-05-11T09:35 (15)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,24.0,END OF TREATMENT,21316.0,32700.0,1841735100.0,16.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,88.0,88,,,,,90.0,90,EOT/ET/Followup,-2.0,D,2018-05-12T09:05 (16)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,25.0,SCREENING,21292.0,50760.0,1839679560.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,387.0,387,,,,Y,387.0,387,EOT/ET/Followup,nan,NA,2018-04-18T14:06 (-9)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,26.0,TREATMENT,21301.0,25500.0,1840431900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,393.0,393,,,,Y,393.0,393,Period 1,nan,E,2018-04-27T07:05 (1)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,27.0,TREATMENT,21301.0,34500.0,1840440900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,393.0,393,,,,,393.0,393,Period 1,0.0,E,2018-04-27T09:35 (1)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,28.0,TREATMENT,21315.0,25500.0,1841641500.0,15.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,389.0,389,,,,Y,389.0,389,Period 2,nan,D,2018-05-11T07:05 (15)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,29.0,TREATMENT,21315.0,34500.0,1841650500.0,15.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,373.0,373,,,,,389.0,389,Period 2,-16.0,D,2018-05-11T09:35 (15)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,30.0,END OF TREATMENT,21316.0,32700.0,1841735100.0,16.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,377.0,377,,,,,387.0,387,EOT/ET/Followup,-10.0,D,2018-05-12T09:05 (16)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,31.0,SCREENING,21292.0,50760.0,1839679560.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,382.0,382,,,,Y,382.0,382,EOT/ET/Followup,nan,NA,2018-04-18T14:06 (-9)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,32.0,TREATMENT,21301.0,25500.0,1840431900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,394.0,394,,,,Y,394.0,394,Period 1,nan,E,2018-04-27T07:05 (1)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,33.0,TREATMENT,21301.0,34500.0,1840440900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,383.0,383,,,,,394.0,394,Period 1,-11.0,E,2018-04-27T09:35 (1)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,34.0,TREATMENT,21315.0,25500.0,1841641500.0,15.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,400.0,400,,,,Y,400.0,400,Period 2,nan,D,2018-05-11T07:05 (15)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,35.0,TREATMENT,21315.0,34500.0,1841650500.0,15.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,383.0,383,,,,,400.0,400,Period 2,-17.0,D,2018-05-11T09:35 (15)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,36.0,END OF TREATMENT,21316.0,32700.0,1841735100.0,16.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,388.0,388,,,,,382.0,382,EOT/ET/Followup,6.0,D,2018-05-12T09:05 (16)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,37.0,SCREENING,21292.0,50760.0,1839679560.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,384.0,384,,,,Y,384.0,384,EOT/ET/Followup,nan,NA,2018-04-18T14:06 (-9)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,38.0,TREATMENT,21301.0,25500.0,1840431900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,393.0,393,,,,Y,393.0,393,Period 1,nan,E,2018-04-27T07:05 (1)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,39.0,TREATMENT,21301.0,34500.0,1840440900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,386.0,386,,,,,393.0,393,Period 1,-7.0,E,2018-04-27T09:35 (1)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,40.0,TREATMENT,21315.0,25500.0,1841641500.0,15.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,396.0,396,,,,Y,396.0,396,Period 2,nan,D,2018-05-11T07:05 (15)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,41.0,TREATMENT,21315.0,34500.0,1841650500.0,15.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,379.0,379,,,,,396.0,396,Period 2,-17.0,D,2018-05-11T09:35 (15)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,42.0,END OF TREATMENT,21316.0,32700.0,1841735100.0,16.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,384.0,384,,,,,384.0,384,EOT/ET/Followup,0.0,D,2018-05-12T09:05 (16)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,43.0,SCREENING,21292.0,50760.0,1839679560.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,1022.0,1022,,,,Y,1022.0,1022,EOT/ET/Followup,nan,NA,2018-04-18T14:06 (-9)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,44.0,TREATMENT,21301.0,25500.0,1840431900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,994.0,994,,,,Y,994.0,994,Period 1,nan,E,2018-04-27T07:05 (1)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,45.0,TREATMENT,21301.0,34500.0,1840440900.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1051.0,1051,,,,,994.0,994,Period 1,57.0,E,2018-04-27T09:35 (1)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,46.0,TREATMENT,21315.0,25500.0,1841641500.0,15.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,942.0,942,,,,Y,942.0,942,Period 2,nan,D,2018-05-11T07:05 (15)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,47.0,TREATMENT,21315.0,34500.0,1841650500.0,15.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,948.0,948,,,,,942.0,942,Period 2,6.0,D,2018-05-11T09:35 (15)
3110-103-002,3110-103-002.103001305,103001305,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,48.0,END OF TREATMENT,21316.0,32700.0,1841735100.0,16.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,941.0,941,,,,,1022.0,1022,EOT/ET/Followup,-81.0,D,2018-05-12T09:05 (16)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21292.0,51253.0,1839680053.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,63.0,63,,,,Y,63.0,63,EOT/ET/Followup,nan,NA,2018-04-18T14:14 (-9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,2.0,TREATMENT,21301.0,24900.0,1840431300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,66.0,66,,,,Y,66.0,66,Period 1,nan,D,2018-04-27T06:55 (1)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,3.0,TREATMENT,21301.0,33900.0,1840440300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,73.0,73,,,,,66.0,66,Period 1,7.0,D,2018-04-27T09:25 (1)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,4.0,TREATMENT,21308.0,24900.0,1841036100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,67.0,67,,,,Y,67.0,67,Period 2,nan,E,2018-05-04T06:55 (8)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,5.0,TREATMENT,21308.0,33900.0,1841045100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,63.0,63,,,,,67.0,67,Period 2,-4.0,E,2018-05-04T09:25 (8)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,6.0,END OF TREATMENT,21309.0,32700.0,1841130300.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,68.0,68,,,,,63.0,63,EOT/ET/Followup,5.0,E,2018-05-05T09:05 (9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,7.0,SCREENING,21292.0,51253.0,1839680053.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-04-18T14:14 (-9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,8.0,TREATMENT,21301.0,24900.0,1840431300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,D,2018-04-27T06:55 (1)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,9.0,TREATMENT,21301.0,33900.0,1840440300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,D,2018-04-27T09:25 (1)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,10.0,TREATMENT,21308.0,24900.0,1841036100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,E,2018-05-04T06:55 (8)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,11.0,TREATMENT,21308.0,33900.0,1841045100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,E,2018-05-04T09:25 (8)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,12.0,END OF TREATMENT,21309.0,32700.0,1841130300.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,E,2018-05-05T09:05 (9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,13.0,SCREENING,21292.0,51253.0,1839680053.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,174.0,174,,,,Y,174.0,174,EOT/ET/Followup,nan,NA,2018-04-18T14:14 (-9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,14.0,TREATMENT,21301.0,24900.0,1840431300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,176.0,176,,,,Y,176.0,176,Period 1,nan,D,2018-04-27T06:55 (1)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,15.0,TREATMENT,21301.0,33900.0,1840440300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,170.0,170,,,,,176.0,176,Period 1,-6.0,D,2018-04-27T09:25 (1)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,16.0,TREATMENT,21308.0,24900.0,1841036100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,162.0,162,,,,Y,162.0,162,Period 2,nan,E,2018-05-04T06:55 (8)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,17.0,TREATMENT,21308.0,33900.0,1841045100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,172.0,172,,,,,162.0,162,Period 2,10.0,E,2018-05-04T09:25 (8)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,18.0,END OF TREATMENT,21309.0,32700.0,1841130300.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,172.0,172,,,,,174.0,174,EOT/ET/Followup,-2.0,E,2018-05-05T09:05 (9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,19.0,SCREENING,21292.0,51253.0,1839680053.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,81.0,81,,,,Y,81.0,81,EOT/ET/Followup,nan,NA,2018-04-18T14:14 (-9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,20.0,TREATMENT,21301.0,24900.0,1840431300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,81.0,81,,,,Y,81.0,81,Period 1,nan,D,2018-04-27T06:55 (1)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21.0,TREATMENT,21301.0,33900.0,1840440300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,79.0,79,,,,,81.0,81,Period 1,-2.0,D,2018-04-27T09:25 (1)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,22.0,TREATMENT,21308.0,24900.0,1841036100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,81.0,81,,,,Y,81.0,81,Period 2,nan,E,2018-05-04T06:55 (8)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,23.0,TREATMENT,21308.0,33900.0,1841045100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,86.0,86,,,,,81.0,81,Period 2,5.0,E,2018-05-04T09:25 (8)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,24.0,END OF TREATMENT,21309.0,32700.0,1841130300.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,84.0,84,,,,,81.0,81,EOT/ET/Followup,3.0,E,2018-05-05T09:05 (9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,25.0,SCREENING,21292.0,51253.0,1839680053.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,409.0,409,,,,Y,409.0,409,EOT/ET/Followup,nan,NA,2018-04-18T14:14 (-9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,26.0,TREATMENT,21301.0,24900.0,1840431300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,400.0,400,,,,Y,400.0,400,Period 1,nan,D,2018-04-27T06:55 (1)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,27.0,TREATMENT,21301.0,33900.0,1840440300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,373.0,373,,,,,400.0,400,Period 1,-27.0,D,2018-04-27T09:25 (1)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,28.0,TREATMENT,21308.0,24900.0,1841036100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,406.0,406,,,,Y,406.0,406,Period 2,nan,E,2018-05-04T06:55 (8)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,29.0,TREATMENT,21308.0,33900.0,1841045100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,402.0,402,,,,,406.0,406,Period 2,-4.0,E,2018-05-04T09:25 (8)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,30.0,END OF TREATMENT,21309.0,32700.0,1841130300.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,406.0,406,,,,,409.0,409,EOT/ET/Followup,-3.0,E,2018-05-05T09:05 (9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,31.0,SCREENING,21292.0,51253.0,1839680053.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,420.0,420,,,,Y,420.0,420,EOT/ET/Followup,nan,NA,2018-04-18T14:14 (-9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,32.0,TREATMENT,21301.0,24900.0,1840431300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,421.0,421,,,,Y,421.0,421,Period 1,nan,D,2018-04-27T06:55 (1)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,33.0,TREATMENT,21301.0,33900.0,1840440300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,412.0,412,,,,,421.0,421,Period 1,-9.0,D,2018-04-27T09:25 (1)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,34.0,TREATMENT,21308.0,24900.0,1841036100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,429.0,429,,,,Y,429.0,429,Period 2,nan,E,2018-05-04T06:55 (8)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,35.0,TREATMENT,21308.0,33900.0,1841045100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,414.0,414,,,,,429.0,429,Period 2,-15.0,E,2018-05-04T09:25 (8)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,36.0,END OF TREATMENT,21309.0,32700.0,1841130300.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,435.0,435,,,,,420.0,420,EOT/ET/Followup,15.0,E,2018-05-05T09:05 (9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,37.0,SCREENING,21292.0,51253.0,1839680053.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,416.0,416,,,,Y,416.0,416,EOT/ET/Followup,nan,NA,2018-04-18T14:14 (-9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,38.0,TREATMENT,21301.0,24900.0,1840431300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,414.0,414,,,,Y,414.0,414,Period 1,nan,D,2018-04-27T06:55 (1)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,39.0,TREATMENT,21301.0,33900.0,1840440300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,398.0,398,,,,,414.0,414,Period 1,-16.0,D,2018-04-27T09:25 (1)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,40.0,TREATMENT,21308.0,24900.0,1841036100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,421.0,421,,,,Y,421.0,421,Period 2,nan,E,2018-05-04T06:55 (8)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,41.0,TREATMENT,21308.0,33900.0,1841045100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,410.0,410,,,,,421.0,421,Period 2,-11.0,E,2018-05-04T09:25 (8)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,42.0,END OF TREATMENT,21309.0,32700.0,1841130300.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,425.0,425,,,,,416.0,416,EOT/ET/Followup,9.0,E,2018-05-05T09:05 (9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,43.0,SCREENING,21292.0,51253.0,1839680053.0,-9.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,948.0,948,,,,Y,948.0,948,EOT/ET/Followup,nan,NA,2018-04-18T14:14 (-9)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,44.0,TREATMENT,21301.0,24900.0,1840431300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,899.0,899,,,,Y,899.0,899,Period 1,nan,D,2018-04-27T06:55 (1)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,45.0,TREATMENT,21301.0,33900.0,1840440300.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,819.0,819,,,,,899.0,899,Period 1,-80.0,D,2018-04-27T09:25 (1)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,46.0,TREATMENT,21308.0,24900.0,1841036100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,892.0,892,,,,Y,892.0,892,Period 2,nan,E,2018-05-04T06:55 (8)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,47.0,TREATMENT,21308.0,33900.0,1841045100.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,942.0,942,,,,,892.0,892,Period 2,50.0,E,2018-05-04T09:25 (8)
3110-103-002,3110-103-002.103001306,103001306,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,48.0,END OF TREATMENT,21309.0,32700.0,1841130300.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,870.0,870,,,,,948.0,948,EOT/ET/Followup,-78.0,E,2018-05-05T09:05 (9)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21294.0,38595.0,1839840195.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,51.0,51,,,,Y,51.0,51,EOT/ET/Followup,nan,NA,2018-04-20T10:43 (-7)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,2.0,TREATMENT,21301.0,25020.0,1840431420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,44.0,44,,,,Y,44.0,44,Period 1,nan,E,2018-04-27T06:57 (1)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,3.0,TREATMENT,21301.0,34020.0,1840440420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,48.0,48,,,,,44.0,44,Period 1,4.0,E,2018-04-27T09:27 (1)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,4.0,TREATMENT,21308.0,25020.0,1841036220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,52.0,52,,,,Y,52.0,52,Period 2,nan,D,2018-05-04T06:57 (8)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,5.0,TREATMENT,21308.0,34020.0,1841045220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,59.0,59,,,,,52.0,52,Period 2,7.0,D,2018-05-04T09:27 (8)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,6.0,END OF TREATMENT,21309.0,32820.0,1841130420.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,58.0,58,,,,,51.0,51,EOT/ET/Followup,7.0,D,2018-05-05T09:07 (9)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,7.0,SCREENING,21294.0,38595.0,1839840195.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-04-20T10:43 (-7)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,8.0,TREATMENT,21301.0,25020.0,1840431420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Abnormal, NCS,,,SINUS BRADYCARDIA,Y,nan,Abnormal, NCS,Period 1,nan,E,2018-04-27T06:57 (1)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,9.0,TREATMENT,21301.0,34020.0,1840440420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,,nan,Abnormal, NCS,Period 1,nan,E,2018-04-27T09:27 (1)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,10.0,TREATMENT,21308.0,25020.0,1841036220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,D,2018-05-04T06:57 (8)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,11.0,TREATMENT,21308.0,34020.0,1841045220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,D,2018-05-04T09:27 (8)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,12.0,END OF TREATMENT,21309.0,32820.0,1841130420.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,D,2018-05-05T09:07 (9)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,13.0,SCREENING,21294.0,38595.0,1839840195.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,140.0,140,,,,Y,140.0,140,EOT/ET/Followup,nan,NA,2018-04-20T10:43 (-7)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,14.0,TREATMENT,21301.0,25020.0,1840431420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,156.0,156,,,,Y,156.0,156,Period 1,nan,E,2018-04-27T06:57 (1)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,15.0,TREATMENT,21301.0,34020.0,1840440420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,149.0,149,,,,,156.0,156,Period 1,-7.0,E,2018-04-27T09:27 (1)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,16.0,TREATMENT,21308.0,25020.0,1841036220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,153.0,153,,,,Y,153.0,153,Period 2,nan,D,2018-05-04T06:57 (8)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,17.0,TREATMENT,21308.0,34020.0,1841045220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,141.0,141,,,,,153.0,153,Period 2,-12.0,D,2018-05-04T09:27 (8)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,18.0,END OF TREATMENT,21309.0,32820.0,1841130420.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,133.0,133,,,,,140.0,140,EOT/ET/Followup,-7.0,D,2018-05-05T09:07 (9)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,19.0,SCREENING,21294.0,38595.0,1839840195.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,93.0,93,,,,Y,93.0,93,EOT/ET/Followup,nan,NA,2018-04-20T10:43 (-7)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,20.0,TREATMENT,21301.0,25020.0,1840431420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,Y,99.0,99,Period 1,nan,E,2018-04-27T06:57 (1)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21.0,TREATMENT,21301.0,34020.0,1840440420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,102.0,102,,,,,99.0,99,Period 1,3.0,E,2018-04-27T09:27 (1)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,22.0,TREATMENT,21308.0,25020.0,1841036220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,93.0,93,,,,Y,93.0,93,Period 2,nan,D,2018-05-04T06:57 (8)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,23.0,TREATMENT,21308.0,34020.0,1841045220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,95.0,95,,,,,93.0,93,Period 2,2.0,D,2018-05-04T09:27 (8)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,24.0,END OF TREATMENT,21309.0,32820.0,1841130420.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,86.0,86,,,,,93.0,93,EOT/ET/Followup,-7.0,D,2018-05-05T09:07 (9)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,25.0,SCREENING,21294.0,38595.0,1839840195.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,459.0,459,,,,Y,459.0,459,EOT/ET/Followup,nan,NA,2018-04-20T10:43 (-7)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,26.0,TREATMENT,21301.0,25020.0,1840431420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,453.0,453,,,,Y,453.0,453,Period 1,nan,E,2018-04-27T06:57 (1)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,27.0,TREATMENT,21301.0,34020.0,1840440420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,439.0,439,,,,,453.0,453,Period 1,-14.0,E,2018-04-27T09:27 (1)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,28.0,TREATMENT,21308.0,25020.0,1841036220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,455.0,455,,,,Y,455.0,455,Period 2,nan,D,2018-05-04T06:57 (8)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,29.0,TREATMENT,21308.0,34020.0,1841045220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,412.0,412,,,,,455.0,455,Period 2,-43.0,D,2018-05-04T09:27 (8)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,30.0,END OF TREATMENT,21309.0,32820.0,1841130420.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,426.0,426,,,,,459.0,459,EOT/ET/Followup,-33.0,D,2018-05-05T09:07 (9)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,31.0,SCREENING,21294.0,38595.0,1839840195.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,424.0,424,,,,Y,424.0,424,EOT/ET/Followup,nan,NA,2018-04-20T10:43 (-7)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,32.0,TREATMENT,21301.0,25020.0,1840431420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,391.0,391,,,,Y,391.0,391,Period 1,nan,E,2018-04-27T06:57 (1)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,33.0,TREATMENT,21301.0,34020.0,1840440420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,395.0,395,,,,,391.0,391,Period 1,4.0,E,2018-04-27T09:27 (1)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,34.0,TREATMENT,21308.0,25020.0,1841036220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,426.0,426,,,,Y,426.0,426,Period 2,nan,D,2018-05-04T06:57 (8)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,35.0,TREATMENT,21308.0,34020.0,1841045220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,411.0,411,,,,,426.0,426,Period 2,-15.0,D,2018-05-04T09:27 (8)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,36.0,END OF TREATMENT,21309.0,32820.0,1841130420.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,422.0,422,,,,,424.0,424,EOT/ET/Followup,-2.0,D,2018-05-05T09:07 (9)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,37.0,SCREENING,21294.0,38595.0,1839840195.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,435.0,435,,,,Y,435.0,435,EOT/ET/Followup,nan,NA,2018-04-20T10:43 (-7)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,38.0,TREATMENT,21301.0,25020.0,1840431420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,411.0,411,,,,Y,411.0,411,Period 1,nan,E,2018-04-27T06:57 (1)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,39.0,TREATMENT,21301.0,34020.0,1840440420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,409.0,409,,,,,411.0,411,Period 1,-2.0,E,2018-04-27T09:27 (1)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,40.0,TREATMENT,21308.0,25020.0,1841036220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,436.0,436,,,,Y,436.0,436,Period 2,nan,D,2018-05-04T06:57 (8)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,41.0,TREATMENT,21308.0,34020.0,1841045220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,411.0,411,,,,,436.0,436,Period 2,-25.0,D,2018-05-04T09:27 (8)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,42.0,END OF TREATMENT,21309.0,32820.0,1841130420.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,423.0,423,,,,,435.0,435,EOT/ET/Followup,-12.0,D,2018-05-05T09:07 (9)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,43.0,SCREENING,21294.0,38595.0,1839840195.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,1171.0,1171,,,,Y,1171.0,1171,EOT/ET/Followup,nan,NA,2018-04-20T10:43 (-7)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,44.0,TREATMENT,21301.0,25020.0,1840431420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1337.0,1337,,,,Y,1337.0,1337,Period 1,nan,E,2018-04-27T06:57 (1)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,45.0,TREATMENT,21301.0,34020.0,1840440420.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1233.0,1233,,,,,1337.0,1337,Period 1,-104.0,E,2018-04-27T09:27 (1)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,46.0,TREATMENT,21308.0,25020.0,1841036220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1136.0,1136,,,,Y,1136.0,1136,Period 2,nan,D,2018-05-04T06:57 (8)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,47.0,TREATMENT,21308.0,34020.0,1841045220.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1001.0,1001,,,,,1136.0,1136,Period 2,-135.0,D,2018-05-04T09:27 (8)
3110-103-002,3110-103-002.103001325,103001325,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,48.0,END OF TREATMENT,21309.0,32820.0,1841130420.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1017.0,1017,,,,,1171.0,1171,EOT/ET/Followup,-154.0,D,2018-05-05T09:07 (9)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21294.0,40334.0,1839841934.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,63.0,63,,,,Y,63.0,63,EOT/ET/Followup,nan,NA,2018-04-20T11:12 (-7)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,2.0,TREATMENT,21301.0,25144.0,1840431544.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,68.0,68,,,,Y,68.0,68,Period 1,nan,D,2018-04-27T06:59 (1)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,3.0,TREATMENT,21301.0,34140.0,1840440540.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,65.0,65,,,,,68.0,68,Period 1,-3.0,D,2018-04-27T09:29 (1)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,4.0,TREATMENT,21308.0,25140.0,1841036340.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,61.0,61,,,,Y,61.0,61,Period 2,nan,E,2018-05-04T06:59 (8)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,5.0,TREATMENT,21308.0,34140.0,1841045340.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,62.0,62,,,,,61.0,61,Period 2,1.0,E,2018-05-04T09:29 (8)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,6.0,END OF TREATMENT,21309.0,32940.0,1841130540.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,63.0,63,,,,,63.0,63,EOT/ET/Followup,0.0,E,2018-05-05T09:09 (9)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,7.0,SCREENING,21294.0,40334.0,1839841934.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-04-20T11:12 (-7)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,8.0,TREATMENT,21301.0,25144.0,1840431544.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,D,2018-04-27T06:59 (1)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,9.0,TREATMENT,21301.0,34140.0,1840440540.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,D,2018-04-27T09:29 (1)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,10.0,TREATMENT,21308.0,25140.0,1841036340.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,E,2018-05-04T06:59 (8)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,11.0,TREATMENT,21308.0,34140.0,1841045340.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,E,2018-05-04T09:29 (8)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,12.0,END OF TREATMENT,21309.0,32940.0,1841130540.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,E,2018-05-05T09:09 (9)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,13.0,SCREENING,21294.0,40334.0,1839841934.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,197.0,197,,,,Y,197.0,197,EOT/ET/Followup,nan,NA,2018-04-20T11:12 (-7)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,14.0,TREATMENT,21301.0,25144.0,1840431544.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,197.0,197,,,,Y,197.0,197,Period 1,nan,D,2018-04-27T06:59 (1)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,15.0,TREATMENT,21301.0,34140.0,1840440540.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,192.0,192,,,,,197.0,197,Period 1,-5.0,D,2018-04-27T09:29 (1)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,16.0,TREATMENT,21308.0,25140.0,1841036340.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,193.0,193,,,,Y,193.0,193,Period 2,nan,E,2018-05-04T06:59 (8)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,17.0,TREATMENT,21308.0,34140.0,1841045340.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,185.0,185,,,,,193.0,193,Period 2,-8.0,E,2018-05-04T09:29 (8)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,18.0,END OF TREATMENT,21309.0,32940.0,1841130540.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,174.0,174,,,,,197.0,197,EOT/ET/Followup,-23.0,E,2018-05-05T09:09 (9)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,19.0,SCREENING,21294.0,40334.0,1839841934.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,82.0,82,,,,Y,82.0,82,EOT/ET/Followup,nan,NA,2018-04-20T11:12 (-7)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,20.0,TREATMENT,21301.0,25144.0,1840431544.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,75.0,75,,,,Y,75.0,75,Period 1,nan,D,2018-04-27T06:59 (1)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21.0,TREATMENT,21301.0,34140.0,1840440540.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,80.0,80,,,,,75.0,75,Period 1,5.0,D,2018-04-27T09:29 (1)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,22.0,TREATMENT,21308.0,25140.0,1841036340.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,78.0,78,,,,Y,78.0,78,Period 2,nan,E,2018-05-04T06:59 (8)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,23.0,TREATMENT,21308.0,34140.0,1841045340.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,81.0,81,,,,,78.0,78,Period 2,3.0,E,2018-05-04T09:29 (8)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,24.0,END OF TREATMENT,21309.0,32940.0,1841130540.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,74.0,74,,,,,82.0,82,EOT/ET/Followup,-8.0,E,2018-05-05T09:09 (9)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,25.0,SCREENING,21294.0,40334.0,1839841934.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,380.0,380,,,,Y,380.0,380,EOT/ET/Followup,nan,NA,2018-04-20T11:12 (-7)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,26.0,TREATMENT,21301.0,25144.0,1840431544.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,397.0,397,,,,Y,397.0,397,Period 1,nan,D,2018-04-27T06:59 (1)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,27.0,TREATMENT,21301.0,34140.0,1840440540.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,404.0,404,,,,,397.0,397,Period 1,7.0,D,2018-04-27T09:29 (1)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,28.0,TREATMENT,21308.0,25140.0,1841036340.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,415.0,415,,,,Y,415.0,415,Period 2,nan,E,2018-05-04T06:59 (8)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,29.0,TREATMENT,21308.0,34140.0,1841045340.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,413.0,413,,,,,415.0,415,Period 2,-2.0,E,2018-05-04T09:29 (8)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,30.0,END OF TREATMENT,21309.0,32940.0,1841130540.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,402.0,402,,,,,380.0,380,EOT/ET/Followup,22.0,E,2018-05-05T09:09 (9)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,31.0,SCREENING,21294.0,40334.0,1839841934.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,392.0,392,,,,Y,392.0,392,EOT/ET/Followup,nan,NA,2018-04-20T11:12 (-7)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,32.0,TREATMENT,21301.0,25144.0,1840431544.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,422.0,422,,,,Y,422.0,422,Period 1,nan,D,2018-04-27T06:59 (1)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,33.0,TREATMENT,21301.0,34140.0,1840440540.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,421.0,421,,,,,422.0,422,Period 1,-1.0,D,2018-04-27T09:29 (1)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,34.0,TREATMENT,21308.0,25140.0,1841036340.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,420.0,420,,,,Y,420.0,420,Period 2,nan,E,2018-05-04T06:59 (8)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,35.0,TREATMENT,21308.0,34140.0,1841045340.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,423.0,423,,,,,420.0,420,Period 2,3.0,E,2018-05-04T09:29 (8)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,36.0,END OF TREATMENT,21309.0,32940.0,1841130540.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,412.0,412,,,,,392.0,392,EOT/ET/Followup,20.0,E,2018-05-05T09:09 (9)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,37.0,SCREENING,21294.0,40334.0,1839841934.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,388.0,388,,,,Y,388.0,388,EOT/ET/Followup,nan,NA,2018-04-20T11:12 (-7)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,38.0,TREATMENT,21301.0,25144.0,1840431544.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,413.0,413,,,,Y,413.0,413,Period 1,nan,D,2018-04-27T06:59 (1)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,39.0,TREATMENT,21301.0,34140.0,1840440540.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,415.0,415,,,,,413.0,413,Period 1,2.0,D,2018-04-27T09:29 (1)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,40.0,TREATMENT,21308.0,25140.0,1841036340.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,418.0,418,,,,Y,418.0,418,Period 2,nan,E,2018-05-04T06:59 (8)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,41.0,TREATMENT,21308.0,34140.0,1841045340.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,419.0,419,,,,,418.0,418,Period 2,1.0,E,2018-05-04T09:29 (8)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,42.0,END OF TREATMENT,21309.0,32940.0,1841130540.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,408.0,408,,,,,388.0,388,EOT/ET/Followup,20.0,E,2018-05-05T09:09 (9)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,43.0,SCREENING,21294.0,40334.0,1839841934.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,938.0,938,,,,Y,938.0,938,EOT/ET/Followup,nan,NA,2018-04-20T11:12 (-7)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,44.0,TREATMENT,21301.0,25144.0,1840431544.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,882.0,882,,,,Y,882.0,882,Period 1,nan,D,2018-04-27T06:59 (1)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,45.0,TREATMENT,21301.0,34140.0,1840440540.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,920.0,920,,,,,882.0,882,Period 1,38.0,D,2018-04-27T09:29 (1)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,46.0,TREATMENT,21308.0,25140.0,1841036340.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,975.0,975,,,,Y,975.0,975,Period 2,nan,E,2018-05-04T06:59 (8)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,47.0,TREATMENT,21308.0,34140.0,1841045340.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,953.0,953,,,,,975.0,975,Period 2,-22.0,E,2018-05-04T09:29 (8)
3110-103-002,3110-103-002.103001327,103001327,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,48.0,END OF TREATMENT,21309.0,32940.0,1841130540.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,950.0,950,,,,,938.0,938,EOT/ET/Followup,12.0,E,2018-05-05T09:09 (9)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21294.0,38295.0,1839839895.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,65.0,65,,,,Y,65.0,65,EOT/ET/Followup,nan,NA,2018-04-20T10:38 (-7)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,2.0,TREATMENT,21301.0,25620.0,1840432020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,67.0,67,,,,Y,67.0,67,Period 1,nan,D,2018-04-27T07:07 (1)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,3.0,TREATMENT,21301.0,34620.0,1840441020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,73.0,73,,,,,67.0,67,Period 1,6.0,D,2018-04-27T09:37 (1)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,4.0,TREATMENT,21308.0,25620.0,1841036820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,60.0,60,,,,Y,60.0,60,Period 2,nan,E,2018-05-04T07:07 (8)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,5.0,TREATMENT,21308.0,34620.0,1841045820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,62.0,62,,,,,60.0,60,Period 2,2.0,E,2018-05-04T09:37 (8)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,6.0,END OF TREATMENT,21309.0,33513.0,1841131113.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,66.0,66,,,,,65.0,65,EOT/ET/Followup,1.0,E,2018-05-05T09:18 (9)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,7.0,SCREENING,21294.0,38295.0,1839839895.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-04-20T10:38 (-7)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,8.0,TREATMENT,21301.0,25620.0,1840432020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,D,2018-04-27T07:07 (1)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,9.0,TREATMENT,21301.0,34620.0,1840441020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,D,2018-04-27T09:37 (1)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,10.0,TREATMENT,21308.0,25620.0,1841036820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,E,2018-05-04T07:07 (8)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,11.0,TREATMENT,21308.0,34620.0,1841045820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,E,2018-05-04T09:37 (8)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,12.0,END OF TREATMENT,21309.0,33513.0,1841131113.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,E,2018-05-05T09:18 (9)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,13.0,SCREENING,21294.0,38295.0,1839839895.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,181.0,181,,,,Y,181.0,181,EOT/ET/Followup,nan,NA,2018-04-20T10:38 (-7)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,14.0,TREATMENT,21301.0,25620.0,1840432020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,180.0,180,,,,Y,180.0,180,Period 1,nan,D,2018-04-27T07:07 (1)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,15.0,TREATMENT,21301.0,34620.0,1840441020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,174.0,174,,,,,180.0,180,Period 1,-6.0,D,2018-04-27T09:37 (1)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,16.0,TREATMENT,21308.0,25620.0,1841036820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,178.0,178,,,,Y,178.0,178,Period 2,nan,E,2018-05-04T07:07 (8)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,17.0,TREATMENT,21308.0,34620.0,1841045820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,176.0,176,,,,,178.0,178,Period 2,-2.0,E,2018-05-04T09:37 (8)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,18.0,END OF TREATMENT,21309.0,33513.0,1841131113.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,174.0,174,,,,,181.0,181,EOT/ET/Followup,-7.0,E,2018-05-05T09:18 (9)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,19.0,SCREENING,21294.0,38295.0,1839839895.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,86.0,86,,,,Y,86.0,86,EOT/ET/Followup,nan,NA,2018-04-20T10:38 (-7)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,20.0,TREATMENT,21301.0,25620.0,1840432020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,81.0,81,,,,Y,81.0,81,Period 1,nan,D,2018-04-27T07:07 (1)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21.0,TREATMENT,21301.0,34620.0,1840441020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,83.0,83,,,,,81.0,81,Period 1,2.0,D,2018-04-27T09:37 (1)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,22.0,TREATMENT,21308.0,25620.0,1841036820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,81.0,81,,,,Y,81.0,81,Period 2,nan,E,2018-05-04T07:07 (8)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,23.0,TREATMENT,21308.0,34620.0,1841045820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,82.0,82,,,,,81.0,81,Period 2,1.0,E,2018-05-04T09:37 (8)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,24.0,END OF TREATMENT,21309.0,33513.0,1841131113.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,82.0,82,,,,,86.0,86,EOT/ET/Followup,-4.0,E,2018-05-05T09:18 (9)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,25.0,SCREENING,21294.0,38295.0,1839839895.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,410.0,410,,,,Y,410.0,410,EOT/ET/Followup,nan,NA,2018-04-20T10:38 (-7)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,26.0,TREATMENT,21301.0,25620.0,1840432020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,403.0,403,,,,Y,403.0,403,Period 1,nan,D,2018-04-27T07:07 (1)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,27.0,TREATMENT,21301.0,34620.0,1840441020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,379.0,379,,,,,403.0,403,Period 1,-24.0,D,2018-04-27T09:37 (1)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,28.0,TREATMENT,21308.0,25620.0,1841036820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,404.0,404,,,,Y,404.0,404,Period 2,nan,E,2018-05-04T07:07 (8)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,29.0,TREATMENT,21308.0,34620.0,1841045820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,415.0,415,,,,,404.0,404,Period 2,11.0,E,2018-05-04T09:37 (8)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,30.0,END OF TREATMENT,21309.0,33513.0,1841131113.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,389.0,389,,,,,410.0,410,EOT/ET/Followup,-21.0,E,2018-05-05T09:18 (9)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,31.0,SCREENING,21294.0,38295.0,1839839895.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,426.0,426,,,,Y,426.0,426,EOT/ET/Followup,nan,NA,2018-04-20T10:38 (-7)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,32.0,TREATMENT,21301.0,25620.0,1840432020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,428.0,428,,,,Y,428.0,428,Period 1,nan,D,2018-04-27T07:07 (1)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,33.0,TREATMENT,21301.0,34620.0,1840441020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,418.0,418,,,,,428.0,428,Period 1,-10.0,D,2018-04-27T09:37 (1)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,34.0,TREATMENT,21308.0,25620.0,1841036820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,407.0,407,,,,Y,407.0,407,Period 2,nan,E,2018-05-04T07:07 (8)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,35.0,TREATMENT,21308.0,34620.0,1841045820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,423.0,423,,,,,407.0,407,Period 2,16.0,E,2018-05-04T09:37 (8)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,36.0,END OF TREATMENT,21309.0,33513.0,1841131113.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,409.0,409,,,,,426.0,426,EOT/ET/Followup,-17.0,E,2018-05-05T09:18 (9)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,37.0,SCREENING,21294.0,38295.0,1839839895.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,421.0,421,,,,Y,421.0,421,EOT/ET/Followup,nan,NA,2018-04-20T10:38 (-7)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,38.0,TREATMENT,21301.0,25620.0,1840432020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,420.0,420,,,,Y,420.0,420,Period 1,nan,D,2018-04-27T07:07 (1)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,39.0,TREATMENT,21301.0,34620.0,1840441020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,404.0,404,,,,,420.0,420,Period 1,-16.0,D,2018-04-27T09:37 (1)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,40.0,TREATMENT,21308.0,25620.0,1841036820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,406.0,406,,,,Y,406.0,406,Period 2,nan,E,2018-05-04T07:07 (8)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,41.0,TREATMENT,21308.0,34620.0,1841045820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,420.0,420,,,,,406.0,406,Period 2,14.0,E,2018-05-04T09:37 (8)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,42.0,END OF TREATMENT,21309.0,33513.0,1841131113.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,402.0,402,,,,,421.0,421,EOT/ET/Followup,-19.0,E,2018-05-05T09:18 (9)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,43.0,SCREENING,21294.0,38295.0,1839839895.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,922.0,922,,,,Y,922.0,922,EOT/ET/Followup,nan,NA,2018-04-20T10:38 (-7)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,44.0,TREATMENT,21301.0,25620.0,1840432020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,883.0,883,,,,Y,883.0,883,Period 1,nan,D,2018-04-27T07:07 (1)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,45.0,TREATMENT,21301.0,34620.0,1840441020.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,821.0,821,,,,,883.0,883,Period 1,-62.0,D,2018-04-27T09:37 (1)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,46.0,TREATMENT,21308.0,25620.0,1841036820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,984.0,984,,,,Y,984.0,984,Period 2,nan,E,2018-05-04T07:07 (8)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,47.0,TREATMENT,21308.0,34620.0,1841045820.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,960.0,960,,,,,984.0,984,Period 2,-24.0,E,2018-05-04T09:37 (8)
3110-103-002,3110-103-002.103001328,103001328,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,48.0,END OF TREATMENT,21309.0,33513.0,1841131113.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,902.0,902,,,,,922.0,922,EOT/ET/Followup,-20.0,E,2018-05-05T09:18 (9)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21294.0,39670.0,1839841270.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,57.0,57,,,,Y,57.0,57,EOT/ET/Followup,nan,NA,2018-04-20T11:01 (-7)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,2.0,TREATMENT,21301.0,25740.0,1840432140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,66.0,66,,,,Y,66.0,66,Period 1,nan,E,2018-04-27T07:09 (1)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,3.0,TREATMENT,21301.0,34740.0,1840441140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,50.0,50,,,,,66.0,66,Period 1,-16.0,E,2018-04-27T09:39 (1)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,4.0,TREATMENT,21308.0,25740.0,1841036940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,62.0,62,,,,Y,62.0,62,Period 2,nan,D,2018-05-04T07:09 (8)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,5.0,TREATMENT,21308.0,34740.0,1841045940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,69.0,69,,,,,62.0,62,Period 2,7.0,D,2018-05-04T09:39 (8)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,6.0,END OF TREATMENT,21309.0,33540.0,1841131140.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,64.0,64,,,,,57.0,57,EOT/ET/Followup,7.0,D,2018-05-05T09:19 (9)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,7.0,SCREENING,21294.0,39670.0,1839841270.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-04-20T11:01 (-7)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,8.0,TREATMENT,21301.0,25740.0,1840432140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,E,2018-04-27T07:09 (1)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,9.0,TREATMENT,21301.0,34740.0,1840441140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,E,2018-04-27T09:39 (1)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,10.0,TREATMENT,21308.0,25740.0,1841036940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,D,2018-05-04T07:09 (8)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,11.0,TREATMENT,21308.0,34740.0,1841045940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,D,2018-05-04T09:39 (8)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,12.0,END OF TREATMENT,21309.0,33540.0,1841131140.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,D,2018-05-05T09:19 (9)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,13.0,SCREENING,21294.0,39670.0,1839841270.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,146.0,146,,,,Y,146.0,146,EOT/ET/Followup,nan,NA,2018-04-20T11:01 (-7)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,14.0,TREATMENT,21301.0,25740.0,1840432140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,152.0,152,,,,Y,152.0,152,Period 1,nan,E,2018-04-27T07:09 (1)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,15.0,TREATMENT,21301.0,34740.0,1840441140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,160.0,160,,,,,152.0,152,Period 1,8.0,E,2018-04-27T09:39 (1)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,16.0,TREATMENT,21308.0,25740.0,1841036940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,147.0,147,,,,Y,147.0,147,Period 2,nan,D,2018-05-04T07:09 (8)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,17.0,TREATMENT,21308.0,34740.0,1841045940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,147.0,147,,,,,147.0,147,Period 2,0.0,D,2018-05-04T09:39 (8)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,18.0,END OF TREATMENT,21309.0,33540.0,1841131140.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,146.0,146,,,,,146.0,146,EOT/ET/Followup,0.0,D,2018-05-05T09:19 (9)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,19.0,SCREENING,21294.0,39670.0,1839841270.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,93.0,93,,,,Y,93.0,93,EOT/ET/Followup,nan,NA,2018-04-20T11:01 (-7)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,20.0,TREATMENT,21301.0,25740.0,1840432140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,86.0,86,,,,Y,86.0,86,Period 1,nan,E,2018-04-27T07:09 (1)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21.0,TREATMENT,21301.0,34740.0,1840441140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,90.0,90,,,,,86.0,86,Period 1,4.0,E,2018-04-27T09:39 (1)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,22.0,TREATMENT,21308.0,25740.0,1841036940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,90.0,90,,,,Y,90.0,90,Period 2,nan,D,2018-05-04T07:09 (8)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,23.0,TREATMENT,21308.0,34740.0,1841045940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,88.0,88,,,,,90.0,90,Period 2,-2.0,D,2018-05-04T09:39 (8)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,24.0,END OF TREATMENT,21309.0,33540.0,1841131140.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,90.0,90,,,,,93.0,93,EOT/ET/Followup,-3.0,D,2018-05-05T09:19 (9)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,25.0,SCREENING,21294.0,39670.0,1839841270.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,392.0,392,,,,Y,392.0,392,EOT/ET/Followup,nan,NA,2018-04-20T11:01 (-7)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,26.0,TREATMENT,21301.0,25740.0,1840432140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,378.0,378,,,,Y,378.0,378,Period 1,nan,E,2018-04-27T07:09 (1)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,27.0,TREATMENT,21301.0,34740.0,1840441140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,416.0,416,,,,,378.0,378,Period 1,38.0,E,2018-04-27T09:39 (1)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,28.0,TREATMENT,21308.0,25740.0,1841036940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,376.0,376,,,,Y,376.0,376,Period 2,nan,D,2018-05-04T07:09 (8)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,29.0,TREATMENT,21308.0,34740.0,1841045940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,362.0,362,,,,,376.0,376,Period 2,-14.0,D,2018-05-04T09:39 (8)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,30.0,END OF TREATMENT,21309.0,33540.0,1841131140.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,378.0,378,,,,,392.0,392,EOT/ET/Followup,-14.0,D,2018-05-05T09:19 (9)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,31.0,SCREENING,21294.0,39670.0,1839841270.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,382.0,382,,,,Y,382.0,382,EOT/ET/Followup,nan,NA,2018-04-20T11:01 (-7)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,32.0,TREATMENT,21301.0,25740.0,1840432140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,396.0,396,,,,Y,396.0,396,Period 1,nan,E,2018-04-27T07:09 (1)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,33.0,TREATMENT,21301.0,34740.0,1840441140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,382.0,382,,,,,396.0,396,Period 1,-14.0,E,2018-04-27T09:39 (1)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,34.0,TREATMENT,21308.0,25740.0,1841036940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,383.0,383,,,,Y,383.0,383,Period 2,nan,D,2018-05-04T07:09 (8)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,35.0,TREATMENT,21308.0,34740.0,1841045940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,390.0,390,,,,,383.0,383,Period 2,7.0,D,2018-05-04T09:39 (8)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,36.0,END OF TREATMENT,21309.0,33540.0,1841131140.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,392.0,392,,,,,382.0,382,EOT/ET/Followup,10.0,D,2018-05-05T09:19 (9)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,37.0,SCREENING,21294.0,39670.0,1839841270.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,385.0,385,,,,Y,385.0,385,EOT/ET/Followup,nan,NA,2018-04-20T11:01 (-7)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,38.0,TREATMENT,21301.0,25740.0,1840432140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,390.0,390,,,,Y,390.0,390,Period 1,nan,E,2018-04-27T07:09 (1)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,39.0,TREATMENT,21301.0,34740.0,1840441140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,393.0,393,,,,,390.0,390,Period 1,3.0,E,2018-04-27T09:39 (1)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,40.0,TREATMENT,21308.0,25740.0,1841036940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,380.0,380,,,,Y,380.0,380,Period 2,nan,D,2018-05-04T07:09 (8)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,41.0,TREATMENT,21308.0,34740.0,1841045940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,380.0,380,,,,,380.0,380,Period 2,0.0,D,2018-05-04T09:39 (8)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,42.0,END OF TREATMENT,21309.0,33540.0,1841131140.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,387.0,387,,,,,385.0,385,EOT/ET/Followup,2.0,D,2018-05-05T09:19 (9)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,43.0,SCREENING,21294.0,39670.0,1839841270.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,1049.0,1049,,,,Y,1049.0,1049,EOT/ET/Followup,nan,NA,2018-04-20T11:01 (-7)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,44.0,TREATMENT,21301.0,25740.0,1840432140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,907.0,907,,,,Y,907.0,907,Period 1,nan,E,2018-04-27T07:09 (1)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,45.0,TREATMENT,21301.0,34740.0,1840441140.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1180.0,1180,,,,,907.0,907,Period 1,273.0,E,2018-04-27T09:39 (1)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,46.0,TREATMENT,21308.0,25740.0,1841036940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,963.0,963,,,,Y,963.0,963,Period 2,nan,D,2018-05-04T07:09 (8)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,47.0,TREATMENT,21308.0,34740.0,1841045940.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,858.0,858,,,,,963.0,963,Period 2,-105.0,D,2018-05-04T09:39 (8)
3110-103-002,3110-103-002.103001329,103001329,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,48.0,END OF TREATMENT,21309.0,33540.0,1841131140.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,929.0,929,,,,,1049.0,1049,EOT/ET/Followup,-120.0,D,2018-05-05T09:19 (9)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21294.0,47558.0,1839849158.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,56.0,56,,,,Y,56.0,56,EOT/ET/Followup,nan,NA,2018-04-20T13:12 (-7)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,2.0,TREATMENT,21301.0,25860.0,1840432260.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,55.0,55,,,,Y,55.0,55,Period 1,nan,E,2018-04-27T07:11 (1)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,3.0,TREATMENT,21301.0,34860.0,1840441260.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,52.0,52,,,,,55.0,55,Period 1,-3.0,E,2018-04-27T09:41 (1)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,4.0,TREATMENT,21308.0,25860.0,1841037060.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,59.0,59,,,,Y,59.0,59,Period 2,nan,D,2018-05-04T07:11 (8)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,5.0,TREATMENT,21308.0,34860.0,1841046060.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,62.0,62,,,,,59.0,59,Period 2,3.0,D,2018-05-04T09:41 (8)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,6.0,END OF TREATMENT,21309.0,33660.0,1841131260.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,58.0,58,,,,,56.0,56,EOT/ET/Followup,2.0,D,2018-05-05T09:21 (9)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,7.0,SCREENING,21294.0,47558.0,1839849158.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-04-20T13:12 (-7)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,8.0,TREATMENT,21301.0,25860.0,1840432260.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,E,2018-04-27T07:11 (1)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,9.0,TREATMENT,21301.0,34860.0,1840441260.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,E,2018-04-27T09:41 (1)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,10.0,TREATMENT,21308.0,25860.0,1841037060.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,D,2018-05-04T07:11 (8)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,11.0,TREATMENT,21308.0,34860.0,1841046060.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,D,2018-05-04T09:41 (8)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,12.0,END OF TREATMENT,21309.0,33660.0,1841131260.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,D,2018-05-05T09:21 (9)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,13.0,SCREENING,21294.0,47558.0,1839849158.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,152.0,152,,,,Y,152.0,152,EOT/ET/Followup,nan,NA,2018-04-20T13:12 (-7)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,14.0,TREATMENT,21301.0,25860.0,1840432260.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,151.0,151,,,,Y,151.0,151,Period 1,nan,E,2018-04-27T07:11 (1)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,15.0,TREATMENT,21301.0,34860.0,1840441260.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,154.0,154,,,,,151.0,151,Period 1,3.0,E,2018-04-27T09:41 (1)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,16.0,TREATMENT,21308.0,25860.0,1841037060.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,157.0,157,,,,Y,157.0,157,Period 2,nan,D,2018-05-04T07:11 (8)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,17.0,TREATMENT,21308.0,34860.0,1841046060.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,151.0,151,,,,,157.0,157,Period 2,-6.0,D,2018-05-04T09:41 (8)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,18.0,END OF TREATMENT,21309.0,33660.0,1841131260.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,164.0,164,,,,,152.0,152,EOT/ET/Followup,12.0,D,2018-05-05T09:21 (9)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,19.0,SCREENING,21294.0,47558.0,1839849158.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,Y,94.0,94,EOT/ET/Followup,nan,NA,2018-04-20T13:12 (-7)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,20.0,TREATMENT,21301.0,25860.0,1840432260.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,95.0,95,,,,Y,95.0,95,Period 1,nan,E,2018-04-27T07:11 (1)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21.0,TREATMENT,21301.0,34860.0,1840441260.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,,95.0,95,Period 1,4.0,E,2018-04-27T09:41 (1)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,22.0,TREATMENT,21308.0,25860.0,1841037060.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,Y,97.0,97,Period 2,nan,D,2018-05-04T07:11 (8)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,23.0,TREATMENT,21308.0,34860.0,1841046060.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,96.0,96,,,,,97.0,97,Period 2,-1.0,D,2018-05-04T09:41 (8)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,24.0,END OF TREATMENT,21309.0,33660.0,1841131260.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,79.0,79,,,,,94.0,94,EOT/ET/Followup,-15.0,D,2018-05-05T09:21 (9)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,25.0,SCREENING,21294.0,47558.0,1839849158.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,428.0,428,,,,Y,428.0,428,EOT/ET/Followup,nan,NA,2018-04-20T13:12 (-7)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,26.0,TREATMENT,21301.0,25860.0,1840432260.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,444.0,444,,,,Y,444.0,444,Period 1,nan,E,2018-04-27T07:11 (1)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,27.0,TREATMENT,21301.0,34860.0,1840441260.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,439.0,439,,,,,444.0,444,Period 1,-5.0,E,2018-04-27T09:41 (1)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,28.0,TREATMENT,21308.0,25860.0,1841037060.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,425.0,425,,,,Y,425.0,425,Period 2,nan,D,2018-05-04T07:11 (8)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,29.0,TREATMENT,21308.0,34860.0,1841046060.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,411.0,411,,,,,425.0,425,Period 2,-14.0,D,2018-05-04T09:41 (8)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,30.0,END OF TREATMENT,21309.0,33660.0,1841131260.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,435.0,435,,,,,428.0,428,EOT/ET/Followup,7.0,D,2018-05-05T09:21 (9)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,31.0,SCREENING,21294.0,47558.0,1839849158.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,413.0,413,,,,Y,413.0,413,EOT/ET/Followup,nan,NA,2018-04-20T13:12 (-7)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,32.0,TREATMENT,21301.0,25860.0,1840432260.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,426.0,426,,,,Y,426.0,426,Period 1,nan,E,2018-04-27T07:11 (1)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,33.0,TREATMENT,21301.0,34860.0,1840441260.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,409.0,409,,,,,426.0,426,Period 1,-17.0,E,2018-04-27T09:41 (1)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,34.0,TREATMENT,21308.0,25860.0,1841037060.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,422.0,422,,,,Y,422.0,422,Period 2,nan,D,2018-05-04T07:11 (8)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,35.0,TREATMENT,21308.0,34860.0,1841046060.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,419.0,419,,,,,422.0,422,Period 2,-3.0,D,2018-05-04T09:41 (8)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,36.0,END OF TREATMENT,21309.0,33660.0,1841131260.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,430.0,430,,,,,413.0,413,EOT/ET/Followup,17.0,D,2018-05-05T09:21 (9)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,37.0,SCREENING,21294.0,47558.0,1839849158.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,418.0,418,,,,Y,418.0,418,EOT/ET/Followup,nan,NA,2018-04-20T13:12 (-7)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,38.0,TREATMENT,21301.0,25860.0,1840432260.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,431.0,431,,,,Y,431.0,431,Period 1,nan,E,2018-04-27T07:11 (1)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,39.0,TREATMENT,21301.0,34860.0,1840441260.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,418.0,418,,,,,431.0,431,Period 1,-13.0,E,2018-04-27T09:41 (1)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,40.0,TREATMENT,21308.0,25860.0,1841037060.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,423.0,423,,,,Y,423.0,423,Period 2,nan,D,2018-05-04T07:11 (8)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,41.0,TREATMENT,21308.0,34860.0,1841046060.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,416.0,416,,,,,423.0,423,Period 2,-7.0,D,2018-05-04T09:41 (8)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,42.0,END OF TREATMENT,21309.0,33660.0,1841131260.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,432.0,432,,,,,418.0,418,EOT/ET/Followup,14.0,D,2018-05-05T09:21 (9)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,43.0,SCREENING,21294.0,47558.0,1839849158.0,-7.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,1071.0,1071,,,,Y,1071.0,1071,EOT/ET/Followup,nan,NA,2018-04-20T13:12 (-7)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,44.0,TREATMENT,21301.0,25860.0,1840432260.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1086.0,1086,,,,Y,1086.0,1086,Period 1,nan,E,2018-04-27T07:11 (1)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,45.0,TREATMENT,21301.0,34860.0,1840441260.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1152.0,1152,,,,,1086.0,1086,Period 1,66.0,E,2018-04-27T09:41 (1)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,46.0,TREATMENT,21308.0,25860.0,1841037060.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1013.0,1013,,,,Y,1013.0,1013,Period 2,nan,D,2018-05-04T07:11 (8)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,47.0,TREATMENT,21308.0,34860.0,1841046060.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,961.0,961,,,,,1013.0,1013,Period 2,-52.0,D,2018-05-04T09:41 (8)
3110-103-002,3110-103-002.103001340,103001340,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,48.0,END OF TREATMENT,21309.0,33660.0,1841131260.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1019.0,1019,,,,,1071.0,1071,EOT/ET/Followup,-52.0,D,2018-05-05T09:21 (9)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21297.0,55391.0,1840116191.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,71.0,71,,,,Y,71.0,71,EOT/ET/Followup,nan,NA,2018-04-23T15:23 (-4)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,2.0,TREATMENT,21301.0,25260.0,1840431660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,70.0,70,,,,Y,70.0,70,Period 1,nan,E,2018-04-27T07:01 (1)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,3.0,TREATMENT,21301.0,34260.0,1840440660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,66.0,66,,,,,70.0,70,Period 1,-4.0,E,2018-04-27T09:31 (1)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,4.0,TREATMENT,21308.0,25260.0,1841036460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,62.0,62,,,,Y,62.0,62,Period 2,nan,D,2018-05-04T07:01 (8)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,5.0,TREATMENT,21308.0,34260.0,1841045460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,72.0,72,,,,,62.0,62,Period 2,10.0,D,2018-05-04T09:31 (8)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,6.0,END OF TREATMENT,21309.0,33060.0,1841130660.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,68.0,68,,,,,71.0,71,EOT/ET/Followup,-3.0,D,2018-05-05T09:11 (9)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,7.0,SCREENING,21297.0,55391.0,1840116191.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-04-23T15:23 (-4)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,8.0,TREATMENT,21301.0,25260.0,1840431660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,E,2018-04-27T07:01 (1)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,9.0,TREATMENT,21301.0,34260.0,1840440660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,E,2018-04-27T09:31 (1)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,10.0,TREATMENT,21308.0,25260.0,1841036460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,D,2018-05-04T07:01 (8)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,11.0,TREATMENT,21308.0,34260.0,1841045460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,D,2018-05-04T09:31 (8)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,12.0,END OF TREATMENT,21309.0,33060.0,1841130660.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,D,2018-05-05T09:11 (9)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,13.0,SCREENING,21297.0,55391.0,1840116191.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,149.0,149,,,,Y,149.0,149,EOT/ET/Followup,nan,NA,2018-04-23T15:23 (-4)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,14.0,TREATMENT,21301.0,25260.0,1840431660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,157.0,157,,,,Y,157.0,157,Period 1,nan,E,2018-04-27T07:01 (1)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,15.0,TREATMENT,21301.0,34260.0,1840440660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,153.0,153,,,,,157.0,157,Period 1,-4.0,E,2018-04-27T09:31 (1)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,16.0,TREATMENT,21308.0,25260.0,1841036460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,163.0,163,,,,Y,163.0,163,Period 2,nan,D,2018-05-04T07:01 (8)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,17.0,TREATMENT,21308.0,34260.0,1841045460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,162.0,162,,,,,163.0,163,Period 2,-1.0,D,2018-05-04T09:31 (8)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,18.0,END OF TREATMENT,21309.0,33060.0,1841130660.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,147.0,147,,,,,149.0,149,EOT/ET/Followup,-2.0,D,2018-05-05T09:11 (9)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,19.0,SCREENING,21297.0,55391.0,1840116191.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,Y,94.0,94,EOT/ET/Followup,nan,NA,2018-04-23T15:23 (-4)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,20.0,TREATMENT,21301.0,25260.0,1840431660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,Y,98.0,98,Period 1,nan,E,2018-04-27T07:01 (1)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,21.0,TREATMENT,21301.0,34260.0,1840440660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,97.0,97,,,,,98.0,98,Period 1,-1.0,E,2018-04-27T09:31 (1)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,22.0,TREATMENT,21308.0,25260.0,1841036460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,93.0,93,,,,Y,93.0,93,Period 2,nan,D,2018-05-04T07:01 (8)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,23.0,TREATMENT,21308.0,34260.0,1841045460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,95.0,95,,,,,93.0,93,Period 2,2.0,D,2018-05-04T09:31 (8)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,24.0,END OF TREATMENT,21309.0,33060.0,1841130660.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,93.0,93,,,,,94.0,94,EOT/ET/Followup,-1.0,D,2018-05-05T09:11 (9)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,25.0,SCREENING,21297.0,55391.0,1840116191.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,384.0,384,,,,Y,384.0,384,EOT/ET/Followup,nan,NA,2018-04-23T15:23 (-4)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,26.0,TREATMENT,21301.0,25260.0,1840431660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,393.0,393,,,,Y,393.0,393,Period 1,nan,E,2018-04-27T07:01 (1)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,27.0,TREATMENT,21301.0,34260.0,1840440660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,390.0,390,,,,,393.0,393,Period 1,-3.0,E,2018-04-27T09:31 (1)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,28.0,TREATMENT,21308.0,25260.0,1841036460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,410.0,410,,,,Y,410.0,410,Period 2,nan,D,2018-05-04T07:01 (8)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,29.0,TREATMENT,21308.0,34260.0,1841045460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,386.0,386,,,,,410.0,410,Period 2,-24.0,D,2018-05-04T09:31 (8)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,30.0,END OF TREATMENT,21309.0,33060.0,1841130660.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,395.0,395,,,,,384.0,384,EOT/ET/Followup,11.0,D,2018-05-05T09:11 (9)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,31.0,SCREENING,21297.0,55391.0,1840116191.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,419.0,419,,,,Y,419.0,419,EOT/ET/Followup,nan,NA,2018-04-23T15:23 (-4)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,32.0,TREATMENT,21301.0,25260.0,1840431660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,425.0,425,,,,Y,425.0,425,Period 1,nan,E,2018-04-27T07:01 (1)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,33.0,TREATMENT,21301.0,34260.0,1840440660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,411.0,411,,,,,425.0,425,Period 1,-14.0,E,2018-04-27T09:31 (1)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,34.0,TREATMENT,21308.0,25260.0,1841036460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,418.0,418,,,,Y,418.0,418,Period 2,nan,D,2018-05-04T07:01 (8)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,35.0,TREATMENT,21308.0,34260.0,1841045460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,424.0,424,,,,,418.0,418,Period 2,6.0,D,2018-05-04T09:31 (8)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,36.0,END OF TREATMENT,21309.0,33060.0,1841130660.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,421.0,421,,,,,419.0,419,EOT/ET/Followup,2.0,D,2018-05-05T09:11 (9)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,37.0,SCREENING,21297.0,55391.0,1840116191.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,407.0,407,,,,Y,407.0,407,EOT/ET/Followup,nan,NA,2018-04-23T15:23 (-4)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,38.0,TREATMENT,21301.0,25260.0,1840431660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,414.0,414,,,,Y,414.0,414,Period 1,nan,E,2018-04-27T07:01 (1)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,39.0,TREATMENT,21301.0,34260.0,1840440660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,404.0,404,,,,,414.0,414,Period 1,-10.0,E,2018-04-27T09:31 (1)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,40.0,TREATMENT,21308.0,25260.0,1841036460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,415.0,415,,,,Y,415.0,415,Period 2,nan,D,2018-05-04T07:01 (8)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,41.0,TREATMENT,21308.0,34260.0,1841045460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,411.0,411,,,,,415.0,415,Period 2,-4.0,D,2018-05-04T09:31 (8)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,42.0,END OF TREATMENT,21309.0,33060.0,1841130660.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,412.0,412,,,,,407.0,407,EOT/ET/Followup,5.0,D,2018-05-05T09:11 (9)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,,nan,,nan,43.0,SCREENING,21297.0,55391.0,1840116191.0,-4.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,836.0,836,,,,Y,836.0,836,EOT/ET/Followup,nan,NA,2018-04-23T15:23 (-4)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,44.0,TREATMENT,21301.0,25260.0,1840431660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,852.0,852,,,,Y,852.0,852,Period 1,nan,E,2018-04-27T07:01 (1)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,45.0,TREATMENT,21301.0,34260.0,1840440660.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,899.0,899,,,,,852.0,852,Period 1,47.0,E,2018-04-27T09:31 (1)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,46.0,TREATMENT,21308.0,25260.0,1841036460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,959.0,959,,,,Y,959.0,959,Period 2,nan,D,2018-05-04T07:01 (8)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,47.0,TREATMENT,21308.0,34260.0,1841045460.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,827.0,827,,,,,959.0,959,Period 2,-132.0,D,2018-05-04T09:31 (8)
3110-103-002,3110-103-002.103001349,103001349,001,Y,1.0,2: ED,8.0,2: ED,8.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,48.0,END OF TREATMENT,21309.0,33060.0,1841130660.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,877.0,877,,,,,836.0,836,EOT/ET/Followup,41.0,D,2018-05-05T09:11 (9)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21298.0,45603.0,1840192803.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,65.0,65,,,,Y,65.0,65,EOT/ET/Followup,nan,NA,2018-04-24T12:40 (-3)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,2.0,TREATMENT,21301.0,25980.0,1840432380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,60.0,60,,,,Y,60.0,60,Period 1,nan,D,2018-04-27T07:13 (1)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,3.0,TREATMENT,21301.0,34980.0,1840441380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,68.0,68,,,,,60.0,60,Period 1,8.0,D,2018-04-27T09:43 (1)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,4.0,TREATMENT,21308.0,25980.0,1841037180.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,82.0,82,,,,Y,82.0,82,Period 2,nan,E,2018-05-04T07:13 (8)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,5.0,TREATMENT,21308.0,34980.0,1841046180.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,77.0,77,,,,,82.0,82,Period 2,-5.0,E,2018-05-04T09:43 (8)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,6.0,END OF TREATMENT,21309.0,33780.0,1841131380.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,57.0,57,,,,,65.0,65,EOT/ET/Followup,-8.0,E,2018-05-05T09:23 (9)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,7.0,SCREENING,21298.0,45603.0,1840192803.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,EOT/ET/Followup,nan,NA,2018-04-24T12:40 (-3)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,8.0,TREATMENT,21301.0,25980.0,1840432380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 1,nan,D,2018-04-27T07:13 (1)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,9.0,TREATMENT,21301.0,34980.0,1840441380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 1,nan,D,2018-04-27T09:43 (1)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,10.0,TREATMENT,21308.0,25980.0,1841037180.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,Y,nan,Normal,Period 2,nan,E,2018-05-04T07:13 (8)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,11.0,TREATMENT,21308.0,34980.0,1841046180.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,Period 2,nan,E,2018-05-04T09:43 (8)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,12.0,END OF TREATMENT,21309.0,33780.0,1841131380.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,NORMAL SINUS RHYTHM;NORMAL ECG,,nan,Normal,EOT/ET/Followup,nan,E,2018-05-05T09:23 (9)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,13.0,SCREENING,21298.0,45603.0,1840192803.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,168.0,168,,,,Y,168.0,168,EOT/ET/Followup,nan,NA,2018-04-24T12:40 (-3)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,14.0,TREATMENT,21301.0,25980.0,1840432380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,172.0,172,,,,Y,172.0,172,Period 1,nan,D,2018-04-27T07:13 (1)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,15.0,TREATMENT,21301.0,34980.0,1840441380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,172.0,172,,,,,172.0,172,Period 1,0.0,D,2018-04-27T09:43 (1)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,16.0,TREATMENT,21308.0,25980.0,1841037180.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,159.0,159,,,,Y,159.0,159,Period 2,nan,E,2018-05-04T07:13 (8)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,17.0,TREATMENT,21308.0,34980.0,1841046180.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,160.0,160,,,,,159.0,159,Period 2,1.0,E,2018-05-04T09:43 (8)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,18.0,END OF TREATMENT,21309.0,33780.0,1841131380.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,167.0,167,,,,,168.0,168,EOT/ET/Followup,-1.0,E,2018-05-05T09:23 (9)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,19.0,SCREENING,21298.0,45603.0,1840192803.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,91.0,91,,,,Y,91.0,91,EOT/ET/Followup,nan,NA,2018-04-24T12:40 (-3)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,20.0,TREATMENT,21301.0,25980.0,1840432380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,91.0,91,,,,Y,91.0,91,Period 1,nan,D,2018-04-27T07:13 (1)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21.0,TREATMENT,21301.0,34980.0,1840441380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,92.0,92,,,,,91.0,91,Period 1,1.0,D,2018-04-27T09:43 (1)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,22.0,TREATMENT,21308.0,25980.0,1841037180.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,92.0,92,,,,Y,92.0,92,Period 2,nan,E,2018-05-04T07:13 (8)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,23.0,TREATMENT,21308.0,34980.0,1841046180.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,94.0,94,,,,,92.0,92,Period 2,2.0,E,2018-05-04T09:43 (8)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,24.0,END OF TREATMENT,21309.0,33780.0,1841131380.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,91.0,91,,,,,91.0,91,EOT/ET/Followup,0.0,E,2018-05-05T09:23 (9)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,25.0,SCREENING,21298.0,45603.0,1840192803.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,385.0,385,,,,Y,385.0,385,EOT/ET/Followup,nan,NA,2018-04-24T12:40 (-3)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,26.0,TREATMENT,21301.0,25980.0,1840432380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,400.0,400,,,,Y,400.0,400,Period 1,nan,D,2018-04-27T07:13 (1)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,27.0,TREATMENT,21301.0,34980.0,1840441380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,387.0,387,,,,,400.0,400,Period 1,-13.0,D,2018-04-27T09:43 (1)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,28.0,TREATMENT,21308.0,25980.0,1841037180.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,342.0,342,,,,Y,342.0,342,Period 2,nan,E,2018-05-04T07:13 (8)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,29.0,TREATMENT,21308.0,34980.0,1841046180.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,359.0,359,,,,,342.0,342,Period 2,17.0,E,2018-05-04T09:43 (8)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,30.0,END OF TREATMENT,21309.0,33780.0,1841131380.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,400.0,400,,,,,385.0,385,EOT/ET/Followup,15.0,E,2018-05-05T09:23 (9)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,31.0,SCREENING,21298.0,45603.0,1840192803.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,401.0,401,,,,Y,401.0,401,EOT/ET/Followup,nan,NA,2018-04-24T12:40 (-3)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,32.0,TREATMENT,21301.0,25980.0,1840432380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,402.0,402,,,,Y,402.0,402,Period 1,nan,D,2018-04-27T07:13 (1)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,33.0,TREATMENT,21301.0,34980.0,1840441380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,414.0,414,,,,,402.0,402,Period 1,12.0,D,2018-04-27T09:43 (1)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,34.0,TREATMENT,21308.0,25980.0,1841037180.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,402.0,402,,,,Y,402.0,402,Period 2,nan,E,2018-05-04T07:13 (8)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,35.0,TREATMENT,21308.0,34980.0,1841046180.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,407.0,407,,,,,402.0,402,Period 2,5.0,E,2018-05-04T09:43 (8)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,36.0,END OF TREATMENT,21309.0,33780.0,1841131380.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,390.0,390,,,,,401.0,401,EOT/ET/Followup,-11.0,E,2018-05-05T09:23 (9)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,37.0,SCREENING,21298.0,45603.0,1840192803.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,396.0,396,,,,Y,396.0,396,EOT/ET/Followup,nan,NA,2018-04-24T12:40 (-3)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,38.0,TREATMENT,21301.0,25980.0,1840432380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,401.0,401,,,,Y,401.0,401,Period 1,nan,D,2018-04-27T07:13 (1)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,39.0,TREATMENT,21301.0,34980.0,1840441380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,405.0,405,,,,,401.0,401,Period 1,4.0,D,2018-04-27T09:43 (1)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,40.0,TREATMENT,21308.0,25980.0,1841037180.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,381.0,381,,,,Y,381.0,381,Period 2,nan,E,2018-05-04T07:13 (8)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,41.0,TREATMENT,21308.0,34980.0,1841046180.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,390.0,390,,,,,381.0,381,Period 2,9.0,E,2018-05-04T09:43 (8)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,42.0,END OF TREATMENT,21309.0,33780.0,1841131380.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,393.0,393,,,,,396.0,396,EOT/ET/Followup,-3.0,E,2018-05-05T09:23 (9)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,43.0,SCREENING,21298.0,45603.0,1840192803.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,918.0,918,,,,Y,918.0,918,EOT/ET/Followup,nan,NA,2018-04-24T12:40 (-3)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,44.0,TREATMENT,21301.0,25980.0,1840432380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,989.0,989,,,,Y,989.0,989,Period 1,nan,D,2018-04-27T07:13 (1)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,45.0,TREATMENT,21301.0,34980.0,1840441380.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,871.0,871,,,,,989.0,989,Period 1,-118.0,D,2018-04-27T09:43 (1)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,46.0,TREATMENT,21308.0,25980.0,1841037180.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,723.0,723,,,,Y,723.0,723,Period 2,nan,E,2018-05-04T07:13 (8)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,47.0,TREATMENT,21308.0,34980.0,1841046180.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,775.0,775,,,,,723.0,723,Period 2,52.0,E,2018-05-04T09:43 (8)
3110-103-002,3110-103-002.103001354,103001354,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,48.0,END OF TREATMENT,21309.0,33780.0,1841131380.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1049.0,1049,,,,,918.0,918,EOT/ET/Followup,131.0,E,2018-05-05T09:23 (9)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,1.0,SCREENING,21298.0,51092.0,1840198292.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,44.0,44,,,,Y,44.0,44,EOT/ET/Followup,nan,NA,2018-04-24T14:11 (-3)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,2.0,TREATMENT,21301.0,25380.0,1840431780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,44.0,44,,,,Y,44.0,44,Period 1,nan,D,2018-04-27T07:03 (1)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,3.0,TREATMENT,21301.0,34380.0,1840440780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,47.0,47,,,,,44.0,44,Period 1,3.0,D,2018-04-27T09:33 (1)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,4.0,TREATMENT,21308.0,25380.0,1841036580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,46.0,46,,,,Y,46.0,46,Period 2,nan,E,2018-05-04T07:03 (8)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,5.0,TREATMENT,21308.0,34380.0,1841045580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,43.0,43,,,,,46.0,46,Period 2,-3.0,E,2018-05-04T09:33 (8)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,6.0,END OF TREATMENT,21309.0,33180.0,1841130780.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,ECG Mean Heart Rate (beats/min),EGHRMN,Safety ECG,44.0,44,,,,,44.0,44,EOT/ET/Followup,0.0,E,2018-05-05T09:13 (9)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,7.0,SCREENING,21298.0,51092.0,1840198292.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,Interpretation,INTP,Safety ECG,nan,Abnormal, NCS,,,SINUS BRADYCARDIA,Y,nan,Abnormal, NCS,EOT/ET/Followup,nan,NA,2018-04-24T14:11 (-3)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,8.0,TREATMENT,21301.0,25380.0,1840431780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Abnormal, NCS,,,SINUS BRADYCARDIA,Y,nan,Abnormal, NCS,Period 1,nan,D,2018-04-27T07:03 (1)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,9.0,TREATMENT,21301.0,34380.0,1840440780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,,nan,Abnormal, NCS,Period 1,nan,D,2018-04-27T09:33 (1)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,10.0,TREATMENT,21308.0,25380.0,1841036580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Normal,,,SINUS BRADYCARDIA;NORMAL ECG,Y,nan,Normal,Period 2,nan,E,2018-05-04T07:03 (8)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,11.0,TREATMENT,21308.0,34380.0,1841045580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Abnormal, NCS,,,SINUS BRADYCARDIA,,nan,Normal,Period 2,nan,E,2018-05-04T09:33 (8)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,12.0,END OF TREATMENT,21309.0,33180.0,1841130780.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,Interpretation,INTP,Safety ECG,nan,Abnormal, NCS,,,SINUS BRADYCARDIA,,nan,Abnormal, NCS,EOT/ET/Followup,nan,E,2018-05-05T09:13 (9)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,13.0,SCREENING,21298.0,51092.0,1840198292.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,PR Interval, Aggregate (msec),PRAG,Safety ECG,186.0,186,,,,Y,186.0,186,EOT/ET/Followup,nan,NA,2018-04-24T14:11 (-3)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,14.0,TREATMENT,21301.0,25380.0,1840431780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,168.0,168,,,,Y,168.0,168,Period 1,nan,D,2018-04-27T07:03 (1)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,15.0,TREATMENT,21301.0,34380.0,1840440780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,PR Interval, Aggregate (msec),PRAG,Safety ECG,172.0,172,,,,,168.0,168,Period 1,4.0,D,2018-04-27T09:33 (1)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,16.0,TREATMENT,21308.0,25380.0,1841036580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,183.0,183,,,,Y,183.0,183,Period 2,nan,E,2018-05-04T07:03 (8)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,17.0,TREATMENT,21308.0,34380.0,1841045580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,181.0,181,,,,,183.0,183,Period 2,-2.0,E,2018-05-04T09:33 (8)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,18.0,END OF TREATMENT,21309.0,33180.0,1841130780.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,PR Interval, Aggregate (msec),PRAG,Safety ECG,173.0,173,,,,,186.0,186,EOT/ET/Followup,-13.0,E,2018-05-05T09:13 (9)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,19.0,SCREENING,21298.0,51092.0,1840198292.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,Y,99.0,99,EOT/ET/Followup,nan,NA,2018-04-24T14:11 (-3)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,20.0,TREATMENT,21301.0,25380.0,1840431780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,101.0,101,,,,Y,101.0,101,Period 1,nan,D,2018-04-27T07:03 (1)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,21.0,TREATMENT,21301.0,34380.0,1840440780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,107.0,107,,,,,101.0,101,Period 1,6.0,D,2018-04-27T09:33 (1)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,22.0,TREATMENT,21308.0,25380.0,1841036580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,Y,99.0,99,Period 2,nan,E,2018-05-04T07:03 (8)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,23.0,TREATMENT,21308.0,34380.0,1841045580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,99.0,99,,,,,99.0,99,Period 2,0.0,E,2018-05-04T09:33 (8)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,24.0,END OF TREATMENT,21309.0,33180.0,1841130780.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QRS Duration, Aggregate (msec),QRSAG,Safety ECG,98.0,98,,,,,99.0,99,EOT/ET/Followup,-1.0,E,2018-05-05T09:13 (9)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,25.0,SCREENING,21298.0,51092.0,1840198292.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QT Interval, Aggregate (msec),QTAG,Safety ECG,449.0,449,,,,Y,449.0,449,EOT/ET/Followup,nan,NA,2018-04-24T14:11 (-3)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,26.0,TREATMENT,21301.0,25380.0,1840431780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,463.0,463,,,,Y,463.0,463,Period 1,nan,D,2018-04-27T07:03 (1)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,27.0,TREATMENT,21301.0,34380.0,1840440780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QT Interval, Aggregate (msec),QTAG,Safety ECG,450.0,450,,,,,463.0,463,Period 1,-13.0,D,2018-04-27T09:33 (1)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,28.0,TREATMENT,21308.0,25380.0,1841036580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,449.0,449,,,,Y,449.0,449,Period 2,nan,E,2018-05-04T07:03 (8)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,29.0,TREATMENT,21308.0,34380.0,1841045580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,449.0,449,,,,,449.0,449,Period 2,0.0,E,2018-05-04T09:33 (8)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,30.0,END OF TREATMENT,21309.0,33180.0,1841130780.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QT Interval, Aggregate (msec),QTAG,Safety ECG,441.0,441,,,,,449.0,449,EOT/ET/Followup,-8.0,E,2018-05-05T09:13 (9)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,31.0,SCREENING,21298.0,51092.0,1840198292.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,385.0,385,,,,Y,385.0,385,EOT/ET/Followup,nan,NA,2018-04-24T14:11 (-3)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,32.0,TREATMENT,21301.0,25380.0,1840431780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,399.0,399,,,,Y,399.0,399,Period 1,nan,D,2018-04-27T07:03 (1)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,33.0,TREATMENT,21301.0,34380.0,1840440780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,401.0,401,,,,,399.0,399,Period 1,2.0,D,2018-04-27T09:33 (1)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,34.0,TREATMENT,21308.0,25380.0,1841036580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,395.0,395,,,,Y,395.0,395,Period 2,nan,E,2018-05-04T07:03 (8)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,35.0,TREATMENT,21308.0,34380.0,1841045580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,382.0,382,,,,,395.0,395,Period 2,-13.0,E,2018-05-04T09:33 (8)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,36.0,END OF TREATMENT,21309.0,33180.0,1841130780.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcB Interval, Aggregate (msec),QTCBAG,Safety ECG,379.0,379,,,,,385.0,385,EOT/ET/Followup,-6.0,E,2018-05-05T09:13 (9)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,37.0,SCREENING,21298.0,51092.0,1840198292.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,405.0,405,,,,Y,405.0,405,EOT/ET/Followup,nan,NA,2018-04-24T14:11 (-3)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,38.0,TREATMENT,21301.0,25380.0,1840431780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,419.0,419,,,,Y,419.0,419,Period 1,nan,D,2018-04-27T07:03 (1)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,39.0,TREATMENT,21301.0,34380.0,1840440780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,417.0,417,,,,,419.0,419,Period 1,-2.0,D,2018-04-27T09:33 (1)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,40.0,TREATMENT,21308.0,25380.0,1841036580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,412.0,412,,,,Y,412.0,412,Period 2,nan,E,2018-05-04T07:03 (8)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,41.0,TREATMENT,21308.0,34380.0,1841045580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,403.0,403,,,,,412.0,412,Period 2,-9.0,E,2018-05-04T09:33 (8)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,42.0,END OF TREATMENT,21309.0,33180.0,1841130780.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,QTcF Interval, Aggregate (msec),QTCFAG,Safety ECG,399.0,399,,,,,405.0,405,EOT/ET/Followup,-6.0,E,2018-05-05T09:13 (9)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,,nan,,nan,43.0,SCREENING,21298.0,51092.0,1840198292.0,-3.0,Day -14 to -1,-2.0,Day -14 to -1,,nan,nan,,RR Interval, Aggregate (msec),RRAG,Safety ECG,1354.0,1354,,,,Y,1354.0,1354,EOT/ET/Followup,nan,NA,2018-04-24T14:11 (-3)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,44.0,TREATMENT,21301.0,25380.0,1840431780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (Predose),Predose,0.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1342.0,1342,,,,Y,1342.0,1342,Period 1,nan,D,2018-04-27T07:03 (1)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,Fed TBM Ubrogepant 1 x 100 mg (Test 3),4.0,45.0,TREATMENT,21301.0,34380.0,1840440780.0,1.0,Period 1 Day 1,1.0,Period 1 Day 1 (2 h),2 h,2.0,1.0,Period 1,RR Interval, Aggregate (msec),RRAG,Safety ECG,1255.0,1255,,,,,1342.0,1342,Period 1,-87.0,D,2018-04-27T09:33 (1)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,46.0,TREATMENT,21308.0,25380.0,1841036580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (Predose),Predose,0.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1292.0,1292,,,,Y,1292.0,1292,Period 2,nan,E,2018-05-04T07:03 (8)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,47.0,TREATMENT,21308.0,34380.0,1841045580.0,8.0,Period 2 Day 8,8.0,Period 2 Day 8 (2 h),2 h,2.0,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1381.0,1381,,,,,1292.0,1292,Period 2,89.0,E,2018-05-04T09:33 (8)
3110-103-002,3110-103-002.103001358,103001358,001,Y,1.0,1: DE,7.0,1: DE,7.0,Part B,2.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,Fasted TBM Ubrogepant 1 x 100 mg (Reference 2),5.0,48.0,END OF TREATMENT,21309.0,33180.0,1841130780.0,9.0,EOT/ET,99.0,End of Treatment,,nan,2.0,Period 2,RR Interval, Aggregate (msec),RRAG,Safety ECG,1348.0,1348,,,,,1354.0,1354,EOT/ET/Followup,-6.0,E,2018-05-05T09:13 (9)
